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Abstract
The work disclosed in this dissertation outlines novel reactions involving indoles and their
applications towards the total synthesis of natural products, tronocarpine and dippinine B.
Showcased in Chapter 2 is a novel mode of activation for donor-acceptor cyclopropanes via
an external hydrogen bond. The hydrogen bond increases the cyclopropane’s electrophilicity
permitting indole nucleophiles to open the ring. The result is 3-postion functionalized
indoles.
An external hydrogen-bond donor, HFIP (1,1,1,3,3,3-hexafluoroisopropanol), is used as a
solvent to provide the medium necessary for favourable hydrogen-bond interaction with
donor-acceptor cyclopropanes. Hydrogen bond activation of donor-acceptor cyclopropanes
was successful in generating a multitude of functional indole products in high yields.
Chapter 3 outlines the application of single electron transfer agent, Mn(OAc)3, to isolate 1,2annulated indoles in a one-pot procedure. The products generated in this novel methodology
create molecular scaffolding that maps nicely onto natural products tronocarpine and
dippinine B. The methodology accesses a variety of 1,2-substituted indoles that tolerated all
substituents tested.
Chapter 4 explores the progress towards realizing the synthesis of the molecules
tronocarpine, and dippinine B. These natural products are desired for their anti-microbial and
anti-fungal properties. Paired with their challenging framework, this makes them intriguing
targets for synthetic chemists. The focal point of the synthetic pathways in this chapter
involves the Mn(OAc)3 radical methodology disclosed in Chapter 3.
Lastly, Chapter 5 reports a thermo-controlled, diastereoselective opening of oxime-ether
tethered donor-acceptor cyclopropanes to generate bicyclic oxazines. The N-O heterocyclic
products can be reductively cleaved to access substituted pyrrolidines with set
stereochemistry from the controlled opening of the cyclopropane. This work reports high
yields and diastereo-control generating cis/trans selective annulated products. Substituted
pyrrolidines are highly sought for pharmaceuticals and natural product synthesis.
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Summary for Lay Audience
Important as a component of many pharmaceuticals, indole is a biological molecule found
throughout the natural world. These pharmaceuticals are important components of treatments
for cancer, depression, Alzheimer’s disease, viral infection, hypertension, and more.
Chemists strive to develop modifications of indole molecules in search of easier, cheaper
routes to both established, and novel pharmaceutical products. The research in this thesis
outlines two new methods for the synthesis of further functionalized indole products. Method
one involves radicals to cyclize an additional ring to an indole precursor. The products
produced map onto the structure of important natural products found in Malaysian plant
Tabernaemontana corymbosa. Method two functionalizes indoles by reacting them with
strained three-membered ring molecules called cyclopropanes. This method is the first
disclosed that does not require metals or high pressure as part of the reaction medium. Using
the new methods developed, work towards natural products that have antifungal and
antimalarial properties was under taken. The final component of this thesis develops a
strategy to isolate highly substituted five-membered rings that contain nitrogen; these
molecules are called pyrrolidines. The pyrrolidine structure is also highly desired in
pharmaceutical targets. To access pyrrolidines, again cyclopropanes are used, but under
specific reaction temperatures selective isomers of the pyrrolidine are isolated.
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Chapter 1
Introduction to the Reactivity and Functionalization of both
Indoles and Donor-Acceptor Cyclopropanes: Including their
Prevalence in Natural Products
This introduction will cover the general reactivity of indole and some of the chemistry
involved in its elaboration to more complex substrates. It will delve into the novel
transformations and functionalization of indoles using both, reactive donor-acceptor
cyclopropanes, and, single electron oxidants. It also will cover some of the vast uses for
donor-acceptor cyclopropanes due to their uniquely reactive behavior — and specifically
how they can impart functionality on indoles. Additionally, this introduction will describe
a selection of natural products that contain indole, and their importance as synthetic
targets for organic chemists. This will put in place the foundation for the works reported
in this dissertation.

1.1

Indole

1.1.1 Lord of the Rings: Indole. And Why We Should Care.
Benzo[b]pyrrole, trivially known as indole (Figure 1) is a heterocyclic, aromatic moiety
abundant throughout the natural world. Indole (1-1) was first discovered in 1866 from
studies pertaining to the dye indigo (1-2).1 It was these studies that involved both indigo
and oleum (fuming sulfuric acid) that lead to its common name, indole.

Indole
powder
Figure 1 - Chemical structures of indole and indigo and the physical appearance of
indole
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Commercially, indole is extracted from coal tar but is also synthesized industrially from
ethylene glycol (1-4) and aniline (1-3) (Scheme 1).2,3 Indole is a white solid (Figure 1),
with a distinctive and pungent smell, proven by its role accounting for some of the smell
in feces. However, in small concentrations indole smells pleasant, and finds commonness
in perfumes and fragrant flowers, such as orange blossoms.4 Indole is also found in other
aromatic flowers, such as jasmine, but even appears in the wood of some trees, like the
American black locust.

Scheme 1 - Synthesis of indole from aniline and ethylene glycol
Indole is found in both plants and animals. Indole is a decomposition product of the
amino acid tryptophan (1-10), a molecule discussed in more detail below. This means
indole is found wherever degradation of chemicals occurs in the body: the liver, the
pancreas, and the intestines. Eventually becoming a waste product, indole is excreted
with feces. 1
Indole is a component of tryptophan (1-10), one of the twenty amino acids vital to protein
formation in the body. Humans do not synthesize tryptophan, rather it must come from
protein in our diet. However, many plants and microorganisms synthesize their own
tryptophan from shikimic acid or anthranilate (1-5) (Scheme 2).5 This synthesis occurs
by alkylating indole with serine (1-9) as demonstrated in Scheme 2. The synthetic
pathway is aided by enzymes such as tryptophan synthase to facilitate such complex
reactions.
The fact that we require tryptophan to survive is an initial indication of how significant
indole is to living things. Indole is a necessity to the biochemical pathways of many
living organisms; it aids in vital organ production within plants6, is an intercellular
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signaling molecule for spore formation in fungii7, and is a precursor to neurotransmitters
such as melatonin and serotonin in the human body.8

Scheme 2 - Indole involvement in the biosynthesis of tryptophan in some plants and
microorganisms
With their biological activity, indole-containing molecules have found desirable uses as
anticancer, antibacterial and antiviral agents.9 This means many pharmaceuticals contain
the indole heterocycle and are currently used as drugs that target disease found all over
the body, covering a wide range of illnesses (Figure 2). From cancer to Alzheimer’s
disease, Figure 2 showcases a number of indole-containing pharmaceuticals and their
prescribed ailment.10,11 Perhaps the most famous of this class, thanks to its not-so-subtle
commercials, is Tadalafil better known as Cialis (Figure 3), a drug used for the treatment
of erectile dysfunction. Tadalafil is known as Adcirca, when it is being used to treat
pulmonary hypertension.12
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Figure 2 – Indole-containing drugs and their effects on the body

Figure 3 – Indole-containing drugs. Dragmacidin D is derived from sea sponge
Spongosorites. Zolmitripan and Sumatripan are used to treat migraines.13 Tadalafil
is a PDE5 inhibitor.
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Another important indole-containing drug is the natural product (-)-reserpine (Figure 4).
(-)-Resperine is used as an antihypertensive and an antipsychotic. (-)-Reserpine was first
isolated in 1952 from snake root, Rauvolfia serpentina.14 (-)-Reserpine has long been a
target for synthetic chemists because of its pharmaceutical use. Its first synthesis,
completed by Woodward et al., dates to just a few years after its published isolation.15
With 10 complete total syntheses to date, (-)-reserpine exemplifies the importance of
natural product synthesis to the chemical community.16 Scientific improvement of bond
connections is important for future access to target molecules, and to define better,
stream-lined routes to these targets. We must continue to research improvements
connecting chemical components to ensure useful compounds are easily attainable.
Whether it be for a pharmaceutical, a material, maybe even a fuel source, until we can
make anything imaginable without struggle, the work of organic chemists is not done.

Figure 4 - (-)-reserpine, a natural product and drug that has long entertained
organic chemists
A recent article published in Chemistry World compiled the wish-list of what medicinal
chemists are seeking:
“1.

Fluorination – Exchanging specific hydrogen for fluorine.

2. Heteroatom alkylation – A reaction that selectively attaches an alkyl group onto
one heteroatom in molecules that have several.
3. Carbon coupling – Stitching together aliphatic carbon atoms: ideally with chiral
control.
4. Making and modifying heterocycles – Reactions to install functional groups
anywhere on aromatic and aliphatic heterocycles.
5. Atom swapping – A reaction that can exchange individual atoms selectively.” 17
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While some of these transformations would absolutely warrant a Nobel prize, I draw your
attention to wish-list item 4 – Making and modifying heterocycles. Returning to the
molecule (-)-reserpine (Figure 4), the indole component is highlighted in red, and we can
see that there is functionality stemming from the 2-position, the 3-position and the 6position of the indole. This example falls heavily into the category of functionalizing
heterocycles.
Chemists have worked hard to design efficient reactions to install bonds off all positions
of the indole heterocycle. Ultimately, we must continue to find the best ways to generate
valuable molecules like the natural products and drugs mentioned in this section. Being
able to manipulate indole with desired components off any section of the heterocycle is
something chemists are striving for. A multitude of drugs, dyes and materials have come
into fruition because of indole, and it is for this reason chemists continue to be fascinated
by improving the chemistry surrounding indole functionalization. To understand how we
may alter indole, an understanding of its reactive nature is required.

1.1.2

General Reactivity of Indole

Indole contains 10 π electrons over 9 atoms, making it an electron-rich molecule capable
of many chemical transformations (Figure 5).

Figure 5 - (left) IUPAC counting of the atom positions around indole, and (right) the
10 π electrons of indole over 9 atoms
Indole is most nucleophilic at the 3-position (Scheme 3, A). Significant research in the
1960’s studied how indole reacted by monitoring its protonation and calculating the
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relative ratios of products formed. Those ratios now correlate well to electron density
maps of indole that help us to explain how indole reacts.18 The initial studies on the
protonation of indole found that the principle conjugate acid of indole is the 3-postion
protonated product (Scheme 3, A).19 Further deuterium exchange experiments
highlighted that proton exchange occurs most prominently at the 1 and 3 positions of
indole, but cases absolutely exist where protonation at the 2 position is also possible.
Protonation of the 2-position is competitive with that of the 3-positon; if the 3-position of
indole is substituted, the 2-position will become the most nucleophilic site (Scheme 3,
B). These studies highlight how indole act as a nucleophile most often at position 3, and
this is what we observe experimentally when indoles are in the presence of an appropriate
electrophile.

Scheme 3 - (A) Resonance structure of indole describing the observed
nucleophilicity at position 3 (B) Nucleophilicity at position 2 of indole when position
3 contains substitution other than H
For example, when an indole is used as the nucleophile in the common Vilsmeier-Haack
reaction (Scheme 4), the resulting product is an aldehyde at position 3 (1-14).20
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Scheme 4 - Vilsmeier-Haack reaction of indole, showcasing nucleophilic position 3
Of course, in chemistry most rules are not law. For example (Scheme 5), using gold
catalysis to synthesize indoles from azides (1-15) results in a metal-bound intermediate
(1-18) achieving umpolung reactivity of indole. The indole substrates in this example act
as electrophiles at the 3-position, versus the nucleophilicity typically seen.21

Scheme 5 - Umpolung reactivity of indole where the 3-position acts as an
electrophile
Substituents around indole also affect the molecule’s reactivity. Computational chemistry
has been used to generate electron density maps of a multitude of substituted indole
molecules. An inclusive study of the electron density of methyl-, fluoro-, nitro-, and
amino- substituted indoles confirmed how the inductive, and mesomeric effects of these
groups change the nucleophilic nature of indole.18 This computational study determined
electron donating groups (-CH3 and -NH2) on the 2 or 5 positions of indole greatly
improve the nucleophilicity of position three by 29 - 88 kJmol-1 . However, when the two
or five position of indole is substituted with -F or -NO2, the proton affinity of position 3
drops between -6.3 and -86.1 kJmol-1. The reasoning for this is further confirmed and
explained by the resonance structures of indole resulting from electron donating or
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withdrawing nature of these groups (Scheme 6). Looking at the electron density around
the aromatic indole, when it bears an EWG (1-19) a resonant positive charge is resultant
on position 3 (1-22). The result is a less nucleophilic carbon compared to its
unsubstituted or electron donating counterparts (1-24).

Scheme 6 - Varied nucleophilic properties of indole due to electron withdrawing or
donating substituents at position 5

Ultimately, indole is a versatile heterocycle capable of myriad chemical transformations.
Due to its reactive nature and its prevalence in the natural world, functionalization of the
indole moiety to produce high-value chemicals is well studied.

1.2 Functionalization of Indoles
Adding functional groups to indoles has been immensely studied over the last ~100 years.
So much so, that this section would be hundreds of pages long if it hoped to be inclusive
of all the impressive chemistry in the field. For example, reviews regarding indoles exist
specifically pertaining to: palladium-catalyzed functionalization 22, organocatalytic
strategies23, catalytic C-C bond functionalization of indoles,24 and methods for 3,4-fused
tricyclic indoles 25, which just scrape the surface. In this section I hope to showcase the
recent literature and general trends pertaining to functionalizing the 1 and 3 position of
indoles, with specific emphasis on cyclization that make scaffolds like the natural
products of focus in this thesis.
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1.2.1

Functionalizing Indole Position 1

Broadly speaking, functionalization of the indole nitrogen is straightforward. It is reliable
and simple. One might expect this because it is much easier to make heteroatom-carbon
bonds than it is to furnish carbon-carbon bonds. To impart function on the indole
nitrogen, deprotonation is required (1-25) and, in the presence of an electrophile, it will
react to create a new N-E bond (1-26, Scheme 7).

Scheme 7- General functionalization of the indole 1 position
Cross-coupling reactions to form N-C bonds (e.g., Buchwald-Hartwig amination) and
these are also used to functionalize the indole nitrogen (Scheme 8, D).26 However, for the
scope of this thesis, simple deprotonation of indole in the presence of an electrophile is
the only method used to afford N-substituted indole products. The chemistry in Scheme 8
showcases some common electrophiles and the resultant N-substituted indole products.
Scheme 8, A, outlines a simple SN2-type reaction to add an alkyl chain on indole (127).27 Protecting groups are often added to indole nitrogen to overcome chemoselectivity
issues. Scheme 8, B, showcases anhydride electrophile Boc2O (1-28), which protects the
indole N-H with a boc group in high yield (1-29).28 Scheme 8, C exemplifies acid
chlorides (1-30) as electrophiles generating acyl indole products such as 1-31.29
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Scheme 8 - Various examples of installing substitution off indole nitrogen

1.2.2

Functionalization of Indole Position 3

In earlier discussion I concluded that the 3-position of the indole is the easiest to
functionalize. Indoles are carbon nucleophiles at this position, and easily make indole-3substituted products. Outlined in Scheme 9 is a series of reactions that impart function on
the indole 3-position. First exemplified (Scheme 9, A) is a straight-forward Michael
addition; using BF3•OEt2 as a catalyst with methyl acrylate (1-34) generates elaborated
indole 1-35.30 More interestingly though, and important to the indoles of interest in this
document, are the recent advances synthesizing tryptamine chains off the indole-3position. Discussed at length in earlier sections, the tryptamine chain is both important,
and common in the natural world. Recently Righi et al. (Scheme 9, B) showed that from
acetal species 1-37, revealing its respective aldehyde under acidic conditions caused
indole 1-36 to attack, generating a benzylic alcohol that is reduced by triethyl silane.31
This pathway yields indoles like 1-38 which now bear a tryptamine chain. This reaction
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tolerated a wide variety of substitution patterns around the starting indole, but only
explored examples bearing electron-donating groups. The greatest limitation was found
to be the choice of protecting group on the amine component of acetal 1-37. Unprotected
amines failed to proceed, and protecting groups Cbz and Ts, caused yields to drop sharply
to the 50-60% range. However, the reagents to perform this functionalization are safe,
inexpensive, and offer access to the valuable tryptamine functionality discussed in
Section 1.1.1.

Scheme 9 - Functionalizing the 3 position of indole
Further elaboration synthesizing tryptamine chains was elucidated by Batolucci et al.
(Scheme 9, C). They applied a “borrowing hydrogen” strategy to provide the reducing
conditions necessary to synthesize tryptamine chains from amino alcohols (1-39).32
Iridium catalyzed, the dehydrogenation of poorly reactive alcohol 1-39 is followed by the
in-situ consumption of the generated hydrogen. This yields the correct oxidation state off
the benzylic position of indole 1-40 furnishing the tryptamine chain (Scheme 9, C).
Another interesting way to functionalize position 3 of indoles is to employ single-electron
transfer (SET) agents (discussed at length vide infra). A brief introductory example to
this chemistry is outlined in Scheme 10, where indoles (1-41) were functionalized with
styrenes (1-40).

13

Scheme 10 - Radical chemistry to generate functionalized indoles at the 3-position
Copper(I) is used as a single-electron oxidant to generate CF3 radicals from NaSO2CF3.
The radicals react with styrenes (1-43) generating final elaborated indoles 1-42 (Scheme
10). The radical (1-44) is oxidized to a cationic intermediate 1-45 which is sufficiently
electrophilic for indole 1-46 to attack and access highly substituted indole 1-47. This
chemistry is limited to electron-rich styrenes to obtain high yields of the substitution
products. Indoles which bear substitution at their 2-position also reacted poorly under
these conditions due to perceived steric interaction preventing the facile addition of
indole to cationic styrene 1-45.

1.2.3 Synthesizing Complex Indole-Containing Molecules
While functionalizing specific carbons on the indole heterocycle is valuable, molecular
targets of interest often have complicated ring systems incorporating indole. These rings
usually join to multiple positions of indole, completing the annulation. For example, the
natural products targeted in Chapter 4 (disclosed in Section 1.5) contain a 6-membered
ring that connects to indole at its 1 and 2 positions (Figure 6).
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Figure 6 - Indole bearing cyclic 1,2 substitution like the molecules of interest in
Chapter 4, plus a couple alternate natural product examples.
Generating annulated indole products can be done in a variety of ways: manipulating
photochemistry, cycloadditions, radicals, or cross-coupling/metal insertion reactions.
In 2015, the Barriault group constructed a straightforward method using UVA light to
build 1,2-annulated indoles with simple and inexpensive alkyl halide chains (Scheme
11).33 Gold containing photocatalyst ([Au2(dppm)2]Cl2) generates a radical by homolysis
the C-Br bond, which rapidly adds to the 2-position of the tethered indole. Loss of a
hydrogen returns the aromatic indole product 1-49. The photochemistry tolerated
substitution on the 3- and 5- positions of indoles without issue, resulting in high yields of
annulated indoles.

Scheme 11 - Employing photochemistry to construct 1,2 annulated indole products.
In 2019, a unique enantioselective synthesis of 1,2-annulated indoles using NHCcatalysis was disclosed by the Hui group (Scheme 12).34 Malonyl-substituted indoles (150) reacted with acrylaldehydes (1-51) facilitated by the NHC catalyst 1-52. Due to the
steric bulk of the NHC 1-52, when connected to the acrylaldehyde component, the
malonyl nucleophile can only perform a Michael addition from one face of the molecule.
The single-sided attack results in the observed enantioselectivity at the quaternary carbon
in molecule 1-53. The enantiomeric excess (ee) ratios were high, ranging from 88-98%
on all 20 substrates generated. The yields of the annulated indole products were also high,
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sitting above 87% for 18 of the 20 products generated. The yields drop when the R group
in acrylaldehyde 1-51 is aliphatic, like a methyl or cyclohexyl group. In these cases,
yields were less than 60%.

Scheme 12 - Enantioselective synthesis of 1,2- cyclized indoles taking advantage of a
[3+4] annulation

En-route to alkaloid (-)-alstoscholarisine A, a molecule that potentially prevents neuronal
decline associated with Alzheimer’s disease, the Yang group optimized
an enantioselective iridium catalyzed Friedel-Crafts alkylation to generate a 1,2annulated indole 1-57 (Scheme 13).35 Using Carreira’s iridium catalyst36 (ligand 1-58 +
the iridium catalyst), acyl indole 1-56 was cyclized to enantiopure indole 1-57 — which
in 8 concise steps, was successfully brought to natural product (-)-alstoscholarisine A.
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Scheme 13 - Enantioselective synthesis of 1,2 annulated indole 1-57 en-route to
natural product (-)-alstoscholarisine A.
Another recent and intriguing annulation of indole involved copper-catalyzed activation
of intramolecular cyclopropenes (1-59), prompting the cyclization with indoles isolating
elaborated products like 1-60 (Scheme 14). Coordination of the copper catalyst with the
double-bond of the cyclopropene creates opened metal complex 1-62. The tethered indole
will attack the resultant electrophilic position yielding intermediate 1-63. Annulation of
the copper alkene to the resultant tertiary cation of the indole, followed by elimination of
the copper catalyst yields the final product (1-65). This straightforward and mild
procedure generated high yields of annulated indoles that the authors are hopeful will aid
in the synthesis of the natural products showcased in Scheme 14.
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Scheme 14 - Copper(I) catalyzed tandem cyclization of indoles with cyclopropenes
and the target natural products the authors hope to access.
Indoles are also easily functionalized via nucleophilic opening of cyclopropanes.
Although, to appreciate this chemistry an introduction to the unique reactivity of
cyclopropanes is required.
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1.3 Donor-Acceptor Cyclopropanes and their Reactivity
with Indoles
1.3.1 Brief Introduction to Cyclopropane Reactivity
Cyclopropanes are unique 3-membered carbocycles that, because of their ring strain, are
exceptionally reactive chemical participants. The internuclear distance of cyclopropane is
60° compared to a normal 109.5° for Csp3-Csp3 bonds , but the inter-orbital distance is
widely accepted as being between 104-106° (Figure 7).37 Since covalent bonds are the
result of orbital overlap, the greater the overlap between orbitals, the stronger the
resultant covalent bond. In the case of cyclopropanes, this overlap is slight at best, and
therefore the bonds are weak. Weak bonds being synonymous with greater reactivity,
explain why cyclopropanes are so reactive.

Figure 7 - Cyclopropane weak orbital overlap model
The initial description of cyclopropane bonding was the molecular orbital model
proposed by Walsh, but his theory was refined by Coulson.37, 38 Coulson explains that by
distorting sp3 hybridization of C-C bonds to technically sp5 (1/6 s density and 5/6 p
density) the C-C bonds contain greater p character to achieve the tight bond angles and
the appearance of bent bonds (Figure 7).39 This idea of hybridization containing greater p
character is supported by observations of cyclopropanes undergoing addition reactions
over substitution, and because of the conjugative resonance effects observed.40 For
example, vinyl cyclopropane (Figure 8) has 1.1-1.3 kcal/mol of empirical resonance
energy as established by UV-Vis experiments. This proves the ability of cyclopropane to

19

conjugate with adjacent unsaturation, cementing the idea of greater p character in the
bonds.41

Figure 8 - Vinyl cyclopropane
Since more electron density is situated outside the internuclear axis, instead of directly
between the carbon nuclei, the nucleophilicity of cyclopropane is similar to olefins,
which have reactive π electrons perpendicular to the C-C bonds. For the same reasons,
the reactivity of cyclopropanes is like olefins. Cyclopropanes, and olefins, with both
acting as electrophiles and nucleophiles.42
What makes cyclopropanes exciting is how we can tune the reactive nature of the strained
molecule by adding substituents around the three-membered ring (Scheme 15). Adding
electron withdrawing groups to a cyclopropane (1-65) we get an “accepting”
cyclopropane, which can be opened with a nucleophile to give homo-Michael products
(1-66, Scheme 15, A). Substituting the cyclopropane with an electron donating group (167) will increase its nucleophilic properties and the carbocycle can attack an electrophile
(Scheme 15, B). When the cyclopropane is substituted with vicinal donating and
accepting groups shown in example 1-69. These are known as donor-acceptor
cyclopropanes (DA CPs). Activation of the accepting moiety via heat43, Lewis acid44,
hydrogen bonding45 or high pressure47 permits nucleophilic attack to open the
cyclopropane yielding new substituted alkyl chains (1-70). If the nucleophile also has an
appended electrophilic group, annulation reactions can occur to generate various cyclic
products (1-71, Scheme 15, C).46
The potential reactivity and applications for chemistry involving donor-acceptor (DA)
type cyclopropanes (CPs) are a major focus within the Kerr group. We as a group have
pioneered the involvement of indole nucleophiles with DA CPs and taken this chemistry
to access valuable natural products. Within the works of this dissertation is a novel
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activation of DA CPs using hydrogen bonds, which means an understanding of how
indoles have reacted with DA CPs in the past is of use.

Scheme 15 - Reactivity of cyclopropanes bearing electron withdrawing and/or
donating groups

1.3.2 Seminal Work: Indoles Reacting with Donor-Acceptor
Cyclopropanes
In 1997, Harrington and Kerr exploited indoles as nucleophiles for opening both
acceptor, and donor-acceptor cyclopropanes.47 Optimized results involved the use of high
pressure (13 kbar) in the presence of Yb(OTf)3 to have N-methylindole (1-72) open
diester cyclopropane (1-73) giving a 70% yield of 1-74 (Scheme 16). The reaction was
explored with diester cyclopropanes also bearing donor groups such as methyl and
phenyl, and explored five different indole nucleophiles achieving high yields of the ringopened products.
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Scheme 16 - Seminal work opening cyclopropanes with indoles
Determined to find more productive and interesting products from indole nucleophiles,
England et al. explored annulation reactions involving indoles opening DA CPs. 48 3susbtituted indoles were capable of opening DA CPs, generating 2,3-annulated indoline
products (1-77) under Lewis acidic conditions (Scheme 17). Interestingly, if the reaction
was left longer, an unusual rearrangement occurred resulting in 2,3-disubstituted indole
products (1-78). This chemistry confirmed high pressure was not required, and activation
of the DA CP with Lewis acid was sufficient to generate annulated products.

Scheme 17 - Annulation reaction of indoles and cyclopropanes (1-77) plus additional
rearrangement to access alternative 2,3-disubstituted products (1-78)
After ring-opening with indole (Scheme 18), 1-79 undergoes favourable alkyl shift
moving the cyclopropyl chain to the 2-position of the indole (1-80), generating a tertiary
carbocation. Elimination driven by re-aromatization offered a route to 2,3-substituted
indoles (1-81) via reaction with DA CPs.

22

Scheme 18 - Alkyl shift generating 2,3-disubstituted indole products
This work was effectively applied by synthesizing a subunit of the kopsane alkaloids, 184 (Scheme 19).49 However, accessing molecules 1-84 and 1-85 required high-pressure
to furnish the caged complexity.

Scheme 19 - Methodology poised for generating the molecular scaffold of kopsane
alkaloids using indoles and donor-acceptor cyclopropanes
A great improvement on this work was reported 11 years later in 2013. Tang et al.
designed an effective methodology for the enantioselective annulation of indoles and DA
CPs (Scheme 20). Catalyzed by copper, and in the presence of their optimized ligand (189), they were able to generate the cyclopentane annulated indoline products (1-88) like
those synthesized by England, but this time with enantiomeric control.50 Tang et al.
generated products with greater than 86% ee and the chemistry was successfully applied
by synthesizing the core of natural product borreverine (Scheme 20).
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Scheme 20 - Enantioselective addition of indoles to donor-acceptor cyclopropanes
In the cases antecedent, the DA CP ring-opening reactions were activated by the presence
of Lewis acid, and sometimes even required the aid of a high-pressure environment. In
2011, the Kerr group improved this model by using an internal hydrogen-bond to activate
DA CPs — abolishing the requirement for Lewis acid activation. It was the start of
research involving alternative reaction conditions for opening DA CPs.

1.3.3 Activation of Donor-Acceptor Cyclopropanes without Lewis
Acids
DA CPs successfully undergo ring-opening reactions with indoles in the absence of acid
catalyst when they contain a both a carbohydroxy, and carboalkoxy group, geminally
substituted (1-90, Scheme 21).51 Via proposed 6-membered ring intermediate (1-92) to
induce co-planarity of the carbonyls, the cyclopropane is sufficiently reactive for
nucleophilic opening with indoles without the aid of a Lewis acid. An extensive
improvement to this work and a more in-depth discussion of the activation mechanism is
the focus of Chapter 2.
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Scheme 21 - Internal Brønsted acid activation of cyclopropanes
Additional Lewis acid-free reactivity of cyclopropanes was reported by the Moran group
in 2018 using Brønsted acid as the activator.52 This work was released just as I had
submitted the manuscript on my novel findings outlined in Chapter 2. The works are
similar, but complement each other well. Moran reported that using 1,1,1,3,3,3hexaflurorisopropanol (HFIP) solvent in the presence of 10 mol% TfOH, DA CPs can be
opened in high yield by electron-rich aromatic nucleophiles 1-94 (Scheme 22). This work
showcased an impressive improvement on previous chemistry as it did not require an
internal hydrogen bond, it avoids the use of high-pressure conditions, and it does not
require a metal catalyst.

Scheme 22 - Bronsted acid catalyzed ring-opening of cyclopropanes
The chemistry worked broadly, capable of generating 40 different aromatic-substituted
products in high yields. This work proposed that HFIP, a strong hydrogen-bond donor, is
necessary to stabilize intermediate 1-98 and increase the C-C bond polarization of the
cyclopropane (1-96 and 1-97) so it is sufficiently susceptible to attack via the aromatic
nucleophile (Scheme 23).
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Scheme 23 - Proposed mechanism for the Brønsted activation of DA CPs
A component of work in Chapter 2 further discusses how HFIP itself is a suitable
hydrogen bond donor, capable of activating cyclopropanes without the need for TfOH. In
addition to functionalizing indoles via reaction with DA CPs, focus in this thesis is also
given to single electron transfer (SET) agents, and their ability to passage new
functionality via radical chemistry.

1.4 Single Electron Transfer Agents and Reactivity with
Indoles
Radical reactions in synthesis, once considered too uncontrollable to be useful, are
becoming increasingly popular due to their capabilities to form C-C bonds53, perform
tandem and cascade reactions in a single flask54, and make complex disconnections
possible for target molecules. Retrosynthetically analyzing bonds in a one e- fashion, over
a two e- mindset, has been changing the way we build molecules.55 Using single-electron
chemistry often lessens the need to make extra adjustments compensating for chemo- and
regioselectivity to generate compatible synthons. This provides one e- chemistry a unique
advantage. Baran et al. exemplify this claim in a comparison of the synthetic routes to
useful glycoside derivative 1-100 (Scheme 24).56,57
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Scheme 24 - comparing 2 e- and 1 e- disconnects to better synthesize product 1-00
The single electron pathway accessed desired glycoside 1-100 in just one step, without
the need to produce the unstable lithiate (1-107) using unsafe lithiations conditions. For
these reasons, radicals are becoming valuable tools in the synthesis of organic molecules.
The research outlined in Chapter 3 employs radical chemistry to functionalize indoles.
Single electron transfer (SET) agents have long been used to reduce carbon centers —
generating radicals that are capable of many bond-forming reactions. Often alkali metals
and tin hydrides dominate this field, especially regarding reductions (Scheme 25). To
name a few famous examples (Scheme 25): Birch reduction (1-109)58 (Li0, Na0), acyloin
condensation(1-110)59 (Na0), and the Barton-McCombie deoxygentation (1-111)60
(Bu3SnH), but a great number of milder and effective SET agents have been used
successfully in chemical synthesis over the last couple years, especially those pertaining
to oxidative radical processes.
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Scheme 25 - Reductive radical reactions
Cerium (IV), iron (III), manganese (III), copper (II), and vanadium (V) are high-valent
metals with easily handled salts capable of exploiting their flexible oxidation states to
generate carbon-centered radicals like 1-114 (Scheme 26, oxidative process).61
Oxidative radical processes generate products that are often the same oxidation state of
the starting material. Compare the reductive and oxidative process in Scheme 26: the
reductive process gains hydrogen replacing the starting alkene with sigma bonds.
Chapter 3 expands on chemistry using Mn(III) as a SET agent, discussing its ability to
oxidatively generate radicals to form C-C bonds with indole containing compounds.
Mn(III) is the most established of these SET agents and the one that I will explore in
great detail.
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Scheme 26 - Comparison of reductive and oxidative radical processes

1.4.1 Introduction to Mn(OAc)3: a SET Agent
Manganese(III) is an oxidative radical former; the radical is generated via formal loss of a
hydrogen. Mn(III) is also known as a SET agent because of its capabilities to oxidatively
produce radicals at carbon centers. Mn(III) is most commonly used as Mn(OAc)3•2H2O,
which is safe, easy to handle, simple to prepare, and comes from the extremely
inexpensive Mn(OAc)2 ($86/kg, MilliporeSigma). Refluxing Mn(OAc)2 in AcOH with
potassium permanganate (KMnO4) produces Mn(OAc)3, which is then crystallized from
H2O yielding Mn(OAc)3•2H2O, the active reagent (Scheme 27). To produce the
anhydrous Mn(OAc)3, acetic anhydride is added during the synthesis.62

Scheme 27 - Synthesis of Mn(OAc)3
Bush et al., who first reported the synthesis of anhydrous Mn(OAc)3, also determined that
the way in which the Mn(OAc)3 is prepared, has an effect on its capabilities as a reagent.
They discovered that if water remained in the crystallographic structure of the Mn(OAc)3,
even in regards to the hydrate complexes, yields of products made from Mn(OAc)3
radical production were lower. They hypothesized that water in the crystal structure
altered the geometry of the molecule in such a way that the Mn(III) was not effective in
coordinating to carbonyl groups.62 To produce quality Mn(OAc)3 the operating chemist
must be sure that the temperature of the acetic acid is between 105-110 °C (no higher)
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before the portion-wise addition of permanganate. I never had any issues synthesizing
Mn(OAc)3•2H2O with this information. The procedure for the synthesis Mn(OAc)3•2H2O
used in this thesis is outlined in Section 3.7. From this point on, Mn(OAc)3, as written,
implies the dihydrate material being used.
Mn(OAc)3 generates carbon-centered radicals on carbonyl compounds such as βdiketones, acetoacetamides and β-ketoesters. Generally speaking, Mn(OAc)3 works to
create radicals α to carbonyls, which can then combine with another suitable partner
(Scheme 28). Mn(OAc)3 works with 1,3-dicarbonyls, or other appropriate electron
withdrawing groups to form lactones (1-122) or cyclic molecules via intramolecular
annulation. Often, greater than stoichiometric amounts of Mn(OAc)3 are used to facilitate
a second oxidation of the radical intermediates (1-121). In Scheme 28, α radical 1-124
reacts intramolecularly with the alkene generating cyclohexane 1-125. The radical in this
case undergoes hydrogen abstraction yielding 1-126. Mn(III) chemistry also works most
reliably when the radical acceptor, often an alkene or alkyne, is tethered within the
molecule to access annulated products in an intramolecular fashion (Scheme 28, 1-123).
Publications involving Mn(OAc)3 largely increased in the 1980’s, and the reagent has
been applied in some interesting ways that will be discussed in the following subsections.
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Scheme 28 - General reaction pathways for Mn(OAc)3 radical chemistry

1.4.2 First Uses of Mn(OAc)3 Chemistry
First reports using Mn(OAc)3 as an oxidative radical former were outlined by Bush and
Heiba in 1968. Both reports expressed the synthesis of lactones like 1-128 from olefins in
the presence of Mn(OAc)3 and acetic acid (Scheme 29, 1968).63,64 The acetic acid
solvent is complexed by manganese, then deprotonation followed by electron transfer
generates radical acetic acid species (1-131) which combined with the olefins. Both
researchers found moderate yields around 70% for the synthesis of lactones from a
variety of olefins.
In 1974 Heiba pushed Mn(III) radicals further by expanding the scope to β-ketoesters (1129) (Scheme 29, 1974).65 Dihydrofurans (1-130) were synthesized in modest yields
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from the carbon-centered radical generated at the alpha position of ethylacetoacetate 1129.

Scheme 29 - First reports of Mn(OAc)3 as a radical initiator to synthesize lactones
from olefins
From the success employing 1,3-dicarbonyl species as radical partners, the field
expanded to use Mn(III) for practical syntheses of complex and desirable molecules. The
chemists that took over from Heiba and Bush are now the experts in the field: Barry
Snider and E. J. Corey.
First though, elucidation of the mechanism for reactions involving Mn(OAc)3 were
explored during this time and proposed by Snider and Fristad. An understanding of how
this oxidative mechanism generates radicals will aid in the comprehension of my
research.

1.4.3 Mn(OAc)3 Mechanism of Action
Kinetic and mechanistic studies on how Mn(OAc)3 generates radicals have been studied
and a well-accepted model generated. The outlined mechanism below (Scheme 30)
shows how the α-radicals of carbonyl compounds (1-132 and 1-136) are generated. It is
agreed that the rate determining step (RDS) in the oxidation reaction is the loss of a
proton from the complexed substrate either 1-132 or 1-136 (Scheme 30). Both Fristad
and Snider proposed how the oxo-centered triangle of Mn(III) (1-133 and 1-137) and
their bridging acetates, initiate radical formation (Scheme 30).66,67
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Scheme 30 - Mechanistic considerations for Mn(OAc)3
The deprotonation of 1-132 to form enolate coordinated product 1-133 occurs as the RDS
and then undergoes rapid electron transfer to give radical 1-134. This radical undergoes
chemistry with suitable reactive partners like alkenes or alkynes. In the Snider example
(Scheme 30), the enolization step is slow to produce 1-137, but the electron transfer
resulting in the loss of Mn(II) and generating radical 1-138 is fast. This claim is aided by
the fact the concentration of alkene (or other radical acceptor) has no effect on the rate of
this reaction. Sufficiently acidic/enolizable substrates are required for Mn(III) to
overcome the slow and rate-determining deprotonation before generating a radical. This
is why the chemistry involving Mn(III) radicals often relies on 1,3-substituted electron
withdrawing substrates such as malonates, or β-ketoesters.

1.4.4 Effects of Other Oxidants in Mn(OAc)3 Reactions
Exemplified in Scheme 28, Mn(III) is often an oxidant twice in the same reaction (1-120
to 1-121), and will oxidize the final radical to a cation that can be quenched by different
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mechanisms to create products. Alternate oxidants are sometimes added as they can
control the final product acquired.68 When manganese is the chosen oxidant its abilities
are limited; only tertiary and benzylic radicals can be oxidized to their respective cation
by manganese. Primary and secondary radicals will not oxidize in the presence of
Mn(III), and will instead undergo H-abstraction (product 1-144 in Scheme 31). Using
Cu(OAc)2 in addition to Mn(OAc)3 addresses this problem; as an external oxidant it
became popular because it could generate different final products. Cu(OAc)2 oxidizes 2°
radicals 350 times faster than Mn(OAc)3. It will also take primary and secondary radicals
to alkenes by direct oxidative elimination instead of H-abstraction (product 1-143 in
Scheme 31).69

Scheme 31 - Termination processes using either external oxidant Cu(OAc)2 or
solvent in the absence of an external oxidant.
To facilitate the enolization and quenching of these reactions, polar protic solvents are the
required reaction medium. DMSO and CH3CN do work, albeit in lower yields. Typically,
and as shown in most of these examples, AcOH or MeOH are the solvents of choice.
With an understanding of the mechanism and quenching routes, efficient exploitation of
Mn(OAc)3 began to offer access to complex products.
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1.4.5 Applications of Mn(OAc)3 in Natural Product Synthesis
Corey first showcased how Mn(OAc)3 radicals could be applied reporting a cascade
reaction capable of generating complex polycyclic structures (Scheme 32).70 Β-ketoacid
1-145 subjected to 1.3 equivalents of Mn(OAc)3 in AcOH resulted in a 63% yield of
molecule 1-146 in an impressive a single step. This work exemplifies how radicals often
make for extremely economic and atom efficient reactions. The structures had impressive
diastereocontrol, generating the cis-fused pentacyclic structures simply due to the nature
of radical chemistry. The pentacycles map nicely onto the ginkgolide group of natural
products.

Scheme 32 - Corey's application to impressive pentacyclic structures using Mn(III)
A year later, in 1985, Snider formally synthesized natural product (±)-podocarpic acid
using Mn(OAc)3 as the focal point of the synthesis (Scheme 33).71 Cascade radical
cyclization of elaborated olefin 1-147 via Mn(OAc)3 furnished the core scaffolding of
(±)-podocarpic acid (1-148). A Clemmensen reduction synthesized product 1-149, Omethylpodocarpate, that was taken to (±)-podocarpic acid in 1956.72

Scheme 33 - Snider's formal synthesis of (±)-podocarpic acid through intermediate
1-149 generated using Mn(OAc)3
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Later in 2002, Mn(OAc)3 in the presence of co-oxidant Cu(OAc)2 furnished the main
scaffolding of natural product vannusal A (1-152) as reported by Nicolaou et al (Scheme
34).73 The spirocyclic molecule 1-151, being geometrically strained, was welcoming to a
radical methodology, which is often a great choice to make tough, tight bonds. From βketoester 1-150, radical cyclization worked in a 76% yield to furnish 1-151 (Scheme 34).
In 2010, the Nicolaou group realized the complete total synthesis of vannusal A and
corrected its originally proposed structure.74

Scheme 34 - Nicolaou's route to vannusal A incorporating a Mn(III) mediated
radical cyclization of spirocycle 1-151
Where the Kerr group expertise shines is using Mn(OAc)3 as a means to perform
cyclization reactions with indoles. In 2008, the total synthesis of mersicarpine was
achieved using an important Mn(OAc)3 cyclization reported by Magolan and Kerr
(Scheme 35).75 Malonyl-tethered indole 1-153, was subjected to the oxidative radical
forming conditions with Mn(OAc)3 generating tricyclic product 1-154. 1-154 was taken
to the target molecule, mersicarpine (1-155, Scheme 35).

Scheme 35 - Kerr group synthesis of mersicaprine functionalizing indole 1-153 via
Mn(III) radical cyclization
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This segues nicely into how Mn(OAc)3 can be used to further functionalize indoles into
desirable synthetic targets.

1.4.6 Mn(OAc)3 and Indole Functionalization
When it comes to indoles, Mn(OAc)3 was first used as an oxidative reagent to take
indolines to their aromatic indole counterpart.76 Original reports (Scheme 36, 1988)
observed that only electron withdrawing components off of the indoline nitrogen (1-156)
were tolerated. As work with Mn(III) progressed, Curiel Tejeda et al. demonstrated an
improvement on the oxidation of indolines (Scheme 36, 2016). Indolines bearing electron
rich substitution (1-158), like a methylene or phenyl group, were also capable of
oxidation to indoles using Mn(OAc)3. The materials explored also underwent a radical
cyclization with the malonyl tether in a single-step yielding annulated indole 1-159.

Scheme 36 - Mn(OAc)3 as a tool to synthesize indoles
Another interesting application of Mn(OAc)3 is observed in its ability to regioselectively
thiocyanate indoles (Scheme 37). At room temperature, in the presence of Mn(OAc)3, a
variety of indoles were thiocyanated in high yields to provide a different functional
handle on indoles. Indole (1-1) with ammonium thiocyanate (1-160) and Mn(OAc)3
produced functionalized indole 1-161 (Scheme 37) in an 83% yield.77 Mechanistically,
radical thiocyanate 1-163 is produced via ligand exchange with ammoniumthiocyanate
and Mn(OAc)3. Radical 1-163 then reacts with the chosen indole, where a second

37

equivalent of Mn(III) oxidizes the radical to cation 1-165. End indole 1-166 is generated
by loss of a proton.

Scheme 37 - Functionalizing indoles with thiocyanate

Continuing our exploration of indoles and manganese (III), methylmalonylation of both
pyrroles and indoles was reported in 1993 starting the wave of publications relating to the
addition of diketone species into indoles. Baciocchi et al. found that methyl
diethylmalonate (1-168) was radically added to indoles when subjected to Mn(OAc)3. 3substitution was the major product (1-169) and a minor fraction of mixed substitution
around the phenyl ring of indole (1-170) was also isolated (Scheme 38).78

Scheme 38 - Addition of malonyl groups to indoles via Mn(III) chemistry
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Expansions on this work would include cyclization reactions where instead a malonyl
group was in the starting indole causing intramolecular reactions (Scheme 39). Magolan
et al. synthesized indoles containing malonyl tethers (1-171) and used a Mn(OAc)3
radical cyclization to generate 1,2-disubstituted indoles bearing a cyclohexane ring (1172) (Scheme 39).79

Scheme 39 - Tethered indoles functionalized to 1,2-cyclized product 1-172 by
Mn(OAc)3
Cyclic substituted indoles, like that of product 1-172, map well onto a vast selection of
natural products. It matches particularly well to products isolated from plant species
Tabernaemontana corymbosa, which will become the next topic of this introductory
material.

1.5 Indole-Containing Natural Products of Interest
The Tabernaemontana genus of Malaysian flowering plants have produced many
interesting isolated and characterized natural products. In Chapter 4 of this thesis will
discuss new progress trying to synthesize two of these isolated indole-alkaloids using
Mn(OAc)3.
The Kam group from the University of Malaya has worked over many years to extract
huge numbers of alkaloids from Tabernaemontana corymobosa. Many of these alkaloids
collected have been useful targets of interest to organic chemists80, but it was first Van
Beek, who had worked with plant extractions from Tabernaemontana chippii to isolate
45 different alkaloids.81 At the time, 34 of them were fully characterized, and 8 of them
were newly discovered molecules. A screening of these new molecules revealed that they
have antifungal and antimicrobial uses. A couple of the alkaloids elucidated by Van
Beek, pleiocarpamine and chippiine, are showcased in Figure 9, with the skeleton of
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interest outlined in red. Unique to this plant, we notice these molecules have a 1,2substituted cyclic indole scaffold, which the Kerr group has become expert in generating
using Mn(OAc)3.

Figure 9 - Select examples of alkaloids isolated from Tabernaemontana chippii.
In 2000, the Kam group isolated the first novel pentacyclic indole natural product that
also contained a 7-membered lactam moiety. This lactam functionality had not been seen
in the alkaloids of Tabernaemontana before. The product isolated, and named as
tronocarpine (Figure 10), was thought to be related to the tacaman-type alkaloids (for
example chippiine (Figure 9) is a member of this family), but no evidence of its presence
in Tabernaemontana corymbosa was discovered. Since this alkaloid has yet to see its
total synthesis completed, and due to its interesting pentacyclic structure, tronocarpine is
an enticing piece of work to the organic chemist. Again, chemistry outlined in this thesis
instilled a confidence that Kerr group methodologies using Mn(OAc)3 would be an
efficient way to fashion this natural product. In addition to its unique structure,
tronocarpine has not yet been tested for its bioactivity, but because of the bioactive nature
of related alkaloids, it is of interest to determine the potential pharmaceutical effects that
tronocarpine may have.
Later in 2001, the Kam group isolated 4 new alkaloids named Dippinine A-D, from the
plant Tabernaemontana corymbosa.82 These new indole alkaloids also contained the
tricyclic scaffolding that I was confident we could generate in an efficient way. Dippinine
B (Figure 10) was of special significance as a molecule because I could perhaps
synthesize it based on the methodology generated in Chapter 3 of this thesis. I have a
great way of generating acyl indoles that cyclize with Mn(OAc)3 and put functional
handles in correct regions to access this interesting natural product. Dippinine B is also
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similar to tronocarpine differing only in the attachment of their tryptamine chains.
Tronocarpine and dippinine B became the target molecules of interest and work towards
their syntheses is reported in Chapter 4.

Figure 10 - Indole alkaloids tronocarpine and dippinine B isolated from
Tabernaemontana corymbose

1.5.1 Previous Synthetic Attempts at Tronocarpine
To date, only three attempts at tronocarpine have been published. Original work towards
the molecule was performed in the Kerr group by past students Jakob Magolan, and
Katarina Sapeta.
In 2006, Magolan outlined a synthesis of the tetracyclic core of tronocarpine, furnishing
rings A, B, C, and D.79 From elaborated indole-3-acetonitrile 1-173 (Scheme 40), the
Mn(OAc)3 oxidative cyclization furnished the D ring of tronocarpine (1-174) complete
with the ester handles that could generate lactam ring C. Raney Ni reduction of nitrile 1174 resulted in the unprompted lactamization of the resultant amine onto the
diastereotopically available ester to yield product 1-175 in an 87% yield. Unfortunately,
attempts to enolize the α-position to the ketone in 1-175 was not possible, and appropriate
functionality to complete tronocarpine could not be installed.
In 2009 Katarina Sapeta successfully furnished the A, B, D, and E rings of tronocarpine,
but did not achieve the required functionality to furnish the total synthesis (Scheme 41).83
Using donor-acceptor cyclopropane 1-176, opening with nucleophile 2-(chloromethyl)-3trimethylsilyl-1-propene (1-177) yields product 1-178, which is then cyclized by an SN2
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reaction. Indole-substituted cyclohexyl 1-179 was synthesized in a 92% yield over 2
steps. Then deprotection of the tosyl group with Mg metal, followed by base-mediate
condensation with the available ester formulated tetracyclic product 1-180 in a 47% yield
over 2 steps. While Sapeta was able to close ring E, that Magolan’s route could not, the
ester of 1-180 is on the incorrect side of the molecule and any further functionalization
was not reported.

Scheme 40 - Progress towards the first total synthesis of tronocarpine in 2006
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Scheme 41 - Progress towards the first total synthesis of tronocarpine in 2009
Finally, the most recent report of an attempted synthesis of tronocarpine came from the
Martinez group in 2014. They successfully synthesized the pentacyclic framework of
tronocarpine, but lacked correct oxidation states for both the methylene bound to the
indole nitrogen and the α,β-unsaturated ketone component of ring E (Scheme 42).84 The
synthesis began from malonyl substituted indole 1-181, which was subjected to a Michael
addition with acrylic aldehyde 1-182, condensation with the indole nitrogen occurred in
one-pot to yield tricyclic moiety 1-183 in a 90% yield. Unfortunately, resultant alcohol 1183 was not stable, and quickly eliminated to form the alkene product 1-184, which the
researchers were forced to work with. To impart the later required syn functionality to
close ring E, lactamization first had to be performed by deprotection of the tryptamine
chain to yield 1-185 in a quantitative yield. Then using palladium-catalyzed
hydrogenation, they could ensure the syn addition of hydrogen to give the
diastereochemistry outlined in product 1-186. From this molecule, a titanium-catalyzed
Dieckmann condensation of 1-186 gave pentacycle 1-187 in a 91 % yield. The report
ends here as the authors mention oxidation attempts to install the alcohol of tronocarpine
were unsuccessful.
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Scheme 42 - Martinez attempt at the total synthesis of tronocarpine in 2014
I was hopeful that some of the learned procedures in these attempted syntheses would aid
in my design to complete the first synthesis of both tronocarpine and dippinine B. This
chemistry is explored extensively in Chapter 4.
With this, I complete the material required to understand the chemistry outlined in
Chapters 2 through 5. They comprise the research component of this thesis, which
ultimately aimed to improve chemistry involving the heterocycle indole.
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Chapter 2: Hydrogen Bond Activation of Donor-Acceptor
Cyclopropanes with 1,1,1,3,3,3-Hexafluoroisopropanol
Chapter 2 Preface

The work outlined in this chapter is adapted from: Irwin, L.C.; Renwick, C.R.; Kerr,
M.A. J. Org. Chem. 2018, 83(11), 6235-6242.
The Kerr group research program focuses heavily on developing novel synthetic
transformations starting with donor-acceptor (DA) cyclopropanes. Chapter 2 summarizes
my novel discovery activating DA cyclopropanes using hydrogen bonding (Scheme 43).

Scheme 43 - Reaction explored in Chapter 2. Activation of DA cyclopropanes via
hydrogen bonding
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2.1

Introduction

Donor-acceptor cyclopropanes (DA CPs) have long fascinated chemists and are a wellestablished field. Of late, there has been a resurgence of activity as new and innovative
uses for these compounds have been reported.85 Donor-acceptor cyclopropanes are often
used as homo-Michael acceptors which makes them useful for functionalizing a wide
variety of nucleophiles and the creation of C-C bonds.86 As expressed in the introduction,
they also behave as dipolarophiles, which has made them useful for the synthesis of
heterocycles87 and carbocycles.88
The Kerr group first reported that indoles nucleophilically open cyclopropanes in the
presence of both Yb(OTf)3 and high pressure back in 1997 (Scheme 44, ref. 88).89
Improvements came in 2011 as we discovered that switching to hemimalonate CP 2-3
only high-pressure was required to open the cyclopropane via proposed hydrogenbonding interaction (Scheme 44, ref. 89).90
However, as the world shifts to employ more sustainable chemical processing, the notion
of removing metals for catalysis is not new.91 This would help preserve the world’s
supply of precious metals and remove the toxic and polluting effects caused by metallic
waste. Performing reactions of DA CPs without the need for environmentally and
economically costly metals, or at unsafe pressure, would be a welcomed methodology.
These ideals sparked this pursuit of hydrogen bonding as a mode of activation for donoracceptor cyclopropanes.
Chapter 2 reports the results of my research in which I showcase how donor-acceptor
cyclopropanes react smoothly with indoles, free from metal-catalysis and high-pressure
conditions. The reaction uses 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) as the solvent or
co-solvent to enforce hydrogen bonding interactions with the carbonyls of the acceptor
portion of DA CPs.
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Scheme 44 - The reaction discussion in Chapter 2 and related research from our
group.

Emmett et al. first report using high-pressure and hemimalonate DA CPs (Scheme 44,
ref. 90) and proposed that an internal hydrogen bond was adequate to stereoelectronically align the two carbonyl groups to receive the impending electron density as
the ring opening events (Figure 11). They believed this to be the case because the
internal hydrogen bond meant there would be a counter-acting electron withdrawing and
electron donating effecting from both the loss, and gain, of a hydrogen bond. The forced
co-planarity of the cyclopropane would lower the overall energy barrier of the initial
nucleophilic attack.
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Figure 11 - Forced co-planarity of hemimalonate CPs activating them for successful
nucleophilic opening.
These results in mind, I proposed that if the hydrogen bond was external, from a source
like HFIP, it would provide a more electron-withdrawing situation for nucleophilic
opening and perhaps work with more than just hemimalonate CPs.

2.2 Optimization of Reaction Conditions
This work commenced using hemimalonate cyclopropanes because they had already
proved their hydrogen-bond receptiveness, and I hoped this would be useful for
optimization (Table 1). I first treated cyclopropane 2-9a with 2 equivalents of Nmethylindole 2-8a in pure HFIP at 60 °C and produced desired adduct 2-10a in a 46%
yield (Table 1, entry 1).
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Table 1 - Optimization of the Reaction Conditions for the Reaction of NMethylindole 2-8a with Cyclopropane Hemimalonate 2-9a

As a control, the reaction was performed using only acetonitrile as a solvent which
resulted in no product (Table 1, entry 2). Believing that the reaction required a hydrogen
bonding solvent, we tried acetic acid, phenol, and trifluoroethanol (TFE) (Table 1,
entries 3, 4 and 5). I chose to examine phenol because its pKa is similar to HFIP, and we
were quite surprised to learn TFE produced no product as it should have similar hydrogen
bonding capabilities compared to HFIP. Intrigued by this result, we tried only
isopropanol (Table 1, entry 8) which gave a small 17% yield of desired adduct 2-10a.
Ultimately optimized conditions were realized with a 50:50 mixture of HFIP:i-PrOH, at a
mild 65 °C and using an aqueous purification process giving a respectable 76 % yield of
2-10a (Table 1, entry 12).
I feel it is important to note that optimization was initially performed using 1,2dimethylindole as the nucleophile. Due to its strength as a nucleophile, it proved to be an
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exceptional example to optimize with. This resulted in other indole nucleophiles failing
to yield products under the same mild conditions that worked for 1,2-dimethylindole.
This is outlined in the reaction scope below (Scheme 45), where 1,2-dimethylindole
produces some of the highest yields of the CP opening reaction. The results of this
optimization are included below (Table 2). The optimized conditions of this reaction
were more mild with 40:60 mixture of HFIP:i-PrOH at 55 °C (Table 2, entry 5). The
milder reaction conditions ceased to perform for a broad scope of nucleophiles, and
results from the 1-methylindole optimization were put in place.
Table 2 - Optimization of the Nucleophilic Opening of Cyclopropane 2-9a with 1,2Dimethylindole 2-8b

2.3 Substrate Scope and Expanded Use of Alternate
Donor-Acceptor Cyclopropanes
Optimal reaction conditions in hand, I turned attention to studying the scope of substrate
performance. I started by exploring hemimalonate cyclopropanes (2-9a and 2-9b) as per
the optimization discussed above. Scheme 45 outlines the products prepared under this
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protocol. A few trends were observed upon completion of this scope. Firstly, Nmethylindole added to cyclopropane 2-9a in a modest 76% yield (2-10a), while indole
itself, was not a productive nucleophile for generating adduct 2-10d. This returned only a
31% yield. Additionally, indole adduct 2-10d was difficult to purify and only crude
results were obtained. These results prompted us to also try N-boc indole as a substrate,
but as per published findings, the indole did not react. Rather the Boc group was removed
(2-10i).92

Scheme 45 - Substrate scope for the reaction of indoles with cyclopropane
hemimalonates.
Substitution at the 2-positon of the indole was well-tolerated as proven by examples 210b and 2-10c. In fact, 1,2-dimethylindole was the best nucleophile studied resulting in
an 83% yield of adduct 2-10b. Substitution on the benzenoid portion of the indole
nucleophiles worked well for electron rich examples; 2-10f yielded 64% of desired
product, and the same was true for 2-10e, a more electron neutral example. However,
electron withdrawing substituents at the 5-position of the indole were not tolerated and
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failed to yield the 5-nitroindole example 2-10j. We tested an electron withdrawing group
on the cyclopropane though, which resulted in a 60% yield of 2-10h.
Having success with hemimalonate cyclopropanes, I looked to compare results using the
parent diester cyclopropane 2-11a-d (Scheme 46). Under the same conditions used for
the hemimalonate products, little to no product was observed and so I had to explore
some new reaction conditions.

Scheme 46 - Substrate scope for the reaction of indoles with diester cyclopropanes.
Upon changing the reaction conditions to use pure HFIP and heating at 80 °C, Nmethylindole was able to open CP 2-11a to give a 35% yield of adduct 2-12b. 2-position
substitution on the indole greatly improved yields as we expected due to their enhanced
nucleophilicity. 2-methylindole and 2-phenylindole adducts (2-12a and 2-12c
respectively) gave improved yields of 91% and 62%. It is suspected that the additional
bulk of the phenyl substituent hindered higher yields. Substitution on the cyclopropane
benzenoid was acceptable for para nitro (2-12d, 19%), bromo (2-12e, 54%) and chloro
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(2-12f, 66%) groups. However, the electron withdrawing nature of these groups saw a
drop in yields from the bare phenyl example as expected.
From the success generated by the diester cyclopropanes, I felt that bis-trifluoroethyl
ester cyclopropanes (2-14a/b) would only improve on this methodology. Our group, as
well as others, have proved that these cyclopropanes have enhanced reactivity due to the
electron withdrawing nature of the added fluorines.93 We were delighted to discover
excellent yields of the indole opened adduct of these cyclopropanes. Scheme 47 outlines
the library of products generated.

Scheme 47 - Substrate scope for the reaction of indoles with cyclopropane fluoroesters.
N-methylindole reacted with CP 2-13a resulting in an 85% yield of product 2-14a. Again,
indole itself resulted in a poor 25% yield of adduct 2-14i. Electron withdrawing groups
on position 5 of the indole, 2-14e, again resulted in a lower yield compared to electron
donating (2-14f, 89%) and electron neutral counter examples (2-14g, 79%). Substitution
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at the 2-position was well tolerated, as 2-phenyl-1-methylindole generated a high 91%
yield of 2-14d. The excellent yields observed for the fluoroethylester-bearing
cyclopropanes are certainly a result of their enhanced withdrawing nature; however, I
also suspected that an additional hydrogen-bonding effect may have been occurring.

2.4 Possible Hydrogen Bonding Motifs
HFIP has been well reported to act as a hydrogen bond donor.94 In the case of the
fluoroethyl esters, we suspect that another interaction involving a hydrogen bond between
HFIP and the fluorines of the cyclopropane could be happening as well. Such interaction
has been reported by the Paquin group, and would explain the great improvement of
yields for these products.95 Outlined below are our proposed interactions of how HFIP
acts as a hydrogen bond donor (Figure 12). While it is still unclear which is occurring,
future studies should aim to elucidate how this reaction works.

Figure 12 - Possible hydrogen bonding motifs for donor-acceptor cyclopropanes in
the presence of HFIP
In the case of the diester CPs (Figure 12, I), hydrogen bonding to the carbonyl oxygen(s)
should be capable of lowering of the activation energy of the nucleophilic attack by
indole. With the hemimalonates CPs the situation becomes a bit more complex (Figure
12, II). It is possible that an internal hydrogen bond, as mentioned earlier, could occur
and this would stereo-align the orbitals of the cyclopropane for the incoming electron
density, but, with HFIP there could also be an additional energy lowering hydrogen bond
to the carbonyl oxygen(s). Finally, examining the fluoroethyl ester CPs (Figure 12, III)
there is the possibility of a hydrogen bond to the fluorine present. This would make the
ethylfluoro groups even more withdrawing in nature facilitating the nucleophilic opening.
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2.5 Other Nucleophiles and Future Directions
While this project reports a simple and catalyst-free method for activating cyclopropanes,
there exists great potential for future chemistry. Firstly, exploring the mechanism of
activation for this reaction is vital to understanding how hydrogen bonding allows these
ring opening reactions to proceed. Simple 13C NMR experiments could be used to
observe the effects of HFIP on cyclopropanes. Taking up hemimalonate and fluoroethyl
diester CPs (2-9a and 2-13a) in CDCl3 and running carbon NMRs at varying
concentrations of HFIP, we may observe the carbonyl carbons shifting downfield as
withdrawing effects are improved. We could compare these results to spectra obtained
with the addition of acidic solvents, like AcOH and phenol, which did not provide ring
opened adducts in the above research. We could also explore varying concentrations of
TFE to determine why it also failed to yield our desired adducts. Perhaps HFIP will
demonstrate a stronger interaction to the carbonyl carbons of the DA CPs.
In addition to NMR experiments, computational chemistry would prove valuable for
exploring the transition states of the hydrogen-bond interactions with cyclopropanes. If
we can understand how the hydrogen bond works, we could better tune substrates in the
future to open greater varieties of cyclopropanes in a catalyst free fashion, or generate
improved conditions using less HFIP.
On this note, this discovery makes a new tool for metal-free synthesis of valuable
hetereo- and carbocycles en-route to natural products. It would be interesting to explore
if annulation reactions where DA CPs act as dipolarophiles also proceed under these
catalyst-free conditions. While I took some time to explore nitrone nucleophiles (2-16)
opening DA CPs in the presence of HFIP, the results were not as expected (Scheme 48).
A few oxazine products (2-18) were generated but in small yields and were not pursued
further. A better understanding of the reaction activation may aid in the pursuit of useful
reaction conditions for other nucleophiles.
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Scheme 48 - Annulation reaction of nitrones opening cyclopropanes to yield oxazine
products
Exploring imine, oxime and enamine nucleophiles would provide us interesting and
catalyst free conditions for the valuable products they produce.
HFIP being such a strong hydrogen bond donor could also play a positive role in some of
the single-electron oxidant chemistry discussed Chapter three. More will be discussed on
this in Chapter three, but perhaps using HFIP it is possible that radical reactions will
proceed at milder conditions resulting in less decomposition and/or by-products.
Hopefully, HFIP would improve yields of intermediate compounds en-route to natural
products like tronocarpine and dippinine B.

2.6 Experimental
2.6.1 General Experimental Details
Reaction flasks were oven-dried at 110 °C and cooled in a desiccator prior to use.
All cyclopropane opening reactions were conducted in sealed tubes that had been flushed
with argon before the addition of reagents unless otherwise indicated. The tubes were
sealed with a Teflon stopper and capped with an aluminum crimping cap. All chemicals
were of reagent quality and used as obtained from commercial sources. HFIP was
purchased from Oakwood Chemical and dried with 3Å molecular sieves. 3Å molecular
sieves were activated in a 300 °C oven for at least 24 h before use. Isopropanol was
purchased as distilled in glass from Caledon Scientific and stored over 3Å molecular
sieves. High resolution mass spectra (HRMS) were obtained on a Thermo Scientific DFS
mass spectrometer using electron impact ionization. Dichloromethane (DCM),
acetonitrile (MeCN) and tetrahydrofuran (THF) were dried and deoxygenated by passing
the nitrogen purged solvents through activated alumina columns. All other reagents and
solvents were used as purchased from Aldrich, Alfa Aesar (VWR), or Caledon. Reaction
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progress was followed by thin layer chromatography (TLC) (Merck, TLC Silica gel 60
F254) visualizing with UV light. The plates were developed using acidic p-anisaldehyde.
Column chromatography was performed using silica gel purchased from Silicycle
Chemical Division Inc. (230-400 mesh). All columns were performed using Still’s
procedure for flash chromatography.96 IR spectra were acquired using an Attenuated
Total Reflection (ATR) PerkinElmer Spectrum Two FT-IR. Melting points were
determined using a Gallenkamp melting point apparatus and are uncorrected. NMR data
were acquired on either a Bruker AvIII 400 or Inova 600 instrument. Samples were
obtained in CDCl3 (referenced to 7.25 ppm for 1H and 77.0 ppm for 13C). Coupling
constants (J) are in Hz. The multiplicities of the signals are described using the following
abbreviations: s = singlet, d = doublet, t = triplet, q = quartet, dd = doublet of doublets, dt
= doublet of triplets, dq = doublet of quartets, m = multiplet, br = broad.

2.6.2 General Experimental Procedure for the Synthesis of Indole
Starting Materials
Commercially available indole starting materials were used as purchased. When not
available the substrates were obtained by N-methylation or alkylation of the parent indole
following published procedures and then confirmed by comparison to reported
characterization data for these compounds. Methylated/alkylated indoles (2-8a-i) were
synthesized following literature procedures 97,98,99,100 using the following conditions:
Desired indole (1 equiv.) was dissolved in dry THF or DMF in an argon-flushed flask to
give a 0.3 M solution. NaH (60% dispersed in mineral oil, 1.5 eq) was added portion wise
at 0 °C and then the reaction septum was returned. The flask was evacuated and placed
under argon once more. The reaction was warmed to room temperature and stirred for
1.5 h. At which point, the reaction was cooled to 0 °C and MeI (1.3 equiv.) or BnBr (1.1
eq) was added dropwise via syringe. The reactions were allowed to stir at room
temperature until TLC analysis confirmed consumption of starting materials, or until 24 h
had passed. Water was added to quench the reaction, and then extracted 3x with Et2O.
The organic layers were combined and washed 1x with brine, and then dried using
MgSO4. Upon filtering and concentrating, the crude mixture was purified via flash
column chromatography (EtOAc:Hex) and pure product was collected.
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2.6.3 Synthesis of Cyclopropane Starting Materials
All diester and hemimalonate cyclopropanes were synthesized via literature methods and
confirmed by comparison to the reported characterization data:
Hemimalonate CPs: Ph (2-9a) and p-NO2 (2-9b) CP 101
Diester CPs: Ph (2-11a), p-NO2 (2-11b), p-Br (2-11c), p-Cl (2-11d) 102 103
Fluorodiester CP: Ph (2-13a) and p-Br (2-13b) 104

2.6.4 General Experimental Procedure: Nucleophilic Opening of
Hemimalonate Cyclopropanes (GP1)

Scheme 49 - General reaction scheme for the products characterized below
Cyclopropane (1equiv.), indole substrate (2 equiv.), and 50:50 i-PrOH:HFIP (for a
concentration of 0.2 M) were added to an argon-flushed sealed tube. The tube was sealed,
submerged into an oil bath at 65−70 °C, and left to react for 12−24 h. Upon confirmation
of the starting material consumption via TLC, the reactions were poured into a roundbottom flask, rinsed with DCM, and then concentrated in vacuo. The crude mixture was
subjected to flash column chromatography using an appropriate eluent system of either
AcOH:MeOH:DCM or AcOH:EtOAc:Hex. In some cases (indicated below), instead of a
column, the crude material was taken up in 2 M NaOH and was extracted with Et2O or
DCM 3x to remove excess indole. The collected aqueous fraction was then acidified with
concentrated HCl (very slowly, with cooling if needed) to a pH of 1. The resulting acidic
aqueous layer was then extracted with EtOAc 3×, and the organic fractions were
combined, washed with brine, dried with MgSO4, filtered, and concentrated in vacuo to
yield a purified product.
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4-(1,2-dimethyl-1H-indol-3-yl)-2-(methoxycarbonyl)-4phenylbutanoic acid (2-10b)
Following GP1, CP 2-9a (0.05 g, 0.23 mmol) and 1,2-dimethylindole
(0.066 g, 0.45 mmol) in 1.2 mL of HFIP:i-PrOH were reacted for
20 h. The reaction was concentrated in vacuo, then taken up in 1 M
NaOH, and placed into a separatory funnel. Extractions using DCM 3× and monitoring
by TLC showed that all the indole had been removed from the aqueous phase. The basic
aqueous layer was then carefully acidified with concentrated HCl to pH = 1 and was
extracted with DCM 3×. The organic layers were washed with brine1×and then dried
with MgSO4. Upon being filtered and concentrated in vacuo, the pure product 2-10b was
isolated as a white solid (0.069 g, 83% yield). Rf= 0.26 (30% EtOAc:1% AcOH:69%
Hex). Characterization data for this compound matched literature reports.101 1H NMR
mixture of diastereomers (400 MHz, CDCl3) δ: 7.46 (t, J= 7.7Hz, 1H), 7.34 (d, J= 7.6
Hz, 2H), 7.23−7.21 (m, 3H), 7.16−7.07 (m,2H), 7.01−6.95 (m, 1H), 4.36−4.26 (m, 1H),
3.65, 3.62, and 3.56 (s, 6H total), 3.36−3.29 (m, 1H), 2.97−2.86 (m, 2H), 2.33 and 2.32
(s, 3H total).
2-(methoxycarbonyl)-4-(1-methyl-2-phenyl-1H-indol-3-yl)-4phenylbutanoic acid (2-10c)
Following GP1, hemimalonate CP 2-9a (0.05 g, 0.23 mmol), 2phenyl-1-methylindole (0.10 g, 0.48 mmol) in 1.2 mL of HFIP:iPrOH
were reacted for 16 h. The reaction was concentrated in vacuo and purified directly via
flash column chromatography. The pure product was isolated as a white solid (0.072 g,
70%). MP = 165-169 °C Rf = 0.37 (40% EtOAc: 1% AcOH: 59% Hexanes)
1H

NMR (599 MHz, CDCl3) mixture of diastereomers δ = 7.63 (t, J = 8.2 Hz, 1H),

7.45 – 7.26 (m, 8H), 7.20 – 7.05 (m, 5H), 4.13 (two t appears as ddd, J = 16.4, 11.0, 5.4
Hz, 1H), 3.56 and 3.55 (s, 3H), 3.46 (s, 3H), 3.29 – 3.21 (m, 1H), 2.92 – 2.71 (m, 2H) 13C
NMR (151 MHz, CDCl3) mixture of diastereomers δ 169.7, 144.8, 140.0, 131.2, 129.4,
128.7, 128.0, 126.4, 122.1, 121.0, 119.9, 110.0, 52.7, 50.5, 40.6, 34.4, 31.2. IRATR (cm-1)
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2954, 1743, 1694, 1468, 1433, 1290, 1146, 744, 699 HRMS (EI) m/z [M+] 427.17746
(calcd for C27H25NO4, 427.17836)
2-(methoxycarbonyl)-4-(1-methyl-1H-indol-3-yl)-4phenylbutanoic acid (2-10a)
Following GP1, hemimalonate CP 2-9a (0.10 g, 0.46 mmol) and 1methylindole (0.126 g, 0.92 mmol) in 2.4 mL of HFIP:iPrOH were
reacted for 20 h. The reaction was concentrated in vacuo, taken up in 1 M NaOH.
Extractions using DCM 3× and monitoring by TLC showed that all the indole had been
removed from the aqueous phase. The basic aqueous layer was then carefully acidified
with concentrated HCl to pH = 1 and was extracted with DCM 3×. The organic layers
were washed with brine1× and then dried with MgSO4. The pure product was isolated as
an off-white solid (0.12 g, 76% yield). Rf = 0.47 (1% AcOH:1% MeOH:8% DCM).
Characterization data for this compound matched literature reports.101
1H

NMR mixture of diastereomers (400 MHz, CDCl3) δ: 9.91 (br, s, 1H), 7.45 (m,

1H), 7.36−7.26 (m, 4H), 7.22−7.15 (m, 3H), 7.02 (m, 1H), 6.90and 6.88 (s, 1H total),
4.26 (m, 1H), 3.74 and 3.68 (s, 6H total), 3.44(m,1H), 2.85m, 1H), 2.71−2.58 (m, 1H).
4-(1H-indol-3-yl)-2-(methoxycarbonyl)-4-phenylbutanoic acid (210d)
Following GP1, hemimalonate CP 2-9a (0.05 g, 0.23 mmol) and
indole (0.054 g, 0.46 mmol) in 1.2 mL of HFIP:iPrOH were reacted
for 20 h. The crude mixture was concentrated in vacuo and purified
by flash column chromatography. Rf= 0.32 (1% AcOH:1% MeOH:98% DCM). The
product was isolated as a yellow oil (0.024 g, 31%). Even after multiple purification
attempts, the characterization data were unclean but had results matching the reported
literature.101
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4-(5-bromo-1-methyl-1H-indol-3-yl)-2-(methoxycarbonyl)-4phenylbutanoic acid (2-10e)
Following GP1, hemimalonate CP 2-9a (0.075 g, 0.34 mmol) and
5-bromo-1-methylindole (0.14 g, 0.68 mmol) in 1.7 mL of
HFIP:iPrOH were heated for 30 h. The crude mixture was
subjected to the extraction method of the purification as described in GP1. The resultant
solid from the extractions was further purified by recrystallization in pentane/DCM to
yield a pure product as a pale-yellow solid (0.10 g, 72%). Rf = 0.5 (1% AcOH:1%
MeOH:98% DCM). Characterization data for this compound matched literature results.101
1H

NMR mixture of diastereomers (400 MHz, CDCl3) δ: 7.54 (m, 1H), 7.31−7.27 (m,

4H), 7.25−7.18 (m, 2H), 7.13 and 7.11 (s, 1H total), 6.92 and 6.89 (s, 1H total),
4.21−4.12 (m, 1H), 3.76 and3.73 and 3.72 and 3.69 (s, 6H total), 3.44−3.37 (m, 1H),
2.85−2.71 (m, 1H), 2.68−2.54 (m, 1H).
4-(5-methoxy-1-methyl-1H-indol-3-yl)-2-(methoxycarbonyl)4-phenylbutanoic acid (2-10f)
Following GP1, hemimalonate CP 2-9a (0.05g, 0.23 mmol) and
5-methoxy-1-methylindole (0.074 g, 0.46 mmol) in 1.2 mL of
HFIP:iPrOH were reacted for 16 h. The reaction was
concentrated in vacuo and purified directly via flash column chromatography. The pure
product was isolated as a white foam (0.056 g, 64%). Rf= 0.27 (40% EtOAc:1%
AcOH:59% Hex).
1H

NMR mixture of diastereomers (400 MHz, CDCl3) δ: 7.34−7.26 (m, 4H),7.19 (t, J

= 7.0 Hz, 1H), 7.14 (d, J = 8.8 Hz, 1H), 6.88 (m, 1H), 6.86−6.79 (m, 2H), 4.19 (m, 1H),
3.76 and 3.67 (s, 3H total), 3.74 and 3.73 (3H total), 3.70 (s, 3H), 3.43 (m, 1H), 2.83 (m,
1H), 2.67−2.55 (m, 1H). 13C NMR mixture of diastereomers (101 MHz, CDCl3) δ:
174.7,169.9, 153.8, 143.4, 132.8, 128.7, 128.5, 128.1, 126.9, 126.7, 116.6, 112.0, 110.1,
101.6, 101.5, 56.0, 52.8, 50.0, 40.8, 35.1 33.0. IRATR (cm-1): 2949, 1732, 1490, 1451,
1212, 1035, 792, 700, 587. HRMS (EI) (m/z): [M+] calcd for C22H23NO5, 381.1576;
found, 381.1574.
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4-(1-benzyl-1H-indol-3-yl)-2-(methoxycarbonyl)-4-phenylbutanoic
acid (2-10g)
Following GP1, hemimalonate CP 2-9a (0.05 g, 0.23 mmol), 1benzylindole (0.095 g, 0.46 mmol) in 1.2 mL of HFIP:iPrOH was
reacted for 16 h. The reaction was concentrated in vacuo and purified
directly via flash column chromatography. The pure product was isolated as a white solid
(0.062 g, 63%) Rf = 0.31 30% EtOAc: 1% AcOH: 69% Hex. Characterization data for
this compound matched literature reports.101
1H

NMR (400 MHz, CDCl3) mixture of diastereomers δ = 7.45 (dd, J = 11.2, 7.9 Hz,

1H), 7.36 – 7.25 (m, 8H), 7.23 – 7.15 (m, 3H), 7.15 – 7.06 (m, 3H), 7.04 – 6.96 (m, 2H),
5.28 (d, J = 2.2 Hz, 1H), 4.28 (two t appearing as q, J = 6.8 Hz, 1H), 3.73 and 3.66 (s, 3H
total), 3.44 – 3.39 (m, 1H), 2.91 – 2.78 (m, 1H), 2.70 – 2.57 (m, 1H).
2-(methoxycarbonyl)-4-(1-methyl-1H-indol-3-yl)-4-(4nitrophenyl)butanoic acid (2-10h)
Following GP1, hemimalonate CP 2-9b (0.05 g, 0.19 mmol), 1methylindole (0.05 g, 0.38 mmol) in 0.65 mL of HFIP:iPrOH was
reacted for 24 h. The reaction was concentrated in vacuo and
purified directly via flash column chromatography. The pure product was isolated as a
yellow foam (0.044 g, 64%). Note: This compound is light sensitive and decomposed
upon 13C NMR data acquisition as evidenced by a color change. Rf = 0.28 (40% EtOAc:
1% AcOH:1% MeOH: 58% Hex).
1H

NMR (599 MHz, CDCl3) mixture of diastereomers δ 8.07 (d, J = 8.7 Hz, 1H), 8.02

(d, J = 8.7 Hz, 2H), 7.37 (dd, J = 8.7, 4.4 Hz, 3H), 7.30 (d, J = 8.8 Hz, 1H), 7.10 (t, J =
7.6 Hz, 1H), 6.95 – 6.88 (m, 1H), 6.86 (d, J = 11.3 Hz, 1H), 4.27 (t, J = 7.7 Hz, 1H), 3.67
(apparent d, J = 3.2 Hz, 1.5H), 3.25 (s, 1.3H), 3.63 and 3.61 (s, 3H), 3.32 (t, J = 8.7 Hz,
1H), 2.81 – 2.64 (m, 1H), 2.55 (td, J = 14.9, 8.7 Hz, 1H) 13C NMR (101 MHz, CDCl3)
mixture of diastereomers δ 177.6, 169.4, 151.6, 146.8, 141.8, 137.5, 130.1, 128.9, 128.5,
126.9, 126.4, 124.0, 123.6, 122.3, 119.5, 119.2, 115.0, 109.6, 52.9, 40.5, 34.6, 33.0, 21.5.
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IRATR (cm-1) 2953, 1733, 1706, 1598, 1514, 1343, 1289, 1152, 855, 737 HRMS (EI) m/z
[M+] 396.1325 (calcd for C21H20N2O6 396.1321).

2.6.5 General Experimental Procedure: Nucleophilic Opening of Bisdimethylester Cyclopropanes (GP2)

Scheme 50 - General reaction conditions to isolate bis-dimethylester
cyclopropane opened products
Cyclopropane (1 equiv.), indole substrate (3 equiv.), and HFIP (for a concentration of 0.3
M) were added to an argon-flushed sealed tube. The tube was sealed, submerged into an
oil bath at 80 °C, and left to react for 12−24 h. Upon confirmation of starting material
consumption via TLC, the reaction was poured into a round-bottom flask, rinsed with
DCM, and then concentrated in vacuo. The crude material was directly subjected to flash
column chromatography using an appropriate eluent system of EtOAc:Hex to isolate a
purified material.

Dimethyl 2-(2-(1,2-dimethyl-1H-indol-3-yl)-2phenylethyl)malonate (2-12a)
Following GP2, CP 2-11a (0.05 g, 0.21 mmol) and 1,2-dimethylindole
(0.093 g, 0.64 mmol) in HFIP (0.7 mL) were subjected to heat for 29 h.
The crude material was purified via flash column chromatography 20%
EtOAc:80% Hex to collect a white solid (0.073 g, 91%).
MP = 81-83 °C Rf = 0.24 (20%EtOAc:80%Hex)
1H

NMR (599 MHz, Chloroform-d) δ = 7.46 (d, J = 8.0 Hz, 1H), 7.35 – 7.33 (m, 3H),

7.25 – 7.20 (m, 4H), 7.16 – 7.10 (m, 3H), 7.00 – 6.96 (m, 1H), 4.28 (t, J = 8.3 Hz, 1H),
3.72 (s, 3H), 3.65 (s, 3H), 3.53 (s, 3H), 3.30 (dd, J = 8.0, 6.8 Hz, 1H), 2.89 (dd, J = 8.9,
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6.5 Hz, 2H), 2.32 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 170.1, 170.0, 144.3, 137.1,
134.3, 128.4, 127.7, 126.7, 126.1, 120.6, 119.6, 119.0, 111.2, 108.8, 52.6, 52.5, 50.6,
39.7, 33.5, 29.7, 10.7. IRATR (cm-1) 2950, 1748, 1724, 1472, 1431, 1249, 1229,
1147,1033, 999. HRMS (EI) m/z [M+] 379.1786 (calcd for C23H24NO4, 379.1784).

Dimethyl 2-(2-(1-Methyl-2-phenyl-1H-indol-3-yl)-2-phenylethyl)malonate (2-12b)
Following GP2, CP 2-11a (0.037 g, 0.16 mmol) and 2phenyl-1-methylindole (0.036 g, 0.17 mmol, 1.1 equiv.) in HFIP (0.5
mL) were subjected to heat for 24 h. The crude material was purified
via flash column chromatography in 20%EtOAc:80%Hex to collect a white solid (0.044
g, 62%).
MP 119−120 °C. Rf = 0.32 (20% EtOAc:80% Hex).
1H

NMR (400 MHz, CDCl3) δ: 7.67 (d, J =8.0 Hz, 1H), 7.49−7.43 (m, 3H), 7.37 (t, J =

7.9 Hz, 3H), 7.33−7.29 (m, 2H), 7.26 (m, 3H), 7.21−7.15 (m, 1H), 7.12 (ddd, J = 8.0, 7.1,
1.0 Hz, 1H), 4.08 (dd, J = 10.7, 5.8 Hz, 1H), 3.56 (s, 3H), 3.48 (s, 3H), 3.45 (s, 3H), 3.24
(dd, J = 9.2, 5.5 Hz, 1H), 2.91−2.72 (m, 2H). 13C NMR (101 MHz, CDCl3) δ: 169.9,
169.8, 144.7, 139.6, 137.7, 131.7, 131.0, 128.4, 127.8, 126.4, 126.1, 121.8, 120.8, 119.6,
112.8, 109.7, 52.4, 50.6, 40.5, 34.2, 31.0. IRATR (cm‑1): 3026, 2953, 1731, 1467, 1435,
1215, 1153, 701. HRMS (EI) (m/z): [M+] calcd for C28H27NO4, 441.1940; found,
441.1948.

Dimethyl 2-(2-(1-Methyl-1H-indol-3-yl)-2-phenylethyl)malonate
(2-12c)

Following GP2, CP 2-11a (0.050 g, 0.21 mmol) and 1-methylindole
(0.083 g, 0.63 mmol) in HFIP (0.7 mL) were subjected to heat for 48
h. The crude material was purified via flash column chromatography in 20% EtOAc:80%
Hex to collect a clear oil (0.026 g, 35%). Rf = 0.24 (20%EtOAc:80%Hex).
Characterization data matched literature reports.100
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1H

NMR (599 MHz, CDCl3) δ: 7.45 (dt, J = 7.8, 0.9 Hz, 1H), 7.34−7.25 (m, 5H), 7.19

(m, 2H), 7.02 (ddd, J = 7.9, 7.0, 1.0 Hz, 1H), 6.88 (s, 1H), 4.22 (t, J = 7.9 Hz, 1H), 3.74
(s, 3H), 3.73 (s, 3H), 3.67 (s, 3H), 3.41 (dd, J = 8.0, 6.6 Hz, 1H), 2.83 (ddd, J = 13.6, 8.0,
7.0 Hz, 1H), 2.62 (ddd, J = 13.6, 8.8, 6.7 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ:
170.0, 143.6, 137.4, 128.7, 128.1, 127.3, 126.6, 126.2, 121.8, 119.6, 119.0, 117.3, 109.3,
52.7, 52.6, 50.2, 40.7, 35.1, 32.8. IRATR (cm−1): 2952, 1754, 1488, 1282, 1159, 974.

Dimethyl 2-(2-(1,2-Dimethyl-1H-indol-3-yl)-2-(4-nitrophenyl)ethyl)malonate (2-12d)

Following GP2, CP 2-11b (0.022 g, 0.08 mmol) and 1,2dimethylindole (0.034 g, 0.24 mmol) in HFIP (0.3 mL) were
subjected to heat for 25 h. The crude material was purified via flash column
chromatography in 30%EtOAc:70%Hex to collect a yellow oil (0.07 g, 19%). Rf = 0.2
(30%EtOAc:70%Hex).
1H

NMR (400 MHz, CDCl3) δ: 8.09 (d, J = 8.8 Hz, 2H), 7.48 (d, J = 8.4 Hz, 2H), 7.34

(d, J = 8.0 Hz, 1H), 7.28 (t, J = 4.4 Hz, 1H), 7.14 (t, J = 8.1 Hz, 1H), 7.02−6.97 (m, 1H),
4.37 (t, J = 8.1 Hz, 1H), 3.73 (s, 3H), 3.67 (s, 3H), 3.54 (s, 3H), 3.27 (dd, J = 8.1, 6.7 Hz,
1H), 2.88 (dd, J = 9.0, 6.7 Hz, 1H), 2.32 (s, 3H). 13C NMR (101 MHz, CDCl3) δ: 169.9,
169.6, 152.1, 146.4, 137.2, 134.7, 128.5, 126.2, 123.7, 121.1, 119.5, 119.0, 109.6, 109.1,
52.7, 52.6, 50.2, 39.6, 33.0, 29.8, 10.7. IRATR (cm−1): 2952, 1732, 1596, 1516, 1471,
1434, 1344, 1251, 1230, 853. HRMS (EI) (m/z): [M+] calcd for C23H24N2O6, 424.1634;
found, 424.1631.
Dimethyl 2-(2-(4-Bromophenyl)-2-(1,2-dimethyl-1H-indol-3-yl)ethyl)malonate (2-12e)
Following GP2, CP 2-11c (0.050 g, 0.16 mmol) and 1,2dimethylindole (0.070 g, 0.48 mmol) in HFIP (0.55 mL) were
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subjected to heat for 24 h. The crude material was purified via flash column
chromatography in 20%EtOAc:80%Hex to collect a viscous yellow oil (0.039 g, 54%).
Rf = 0.26 (20% EtOAc:80% Hex).
1H

NMR (400 MHz, CDCl3) δ: 7.43 (d, J = 7.9 Hz, 2H), 7.40−7.35 (m, 2H), 7.31−7.26

(m, 2H), 7.23 (s, 1H), 7.20−7.12 (m, 1H), 7.02 (m, 1H), 4.26 (t, J = 8.1 Hz, 1H), 3.76 (s,
3H), 3.69 (s, 3H), 3.57 (s, 3H), 3.30 (t, J = 7.9 Hz, 1H), 2.88 (m, 2H), 2.34 (s, 3H). 13C
NMR (101 MHz, CDCl3) δ: 170.0, 169.8, 143.4, 137.1, 134.4, 131.4, 129.5, 126.4,
120.8, 119.9, 119.3, 119.2, 110.5, 108.9, 52.6, 52.5, 50.4, 39.1, 33.3, 29.8, 10.6. IRATR
(cm‑1): 2947, 1730, 1433, 1368, 1222, 1150, 735, 691. HRMS (EI) (m/z): [M+] calcd for
C23H24BrNO4, 457.0889; found, 457.0889

Dimethyl 2-(2-(4-Chlorophenyl)-2-(1,2-dimethyl-1H-indol-3-yl)ethyl)malonate (2-12f)
Following GP2, CP 2-11d (0.050 g, 0.19 mmol) and 1,2dimethylindole (0.081 g, 0.59 mmol) in HFIP (0.6 mL) were
subjected to heat for 48 h. The crude material was purified via flash
column chromatography in 20% EtOAc:80% Hex to collect a clear oil (0.051 g, 66%). Rf
= 0.23 (20% EtOAc:80% Hex).
1H

NMR (400 MHz, CDCl3) δ: 7.44 (d, J = 7.9 Hz, 1H), 7.34−7.27 (m, 3H), 7.26−7.22

(m, 2H), 7.20−7.14 (m, 1H), 7.04 (t, J = 8.0 Hz, 1H), 4.29 (t, J = 8.1 Hz, 1H), 3.77
(s,3H), 3.70 (s, 3H), 3.58 (s, 3H), 3.31 (dd, J = 7.9, 6.9 Hz, 1H), 2.89 (m, 2H), 2.35 (s,
3H). 13C NMR (101 MHz, CDCl3) δ: 170.0, 169.8, 142.8, 137.1, 134.4, 131.8, 129.1,
128.4, 126.4, 120.8, 119.3, 119.2, 110.6, 108.9, 52.6, 52.5, 50.4, 39.1, 33.3, 29.7, 10.6.
IRATR (cm−1): 2951, 1731, 1490, 1471, 1434, 1250, 1151, 1013. HRMS (EI) (m/z):
[M+] calcd for C23H24ClNO4, 413.1394; found, 413.1393.
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2.6.6 General Experimental Procedure: Nucleophilic Opening of Bistrifluoroethylester Cyclopropanes (GP3)

Scheme 51 - General reaction scheme for the nucleophilic opening of bistrifluoroethylester cyclopropanes
Cyclopropane (1 equiv), indole substrate (3 equiv), and HFIP (for a concentration
of 0.3 M) were added to an argon-flushed sealed tube. The tube was sealed off,
submerged into an oil bath at 80 °C, and left to react for 8−24 h. Upon confirmation of
starting material consumption via TLC, the reaction was poured into a round-bottom
flask, rinsed with DCM, and then concentrated down in vacuo. The crude material was
directly subjected to flash column chromatography using an appropriate eluent system of
EtOAc:Hex to isolate a purified material.

Bis(2,2,2-trifluoroethyl) 2-(2-(1-Methyl-1H-indol-3-yl)-2phenylethyl)malonate (2-14a)

Following GP3, CP 2-13a (0.050 g, 0.13 mmol) and 1methylindole (0.053 g, 0.41 mmol) in HFIP (0.5 mL) were
subjected to heat for 24 h. The crude material was purified via flash column
chromatography in 12% EtOAc:88% Hex to collect a clear oil (0.057 g, 85%). Rf = 0.38
(12% EtOAc:88% Hex).
1H

NMR (400 MHz, CDCl3) δ: 7.47 (d, J = 8.0 Hz, 1H), 7.35−7.27 (m, 5H), 7.24−7.18

(m, 2H), 7.09−7.01 (m, 1H), 6.88 (s, 1H), 4.57−4.38 (m, 4H), 4.26 (t, J = 8.0 Hz, 1H),
3.75 (s, 3H), 3.60 (t, J = 7.2 Hz, 1H), 2.96−2.85 (m, 1H), 2.76−2.65 (m, 1H). 19F NMR
(376 MHz, CDCl3) δ: −73.74 (t, J = 7.3 Hz, 3F) −73.75 (t, J = 7.6 Hz, 3F). 13C NMR
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(101 MHz, CDCl3) δ: 167.3, 143.0, 137.5, 128.8, 128.0, 127.1, 126.9, 126.4, 122.7 (q,
1

JC−F= 277 Hz), 122.7 (q, 1JC−F= 277 Hz), 122.0, 119.6, 119.2, 116.5, 109.4, 61.16 (q,

2

JC−F = 37 Hz), 49.7, 40.7, 34.8, 32.9. IRATR (cm−1): 3028, 1754, 1410, 1281, 1216, 1164,

1136, 977, 703. HRMS (EI) (m/z): [M+] calcd for C24H21F6NO4, 501.1375; found,
501.1372.

Bis(2,2,2-trifluoroethyl) 2-(2-(1-Benzyl-1H-indol-3-yl)-2phenylethyl)malonate (2-14b)

Following GP3, CP 2-13a (0.05 g, 0.13 mmol) and 1benzylindole (0.084 g, 0.41 mmol) in HFIP (0.5 mL) were
subjected to heat for 8 h. The crude material was purified via flash column
chromatography in 10% EtOAc:90% Hex to collect a clear oil (0.070 g, 90%). Rf = 0.23
(10% EtOAc:90% Hex).
1H

NMR (400 MHz, CDCl3) δ: 7.47 (d, J = 7.9 Hz, 1H), 7.35−7.25 (m, 7H), 7.22 (dt, J

= 8.6, 2.8 Hz, 2H), 7.18−7.09 (m, 3H), 7.04 (ddd, J = 8.0, 7.0, 1.0 Hz, 1H), 6.99 (s, 1H),
5.29 (s, 2H), 4.57−4.38 (m, 4H), 4.28 (t, J = 8.0 Hz, 1H), 3.62−3.55 (m, 1H), 2.91 (dt, J =
14.1, 7.5 Hz, 1H), 2.71 (ddd, J = 13.9, 8.8, 6.8 Hz, 1H). 19F NMR (376 MHz, CDCl3) δ:
−73.72 (t, J = 8.1 Hz, 3F), −73.75 (t, J = 8.4 Hz, 3F). 13C NMR (101 MHz, CDCl3) δ:
167.3, 167.2, 142.8, 137.5, 137.0, 128.8, 128.7, 127.9, 127.7, 127.3, 126.8, 126.7, 125.6,
122.6 (q, 1JC−F = 278 Hz), 122.5 (q, 1JC−F = 277 Hz), 122.2, 119.6, 119.4, 117.2, 109.9,
61.04 (q, 2JC−F = 37 Hz), 50.1, 49.5, 40.7, 34.7. IRATR (cm−1): 3030, 1753, 1453, 1280,
1216, 1165, 977, 908. HRMS (EI) (m/z): [M+] calcd for C30H25F6NO4, 577.1688; found,
577.1688.

Bis(2,2,2-trifluoroethyl) 2-(2-(1,2-Dimethyl-1H-indol-3-yl)2-phenylethyl)malonate (2-14c).
Following GP3, CP 2-13a (0.05 g, 0.13 mmol) and 1,2dimethylindole (0.059 g, 0.41 mmol) in HFIP (0.5 mL) were
subjected to heat for 18 h. The crude material was purified via
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flash column chromatography in 12.5%EtOAc:87.5%Hex to collect a clear oil (0.050 g,
72%). Rf = 0.47 (20% EtOAc:80% Hex).
1H

NMR (400 MHz, CDCl3) δ: 7.50 (d, J = 8.0 Hz, 1H), 7.36−7.32 (m, 2H), 7.30−7.22

(m, 3H), 7.20−7.11 (m, 2H), 7.02 (ddd, J = 8.0, 7.1, 1.0 Hz, 1H), 4.50 (m, 2H (two
overlapping dq unresolved)), 4.35−4.12 (m, 1H), 3.66 (s, 3H), 3.51 (dd, J = 9.3, 5.2 Hz,
1H), 3.07−2.87 (m, 2H), 2.32 (s, 3H). 19F NMR (376 MHz, CDCl3) δ: −73.71 (t, J = 8.3,
3F), −73.87 (t, J = 8.3 Hz, 3F). 13C NMR (101 MHz, CDCl3) δ: 167.3, 143.9, 137.1,
134.7, 128.5, 127.6, 126.5, 126.3, 122.7 (q, 1JC−F= 277 Hz), 122.6 (q, 1JC−F= 278 Hz),
120.8, 119.4, 119.3, 110.3, 109.0, 61.1 (q, 2JC−F = 36 Hz), 60.9 (q, 2JC−F = 37 Hz), 50.0,
39.9, 33.4, 29.8, 10.5. IRATR (cm−1): 2941, 1753, 1409, 1280, 1162, 976, 700, 561.
HRMS (EI) (m/z): [M+] calcd for C25H23F6NO4, 515.1531; found, 515.1525.

Bis(2,2,2-trifluoroethyl) 2-(2-(1-Methyl-2-phenyl-1H-indol3-yl)-2-phenylethyl)malonate (2-14d)
Following GP3, CP 2-13a (0.050 g, 0.13 mmol) and 2-phenyl-1methylindole (0.084 g, 0.41 mmol) in HFIP (0.5 mL) were
subjected to heat for 4 h. The crude material was purified via
flash column chromatography in 10% EtOAc:90% Hex to collect a clear oil (0.071 g,
91%). Rf = 0.32 (15% EtOAc:85% Hex).
1H

NMR (599 MHz, CDCl3) δ: 7.62 (d, J = 8.0 Hz, 1H), 7.42 (m, 3H), 7.36 (d, J = 8.2

Hz, 1H), 7.32 (d, J = 7.5 Hz, 2H), 7.27−7.22 (m, 5H), 7.17 (t, J = 7.3 Hz, 1H), 7.10 (t, J =
7.5 Hz, 1H), 4.30 (dq, J = 12.6, 8.4 Hz, 1H), 4.19 (dq, J = 12.5, 8.3 Hz, 1H), 4.15−4.08
(m, 2H), 4.00 (dq, J = 12.6, 8.3 Hz, 1H), 3.56 (s, 3H), 3.39 (dd, J = 8.9, 5.4 Hz,
1H), 2.94 (ddd, J = 13.9, 11.5, 5.4 Hz, 1H), 2.80 (ddd, J = 14.1, 8.9, 5.4 Hz, 1H). 19F
NMR (376 MHz, CDCl3) δ: −73.74 (t, J = 8.3 Hz, 3F), −73.88 (t, J = 8.9 Hz, 3F). 13C
NMR (151 MHz, CDCl3) δ: 167.0, 166.8, 144.1, 139.7, 137.6, 131.4, 130.8, 128.5,
128.4, 128.4, 127.6, 126.2, 126.1, 122.51 (q, 1JC−F = 277 Hz), 122.4 (q, 1JC−F = 277
Hz) 121.8, 120.5, 119.7, 111.8, 109.7, 60.9 (q, 2JC−F = 36 Hz), 60.7 (q, 2JC−F = 38 Hz),
49.9, 40.4, 33.9, 30.9. IRATR (cm−1): 3091, 2940, 1774, 1756, 1279, 1240, 1165, 1138,
970, 742, 699, 648. HRMS (EI) (m/z): [M+] calcd for C30H25F6NO4, 577.1688; found,
577. 1693.
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Bis(2,2,2-trifluoroethyl) 2-(2-(1-Methyl-5-nitro-1Hindol-3-yl)-2-phenylethyl)malonate (2-14e)

Following GP3, CP 2-13a (0.050 g, 0.13
mmol) and 5-nitro-1-methylindole (0.071 g, 0.41 mmol) in
HFIP (0.5 mL) were subjected to heat for 20 h. The crude material was purified
via flash column chromatography in 40% EtOAc:60% Hex to collect a yellow solid
(0.035 g, 47%). MP 78−81 °C. Rf = 0.28 (40% EtOAc:60% Hex).
1H

NMR (400 MHz, CDCl3) δ: 8.36 (d, J = 2.1 Hz, 1H), 8.09 (dd, J = 9.1, 2.2 Hz, 1H),

7.37−7.26 (m, 6H), 7.06 (s, 1H), 4.65−4.40 (m, 4H), 4.26 (dd, J = 9.0, 6.9 Hz, 1H), 3.81
(s, 3H), 3.54 (dd, J = 7.9, 6.6 Hz, 1H), 2.84 (m, 1H), 2.70 (ddd, J = 14.0, 9.2, 6.6 Hz,
1H). 19F NMR (376 MHz, CDCl3) δ: −73.69 to −73.87 (m, 6F). 13C NMR (101 MHz,
CDCl3) δ: = 167.1, 141.9, 141.5, 140.1, 129.2, 129.1, 127.9, 127.5, 126.4, 122.7 (q, 1JC−F
= 277.5 Hz), 122.6 (q, 1JC−F= 277.3 Hz) 120.0, 117.9, 116.8, 109.4, 61.30 (q, 2JC−F = 37.2
Hz), 49.4, 40.4, 34.7, 33.4. IRATR (cm‑1): 2940, 1758, 1488, 1322, 1283, 1160, 1064,
973. HRMS (EI) (m/z): [M+] calcd for C24H20F6N2O6, 546.1226; found, 546.1226.

Bis(2,2,2-trifluoroethyl) 2-(2-(5-Methoxy-1-methyl-1Hindol-3-yl)-2-phenylethyl)malonate (2-14f)

Following GP3, CP 2-13a (0.050 g, 0.13 mmol) and 5methoxy-1-methylindole (0.065 g, 0.41 mmol) in HFIP (0.5
mL) were subjected to heat for 18 h. The crude material was purified via flash column
chromatography in 12.5% EtOAc:87.5% Hex to collect a clear oil (0.0632 g, 89%). Rf =
0.34 (20% EtOAc:80% Hex).
1H

NMR (400 MHz, CDCl3) δ: 7.33−7.29 (m, 4H), 7.22 (ddd, J = 8.6, 4.8, 3.3 Hz, 1H),

7.16 (d, J = 9.1 Hz, 1H), 6.90−6.82 (m, 3H), 4.58−4.40 (m, 4H), 4.19 (t, J = 8.0 Hz, 1H),
3.77 (s, 3H), 3.72 (s, 3H), 3.59 (t, J = 7.2 Hz, 1H), 2.88 (dt, J = 14.1, 7.5 Hz, 1H), 2.68
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(ddd, J = 14.0, 8.7, 6.8 Hz, 1H). 19F NMR (376 MHz, CDCl3) δ: −73.73 (t, J = 8.7 Hz,
3F), −73.76 (t, J = 8.6 Hz, 3F). 13C NMR (101 MHz, CDCl3) δ: 167.4, 167.3, 153.9,
143.0, 132.9, 128.8, 128.0, 127.4, 126.9, 122.7 (q, 1JC−F = 277 Hz), 116.0, 112.1, 110.2,
101.5, 61.15 (q, 2JC−F = 37 Hz), 55.9, 49.6, 40.7, 34.7, 33.0. IRATR (cm‑1): 2945,
1753, 1623, 1491, 1280, 1162, 1136, 1058, 701. HRMS (EI) (m/z): [M+] calcd for
C25H23F6NO5, 531.1481; found, 531.1483.

Bis(2,2,2-trifluoroethyl) 2-(2-(5-Bromo-1-methyl-1Hindol-3-yl)-2-phenylethyl)malonate (2-14g)

Following GP3, CP 2-13a (0.05 g, 0.13 mmol) and 5-bromo1-methylindole (0.085 g, 0.41 mmol) in HFIP (0.5 mL) were
subjected to heat for 16 h. The crude material was purified via flash column
chromatography in 15% EtOAc:85% Hex to collect a pale-yellow oil (0.062 g, 79%). Rf
= 0.40 (15% EtOAc:85% Hex). 1H NMR (400 MHz, CDCl3) δ: 7.45 (d, J = 8.0 Hz, 1H),
7.33−7.26 (m, 4H), 7.23−7.17 (m, 2H), 7.03 (ddd, J = 8.0, 7.0, 1.0 Hz, 1H), 6.87 (s, 1H),
4.56−4.37 (m, 4H), 4.24 (t, J = 8.0 Hz, 1H), 3.75 (s, 3H), 3.58 (t, J = 7.2 Hz, 1H), 2.88
(dt, J = 14.1, 7.5 Hz, 1H), 2.69 (ddd, J = 14.0, 8.6, 7.0 Hz, 1H). 19F NMR (376 MHz,
CDCl3 δ: −73.73 (t, J = 7.6 Hz, 3F), −73.76 (t, J = 8.2 Hz, 3F). 13C NMR (101 MHz,
CDCl3 δ: 167.3, 143.0, 137.5, 128.8, 128.0, 127.1, 126.9, 126.4, 122.7 (q, 1JC−F = 277
Hz), 122.6 (q, 1JC−F= 277 Hz), 122.0, 119.6, 119.2, 116.5, 109.4, 61.17 (q, 2JC−F = 37 Hz),
49.7, 40.7, 34.8, 32.9. IRATR (cm−1): 2935, 1753, 1411, 1279, 1162, 976,
703, 664. HRMS (EI) (m/z): [M+] calcd for C24H20BrF6NO4, 579.0478; found,
579.0478.

Bis(2,2,2-trifluoroethyl) 2-(2-(4-Bromophenyl)-2-(1-methyl1Hindol-3-yl)ethyl)malonate (2-14h)
Following GP3, CP 2-13b (0.050 g, 0.11 mmol) and 1methylindole (0.044 g, 0.33 mmol) in HFIP (0.4 mL) were
subjected to heat for 24 h. The crude material was purified via
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flash column chromatography in 5% EtOAc:85% Hex to collect a clear oil (0.061 g,
95%). Rf = 0.35 (15% EtOAc:85% Hex).
1H

NMR (400 MHz, CDCl3) δ: 7.45−7.37 (m, 3H), 7.29 (d, J = 8.2 Hz, 1H), 7.24−7.15

(m, 3H), 7.08−7.01 (m, 1H), 6.88 (s, 1H), 4.61−4.36 (m, 4H), 4.21 (t, J = 8.0 Hz, 1H),
3.76 (s, 3H), 3.57 (t, J = 7.2 Hz, 1H), 2.86 (dt, J = 14.0, 7.6 Hz, 1H), 2.66 (ddd, J = 14.0,
8.1, 7.2 Hz, 1H). 19F NMR (376 MHz, CDCl3) δ: −73.73 (t, J = 8.2 Hz, 3F), −73.74 (t, J
= 7.5 Hz, 3F). 13C NMR (101 MHz, CDCl3) δ: = 167.3, 167.2, 142.2, 137.5, 131.9, 129.7,
126.9, 126.4, 122.7 (q, 1JC−F = 277 Hz), 122.2, 120.7, 119.4, 115.7, 109.5, 61.20 (q, 2JC−F
= 37 Hz), 49.5, 40.1, 34.6, 32.9. IRATR (cm−1): 3422, 2945, 1754, 1411, 1279, 1162, 976,
701, 664. HRMS (m/z): [M+] calcd for C24H20BrF6NO4, 579.0480; found, 579.0454.

Bis(2,2,2-trifluoroethyl) 2-(2-(1H-Indol-3-yl)-2-phenylethyl)malonate (2-14i)

Following GP3, CP 2-13a (0.050 g, 0.13 mmol) and
indole (0.047 g, 0.41 mmol) in HFIP (0.5 mL) were subjected to
heat for 24 h. The crude material was purified via flash column chromatography in
20%EtOAc:80%Hex to collect a clear oil (0.017 g, 25%). Rf = 0.23 (20% EtOAc:80%
Hex).
1H

NMR (400 MHz, CDCl3) δ: 8.02 (s, br, 1H), 7.45 (d, J = 8.4 Hz, 1H), 7.37−7.27 (m,

5H), 7.24−7.13 (m, 2H), 7.08−7.00 (m, 2H), 4.59−4.38 (m, 4H), 4.26 (t, J = 8.0 Hz, 1H),
3.58 (t, J = 7.2 Hz, 1H), 2.90 (dt, J = 14.0, 7.5 Hz, 1H), 2.70 (ddd, J = 14.0, 8.7, 6.9 Hz,
1H). 19F NMR (376 MHz, CDCl3) δ: −73.75 (q, J = 8.9 Hz). 13C NMR (101 MHz,
CDCl3) δ: 167.4, 167.3, 142.8, 136.7, 128.8, 128.0, 127.0, 126.7, 122.7 (q, 1JC−F = 277
Hz), 122.5, 121.5, 119.8, 119.5, 118.2, 111.3, 61.17 (q, 2JC−F = 37 Hz), 49.7, 40.7, 34.7.
IRATR (cm−1): 3422, 1752, 1457, 1413, 1281, 1165, 977. HRMS (EI) (m/z): [M+] calcd
for C23H19F6NO4, 487.1218; found, 487.1219
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Chapter 3 : One-Pot Michael Addition/Radical Cyclization
Reaction of N-Acryloyl Indoles
Chapter 3 Preface
The material in this chapter is adapted from: Irwin, L.C.; Kerr, M.A. Synlett 2017, 28,
2859-2864.
This chapter describes using Mn(OAc)3 as a single electron oxidant to generate complex
multi-ring systems incorporating indoles (Scheme 52). The scaffolds acquired map well
on to a variety of natural products. In a one-pot protocol, a Michael addition of 1,3
dicarbonyl nucleophiles results in a molonyl-tether, which is oxidized by Mn(OAc)3 and
cyclizes onto various substituted indoles. This method is being applied to the total
syntheses of tronocarpine and dippinine B (Chapter 4). A library scope to reflect on the
utility of this protocol is also discussed.

Scheme 52 - Reaction explored in Chapter 2. A one-pot Michael addition then
Mn(III) mediated cyclization of indoles.

3.1 Introduction
Indoles are biological powerhouses. Indoles have proven useful as a variety of anticancer,
antibacterial and antiviral drugs.105 Few indole alkaloids exist that bear a 6-membered
ring, substituted in a 1,2 fashion, off the indole core. This type of bioactive indole has
been found in the flowering Malaysian plant Tabernaemontana corymbosa.106 These
compounds, such as tronocarpine, chippiine, and ervataine, have intriguing bioactive
properties and novel pentacyclic structures that present a challenge to organic chemists
attempting the first total syntheses of these molecules (Figure 13). 106,107
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Figure 13 - Indole-containing natural products isolated from Tabernaemontana
corymbosa.
Due to the importance of indoles in both medicinal and natural products chemistry, being
able to functionalize this heterocyclic motif is important.108 When it comes to further
elaboration of indole scaffolds, we became interested in single electron transfer (SET)
agents used to forge carbon-carbon bonds via electrophilic radicals. Mn(OAc)3 is a SET
agent capable of generating carbon-centered radicals from enolizable carbonyl
compounds.109,110,111 Radicals generated by Mn(OAc)3 can insert into indoles at the 2, 3,
or 4 position further elaborating these heterocycles.
The mechanism for the oxidative radical generation and insertion into indoles, while
discussed in the introductory chapter of this thesis, is outlined in detail below regarding
how I sought to manipulate this chemistry to elaborate indoles (Scheme 53).

Scheme 53 - Mechanism for radical generation and ring closure of malonate species
onto indole.
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From 3-1, Mn(OAc)3 oxidizes the enolizeable carbon to an electrophilic radical (3-2).
The radical attacks the two position of the indole to produce the favoured 6-membered
ring (3-3). Another equivalent of Mn(OAc)3 oxidizes the remaining radical (3-3) to a
tertiary cation (3-4) which, via elimination of a proton, yields the indole driven by rearomatization. The result is the 1,2 substituted indole and cyclized product 3-5.
Previous work from the Kerr group demonstrated that from indoline (3-7) starting
materials we could generate indoles bearing pendant β-dicarbonyl products (3-9) that
would undergo radical cyclization onto indoles (Scheme 54).112 This work was restricted
to acryloyl chloride 3-8 to acylate indolines, which then needed to be oxidized to acylated
indoles before being subject to Michael addition (MA) with dimethyl malonate. Often to
access the indolines for acylation, its indole was reduced leading to a redundant
reduction/oxidation procedure (Scheme 54). The synthetic world is doing its best now to
minimize oxidation/reduction manipulations especially when it comes to ideal total
synthesis (see Baran’s ideality in synthesis).113

Scheme 54 - Previous Kerr group work using single-electron oxidant Mn(OAc)3 to
perform C-H insertion at 2 position of indoles
With improvements needed, and a desire to complete the total syntheses of tronocarpine
and dippiinne B, an efficient route at accessing these six-membered rings fused to the
1,2-face of an indole core was something to be sought.

3.2 Proposed Research
It was my hope that I may first obviate the isolation of intermediate substrates and
generate the tricyclic scaffolds like 3-10 in a one-pot procedure. I also sought to expand
the substrate scope and have greater substitution on the indoles and acryloyl components
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of the starting materials. From acylated indoles 3-13, we theorized that the Michaeladdition with a malonic entity 3-14 could be performed, and then in the same pot, add
SET agent Mn(OAc)3 to complete the radical cyclization to generate products 3-15
(Scheme 55).

Scheme 55 - Proposed one-pot protocol to generate functionalized indoles 3-15
The proposed work would cut down three synthetic steps and yield more substituted
products than our earlier work. It also removed the redundant reduction/oxidation step
previously employed and it starts from cheaper materials.

3.3 Optimization of the One-Pot Michael Addition and
Mn(OAc)3 Cyclization of Indoles
To determine if this protocol was viable, optimization attempts began by acylating 3methylindole with methacryloyl chloride and using the resultant N-acryloylindole (3-16a)
as our test subject. Dimethylmalonate was our chosen nucleophile because of its
preexisting use with Mn(OAc)3 to generate radicals. Acylation to generate acryloyl
indoles like 3-16a was performed directly from the indoles using a modified and
improved experimental procedure: the details of which are outlined in the experimental
portion of this chapter (Subsection 3.7). Table 3 explores the conditions used to optimize
the formation of product 3-17a.
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Table 3 - Optimization of the One-Pot Michael Addition, Radical Cyclization of Nacryloyl indoles

a

Entry

Nuc. (equiv.)

Base

Solvent 1

Solvent 2

Mn(III)a (equiv.)

Temp
(°C)

Yield of
3-17a
(%)

1

3

-

MeOH

-

6

65

trace

2

3

-

AcOH

-

6

110

5

3

1.5

NEt3

DCM

-

3

35

0

4

2

K2CO3

MeOH

-

3

65

0b

5

2

DBU

MeOH

-

3

65

0b

6

2

DBU

MeCN

MeOH

3

65

43c

7

2

NaH

THF

AcOH

6

110

50c

8

2

NaH

THF

MeOH

6

65

36c

9

2

NaH

THF

AcOH

5

110

23c

10

1.2

NaH

THF

AcOH

4

110

42d

11

1.2

NaH

THF

AcOH

6

110

47d

12

1.5

NaH

THF

AcOH

6

110

57d

13

1.5

NaH

THF

AcOH

7

110

65d

14

1.5

NaH

THF

AcOH

10

110

58d

Mn(OAc)3
Deacylation occurred yielding 3-methylindole
c
Aqueous workup after the completion of both reactions
d
Nonaqueous workup after the completion of both reactions
b
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The first attempt (Table 3, entry 1) involved trying the Michael addition of dimethyl
malonate into the acryloyl indole using a single solvent, MeOH. MeOH, being a polar
protic solvent, is an optimal choice for the radical component of the reaction and we felt
as though it may be polar enough to facilitate the Michael addition of the
dimethylmalonate. The Michael addition was slow and did not proceed to completion.
Adding 6 equivalents of Mn(OAc)3 yielded a messy reaction and only a trace amount of
desired product 3-17a was isolated. However, this was a promising first attempt. Upon
acquiring a small amount of our desired product, we felt as though it was possible to
increase the yields to a respectable value.
AcOH having a lower pH than MeOH and being a suitable polar protic solvent for the
radical generation, we hoped it may have better success in mediating the Michael
addition portion of the reaction (Table 3, entry 2). Only a small improvement was noted,
isolating 5% of product 3-17a. At this point, we turned our attention to using bases to
mediate the Michael addition in an attempt for the best yield possible. NEt3 in DCM
failed to yield any desired product (Table 3, entry 3). This result was expected as there is
no precedent for DCM being a suitable solvent for Mn(OAc)3 radical generation.
Switching back to MeOH as a solvent and using either DBU or K2CO3 as bases, (Table
3, entry 4 and 5) resulted in deacylation of the starting material. Deacylation was
suspected to be the result of the production of small nucleophiles -OMe and/or -OH
(Scheme 56).
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Scheme 56 - Mechanism of deacylation resulting in the isolation of starting indoles.
Knowing that competitive side diacylation was possible, using water-free solvents for the
Michael addition became imperative for success. This led to using acetonitrile in the
presence of DBU for the Michael addition (Table 3, entry 6) and then adding MeOH to
facilitate the radical cyclization. This change to a two-solvent system resulted in 43% of
product 3-17a. Excited, we switched to THF and NaH as the environment for the Michael
addition, and using AcOH for the radical cyclization based on the positive result it gave
in entry 2. These changes further increased the yield of 3-17a to 50% (Table 3, entry 7).
At this point, observations indicated that aqueous workup was troublesome and often the
manganese would make emulsions that could not be broken up or dealt with. Without
doubt, these emulsions were hindering my ability to isolate the maximum amount of
product and so I switched to a non-aqueous workup involving only filtration and flash
column chromatography to isolate pure 3-17a. As per Table 3, entry 12, lowering the
nucleophile equivalents and switching to the non-aqueous work-up resulted in a higher
57% yield of 3-17a. Finally, upping the equivalents of Mn(III) from 6 to 7 provided a
modest 65% yield of isolatable product 3-17a. This would become the optimized
conditions as increasing the amount of Mn(III) to 10 equivalents provided lower yields.

3.4 Library of Generated Products
A substrate scope of the one-pot protocol was investigated on a variety of N-acryloyl
indoles using the optimized conditions (Table 4). We started by testing different 1,3-
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dicarbonyl reagents. Acetylacetone (Table 4, entry 2) and methylacetoacetate (Table 4,
entry 3) both yielded desired products 3-17b and 3-17c in a 59% and 54% yield
respectively. However, when first testing these reagents under the optimized procedure,
competitive aldol condensation of the 1,3-dicarbonyl reagents halted the progress of any
successful Michael addition.114 Using weaker K2CO3 as a base solved this competition
resulting in desired annulation products 3-17b and 3-17c. The procedure is outlined in the
experimental details of this chapter.
When comparing substituents on the acryloyl component of substrate 3-16 (R1 and R2) an
α-methyl substituent (3-16a) versus a hydrogen (3-16c) produced slightly better yields.
This is thought to be a result of a lesser tendency to polymerize, which was a problem
faced when working with the acryloyl indole 3-16c. With a bulky phenyl substituent at
the β-position (R2, 3-16d) yield of the N-acryloylindole dropped significantly. Steric
hinderance of the phenyl group resulted in a tougher Michael addition lowering the
overall yield of 3-17f.
Examining the electronics of the indole, substitution was varied at the 5-position, R4 of
substrate 3-16. Electron-neutral or -donating groups produced higher yields (3-17i and 317g) than their electron withdrawing counterpart, the nitro group 3-17h, where the yield
was much lower at 36%. We hypothesized that because the reaction proceeds through an
electrophilic radical (Scheme 53, 3-3 and 3-4), less electron density would destabilize its
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Table 4 - Substrate Scope One-Pot MA, radical cyclization
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ability to form and produce a lower yield of desired adduct 3-17h.
Variation at R3 of 3-16 gave intuitive results: with a methyl group present (3-17a, 65%),
yields were improved due to stabilization of both the radical and cation formed at the 3position of the indole (Table 4, entry 1 and entry 4). Without the methyl group present
(3-16b) the cyclized product 3-17d was returned in a lower 45% yield.
Finally, we generated an elaborated N-acryloyl indole 3-16h (details discussed in Chapter
4) that, when subjected to the protocol designed in this research, gave scaffolding 3-17j,
which maps nicely on to natural product tronocarpine and dippinnine B. While the yield
was lower due to the complexity of the substrate, this reaction was further optimized
during studies towards the total synthesis of tronocarpine (Chapter 4).
Mn(OAc)3 has been shown in previous research to oxidize indolines to their respective
indoles.115 In one-pot we hoped to perform the Michael addition, oxidize the starting
acryloyl indoline to its indole, and generate the 1,3-dicarbonyl radical to cyclize onto the
newly formed indole. Using N-acryloyl indoline 3-18 and 9 equivalents of Mn(OAc)3,
desired oxidized adduct 3-17e was generated (Scheme 57). Ultimately performing three
synthetic steps in a one-pot procedure.

Scheme 57 - Three steps; oxidation of indoline to indole, Michael addition of
dimethyl malonate and radical cyclization to generate 1,2 annulated indole 3-17e.

3.5 Conclusion and Future Directions
The research outlined in Chapter 3 demonstrates the discovery of the one-pot
procedure to prepare highly substituted 1,2-annulated indole products that allow further
functionalization towards a variety of natural products. Starting from acylated indoles,
generated in a single step (Section 3.7.3), a Michael addition of a 1,3-dicarbonyl moiety
followed by radical cyclization to the 2-position of indoles provided a variety of
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annulated products (Table 4). This chemistry is being used towards the total syntheses of
tronocarpine and dippinnine B which is further discussed in Chapter 4.
I think that Mn(OAc)3 has been well exploited as a SET agent for the radical
cyclization of indoles, and it does possess a downfall in its inconsistency dependent on
where you source your supply (purchase vs. make). I have, however, a perfected
procedure to make quality Mn(OAc)3 repeatably. This procedure is outlined in
Subsection 3.7.2. Mn(OAc)3 can also be a tricky reagent during reaction work-up if all of
it does not reduce and you are left with a thick brown emulsion that traps additional
product. This will result in lowered yields. However, I observed that when the colour of a
reaction changes from dark brown to bright white-orange, the manganese has reduced
and becomes much easier to work up and no emulsion will exist. Yields are significantly
better when this is the case. In a live video presentation facilitated by the American
Chemical Society, Phil Baran presented unpublished work that originally involved the
use of Mn(OAc)3. However, they too came across similar emulsion problems.
Electrochemical generation of radicals was the solution for the transformation they were
pursuing. Electrochemistry is becoming a clean, easy, and fast way to generate radicals
for organic synthesis and I think that functionalizing indoles with radicals avoiding the
use of metals is a better pathway to research.116 While the upfront cost of electrochemical
cells, electrodes, and glassware is daunting, electrochemistry ultimately becomes cheaper
than most traditional synthetic reactions, and often sees easier, cleaner purification.117
It is also likely that exploring one of the many other single electron oxidants would
perhaps provide higher yields of products towards the synthesis of target molecules.
Ceric ammonium nitrate (CAN, (NH4)2Ce(IV)(NO3)6) is relatively inexpensive (although,
more expensive than manganese), but is soluble in a much wider variety of organic
solvents. Easily handled, it performs identical chemistry to that of Mn(OAc)3.118
Experimentation to generate the intermediates en-route to tronocarpine and dippinnine B
using CAN might be another effective tool for increasing the yields of 1,2-annulated
indole products.
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3.6 Experimental
3.6.1

General Experimental Details

All reactions were conducted under an argon atmosphere unless otherwise indicated.
Flasks were oven-dried and cooled in a desiccator prior to use. All chemicals were of
reagent quality and used as obtained from commercial sources with the exception of the
Mn(OAc)3•2H2O, which was prepared by literature procedure with heavy modification,
the exact procedure used is outlined below.119 High resolution mass spectra (HRMS)
were obtained on a Thermo Scientific DFS mass spectrometer using electron impact
ionization. Dichloromethane (DCM), acetonitrile (MeCN), toluene, benzene, and
tetrahydrofuran (THF) were dried and deoxygenated by passing the nitrogen purged
solvents through activated alumina columns. All other reagents and solvents were used as
purchased from Aldrich, Alfa Aesar (VWR), or Caledon. Reaction progress was followed
by thin layer chromatography (TLC) (Merck, TLC Silica gel 60 F254) visualizing with
UV light, and the plates were developed using acidic p-anisaldehyde or vanillin. Column
chromatography was performed using silica gel purchased from Silicycle Chemical
Division Inc. (230-400 mesh). All columns were performed using Still’s procedure for
flash chromatography.120 IR spectra were acquired using a PerkinElmer Spectrum Two
FT-IR. Melting points were determined using a Gallenkamp melting point apparatus and
are uncorrected. NMR experiments were performed on either a BrukerAvIII 400, Varian
Inova 400 or Inova 600 instrument and samples were obtained in CDCl3 (referenced to
7.25 ppm for 1H and 77.0 ppm for 13C). Coupling constants (J) are in Hz. The
multiplicities of the signals are described using the following abbreviations: s = singlet, d
= doublet, t = triplet, q = quartet, dd = doublet of doublets, dt = doublet of triplets, m =
multiplet, br = broad.

3.6.2

Procedure for Synthesis Mn(OAc)3•2H2O

In a 2 L round bottom, add suitable stir bar and 100 g of Mn(OAc)2•4H2O. To the flask
add 700 mL of AcOH and lower into an oil bath in which the temperature reads
somewhere between 105-110 °C. Do not allow the temperature outside of this range,
especially to the hotter end of the spectrum. Equip reflux condenser and stir the reaction
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vigorously. Weigh out 16.08 g of KMnO4 in a weigh boat and monitor the reaction to see
that the Mn(OAc)2•4H2O is mostly dissolved. There will be shiny flakes when it is mixed
in well. This usually takes 5-10 mins. Approximate about ten even amounts of the
KMnO4 for its addition. Add one of the 10 portions of KMnO4 every 2 minutes to the
heated mixture, with stirring, until it’s all gone (10 times, 20 minutes). Let the reaction
stir for 25 minutes after the complete addition of KMnO4, again being sure the oil bath
does not exceed 110 °C. Remove the reaction from the oil bath, turning the hot plate off
and allowing the mixture to cool to room temperature with stirring and without the aid of
an ice bath, or other external cooling method. This will take 1-2 hours. In a large 2L or
3L Erlenmeyer, add 176 mL of water as accurately as possible. A 200 mL graduated
cylinder works well enough. Add the room temperature reaction mixture of Mn(OAc)3 to
the Erlenmeyer charged with water, and leave in a fume hood to crystallize for 2 days.
You can seal the Erlenmeyer with parafilm if you’d like, ensuring plenty of air holes are
added. After this time has passed, filter the mixture using a large ceramic Buchner funnel
equipped with filter paper. Wash the collected solid with ether 5-7 times until the dark
particulates have been washed through, and as the solid dries, it takes on an orangebrown colour versus dark brown (Figure 14). In a fume-hood, scrape the solid off the
filter paper onto Teflon sheet, or saran wrap, and spread out the powder to a thin layer for
quick drying. Allow the Mn(OAc)3•2H2O to air dry. Do NOT subject the material to long
periods of suction vacuum (even while washing with ether) or place on a high-vacuum
pump. Once dry, and the material a nice bright orange, store in a glass screw top bottle.
Yield: 109 g, quantitative yield.

Figure 14 - Comparison of the “good” and “bad” colour of Mn(OAc)3 reagent.
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3.6.3

Experimental Procedure A: Synthesis of Acryloyl Indoles

Scheme 58 - General procedure for the synthesis of
acryloyl indoles

A modified procedure from the literature.121 To a round-bottom charged with DCM (0.1
M) was added indole (1 equiv.), powdered NaOH (5 equiv.) and tetrabutylammonium
hydrogensulfate (Bu4NHSO4) (0.1 equiv.). The mixture was stirred for 30 minutes, at
which point desired acid chloride (2.5 equiv.) was added to the reaction dropwise. The
reaction was monitored by TLC until complete consumption of starting materials was
observed. To the flask was added water and the mixture moved to a separatory funnel.
The aqueous layer was extracted 3x with DCM, and the organic layers combined and
washed with brine. The collected organic fraction was dried with MgSO4, filtered and
concentrated in vacuo. The crude product was purified by flash column chromatography
(Ethyl acetate: Hexanes).
2-methyl-1-(3-methyl-1H-indol-1-yl)prop-2-en-1-one (3-16a)
Following Experimental Procedure A, compound 3-16a was obtained
from commercially available 3-methylindole (skatole) (3.0 g, 22.9 mmol),
Bu4NHSO4 (0.78 g, 2.29 mmol), NaOH (4.58 g, 114 mmol), methacryloyl chloride (5.98
g, 57.2 mmol, 5.6 mL) in 229 mL DCM. After stirring at rt for 2 h, the reaction was
complete. 3-16a was acquired as a yellow oil (2.81 g, 62 %). Rf = 0.38 (10% EtOAc in
hexanes)
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1H

NMR (400 MHz, CDCl3) δ 8.41 (d, J = 7.7 Hz, 1H), 7.51 (d, J = 6.9 Hz, 1H), 7.41 –

7.27 (m, 2H), 7.24 (s, 1H), 5.68 – 5.59 (m, 1H), 5.47 – 5.40 (m, 1H), 2.27 (s, 3H), 2.19 –
2.11 (m, 3H). Spectral data matched literature report of this compound.121
1-(indolin-1-yl)-2-methylprop-2-en-1-one (3-20)
3-20 was synthesized following literature procedure.122 All spectral data
matched. Crude product was used and pushed directly to product 3-16b.

1-(1H-indol-1-yl)-2-methylprop-2-en-1-one (3-16b)
Indoline 3-20 (1.59 g, 8.49 mmol) was dissolved in toluene (34 mL) and
DDQ (2.32 g, 10.2 mmol) was added. The reaction was heated overnight at reflux for 16
h, at which point TLC confirmed consumption of starting material. The solvent was
removed from the crude mixture in vacuo and then re-dissolved in DCM with 6g of silica
added. The DCM was removed under pressure to give the crude material adsorbed to
silica. Dry loaded flash column chromatography (5% EtOAc in hexanes) yielded pure
acylated indole product 3-16b as an orange oil (0.93 g, 59% over 2-steps). Rf = 0.28 (5%
EtOAc in hexanes)
1H

NMR (400 MHz, CDCl3) δ = 8.42 (d, J = 8.2 Hz, 1H), 7.57 (d, J = 7.6 Hz, 1H), 7.47

(d, J = 3.8 Hz, 1H), 7.36 (td, J = 8.3, 7.9, 1.3 Hz, 1H), 7.29 (td, J = 7.6, 1.1 Hz, 1H), 6.60
(d, J = 3.8 Hz, 1H), 5.68 (d, J = 1.0 Hz, 1H), 5.46 (s, 1H), 2.16 (s, 3H) 13C NMR (101
MHz, CDCl3) δ = 169.8, 140.0, 135.7, 131.1, 127.1, 125.0, 124.0, 122.0, 120.9, 116.6,
108.6, 20.1 IRATR (cm-1) 2922, 1683, 1534 1449, 1378, 1343, 1200, 1154, 1075, 888
HRMS m/z [M+] 185.0839 (calcd for C12H11NO,185.0841)
1-(1H-indol-1-yl)prop-2-en-1-one 3-16c
Acylated indole was synthesized following literature procedure.122 The title
product was acquired as an orange solid (0.79 g, 53 % yield over 2-steps). Spectral data
matched reported literature. MP = 44 - 47˚C
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1H

NMR (400 MHz, Chloroform-d) δ = 8.51 (d, J = 8.3 Hz, 1H), 7.58 (d, J = 7.7 Hz,

1H), 7.51 (d, J = 3.7 Hz, 1H), 7.37 (t, J = 7.7 Hz, 1H), 7.30 (t, J = 7.2 Hz, 1H), 6.97 (dd,
J = 16.7, 10.4 Hz, 1H), 6.73 – 6.60 (m, 2H), 6.04 (d, J = 10.4 Hz, 1H)
(E)-1-(1H-indol-1-yl)-3-phenylprop-2-en-1-one 3-16d
Indoline (1.50 g, 12.6 mmol) was dissolved in THF (25 mL)
followed by the addition of K2CO3 (3.48g, 25.2 mmol) to the
round bottom. The mixture was cooled to 0 ˚C and cinnamoyl chloride (2.31 g, 13.9
mmol dissolved in 4 mL THF) was added via syringe to the mixture dropwise. The
reaction was warmed to rt and stirred for 6 h. The mixture was quenched with H2O and
the aqueous layer extracted 3 times with EtOAc. The combined organic layers were
washed with brine once, dried with MgSO4 and concentrated under pressure. The crude
mixture (3.09 g, 12.4 mmol, yellow solid) obtained was immediately pushed forward and
dissolved in toluene (50 mL) followed by the addition of DDQ (3.38 g, 14.9 mmol) and
refluxed for 12 h. The toluene was removed from the crude mixture in vacuo and then the
crude re-dissolved in DCM with 6 g of silica added. The DCM was removed under
pressure to give the crude material adsorbed to silica. Dry loaded flash column
chromatography (10% EtOAc in hexanes) was performed to collect acylated indole 3-16d
as a yellow-solid (1.30 g, 42% over 2-steps). Rf = 0.42 (50% EtOAc in hexanes) MP =
110 – 112 ˚C
1H

NMR (400 MHz, Chloroform-d) δ = 8.54 (d, J = 8.8 Hz, 1H), 8.00 (d, J = 15.4 Hz,

1H), 7.64 (m 3H), 7.59 (d, J = 7.7 Hz, 1H), 7.46 – 7.42 (m, 3H), 7.38 (t, J = 7.7 Hz, 1H),
7.34 – 7.19 (m, 2H), 6.70 (d, J = 4.2 Hz, 1H) 13C NMR (101 MHz, Chloroform-d) δ =
164.4, 146.7, 136.0, 134.6, 130.9, 129.2, 128.5, 125.2, 124.7, 123.9, 121.0, 117.4, 117.0,
109.3. IR (cm-1) 3157, 3054, 1665, 1609, 1536, 1447, 1346, 1297, 1225, 1143, 709.
HRMS m/z [M+] 247.0995 (calcd for C17H13NO, 247.0997).
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1-(5-bromo-1H-indol-1-yl)-2-methylprop-2-en-1-one (3-16e)
Following Experimental Procedure A compound 3-16e was obtained
from commercially available 5-bromoindole (2.0 g, 10.2 mmol),
Bu4NHSO4 (0.35 g, 1.02 mmol), NaOH (2.04 g, 52 mmol),
methacryloyl chloride (2.67 g, 25.5 mmol, 2.5 mL) in 100 mL DCM. The reaction was
stirred for 20 h. 3-16e was obtained as a white solid (1.94 g, 72%). Rf= 0.38 (10% EtOAc
in hexanes). MP = 32 - 34˚C NOTE: 5-bromoindole and its acylated derivative will
decompose in light over time.
1H

NMR (400 MHz, Chloroform-d) δ = 8.28 (d, J = 8.8 Hz, 1H), 7.70 (d, J = 1.8 Hz,

1H), 7.48 (d, J = 3.6 Hz, 1H), 7.44 (dd, J = 8.8, 1.9 Hz, 1H), 6.53 (d, J = 3.7 Hz, 1H),
5.70 (s, 1H), 5.47 (s, 1H), 2.15 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 169.6, 134.4,
132.8, 128.3, 127.8, 123.6, 122.6, 118.0, 117.3, 107.7, 20.1. IR (cm-1) 3019, 2400, 1691,
1445, 1366, 1340, 1216, 813, 778, 669. HRMS m/z [M+] 262.9941 (262.9946 calcd for
C12H10BrNO)

2-methyl-1-(5-nitro-1H-indol-1-yl)prop-2-en-1-one (3-16f)
Following Experimental Procedure A compound 3-16f was
synthesized from 5-nitroindole (1 g, 6.17 mmol), Bu4NHSO4 (0.21 g,
0.62 mmol), NaOH (1.23 g, 30.9 mmol) and methacryloyl chloride (1.61 g, 15.4 mmol,
1.5 mL) in 62 mL of DCM. The reaction was stirred for 2.5 h at which point TLC
confirmed consumption of starting material. 3-16f was obtained as a white powder (0.76
g, 53%). Rf = 0.21 (15% EtOAc in hexanes). MP = 125 – 126˚C NOTE: 5-nitroindole
will decompose over time in light.
1H NMR (400 MHz, CDCl3) δ = 8.54 – 8.41 (m, 1H), 8.23 (dd, J = 9.2, 2.2 Hz, 1H),
7.64 (d, J = 3.8 Hz, 1H), 6.77 – 6.69 (m, 1H), 5.80 (s, 1H), 5.55 (s, 1H), 2.18 (s, 3H) 13C
NMR (101 MHz, CDCl3) δ = 169.5, 144.5, 139.3, 138.8, 130.9, 130.0, 123.8, 120.2,
117.2, 116.7, 108.8, 19.9 IRATR (cm-1) 1695, 1517, 1536, 1442, 1333, 1193, 884, 828,
777, 745 HRMS m/z [M+] 230.0691 (calcd for C12H10N2O3, 230.0691)
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1-(5-methoxy-1H-indol-1-yl)-2-methylprop-2-en-1-one (3-16g)
Following Experimental Procedure A compound 3-16g was
synthesized from 5-methoxyindole (2.0 g, 13.6 mmol), Bu4NHSO4 (0.46 g, 1.36 mmol),
NaOH (2.72 g, 68.0 mmol) and methacryloyl chloride (3.55 g, 34.0 mmol, 3.3 mL) in
140 mL DCM. Reaction was stirred overnight for 18 h. 3-16g was obtained as a yellow
oil (2.39 g, 82%). Rf = 0.33 (15% EtOAc in hexanes).
1H

NMR (400 MHz, Chloroform-d) δ = 8.32 (d, J = 9.0 Hz, 1H), 7.44 (d, J = 3.7 Hz,

1H), 7.03 (s, 1H), 6.96 (dd, J = 9.0, 2.4 Hz, 1H), 6.53 (d, J = 3.7 Hz, 1H), 5.65 (s, 1H),
5.44 (s, 1H), 3.85 (s, 3H), 2.15 (s, 3H) 13C NMR (101 MHz, CDCl3) δ = 169.5, 156.8,
139.9, 132.1, 130.4, 127.8, 121.8, 117.4, 113.4, 108.5, 103.7, 55.8, 20.2 IR (cm-1) 1682,
1534, 1472, 1371, 1278, 1201, 1158, 1033, 909, 722. HRMS m/z [M+] 215.0954 (calcd
for C13H13NO2, 215.0946)
tert-butyl (2-(1-(2-methylenehex-5-enoyl)-1H-indol-3yl)ethyl)carbamate 3-16h
Acrylic acid (2-methylenehex-5-enoic acid) (6.20 g, 49.1 mmol, 1
equiv.) was added to a 25 mL round-bottom and put under and inert
atmosphere of argon. Oxalyl chloride (4.45 mL, 51.0 mmol, 1.05 equiv.) was added
slowly to the flask followed by a single drop of DMF. This reaction mixture was stirred
two hours. To a 500 mL round-bottom was added boc-protected tryptamine (6.39 g, 24.5
mmol, 1 equiv.) in 250 mL of DCM. Bu4NHSO4 (0.83 g, 2.45 mmol, 0.1 equiv.) was
added to the tryptamine followed by powdered NaOH (4.91 g, 122.7 mmol, 5 equiv.).
The reaction was put under and inert atmosphere of argon and allowed to stir for a
minimum of 15 min. At this point the acid chloride generated in the 25 mL round bottom
was cannula transferred over in its entirety (~7.10 g, 49.1 mmol, 2 equiv). The mixture
was allowed to stir under argon for 1 h, at which point TLC confirmed complete
consumption of starting material. The reaction was quenched with water, and extraction
with DCM 3x was performed. The combined organic extracts were washed with water
once, followed by brine and then dried with MgSO4. The solvent was removed in vacuo
to yield the crude material. Purification of the crude compound by flash column
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chromatography was performed using 30% EtOAc:Hexanes to yield the product as a
slightly yellow oil (8.81 g, 83%). Rf = 0.46 (30% EtOAc:Hexanes)
1H

NMR (400 MHz, CDCl3) ∂ = 8.43 (d, J = 8.2 Hz, 1H), 7.54 (d, J = 7.8 Hz, 1H), 7.37

(t, J = 7.7 Hz, 1H), 7.33 – 7.27 (m, 2H), 5.81 (ddt, J = 16.9, 10.2, 6.6 Hz, 1H), 1H), 5.65
(s, 1H), 5.45 (s, 1H), 5.08 – 4.96 (m, 2H), 4.63 (br, s, 1H), 3.44 (q, J = 6.6 Hz, 2H), 2.88
(t, J = 6.9 Hz, 2H), 2.62 (t, J = 7.4 Hz, 2H), 2.34 – 2.26 (m, 2H), 1.43 (s, 9H) 13C NMR
(101 MHz, CDCl3) ∂ = 169.3, 156.0, 143.9, 137.2, 136.2, 131.1, 125.3, 123.9, 121.2,
119.0, 116.9, 116.0, 40.17, 32.0, 33.2, 28.5, 25.7 IR (cm-1) 3356, 2976, 2928, 1684,
1630, 1510, 1451, 1356, 1248, 1170 HRMS m/z [M+] 368.2094 (calcd for C22H28N2O3,
368.2099)

3.6.4
Experimental Procedure B: One-Pot Michael Addition,
Oxidative Radical Cyclization

Scheme 59 - General reaction for the synthesis of 1,2-disubstituted indole annulation
products
To an argon flushed round-bottom was added half of the total THF (0.15 M) required
followed by NaH (60% dispersed in mineral oil, 1.5 equiv.). The 1,3-dicarbonyl species
(1.5 equiv.) was added dropwise via syringe with stirring. The resultant mixture was
stirred for 15 mins at which point the desired acryloyl indole (1 equiv.) dissolved in the
other half- volume of THF and added via syringe. The Michael addition was monitored
by TLC. Once TLC confirmed complete consumption of starting indole, Mn(OAc)3 (7
equiv.) was added to the round bottom flask followed by AcOH (0.12 M). The flask was
equipped with a reflux condenser and put back under an argon atmosphere. The reaction
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was brought to 110 ˚C and refluxed until the mixture changed colour from dark brown to
containing obvious white solid with yellow/orange solution colour. At this point TLC
analysis always indicated complete consumption of starting materials. The crude reaction
mixture was cooled to rt (without ice, just resting) and then diluted with a large excess of
EtOAc. The solution was filtered through a thick pad of celite and then flushed with even
more EtOAc. The solvent was removed under reduced pressure with added toluene to aid
in the removal of acetic acid. Obtained dried crude product was purified with flash
column chromatography (EtOAc:Hexanes). The desired fractions of the column were
collected to a separatory funnel and washed twice with 1 M NaOH solution to remove coeluted dimethyl malonate (only in the cases where the malonate had the same Rf as
product, when they were different the column was sufficient to purify) and then followed
with a brine wash. The organic layer was collected, dried with MgSO4 and concentrated
in vacuo to yield product.

dimethyl 7,10-dimethyl-6-oxo-7,8-dihydropyrido[1,2-a]indole9,9(6H)-dicarboxylate (3-17a)
Following Experimental Procedure B 3-17a was synthesized from
acyl-indole 3-16a (0.30 g, 1.51 mmol), NaH (0.091 g, 2.27 mmol), dimethyl malonate
(0.30 g, 2.27 mmol, 0.26 mL) in 10 mL of THF then Mn(OAc)3 (2.80 g, 10.6 mmol) in
acetic acid (13 mL). 3-17a was isolated as a yellow solid (0.33 g, 65%) Rf = 0.40 (20%
EtOAc in hexanes) MP = 126 – 129 ˚C
1H

NMR (400 MHz, CDCl3) ∂ = 8.50 (d, J = 8.2 Hz, 1H), 7.50 (d, J = 7.7 Hz, 1H), 7.35

(t, J = 7.7 Hz, 1H), 7.30 (t, J = 7.5 Hz, 1H), 3.83 (s, 3H), 3.79 (s, 3H), 2.90 (ddq, J =
12.6, 6.5, 6.3 Hz, 1H), 2.84 (dd, J = 13.0, 4.4 Hz, 1H), 2.39 (t, J = 13.0 Hz, 1H), 2.16 (s,
3H), 1.42 (d, J = 6.8 Hz, 3H) 13C NMR (101 MHz, CDCl3) ∂ = 170.9, 170.4, 169.0,
134.5, 131.1, 128.2, 125.7, 124.0, 118.6, 117.9, 116.8, 55.7, 53.6, 37.5, 35.4, 15.7, 9.2
IRATR (cm-1) 3027, 2954, 1785, 1702, 1456, 1386, 1385, 1308, 1245, 751 HRMS m/z
[M+] 329.1268 (calcd for C18H19NO5, 329.1263)
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1,1'-(7,10-dimethyl-6-oxo-6,7,8,9-tetrahydropyrido[1,2-a]indole-9,9diyl)diethanone (3-17b)
To an oven-dried round bottom was added acylated indole 3-16a (0.20 g,
1.00 mmol), acetylacetone (0.50 g, 5.00 mmol, 0.51 mL), K2CO3 (0.14 g, 1 mmol), 6 mL
of THF and one drop of water. The flask was equipped with reflux condenser and the
mixture heated at 55 ˚C for 24 h at which point starting materials had been consumed. To
the reaction was then added Mn(OAc)3 (1.87 g, 7.0 mmol) and acetic acid (8 mL) and
refluxed at 110 ˚C for 3 h. The mixture was then worked up as described in
Experimental Procedure B from this point onwards. Product 3-17b was obtained as an
orange solid (0.17 g, 59%). Rf = 0.33 (20 % EtOAc in hexanes) MP = 158 – 161˚C
1H

NMR (400 MHz, CDCl3) ∂ = 8.52 (d, J = 8.1 Hz, 1H), 7.52 (d, J = 7.1 Hz, 1H), 7.40

(t, J = 7.0 Hz, 1H), 7.34 (t, J = 7.4 Hz, 1H), 2.85 – 2.69 (m, 2H), 2.26 (s, 3H), 2.24 (s,
3H), 2.22 (s, 3H), 1.42 (d, J = 6.6 Hz, 3H) 13C NMR (101 MHz, CDCl3) ∂ = 205.5,
204.0, 171.2, 134.9, 130.9, 129.0, 126.2, 124.3, 118.7, 116.9, 67.1, 35.4, 28.8, 26.2, 16.0,
10.1 IRATR (cm-1) 2936, 1708, 1607, 1455, 1364, 1305, 1190, 1153, 1128, 1080, 754.
HRMS m/z [M+] 297.1365 (calcd for C18H19NO3, 297.1365)

methyl 9-acetyl-7,10-dimethyl-6-oxo-6,7,8,9-tetrahydropyrido[1,2a]indole- 9-carboxylate (3-17c)
To an oven-dried round bottom was added acylated indole 3-16a (0.25
g, 1.25 mmol), methyl acetoacetate (0.73 g, 6.25 mmol, 0.67 mL), K2CO3 (0.09 g, 0.63
mmol), 8 mL of THF and one drop of water. The flask was equipped with reflux
condenser and the mixture heated at 55 ˚C for 24 h at which point starting materials had
been consumed. To the reaction was then added Mn(OAc)3 (2.35 g, 8.75 mmol) and
AcOH (10 mL) and reacted at 110 ˚C for 6 h. The mixture was then worked up as
described in Experimental Procedure B from this point onwards. Product 3-17c was
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obtained as a yellow solid (0.21 g, 54%). Rf = 0.34 (20% EtOAc in hexanes) MP = 107 –
111 ˚C
1H

NMR (400 MHz, CDCl3) diastereomers ∂ = 8.50 (d, J = 8.0 Hz, 1H), 7.51 (d, J = 7.7

Hz, 1H), 7.41 – 7.27 (m, 2H), 3.84 (diastereomer a) and 3.78 (diastereomer b) (s, 3H),
2.97 – 2.66 (m, 2H), 2.45 – 2.31 (m, 1H), 2.27 (diastereomer a) and 2.23 (diastereomer b)
(s, 3H), 2.20 (diastereomer a) and 2.17 (diastereomer b) (s, 3H), 1.44 (diastereomer b) (d,
J = 6.8 Hz, 3H) and 1.38 (diastereomer a) (d, J = 6.7 Hz, 3H) 13C NMR (101 MHz,
CDCl3) (both diastereomer a and b) ∂ = 202.8, 202.2, 171.0, 170.9, 169.4, 134.6, 130.9,
130.8, 129.1, 127.8, 124.0, 118.6, 118.4, 118.1, 116.8, 116.7, 116.5, 62.9, 59.9, 53.2,
53.2, 36.5, 35.7, 35.5, 35.0, 28.1, 25.4, 16.0, 15.5, 9.5, 9.3 IRATR (cm-1) 2952, 1716,
1456, 1365, 1307, 1239, 1153, 1130, 1084, 754. HRMS m/z [M+] 313.1312 (calcd for
C18H19NO4, 313.1314)

dimethyl 7-methyl-6-oxo-7,8-dihydropyrido[1,2-a]indole-9,9(6H)dicarboxylate (3-17d)
Following Experimental Procedure B, 3-17d was synthesized from
acryloyl indole 3-16b (0.25 g, 1.35 mmol), dimethyl malonate (0.27 g, 2.02 mmol, 0.23
mL), NaH (0.081 g, 2.02 mmol) in 9 mL of THF. Following completion of the Michael
addition was then added Mn(OAc)3 (2.53 g, 9.40 mmol) and acetic acid (11 mL). 3-17d
was isolated as a pale orange solid (0.18 g, 45%). Rf = 0.27 (20 % EtOAc in hexanes).
MP = 109 – 113˚C
1H

NMR (400 MHz, CDCl3) ∂ = 8.48 (d, J = 8.2 Hz, 1H), 7.52 (d, J = 8.4 Hz, 1H), 7.39

– 7.31 (m, 1H), 7.28 (m, 1H), 6.68 (s, 1H), 3.89 (s, 3H), 3.77 (s, 3H), 2.80 (ddd, J = 13.3,
6.7, 4.5 Hz, 1H), 2.72 (dd, J = 13.6, 4.5 Hz, 1H), 2.51 (t, J = 13.5 Hz, 1H), 1.43 (d, J =
6.8 Hz, 3H).

13C

NMR (101 MHz, CDCl3) ∂ = 171.0, 169.6, 168.8, 135.4, 133.0, 129.3,

125.5, 124.3, 120.8, 116.8, 109.2, 55.7, 53.7, 42.0, 36.4, 35.3, 15.9. IRATR (cm-1) 2956,
2923, 2852, 1746, 1708, 1437, 1300, 1144, 1063, 836. HRMS m/z [M+] 315.1112 (calcd
for C17H17NO5, 315.1107).
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dimethyl 6-oxo-7,8-dihydropyrido[1,2-a]indole-9,9(6H)dicarboxylate (3-17e)
Following Experimental Procedure B, 3-17e was synthesized from
acryloyl indole 3-16c (0.30 g, 1.75 mmol), dimethyl malonate (0.27 g, 2.60 mmol, 0.30
mL), NaH (0.10 g, 2.60 mmol) in 12 mL of THF. Following the completion of the
Michae addition, Mn(OAc)3 (3.27 g, 12.2 mmol) was then added with 14 mL of acetic
acid. 15e was isolated as an orange oil (0.20 g, 38%) Rf = 0.17 (20% EtOAc in hexanes).
Or alternative procedure from indoline 3-18: Acylated indoline 3-18 was synthesized
following literature procedure.122 To a round bottom under argon was added THF (6 mL)
followed by NaH (0.10 g, 2.60 mmol) followed by dimethyl malonate (0.34 g, 2.6 mmol,
0.3 mL) dropwise via syringe and the mixture was allowed to stir for 15 min. Acylated
indoline 3-18 (0.3 g, 1.70 mmol) dissolved in 5 mL THF was added to the reaction via
syringe and the reaction was monitored by TLC for completion of the Michael addition.
Upon completion, to the flask was added 17 mL acetic acid and Mn(OAc)3 (4.02 g, 15.0
mmol) and the round bottom equipped with a reflux condenser. The mixture was heated
to reflux for 22 h at which point TLC confirmed the reaction was complete. The mixture
was cooled to room temperature and filtered through a pad of celite and rinsed thoroughly
with ethyl acetate. The crude mixture was concentrated in vacuo and then subjected to
flash column chromatography to isolate 3-17e as an orange oil (0.083 g, 16%) the
collected fraction from the column were washed once with 1M NaOH to remove traces of
dimethyl malonate. Rf = 0.17 (20% EtOAc in hexanes)
1H

NMR (400 MHz, CDCl3) ∂ = 8.47 (d, J = 8.2 Hz, 1H), 7.52 (d, J = 7.7 Hz, 1H), 7.35

(t, J = 8.4 Hz, 1H), 7.30 – 7.26 (m, 1H), 6.69 (s, 1H), 3.84 (s, 6H), 2.85 – 2.78 (m, 2H),
2.68 (t, J = 6.6 Hz, 2H) 13C NMR (101 MHz, CDCl3) ∂ = 168.0, 166.6, 134.3, 131.8,
128.0, 124.6, 123.4, 119.8, 115.8, 108.4, 54.4, 52.7, 29.9, 27.5 IR (cm-1) HRMS m/z
[M+] 301.0959 (calcd for C16H15NO5, 301.0950)
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dimethyl 6-oxo-8-phenyl-7,8-dihydropyrido[1,2-a]indole-9,9(6H)dicarboxylate (3-17f)
Following Experimental Procedure B 3-17f was synthesized from
acryloylindole 3-16d (0.30 g, 1.21 mmol), dimethyl malonate (0.24 g,
1.80 mmol, 0.21 mL), NaH (0.072 g, 1.80 mmol) in 8 mL of THF. Followed up with
Mn(OAc)3 (2.28 g, 8.50 mmol) and acetic acid (10 mL). 3-17f was isolated as a white
solid (0.12 g, 27%) Rf = 0.25 (20% EtOAc in hexanes). MP = 54 – 57 ˚C
1H

NMR (400 MHz, CDCl3) ∂ = 8.55 (d, J = 8.2 Hz, 1H), 7.60 (d, J = 8.3 Hz, 1H), 7.44

– 7.37 (m, 1H), 7.33 (td, J = 7.5, 1.1 Hz, 1H), 7.22 – 7.12 (m, 3H), 7.01 (s, 1H), 6.96 (dd,
J = 7.5, 2.0 Hz, 2H), 4.26 (dd, J = 6.0, 4.3 Hz, 1H), 3.76 (s, 3H), 3.72 – 3.65 (m, 1H),
3.55 (s, 3H), 3.08 (dd, J = 17.7, 4.3 Hz, 1H) 13C NMR (101 MHz, CDCl3) ∂ = 168.6,
167.5, 167.4, 138.8, 135.0, 131.3, 129.6, 128.9, 128.0, 125.7, 124.5, 121.0, 117.0, 112.9,
77.5, 58.7, 53.8, 53.0, 44.7, 42.0, 38.2 IRATR (cm-1) 3034, 2953, 1736, 1696, 1452, 1371,
1323, 1234, 1202, 1167 HRMS m/z [M+] 377.126904 (calcd for C22H19NO5, 377.12632)

dimethyl 2-bromo-7-methyl-6-oxo-7,8-dihydropyrido[1,2a]indole-9,9(6H)-dicarboxylate (3-17g)
Following Experimental Procedure B 3-17g was synthesized
from acryloyl-indole 3-16e (0.30 g, 1.14 mmol), dimethyl malonate (0.22 g, 1.70 mmol,
0.19 mL), NaH (0.068 g, 1.70 mmol) in 8 mL THF, then followed with Mn(OAc)3 (2.14
g, 8.00 mmol) in acetic acid (10 mL). 3-17g was isolated as a yellow solid (0.28 g, 63%)
Rf = 0.29 (20% EtOAc in hexanes) MP = 118 – 122˚C
1H

NMR (400 MHz, CDCl3) ∂ = 8.35 (d, J = 8.8 Hz, 1H), 7.65 (s, 1H), 7.44 (d, J = 10.7

Hz, 1H), 6.62 (s, 1H), 3.90 (s, 3H), 3.79 (s, 3H), 2.80 (ddd, J = 13.2, 6.7, 4.6 Hz, 1H),
2.73 (dd, J = 13.6, 4.5 Hz, 1H), 2.51 (t, J = 13.5 Hz, 1H), 1.43 (d, J = 6.8 Hz, 3H) 13C
NMR (101 MHz, CDCl3) ∂ = 170.7, 169.1, 168.3, 134.1, 133.9, 130.9, 128.2, 123.3,
118.0, 117.4, 108.2, 55.5, 53.6, 36.1, 35.1, 15.6 IRATR (cm-1) 1738, 1445, 1383, 1352,
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1305, 1268, 1242, 1183, 1148, 1075 HRMS m/z [M+] 393.0205 (calcd for C17H16BrNO5,
393.0212)

dimethyl 2-methoxy-7-methyl-6-oxo-7,8-dihydropyrido[1,2a]indole- 9,9(6H)-dicarboxylate (3-17i)
Following Experimental Procedure B 3-17i was synthesized
from acryloyl-indole 3-16g (0.30 g, 1.39 mmol), dimethyl malonate (0.28 g, 2.09 mmol,
0.24 mL), NaH (0.084 g, 2.09 mmol) in THF (9 mL) followed then by Mn(OAc)3 (2.61 g,
9.70 mmol) and acetic acid (11 mL). 3-17i was isolated as a pale-yellow solid (0.29 g,
61%). Rf = 0.24 (25% EtOAc in hexanes) MP = 117 – 120˚C
1H

NMR (400 MHz, CDCl3) ∂ = 8.36 (d, J = 8.9 Hz, 1H), 7.02 – 6.87 (m, 2H), 6.61 (s,

1H), 3.89 (s, 3H), 3.83 (s, 3H), 3.77 (s, 3H), 2.83 – 2.65 (m, 2H), 2.50 (t, J = 13.4 Hz,
1H), 1.42 (d, J = 6.7 Hz, 3H) 13C NMR (101 MHz, CDCl3) ∂ = 170.6, 169.6, 168.7,
156.9, 133.5, 130.3, 130.1, 117.5, 113.8, 109.1, 103.6, 55.8, 53.7, 36.4, 35.1, 15.9 IRATR
(cm-1) 2955, 2837, 1732, 1615, 1435, 1383, 1105, 1073, 1030, 912.9 HRMS m/z [M+]
345.1221 (calcd for C18H19NO6, 345.1212)

dimethyl 7-methyl-2-nitro-6-oxo-7,8-dihydropyrido[1,2a]indole- 9,9(6H)-dicarboxylate (3-17h)
Following Experimental Procedure B 3-17h was synthesized
from acryloyl-indole 3-16f (0.30 g, 1.30 mmol), dimethyl malonate (0.26 g, 1.95 mmol,
0.22 mL), NaH (0.078 g, 1.95 mmol) in 9 mL of THF, followed by Mn(OAc)3 (2.44 g,
9.10 mmol) and acetic acid (11 mL). 3-17h was isolated as a white solid (0.17 g, 36%).
Rf = 0.34 (30% EtOAc in hexanes). MP = 135 – 140 ˚C
1H

NMR (400 MHz, CDCl3) ∂ = 8.58 (d, J = 9.5 Hz, 1H), 8.43 (d, J = 2.3 Hz, 1H), 8.22

(dd, J = 9.1, 2.3 Hz, 1H), 6.83 (s, 1H), 3.92 (s, 3H), 3.80 (s, 3H), 2.86 (dqd, J = 13.5, 6.9,
4.6 Hz, 1H), 2.76 (dd, J = 13.8, 4.5 Hz, 1H), 2.53 (t, J = 13.6 Hz, 1H), 1.45 (d, J = 6.8
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Hz, 3H) 13C NMR (101 MHz, CDCl3) ∂ = 171.1, 168.9, 168.2, 144.7, 138.3, 136.3,
129.3, 120.7, 117.0, 109.5, 55.6, 54.0, 36.0, 35.4, 15.7 IRATR (cm-1) 3128, 2959, 1739,
1717, 1562, 1516, 1443, 1333, 1232, 1174 HRMS m/z [M+] 360.0954 (calcd for
C17H16N2O7, 360.0958)

dimethyl 7-(but-3-en-1-yl)-10-(3-((tertbutoxycarbonyl)
amino)propyl)-6-oxo-7,8-dihydropyrido[1,2-a]indole9,9(6H)-dicarboxylate (3-17j)
Following Experimental Procedure B, 3-17j was synthesized
from acryloyl indole 3-16h (0.26 g, 0.69 mmol), dimethyl malonate (0.18 g, 1.39 mmol,
0.16 mL), NaH (0.06 g, 1.39 mmol) in 5 mL of THF. Upon the completion of the
Michael addition, to the reaction mixture was added Mn(OAc)3 (1.11 g, 4.14 mmol) and
10 mL of MeOH (instead of acetic acid). The mixture was heated under argon at 65 ˚C
for a minimum of 20 h before proceeding with work-up as per Experimental Procedure
B. 3-17j was isolated as a white solid (0.11 g, 30%) Rf = 0.27 (25% EtOAc in hexanes).
MP = 106 – 110˚C
1H

NMR (400 MHz, CDCl3) ∂ = 8.50 (d, J = 8.0 Hz, 1H), 7.66 (d, J = 7.6 Hz, 1H), 7.36

(t, J = 7.1 Hz, 1H), 7.30 (t, J = 7.5 Hz, 1H), 5.83 (ddt, J = 17.2, 10.2, 6.3 Hz, 1H), 5.13 –
5.00 (m, 2H), 4.81 (br, s, 1H), 3.85 (s, 3H), 3.80 (s, 3H), 3.42 (dt, J = 12.4, 6.0 Hz, 2H),
2.93 – 2.83 (m, 2H), 2.77 – 2.59 (m, 2H), 2.38 (t, J = 13.1 Hz, 1H), 2.33 – 2.17 (m, 3H),
1.67 (q, J = 8.3 Hz, 1H), 1.43 (s, 9H) 13C NMR (101 MHz, CDCl3) ∂ = 170.5, 170.4,
168.9, 156.0, 137.5, 134.8, 128.7, 125.9, 124.3, 119.5, 119.0, 116.9, 115.9, 55.9, 53.9,
53.7, 39.3, 35.0, 30.8, 28.9, 28.6 IR (cm-1) 3272, 2956, 1736, 1697, 1456, 1377, 1242,
1167, 1075, 76 HRMS m/z [M+] 498.2361 (calcd for C27H34N2O7, 498.2366)
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Chapter 4 : Progress Towards the Total Synthesis of
Tronocarpine and Dippinine B
The work outlined in this chapter is unpublished.

4.1 Introduction and Overview
Tronocarpine and dippinine B (Scheme 60) are natural products isolated from the
Malaysian tree, Tabernaemontana corymbosa. Many of the alkaloids found in this plant
exhibit anti-malarial and antibiotic activity. Tronocarpine contains a novel pentacylic
framework and a 7-membered lactam not usually seen amongst previously isolated
vobasiny-iboga indoles.
Outlined in this chapter is the progress, trials, and tribulations towards accessing the first
total syntheses of tronocarpine and dippinine B. At the focal point of this total synthesis
lies the methodology discussed in Chapter 3; Mn(III) radical cyclizations involving
indoles. It is this chemistry that is used to make the main scaffold of tronocarpine.

Scheme 60 – Natural product targets in Chapter 4, tronocarpine and dippinine B.

4.2 First Retrosynthetic Analysis of Tronocarpine and
Dippinine B
Analyzing the bond connections of tronocarpine we strategized that its first total
synthesis could be completed as outlined in Scheme 61. Working through Scheme 61:
reductive lactamization of cyanoindole intermediate 4-1 will form the 7-membered C ring
of tronocarpine. The reduction of the cyano group followed by lactamization on the
available ester has precedent in past Kerr group work using Raney nickel and H2.123
Reduction of the ketone adjacent to the indole nitrogen (4-1) will fashion the desired
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alcohol seen in tronocarpine. A Dieckmann condensation between the methyl ketone and
diastereotopically available ester of 4-2 would fashion the E ring of tronocarpine.
Oxidative manipulation will be required to install the α, β-unsaturation of compound 4-1.

Scheme 61 - Retrosynthetic Analysis 1: First proposed route to tronocarpine
Manganese (III) mediated radical cyclization will construct the D ring of 4-2. This would
come from elaborated acryloyl indole 4-3 using the one-pot Michael addition, radical
cyclization outlined in Chapter 3. To fashion elaborated indole 4-3, acylation of
commercially available indole-3-acetonitrile (4-5) with acrylic acid 4-4, would map the
carbons required for tronocarpine.
Examining dippinine B, the retrosynthetic analysis (Scheme 62) is identical to
tronocarpine, but instead of reductive lactamization to construct the ring C, a Michael
addition of nitrile reduced substrate 4-1 is required.
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Scheme 62 - Retrosynthetic Analysis 2: Proposed route to dippinine B
Tronocarpine and dippinine B differ only in the connection of their tryptamine chain
amine; access to both natural products would likely occur from the same intermediates.
For this reason, often just one natural product is discussed, but we were always mindful
that either natural product may be synthesized depending on the reactivity of the
tryptamine chain. At any point, we could have generated either tronocarpine or dippinine
B when trying to close the final rings; tronocarpine requiring a lacatamization with one of
the esters, and dippinine B requiring a Michael addition with the α,β-unsaturated methyl
ketone.
Common to both retrosynthetic analyses is acrylic acid 4-4, and this target was the first
focus of our synthetic efforts.

4.3 First Generation Synthetic Route Towards Tronocarpine
4.3.1

Accessing Acrylic Acid 4-4

Initial work had me hopeful starting from commercially available δ-hexanolactone 4-6.
We proposed that opening lactone 4-6 with sodium methoxide NaOMe, to generate ester
4-7, would put a functional alcohol handle in the correct spot for the required ketone in
acrylic acid 4-4 (Scheme 63). The protected alcohol (4-8) could later be oxidized to the
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methyl ketone and Eschenmoser’s methenylation would provide the acrylic olefin of 410. 124,125

Scheme 63 - First work towards synthesizing acrylic acid 4-4
Unfortunately, opening lactone 4-6 proved troublesome, and re-lactonization of 4-7 back
to starting material was prevalent during attempts to purify the material.
We turned our attention to 4-acetylbutyric acid (4-11) as a better starting material for
synthesizing acid 4-4 (Scheme 64). Though the ketone of 4-11 was ideal for the end goal,
its existence would prove to be a chemoselective nightmare for furnishing the olefinic
component of 4-4. A redundant reduction and protection was first performed. Reduction
of ketone 4-11 was trivial with NaBH4, but low yielding (4-12, 47%). Esterification to set
up the precursor for Eschenmoser chemistry (4-13) worked, but was also low yielding,
returning some δ-hexanolactone 4-6. This route was quickly abandoned even though
alternatives, such as alcohol protection, could have afforded more of the desired material.

Scheme 64 - Failed route to acrylic acid 4-4 from 4-acetylbutyric acid
Rather than chemoselectively reducing the ketone of 4-11, reduction of both the acid and
ketone resulted in diol 4-14 (Scheme 65). The diol was successfully oxidized via Swern
protocol or using PCC (4-15 and 4-16). PCC proved higher yielding, isolating 33% of
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aldehyde 4-16. Aldehyde in hand, first attempts of Eschenmoser’s methenylation were
performed. Success was achieved in a low yielding 16% of acrylate 4-17. Pinnick
oxidation of this material to isolate acrylic acid 4-18 worked, but crudely, and in an
unviable <5% yield. Ultimately, the pathway in Scheme 65 was plagued with low yields
and a step-count that could only make a fit-bit user happy. This was not the ideal start to
any synthesis.
Hitting multiple dead-ends and finding it troublesome to prevent lactonization of the
material being isolated, our attention had to switch to alternative routes. We hypothesized
that acylation of material on to the indole first would yield a more robust substrate to
work with.

Scheme 65 - Unviable route to acrylic acid 4-4.

4.3.2
Chain

Acylation of Indole First: Attempt to Access Acrylic Acid

From the work in Chapter 3, the capability to acylate indoles consistently and with
varying functionality, suggested an alternative route accessing intermediate 4-23 with the
acryloyl component tethered to the indole nitrogen. I could take the available 4acetylbutyric acid 4-11, and acylate phthalimide protected tryptamine 4-19 or indole-3acetonitrile 4-5. I could later install the required alkene component (Scheme 66).
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Scheme 66 - Synthetic route attempting to access acryloyl tryptamine intermediate
4-23.
Acid 4-11 smoothly converted to its acid chloride with SOCl2, and acylation to
phthalimido-tryptamine 4-19 was successful in 43% yield over two steps. Phthalimidotryptamine (4-19) was used because it was available in the lab, and indole-3-acetonitrile
was expensive for pursuing optimized conditions. Protecting the ketone of intermediate
4-20 with ethanethiol resulted in thioacetal 4-21 in a 71% yield. This would inhibit any
alternate Eschenmoser products in the next step. Unfortunately, attempts at the
methenylation did not provide any desired product, and progression to desired acryloyl
indole 4-23 was halted.
At this point, concerns regarding the use of a phthalimide protecting group were brought
forward. Previous Kerr group member Bryan Landschoot had troubles getting Mn(III)
radical chemistry to work on substrates that made use of the protecting group. To avoid
future complications, the phthalimide protected tryptamine was abandoned and this route
was reconsidered. Switching to indole-3-acetonitrile as per the original retrosynthesis,
resulted in yet another dead-end (Scheme 67).
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Per Scheme 67, acylation of 4-5 resulted in a higher yield of acryloyl indole 4-25
(>94%), and ketone protection with the more easily removed acetal of ethylene glycol
was performed. 4-26 was isolated in a 56% yield. Eschenmoser olefination attempts were
again fruitless under different bases and product 4-27 failed to be isolated.

Scheme 67 - Indole-3-acetonitrile as a starting indole in the attempt to isolate
acryloyl indole 4-23
The Eschenmoser methenylation route to install the necessary α,β-unsaturated component
of a Michael acceptor was proving to be the wrong strategy to synthesize natural products
tronocarpine and dipinine B. A completely different route needed to be established.

4.3.3
Successful Generation of Acrylic Acid 4-28 and Optimization
of the Synthetic Route
Attempts at synthesizing product 4-4 failed repeatedly and with methenylation proving
troublesome, an alternate route was sought. Masking the ketone in earlier synthetic
attempts was redundant, and we had worries it was going to become a difficult task to
either: 1) unmask the ketone in whatever its protected form was or 2) prevent it from
interfering with important reactions to come. In a group meeting with visiting speaker
Alison Frontier, had the wisdom to suggest masking the ketone as a terminal olefin,
removing all worries of chemoselective issues to come. The terminal olefin could be
oxidized by a Wacker oxidation and allow control over when the ketone came into play.
This proved to be an exceptional idea and the new synthetic target of 4-28 was realized
(Figure 15).
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Figure 15 - New acrylic acid target 4-28
This new target would serve its purpose of being a suitable acylating reagent with indole3-acetonitrile; it contained both the appropriate Michael accepting functionality, and the
olefin capable of interconversion via Wacker oxidation to the ketone for Dieckmann
cyclization.
Work published by Stetter et al. used hemimalonate esters (4-29) in the presence of
formaldehyde, pyridine, and catalytic piperidine to perform decarboxylative Mannichtype reactions that generated acrylic esters (4-30) (Scheme 68).126

Scheme 68- Stetter's work generating acrylic esters.
With knowledge of Stetter’s work, I needed to develop a hemimalonate compound with
the appropriate terminal alkene-bearing chain (4-34). Scheme 69 outlines the chemical
pathway to successfully generate acrylic acid 4-28. Starting from dimethylmalonate (431), alkylation with 4-bromo-1-butene (4-32) generated alpha-substituted product 4-33 in
a high 93% yield and at sufficient purity to avoid the use of column chromatography. The
first route used a monosaponification of product 4-33 to access hemimalonate 4-34 in an
89% yield without requiring column purification. From the hemimalonate 4-34, Stetter’s
decarboxylative Mannich-type reaction was employed and I were thrilled to isolate a 78%
yield of acrylic ester 4-36. Saponifcation of ester 4-36 generated an 88% yield of 4-28 for
the first successful synthesis of an acrylic acid we sought. This first-generation synthesis
isolated product 4-28 in 4 steps and a 57% overall yield.
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Scheme 69 - The first successful synthesis of 4-28 and it's improved 3-step synthesis
However, I figured that one step could be cut from this forward synthesis to avoid
working with the extremely volatile and acrid smelling 4-34. Instead of monosaponifying
product 4-33, I performed a double saponification resulting in malonic acid 4-35. This
acid also successfully underwent the decarboxylative Mannich procedure and yielded
desirable acrylate 4-28 in 3 steps and a 67% overall yield. Acid 4-28 was now easily
synthesizable in large quantities (~10 g from 25 g of 4-bromo-1-butene, 4-32) and
progress towards piecing together tronocarpine could be explored further.

4.4 Second Generation Synthesis Towards Tronocarpine
4.4.1

Indole-3-acetonitrile

Acid 4-28 in hand, the second attempt at piecing together the framework of tronocarpine
and dippinine B commenced and issues with this route quickly became apparent (Scheme
70).
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Scheme 70 - Progress towards tronocarpine using indole-3-acetonitrile and acrylate
4-28.
From acid 4-28 (Scheme 70), acylation of indole-3-acetonitrile (4-5) was troublesome,
and resulted in a lot of destroyed material before realizing that after two hours, significant
decomposition takes over despite indole 4-5 not being consumed. Two hours was
determined to be the optimal amount of time to isolate just a 48% yield of acryloyl indole
4-37. Many attempts were made to increase this yield because of the quantitative results
achieved when acylating indole 4-5 with 4-acetylbutyric acid (4-11). However, this
earlier reaction (Scheme 67) was complete in just 15 minutes. Although never cleanly
isolated, it is suspected that a grammine-type fragmentation of indole 4-5 was occurring
under these basic conditions. The maximum amount of product 4-37 isolated was 48%.
This was a significant hint that using a nitrile-substituted indole would not be ideal for
the progression of this synthesis, but there was enough material to continue forward.
From product 4-37, the Michael addition with dimethyl malonate yielded tethered
product 4-38 in an 80% yield (Scheme 70). The Mn(OAc)3 radical cyclization to the 2-
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position of indole 4-39 proceeded in a respectable 65% yield and then first attempt at a
Wacker oxidation resulted in a 71% yield of ketone 4-40. Unfortunately, all attempts at a
Dieckmann cyclization from this ketone product were unsuccessful. Bases such as NaH
and NaOMe failed to generate any indication of product 4-41. Decomposition was
prevalent under these basic conditions. I tried a TiCl4 catalyzed reaction to access product
4-41 and at temperatures ranging between 0 °C and -78 °C, decomposition again
prevailed. With the issues of isolating product 4-41 in clean, and appreciable amounts, I
hypothesized that using a boc-protected tryptamine (4-42) would give us more reliable
results.

4.4.2

Boc-Tryptamine Indole Source

Chemistry was repeated using tryptamine 4-42 in place of indole-3-acetonitrile (Scheme
71). Initial acylation of tryptamine indole 4-42 with acrylate 4-28 proceeded in a higher
86% yield than when indole-3-acetonitrile was used, yielding 4-43 (Scheme 71). Michael
addition with dimethylmalonate provided an 83% yield of 4-44 and the Mn(OAc3) radical
cyclization gave us desired 1,2-cyclized indole 4-45.

Scheme 71 - Tryptamine as the indole source to synthesize lactam 4-46
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At this point, lactamization of 4-45 was realized with the procedure outlined by TorresOchoa using p-toluenesulfonic acid followed by K2CO3 and methanol. The results were
high yielding, generating 98% of lactam 4-46 in a single diastereomer (Scheme 71).
Because we had performed the lactamization first, there was the possibility that the amine
tether could attack either accessible ester without constraint (Scheme 72). It was here I
hoped luck was on our side and this lactamization yielded the correct diastereomer (446a) as the molecule exists in nature (Scheme 72).

Scheme 72 - Possible diastereomeric results of the lactam formation 4-46.
Due to geometric constraints, the wrong diastereomer (4-46b) of the lactamized product
would not be suitable to complete the final Dieckmann cyclization to form ring E. To
determine which diastereomer was isolated, we first used a 1D NOESY NMR irradiating
the methyl ester protons. If the proton on the other quaternary center felt any throughspace NOESY interaction to the methylester, it was likely that these protons were on the
same face of the molecule (corresponding to product 4-46b). Unfortunately, these
protons were also possibly outside the detection distance of a NOESY interaction. When
the NMR results were devoid of a NOESY correlation, it did not conclusively indicate
that the wrong diastereomer was isolated. X-ray crystallography had to be used to
determine which diastereomer of 4-46 was being generated. While crystal growing
experiments were attempted, progress for generating ring D of tronocarpine was explored
anyways.

4.4.3 Exploring an Aldol Reaction to Generate Ring E
3.45 g of lactam 4-46 was easily synthesized. Due to the previous shortcomings
experienced when trying to complete ring E with a Deickmann cyclization, an
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intramolecular Aldol reaction was considered to form the ring. Aldehyde 4-48 (Scheme
73) would be far more reactive than ester (4-40), and the closed E ring would exist in the
correct oxidation state seen in tronocarpine without further manipulation.
Reduction attempts of 4-46 (Scheme 73) using DIBAL-H to stop directly at the aldehyde
were unsuccessful. When DIBAL-H was used at -78 ˚C no reaction occurred and starting
material was recovered. Only upon warming the solution did we observe reduction of the
indole acyl ketone and ester. The 1H NMR evidence supported a mixture of diastereomers
that was difficult to conclusively analyze as the desired product. The evidence of the
indole 7-position proton shifting upfield by approximately 1 ppm indicated the reduction
of indole acyl ketone 4-46 had potentially occurred. The methyl ester peak was also
absent. However, it was only crude and messy mixtures of product 4-47 were isolated.
The reduced product 4-47 was pushed into a DMP oxidation in attempt to get material
that we could accurately elucidate, but again isolated a crude and unpurifiable mixture
that had evidence of an aldehyde. This chemistry was extraordinarily finicky,
unreproducible, and never gave clean results.

Scheme 73 - Attempt at accessing the full pentacyclic structure of tronocarpine

122

Lacking confidence in the products generated in Scheme 73, finding a clean and high
yielding method to confidently generate diol 4-47, preferably as one diastereomer, was
sought.
Confident that an Aldol reaction would close ring E of tronocarpine, generating diol 4-47
so it could be further oxidized to product 4-48 was aggressively explored (Scheme 74).

Scheme 74 - Ideal route incorporating an Aldol reaction to generate the pentacyclic
framework of tronocarpine
In an attempt to isolate diol 4-47 cleanly, lactam 4-46 was subject to a variety of reducing
agents under differing reaction conditions. This work is summarized in Table 5, and can
be precisely summarized as: the methyl ester of product 4-46 is difficult to reduce, and it
did not happen. It is likely that this methyl ester was sterically inaccessible.
Sterically hindered reducing agents like DIBAL-H and LiEt3BH (Table 5, entry 1 and
entry 10) exhibited difficulty transferring hydride to the carbonyl carbon and starting
material was recovered in these cases.
Table 5 - Attempts to reduce lactam 4-46 and form desired diol 4-47a

Entry

1
2

Reducing
Agent
(equiv.)
DIBAL-H (3)
NaBH4 (40)

Temperature
(˚C)

Solvent

-78 ˚C
reflux

DCM
MeOH

Result or
Product Yield
4-46 recovered
Product 4-47b
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3
4*
5

DIBAL-H (5)
DIBAL-H (10)
LiBH4

-78 ˚C
-78 ˚C
rt - 50 ˚C

DCM
DCM
1:1
MeOH:THF

4-46 recovered
4-46 recovered
4-46 recovered

6

rt

7**

CaCl2 (5),
NaBH4 (10)
DIBAL-H (5)

-78 ˚C - rt

1:1
MeOH:THF
DCM

8

DIBAL-H (5)

rt

DCM

9

rt

EtOH

10
11

NaBH4 (10),
CeCl3 (1.5)
LiEt3BH (3)
LiEt3BH (3)

4-47b*** +
Decomposition
4-47a suspected
as diastereomers
(37%) and
Product 4-47b
4-47a suspected
as diastereomers
(40%) and
4-47b
4-47b (2 days)

0 ˚C
rt

DCM
THF

12

LiEt3BH (10)

0 ˚C

THF

13

LiCl (5),
NaBH4 (5)
LAH

rt

THF

rt

THF

14

4-47b
4-47a
diastereomers
(24%) + Product
B
Product 4-47a
diastereomers
(20%) + Product
B
SM and 4-47b
Product 4-47a
(26%)
Significantly one
diastereomer,
clean

*

Indicates that a different solution of DIBAL was trialed in case of decomposed/aged reagent used in
previous attempts
**
Indicates brand new bottle of DIBAL-H
***
Product B is undesirable and was not isolated to determine an accurate yield

A wide variety of reducing agents (LAH, LiBH4, LiEt3BH, DIBAL-H, NaBH4) can
reduce the indole acylated ketone, which, while good news for the final structures of
tronocarpine and dippinine B, was not helpful here as the methyl ester was not reduced
further. This pathway reducing the methyl ester in lactam 4-46 was not a viable pathway
and no further focus was given to this route.
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Additional ways to generate a more reactive ester or install a primary alcohol at that
position were explored. Krapcho conditions were examined to see if the ester could be
removed. It seemed plausible that the anion produced in situ could attack
paraformaldehyde to generate a primary alcohol without the use of reductive conditions,
thereby removing the possibility of also reducing the indole acyl ketone (Scheme 75).
Unfortunately, this chemistry was also unsuccessful and under forcing microwave
conditions, starting materials were recovered along with evidence of the hydrogencontaining Krapcho product (Scheme 75).

Scheme 75- Krapcho attempt to install alcohol chain via attack of
paraformaldehyde

4.4.4
Crystal Structure and Attempts to Epimerize the
Diastereotopic Center
Results of the X-ray crystal structure returned with unfortunate news. The amine had
closed selectively onto the wrong ester leaving the remaining existing in the opposite
plane of the alkene chain (4-46b) (Figure 16). These results meant that closure of ring E
via the planned Dieckmann cyclization would be impossible unless the chain alpha to the
indole acyl ketone was epimerized.

125

Figure 16 - Crystal structure of lactam product 4-46 indicating undesirable
diastereochemistry
To test if epimerization was possible, lactam 4-46b was deprotonated with LDA and
quenched with D2O. NMR results of this experiment concluded that exclusive
deprotonation of the amide N-H had occurred (Figure 17). Knowing the amide proton
was so easily removed allowed for re-examination of our pathway to ensure that we kept
that proton protected while making any transformations under basic conditions. A route
in which I explore protections of this amine are discussed in vide.

126

Figure 17 - 1H NMR of deprotonated lactam showing loss of amide proton when
quenched with D2O

Due to the unfavourable chemical complications caused by the tryptamine chain, I opted
to explore a brief model study using indole as our acylating substrate. With a lack of
acidic protons, I hoped that this model would provide positive evidence that the E ring of
tronocarpine could be formed by Dieckmann type condensation. The results of this model
study are outlined in Scheme 76 and Table 6. Acylation with indole proceeded smoothed
to product 4-50 and radical cyclization afforded tricylic product 4-51 in a 45% yield over
2 steps. The Wacker oxidation isolated ketone 4-53 in a 66% yield.
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Scheme 76- Model study using indole to isolate tricylic product 4-52 for cyclization
testing
Product 4-52 in hand, attempts to cyclize the enol of the ketone to one of the esters (4-53)
moved forward. The results of these ring-closing attempts are outlined in Table 6.
Table 6 - Experimental conditions explored to generate product 4-53

Entry

Reagent

Solvent

Temperature

Result

(˚C)
1

NaH

THF

25

decomposition

2

NaH, MgI2

THF

25

decomposition

3

TiCl4, NEt3

DCM

-10

decomposition

The model study provided little proof that we could successfully close ring E of
tronocarpine via ketone to ester Dieckmann cyclization. At this point, and to work around
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the difficulties of E-ring formation via Diekmann, I thought varying the Michael addition
nucleophile could impart alternative reactivity that would allow us to close this difficult
ring. In addition to changing the nucleophile, an exploration simply protecting the amide
was also constructed to determine if these changes would result in forward progress.

4.4.5 Short Exploration of Protecting the Amide
Determining that the amide N-H was preventing attempts at epimerizing the alpha
diastereotopic center and preventing the formation of a reactive enolate, the obvious
solution was to protect the amide (Scheme 77). From closed lactam product 4-46
protection of the amide proceeded smoothly with Boc2O in an 87% yield (4-54). Quick
attempts to reduce the methylester in product 4-54 were explored with CeBH4 and LiBH4
but failed to yield any of diol product 4-55. Wacker oxidation of 4-54 generated ketone 456 in a 62% yield and again decomposition resulted from attempts to close ring E (4-58)
under basic conditions.

Scheme 77 - Protection of amide N-H to try and close ring E or reduce methylester
Exhaustive attempts to close ring E from the precursor to the lactam 4-59 are outlined in
Table 7 using the fully protected tryptamine chain. Product 4-59 was subjected to a
variety of basic and acidic conditions to determine if ring E would close to keto/enol
product 4-60/4-61 (Table 7).
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Table 7 - Attempts to cyclize ring E from doubly protected amine 4-59

Entry

Reagents

Solvent

Conditions

Result 4-60/461

1

NaH

THF

0 °C

Unelucidated
mixture

2

NaH

THF

-78 °C

4-59 recovered

3

NaH

Benzene

80 °C

Decomp.

4

K2CO3

MeOH

70 °C

0%

5

TiCl4, NEt3

DCM

0 °C

Boc removal

6

NaOMe

Et2O

rt

0%

7

MgCl2

DCM

rt

0%, 4-59
recovered

8

MgCl2, DBU

DCM

rt

0%, 4-59
recovered

9

Na0

MeOH

65 °C

Decomp.

10

NaH, MgCl2

Benzene

80 °C

Decomp.

11

MgCl2

DCM

µw 80 °C

4-59 recovered
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Under strongly basic conditions with NaH, decomposition of the starting material 4-59
was prevalent at temperatures above 0 °C (Table 7, entry 1, 2, 3 &10). While at 0 °C
with NaH, a complex inseparable and unelucidated mixture was generated, which was
ultimately unhelpful for progression towards the total synthesis of tronocarpine. Attempts
at using titanium catalyzed ring closure simply resulted in the deprotection of one of the
Boc groups on amine 4-59 (Table 7, entry 5). All other attempts (using MgCl2, MgCl2
and base, or NaOMe) to close ring E resulted in either decomposition or the recovery of
starting material (Table 7, entry 6,7,8 & 9). Stuck at trying to synthesize ring E of
tronocarpine the synthetic route had to be modified again.

4.5 Third Generation Pathway Towards Tronocarpine:
Exploration of Alternate Michael Addition Nucleophiles
Due to the promise of similar literature reactions, forward progress was attempted
following the same idea that an aldol would correctly close ring E.127 The aldehydes
electrophilicity would be greater than the methyl ester previously explored and for this
reason we expected the reaction to proceed under milder conditions.128 Exemplified in
Scheme 78, intermediate 4-62 would provide the necessary aldehyde functionality and
could come from an alternate Michael addition nucleophile, while still being susceptible
to radical generation by Mn(OAc)3.

Scheme 78 - Intermediate 4-62 that would be able to access acceptable aldol
condensation candidate 4-63
The first hypothesis tested used desired aldehyde (4-66) and its acetal (4-65) as potential
nucleophiles. Product 4-65 was commercially available, and its deprotection was
straightforward in TFA and water (Scheme 79) but the final product (4-66) could not be
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purified without destroying the material and had to be used crude from the deprotection
reaction.

Scheme 79 - Two potential aldehyde bearing nucleophiles 4-65 and 4-66
Any attempts to use either 4-65 or 4-67 as nucleophiles in the Michael addition with acyl
indole generated either deacylated material (1-1) or failed (Scheme 80). Due to the
increased difficulty of deprotonating the single carbonyl species, and the fact that E1cB
elimination could expel ethoxide, which readily deacylated the starting indole, no desired
product was obtained from these attempts.

Scheme 80 - Attemots at using acetal protected aldehydes for Michael addition
reactions
Since the free aldehyde species 4-66 was unstable, we turned our attention to attaching
these nucleophiles to the amine of tryptamine, in hopes of accessing a stable aldehyde
(Scheme 81). From acetal 4-65, saponification to acid 4-69 set up an EDC coupling that
worked nicely with tryptamine (4-70) producing a 75% yield of 4-71. From the acetal
substituted tryptamine we were able to acylate with the usual acyl chloride 4-72 and
generate product 4-73. From here we envisioned (Scheme 82) that revealing the aldehyde
4-74 and performing an intramolecular Michael addition would generate macrocyclic
product 4-75.
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Scheme 81 - Route to product 4-73 to access a stable aldehyde.

Scheme 82 - Proposed access to macrocycle 4-75.
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Unfortunately, attempts to isolate the aldehyde or the macrocycle failed to yield desired
products and again we were plagued with issues of deacylating the acryloyl alkene chain
(Table 8).
Table 8 - Experimental attempts to isolate aldehyde 4-74

Entry

Conditions

Result 4-74 (%)

notes

1

TFA, “wet” DCM

0

Decomp.

2

oxalic acid, H2O,

0

Deacylation

0

Decomp.

0

NMR of aliquot had

THF
3

Amberlyst-15,
acetone, H2O

4

1. Amberlyst-15,
acetone, H2O,
40 °C
2. K2CO3, THF,
50 °C

an aldehyde peak;
in case it was
sensitive, I tried the
Michael addition in
the same pot
without aldehyde
isolation.
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5

5% HCl, d-

0

MeCN, 40 °C

Aldehyde present in
crude NMR, was
not successfully
isolated

6

Pyrrolidine,

0

Deacylation

MeOH
It is likely that because water is required to free the aldehyde for the Michael addition,
this was enough to cause deacylation of starting material 4-73, and the decomposition of
materials. Although it was helpful that in Table 8 (Entries 4 and 5) the NMR data had
an aldehyde peak, I was never able to harness the aldehyde successfully. Table 8, Entry
6 outlines the use of pyrrolidine to try to make an enamine in-situ that was more
nucleophilic to undergo Michael addition but only deacylation occurred.
Although it is not a differing Michael addition nucleophile, and because the route had
been established to product 4-71, I thought I could try forming the product cyclized on
the 2-position of the indole (4-76) and then work to establishing the carbon-carbon bond
to the acryloyl component (Scheme 83). A few radical-based attempts were explored to
generate cyclized product 4-76 (Scheme 83). Both Mn(OAc)3 and ceric ammonium
nitrate (CAN) failed to yield any cyclized product. If product 4-76 was accessible, we
hoped that the 1,3-dicarbonyl containing ring could be deprotonated to under-go Michael
addition after the indole was acylated. These attempts were unsuccessful at generating the
reactivity required for an aldol type ring-closure, and so the research pathways were
altered to explore thioesters as means to access aldehyde functionality.
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Scheme 83 - Single-electron oxidants used in attempt to make product 4-76.

4.6 Fourth Generation Route: Using Thioester Reduction to
Access Aldehyde Reactivity
A couple prevalent reactions exist to convert thioesters selectively to aldehydes. The
Fukuyama reduction chemoselectively reduces thioesters to aldehydes in the presence of
a palladium catalyst and triethylsilane (Scheme 84).129

Scheme 84 - Reduction of a thioester to an aldehyde
This reaction has great chemoselectivity and works well in the presence of amides, esters,
ketones, and is an alternative method of mildly reducing acids, which are easily
converted to thiol esters. Using this reaction, I hoped that selective reductions of a
thioester would easily install a desired aldehyde from a product 4-77 outlined in Figure
18.
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Figure 18 - Proposed intermediate to try and access a desired aldehyde via
Fukuyama reduction
The chemistry to access product 4-77 proceeded with ease using the previously
established route to these tricyclic indole scaffolds (Scheme 85). Starting from the

Scheme 85 - Synthetic pathway to access thioester containing scaffolds 4-81 and 4-83
acylated N-Boc protected tryptamine 4-43 (Scheme 85), Michael addition with a
thioester malonate 4-78 worked in a 67% yield to access 4-79. The Mn(OAc)3 radical
cyclization proceeded in a high 93% yield to generated 1,2-disbstituted indole 4-80. A
report indicated that terminal alkenes may interfere with the palladium catalyst, product
4-80 was therefore taken to the ketone via a Wacker oxidation (4-81, 73% yield) and then
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to the doubly protected amine via Boc protection (4-82) and Wacker oxidation generated
4-83 (40% over two steps).130
From material 4-83 I explored Dieckmann-type condensations between the methyl ketone
and the thioester to test if the more reactive thioester performed favourably compared to
previous attempts to closed ring E. Unfortunately, basic conditions of NaH or NaOMe
failed to cyclize the generated enolate onto the thioester to access 4-84 (Scheme 86).
Under methoxide conditions, the diester material used in previous routes was observed
(4-59).

Scheme 86 - Attempts at generating ring E of tronocarpine from the thioester
scaffold
From material 4-81, the Fukuyama reduction was explored to isolate aldehyde 4-85.131
The results of these attempts are outlined in Table 9. Using Pd(OAc)2 as the palladium
source, and 5 equivalents of triethyl silane (Et3SiH) in acetone, the result was no reaction
(Table 9, Entry 1). Despite intense bubbling, assumed to be from gaseous sulfur
byproducts, only starting material was observed in the crude NMR. Changing the solvent
from acetone to DCM gave no improvement (Table 9, Entry 2), but because DCM was
easier to keep dry, it was used for remaining attempts. Adding the silane slowly over 1.5
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h to release hydrogen in a more controlled manner also failed to generate aldehyde 4-85
(Table 9, Entry 3) and adding 2,6-lutidine, a reagent that had been known to accelerate
the reaction, also failed to yield positive results (Table 9, Entry 5&6).
Table 9 - Fukuyama reduction attempts to isolate aldehyde 4-85

Entry

Reagents

Solvent

Conditions

Result 4-85
(% yield)

1

Pd(OAc)2 (0.3

Acetone

rt

0

DCM

rt

0

DCM

rt, silane added

0

equiv). Et3SiH
(5 equiv.)
2

Pd(OAc)2 (0.3
equiv.), Et3SiH
(5 equiv.)

3

4

Pd(OAc)2 (0.3
equiv.), Et3SiH

slowly over 1.5

(5 equiv.)

h

Pd(OAc)2 (0.3
equiv.),
(Et3SiH 2.3
equiv.), 2,6lutidine

DCM

rt

0
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5

Pd(OAc)2 (0.3

DCM

rt

0

DCM

rt, silane added

0

equiv.), Et3SiH
(4 equiv.), 2,6lutidine
6

Pd(OAc)2 (0.3
equiv.), Et3SiH

over 1 h

(5 equiv.), 2,6lutidine
Unsure of why this reaction was failing, my best hypothesis was interference from the
nitrogen-containing tryptamine -chain. Another substrate was synthesized from indole to
avoid having nitrogen present, opting to add the tryptamine chain later. To access
tryptamine lacking thioester intermediate 4-86, I again applied the optimized route
(Scheme 87); acylating indole with acrylic acid 4-28 and using methylthiomalonate 4-78
as the Michael nucleophile. Acylation of indole proceeded in a high 93% yield, and the
Michael addition followed by radical cyclization occurred in a 44% yield over two-steps.
Finally, Wacker oxidation elucidated methyl ketone 4-86 in a 25% yield as this reaction
failed to consume all starting material.

Scheme 87 - Synthetic route to product 4-86.
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Fukuyama reduction attempts were applied to product 4-86 and the results are outlined in
Table 10. Switching the palladium source to Pd/C resulted in a violently gaseous reaction
which we had hoped meant we were expelling ethanethiol but only starting material was
ever isolated (Table 10, Entry 1 & 2). Varying solvent concentration of the reactions
also gave disappointing results. Addition of silane slowly also did not change the reactive
outcome of this reaction (Table 10, Entry 2&3).
Table 10 – Fukuyama reaction conditions attempted on model product 4-86

Entry

Reagents

Solvent

Conditions

Results 4-87
(% yield)

1

Pd(Oac)2 (0.3

DCM (0.5 M)

equiv.), Et3SiH

Silane added

0

slowly over 1 h

(5 equiv.)
2

Pd/C (0.5

Acetone (0.5

Silane added

equiv.), Et3SiH

M)

slowly over 1 h

Pd/C (0.5

Acetone (0.5

Silane added at

equiv.), Et3SiH

M)

one time

DCM (1 M)

Silane added

0

(3 equiv.)
3

0

(3 equiv.)
4

Pd/C (0.5
equiv.), Et3SiH
(3 equiv.)

slowly over 1 h

0
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Disappointed by the results of these experiments, a quick test reaction confirmed that
these undesired results were not an effect of bad reagents, or experimental technique
(Scheme 88). We were able to generate simple aldehyde 4-91 using the Fukuyama
protocol. This simple test confirmed that for the purposes of closing tronocarpines ring E,
a Fukuyama reduction was not the answer. Truly at a roadblock, a complete overhaul of
my original retrosynthetic analysis of tronocarpine and dippinnine B was required.

Scheme 88 - Confirmation of the Fukuyama reaction conditions

4.7 Fifth Generation Synthesis Towards Tronocarpine and
Dippinnine B

4.7.1 Retrosynthetic Analysis Using New Acrylic Acid Moiety 4-93
Having such trouble in earlier synthetic attempts at these molecules, we thought forming
ring E before attaching it to the required tryptamine moiety would solve the issues of
forming this ring late-stage. This concept would require the synthesis of a cyclic acid (493) that could be used as the acylating agent (Scheme 89). The formation of the lactam
ring in tronocarpine would still involve an amine condensation of product 4-1 into the
methyl ester. This route relies heavily on a SET agent being capable of generating the
alpha radical on a vinylogous 1,3 dicarbonyl system as showcased in product 4-92. There
exists no precedent to such vinylogous system generating radicals with Mn(OAc)3, but I
was hopeful this system could close the ring to the 1,2-indole product 4-1. Product 4-92
would be generated from an acylation reaction between tryptamine moiety 4-42 and the
new carboxylic acid target 4-93. The success of this route relied heavily on the ability to
generate product 4-93.
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Scheme 89 – Retrosynthetic Analysis 3: pathway using a cyclic acid as an acylation
agent
To generate acid 4-93 a synthesis had to be designed (Scheme 89). The first
retrosynthesis proposed was again following the idea that an aldol between an aldehyde
and methyl ketone enolate would generate the alpha/beta unsaturation observed in
product 4-93. This route would involve reactions with potential for chemoselective
issues, but the retrosynthetic analysis is outlined below (Scheme 90). The aldol reaction
of ketone/aldehyde product 4-94 would successfully furnish acid 4-93. To generate such
a complex hydrocarbon chain (4-95), we would use a Michael addition between acid 4-97
and acrylate 4-96 bearing protected alcohol. Both products (4-96 and 4-97) have
literature established routes.132, 133
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Scheme 90 - Retrosynthetic Analysis 4: using an aldol to generate cyclic acid 4-93
Commencing synthetic progress to acid 4-93, the alcohol acrylate 4-100 was generated
first using a Baylis-Hillman reaction of methyl acrylate (4-98) and paraformaldehyde in
the presence of DABCO (Scheme 91).

Scheme 91 - Initial attempts to synthesize acid 4-93
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While it is a low yielding reaction (15%), the materials are inexpensive, and the reaction
is easily scaled. There existed no previous precedence at protecting the alcohol on
product 4-100 and it quickly became apparent why; in the presence of base, and either
TMS-Cl or TBS-Cl, the material quickly polymerized. This polymerization problem was
never overcome, and this route was quickly abandoned.

4.7.2 Second Retrosynthetic Analysis to Access Tronocarpine
through Similar Cyclic Acid Moiety 4-102
Reviewing past attempts accessing tronocarpine from previous Kerr group members,
Katarina Sapeta had developed a route which successfully generating ring E, but she was
unable to impart the correct functionalization for the rest of tronocarpine.134 Her
methodology elucidated that DA CPs can be opened with 2-(chloromethyl)-3trimethylsilyl-1-propene (4-106) and following base-mediated ring closure would
generate 1,3,5 substituted cyclohexane products (Scheme 92). I envisioned that this
cyclohexane (4-105) could be modified to the cyclohexene (4-102) bearing the α,β
unsaturated ketone required for tronocarpine (Scheme 92).
Starting from vinyl cyclopropane 4-107 (Scheme 92), opening with 4-106 would
generate vinyl cyclohexane 4-105. Manipulations using hydroboration, protection and
Wacker oxidation would ideally install the primary alcohol and ketone exemplified in
product 4-104.135 Selenoxide elimination would generate internal alkene 4-103 for the α,β
unsaturated ketone 4-102. A Krapcho decarboxylation would remove one of the esters
and then product 4-102 could be acylated after the primary alcohol is oxidized via Jones
oxidation to a carboxylic acid. Product 4-92 outlined earlier (Scheme 89) could be
subjected to radical closure to the indole through the vinylogous reactivity of the 1,3dicarbonyl moiety. If this chemistry proved troublesome, other reactions could be
explored, like α-halogenation for other coupling transformations. 4-1 would furnish
tronocarpine by the lactamization and reduction as discussed in the previous
retroanalyses.
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Scheme 92 - Retrosynthetic Analysis 5: Route to tronocarpine incorporating
cyclohexene 4-102

4.7.3

Chemistry Employed to Realize Retrosynthetic Analysis 5

Vinyl cyclopropane 4-107 is easily synthesized and was subjected to silane 4-106. 4-106
and TiCl4 in DCM at -78 °C opened vinyl cyclopropane 4-107 in yields up to 88% of 4108, but the reaction became troublesome when trying to scale-up (Table 11). Silane
piece 4-106 is also incredibly expensive at $112/g and is strangely no cheaper to
synthesize ourselves. As Sapeta et al. were working on a much smaller scale this was no
issue, but this became the first limiting factor of this synthetic route. During scale-up, any
reaction using more than 100 mg of cyclopropane saw a sharp decline in yields from
around 75% down to 30-55% (Table 11, Entry 1, 2, 3, 4, 5). Column chromatography
seemed to drastically cut yields, and because the crude NMRs were not full of impurities,
I began pushing crude material forward into the cyclization, which could then be purified
with ease. Interestingly, the yields increased by 10% when less than 100 mg of
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cyclopropane 4-107 was used. To generate enough working material, I purchased 5 g of
silane 4-106 and ran the reaction on multiple 100 mg scales.
Table 11 - Effects of Scale-Up in synthesizing chain 4-108

a

Entry

Scale of CP 4-107

Yield 4-108 (%)

1

100 mg

76 %

2

500 mg

55 %a

3

500 mg

48 %a

4

500 mg

55 %a

5

1g

36 %a

6

1g

Did not complete

7

500 mg

33 %b

8

100 mg

78 %

9

50 mg

88 %

Crude yield b Purified yield

Product 4-108 in hand, cyclization with NaH in DMF worked well giving a 96% yield of
1,3,5-substituted cyclohexane product 4-105. Wacker oxidation selectively oxidized the
vinyl group to generate methyl ketone 4-109 in 81% yield.
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Scheme 93 - Ring closure and Wacker oxidation to access cyclohexane 4-109
With product 4-109 accessible, it became time to optimize the synthesis of hydroboration
product 4-110. Aware that chemoselectivity with the ketone was a potential issue, I
expected that I may also get reduced secondary alcohol products (4-111) but hoped that
functionality could be restored. Literature precedent also existed for the hydroboration of
alkenes in the presence of ketones that left the ketones unaffected.135,136, 137 The results of
optimizing the hydroboration product are outlined in Table 12.
Table 12 - Optimization of hydroboration reaction

Entry

Borane

Solvent

Condition

Result

Reagent
1

BH3•THF

THF

0 °C

4-111a

2

BH3•THF

THF

25 °C

4-111a

3

BH3•THF

THF

-78 °C

4-111a

148

4

THF

0 °C-25 °C

Starting
material
recovered.

(2.5
equiv.), H2O2,
15% NaOH
5

THF

0 °C-25 °C

Structure of
isolated
material
inconclusive.

(2.5 equiv.)
H2O2, 15%
NaOH
(removed
stabilizer from
2-methyl-2butene)
6

THF

0 °C-45 °C

- 8 spots by
TLC.

(2.5

- 4 mg of

equiv.), H2O2,

product 4-110

15% NaOH

(7 % yield)

(removed
stabilizer from
2-methyl-2butene)
7

9-BBN (1
equiv.), NaBO3

THF

25 °C

Decomp.
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8

9-BBN (1.2

THF

0 °C

16%, 4-110

THF

0 °C – 25 °C

37%, 4-111

THF

25 °C

20% (brsm) 4-

equiv.), H2O2,
3M NaOH
9

9-BBN (1.5
equiv.), H2O2,
3M NaOH

10

110
(1 equiv.),
NaBO3, H2O
11

THF

25 °C

7% 4-110

THF

0 °C

4-109

(1.2 equiv.),
NaBO3, H2O
12

recovered
(1 equiv.),
NaBO3, H2O
13

THF

0 °C

15% 4-110
Best results.

(1.2 equiv.),
NaBO3, H2O

Repeatable.
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14

THF

25 °C

8% 4-110

(1.5 equiv.),
NaBO3, H2O
a

Not purified or isolated

Only low yields of product 4-110 were isolated throughout the experiments detailed in
Table 12, and the best borane reagent was determined to be cyclohexylborane (Table 12,
Entry 13). When worked-up in the presence of NaBO3 and H2O it at least reliably
produced yields of product 4-110.
As a note, protecting the ketone with an acetal (4-112) and subjecting the material to the
cyclohexylborane hydroboration had no positive effect on the results (Scheme 94). No
desired product (4-113) was formed.

Scheme 94 - Protected acetal 4-112 also failed to produce desired hydroboration
product 4-113
From the very small amount of product 4-110 generated, forward synthetic progress was
pursued first protecting the newly generated alcohol (Scheme 95). Protection with TBSCl worked well (4-114), but attempts at selenoxide elimination were not fruitful. PhSeCl
and PhSeBr were explored in attempts to generate phenylselenide product 4-115 that
could be eliminated in the presence of peroxide. No desired product (4-116a/b) was
isolated.
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Scheme 95 - Synthetic progress in attempts to generated cyclohexene 4-116a
In the reality that sometimes is natural product synthesis, cost and budget became a factor
in our planned route. Due to the lack of material acquired and the expense of silane 4106, accessing gram-scale products was not feasible. Unfortunately, again, we had to turn
our attention to a new, and more supportable route, to the natural products desired.

4.8 Sixth Generation Synthesis Towards Tronocarpine and
Dippinine B
4.8.1 Retrosynthetic Analysis 6 Incorporating Enyne Metathesis
Enyne metathesis between an alkene and an alkyne is an extraordinarily powerful tool for
generating conjugated alkene products.138 This reaction has been used to synthesize vinyl
cyclohexene rings like that showcased in product 4-117.139 With the reliable nature of the
Wacker oxidation in all synthetic attempts up to this point, we felt confident that the
alkene generated from such enyne metathesis (4-117), could be interconverted to desired
α,β-unsaturated ketone (4-1) in ring E in tronocarpine (Scheme 96).
Retrosynthetically analyzing such a route (Scheme 96) meant we would require novel
alkene and alkyne functional groups in our intermediates to appropriately yield desired
cyclohexene 4-117. Outlined in Scheme 96, lactamization between tryptamine chain and
methyl ester would again close the final ring of tronocarpine from product 4-1. 4-1 would
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be generated from vinylogous 1,3-dicarbonyl cyclization via radical activation, and this
cyclohexene functionality would be imparted by the enyne metathesis of substrate 4-118.
To generate substrate 4-118 acylation with a slightly different alkyne-bearing acrylic acid
(4-119) would need to be performed. This acrylic acid would again come from the
previously used decarboxylative Mannich after simple alkylation of dimethylmalone (431) with propargyl bromide (4-121).

Scheme 96 - Retrosynthetic Analysis 6: using enyne metathesis to generate ring E of
tronocarpine
Confident that the scale up of this route would be much easier, and with cheaper starting
materials, exploration of this new proposal commenced.

153

4.8.2 Forward Progress Exploring the Enyne Metathesis
Retrosynthetic Route 6
Initial progress exploring Retroanalysis 6 proceeded exceedingly well. On a first run
through we were able to finally access acylated indole containing cyclohexene ring 4-117
(Scheme 97). Step 1 was difficult to purify, acylating dimethylmalonate 4-31 with
propargyl bromide (4-121), a by-product of the dialkylated species was prominent. The
yield was low enough to justify purchasing commercially available 4-122. Saponification
(4-123) followed by decarboxylative Mannich again proved successful yielding acrylic
acid 4-119 in a 47% yield over two steps.
Acrylic acid 4-119 was successfully coupled to protected tryptamine in an 84% yield,
giving acryloyl indole 4-124. A Michael addition was possible using acrylate 4-125 in the
presence of LDA.140,141 However, this reaction was finicky, and it was necessary to
quench the material at the first signs of a second new spot by TLC. This was a
decomposition product that upon its formation, a 0% yield of product 4-118 would result.
Because yields of 4-118 were low on this reaction because it had to be quenched while
starting material remained. So, while low yielding, the terminal alkene was accessible
and set up the functionality for the desired enyne metathesis. Enyne metathesis attempts
were explored and using both Grubbs 1 and Grubbs 2 catalysts142 we could generate a
mixture of diastereomers (4-117). The exploration of the enyne metathesis is outlined in

Table 13.
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Scheme 97 - Synthetic pathway to enyne metathesis product 4-117
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Table 13 - Exploration of Enyne Metathesis

Entry

Catalyst

Solvent

1

Grubbs 1 (10

DCM

mol%)

Atmosphere a Temperature
Ethylene (1

rt

atm)

Result 4-117
41%
separable
diastereomers

2

Grubbs II (10

toluene

Argon

90 °C

7%

DCM

Ethylene (1

35 °C

47%

mol%)
3

Grubbs II (10
mol%)

atm)

separable
diastereomers

4

Grubbs II

DCM

Ethylene (1

35 °C

atm)

separable

(10 mol%)

5

Grubbs II (10

38%

diastereomers
DCM

mol%)

Ethylene (1

35 °C

atm)

42%
separable
diastereomers
- Tripled the
scale size

6

Grubbs I (10
mol%)

DCM

Ethylene (1
atm)

35 °C

Mixture of 4117 and 4125; DNC

156

a

Ethylene is flushed directly into reaction solution for 5 mins before being placed under a

balloon atmosphere of ethylene.
In order to generate the appropriate vinylogous reactivity for the ring closure reaction
with Mn(III), a Wacker oxidation was required to generate ketone product 4-127
(Scheme 98). However, in all attempts of this reaction, nothing happened. Subjected to
long lengths of time and heating the mixture, starting material (4-117) always remained.
A literature investigation confirmed that these conjugated substrates can sometimes be
unreactive to palladium chemistry because coordination to the conjugated alkene system
(4-126) will trap the palladium preventing it from any further reactivity (Scheme 98).143

Scheme 98 - Failed reactivity of the Wacker oxidation on product 4-117
This is where the project ended. I hope a future graduate student can be convinced to give
this another attempt. Perhaps my tribulations will aid in their design of a successful
pathway to these molecules. I outline in the following section possible re-works that
could be attempted. To the future student that may be reading this: feel free to contact
me.

4.9 Conclusions and Future Outlook
Although exploration of 6 possible routes towards natural products tronocarpine and
dippinine B were fruitless, a large amount of knowledge was acquired regarding ways in
which the pentacyclic scaffolding of these molecules should not be formed. Ring E being
as troublesome as it was to synthesize, should absolutely be constructed as a separate
component that is later connected to the indole half of the molecule (Figure 19).
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Using SET agents to cyclize the cyclohexene ring of these molecule, while successful,
has never worked on a vinylogous substrate. I think exploration of this chemistry would
in and of itself be publishable if a methodology could be developed. I suspect using a
SET agent on vinylogous 1,3-dicarbonyl electrophiles (4-129) in the presence of indoles
(4-129) may generate products like 4-140 (Scheme 99).

Scheme 99 - Chemistry worth exploring generating radical on vinylogous dicarbonyl
molecules
I am also still confident that product 4-93 is a great substrate towards overcoming the
hurdles outlined in this chapter.

Figure 19 - Ring E component to access molecules tronocarpine and dippinine B
If substrate 4-93 can be attached to tryptamine (4-131), the route outlined in Scheme 100
would theoretically be capable of overcoming the chemoselectivity and non-reactivity
issues that were discovered. If chemistry can be developed to cyclize to the indole and
generate a product along the lines of 4-132 or 4-134, oxymercuration should be capable
of imparting the oxidation required to the α,β unsaturated ketone in 4-135. With a ketone
installed (4-135), deprotection of the amine should perform the Michael addition likely in
the same pot as the deprotection furnishing the ring in product 4-136 on the way to
dippinine B. Protecting the methyl ketone will be crucial for successful reduction of the
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indole bound ketone with NaBH4 (4-137). Deprotection to elucidate methyl ketone back
would complete the synthesis of dippinine B.

Scheme 100 - Potential route to complete natural products tronocarpine and
dippinine B
At substrate 4-132, deprotection the amine first will close the lactam ring generating 4133. Reduction of the ketone in product 4-133 with NaBH4 will be easier done without
the methyl ketone furnished yielding 4-134. Finally, oxidation of 4-134 via Wacker, if the

159

palladium is not rendered inert by this more constrained molecule or by oxymercuration,
would furnish tronocarpine.
Should it become viable to further progress the route outlined in Retrosynthetic Analysis
5, Section 4.7.3 (Scheme 92), I have a few suggestions of how to both improve and
progress the chemistry of this synthetic pathway. Access to compound 4-114 is possible
as discussed earlier, if improvements to the hydroboration step of this product can access
more material, there exists the possibility that one of many oxidation reactions could
install the desired α/β unsaturated functionality in desired compound 4-138 (Scheme
101). All of the reactions in Scheme 101 would be worth exploring to access the valuable
product 4-138. Saegusa outlines how from silyl enol ethers (4-139) Pd(II) chemistry will
access products like 4-140.144 Nicolaou and Stahl have outlined using IBX or palladium
chemistry with oxygen as easily accessible pathways to get directly to the α/β unsaturated
ketones (4-142, 4-144).145 Brown showcases B-I-9-BBN paired with Pd to oxidize
ketone substrates (4-146) and Legault showcases iodine reagents that add OTs groups
that could be eliminated to give desired functionality (4-150b).146 Finally, Newhouse
explored zinc reagents helping to facilitate palladium oxidation chemistry again that
could give the desired product 4-138.147 As a note, any work involving IBX in this way
requires very dry conditions (DMSO distilled before every reaction) and the IBX is
recommended to be made by the operating chemist.
In compiling the work towards synthesizing tronocarpine and dippinine B, it became
apparent that generating a macrocyclic intermediate from the thioester containing
components was never attempted (Scheme 102). This may be a solution to getting around
the road-blocks found in this project. From an intermediate like 4-151 (Scheme 102), the
difference in reactivity between methyl ester and thioester may allow selective closure of
the tryptamine amine to generate amide macrocycle 4-152. If R of 4-151 is a carboxylic
acid, an EDC coupling may fashion the same macrocycle. This macrocycle may have
completely different reactivity to close ring E of tronocarpine and dippinine B. The
intermediate 4-152 should have no problems with radical closure to the indole component
via SET agent.
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Scheme 101 - Oxidations worth trying to elucidate the alpha/beta functionality of
compound 4-138
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Scheme 102 - Generating macrocycle to access novel intermediate that may aid the
synthesis of tronocarpine
I hope further progress resulting in the successful synthesis of these molecules is
harnessed in the future.

4.10

Experimental

4.10.1 General Experimental Details
All reactions were conducted under an air atmosphere unless otherwise indicated. Flasks
were oven dried and cooled in a desiccator prior to use. All chemicals were of reagent
quality and used as obtained from commercial sources except for the Mn(OAc)3●2H2O,
which was prepared by modified literature procedure (the exact procedure noted in
Chapter 3). NMR experiments were performed on either a Bruker AvIII 400, Varian
Inova 400 and Inova 600 instruments and samples were obtained in CDCl3 (referenced to
7.25 ppm for 1H and 77.0 ppm for 13C). Coupling constants (J) are in Hz. The
multiplicities of the signals are described using the following abbreviations: s = singlet, d
= doublet, t = triplet, q = quartet, dd = doublet of doublets, dt = doublet of triplets, m =
multiplet, br = broad. High resolution mass spectra (HRMS) were obtained on Thermo
Scientific DFS mass spectrometer using electron impact ionization. Microwave reactions
were performed in a 400 W Biotage Initiator 2.0 microwave reactor. Dichloromethane
(DCM), acetonitrile (MeCN), toluene, benzene and THF were dried and deoxygenated by
passing the nitrogen purged solvents through activated alumina columns. THF was
additionally distilled from CaH2 and stored over 4Å molecular sieves. All other reagents
and solvents were used as purchased from Sigma-Aldrich, Alfa Aesar, Caledon or
Oakwood Chemicals. Reaction progress was followed by thin layer chromatography
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(TLC) (Merck, TLC Silica gel 60 F254) visualizing with UV light, and the plates were
developed using acidic p-anisaldehyde or potassium permanganate. Column
chromatography was performed using silica gel purchased from Silicycle Chemical
Division Inc. (230-400 mesh). All columns were performed using Still’s procedure for
flash chromatography.96 IR spectra were acquired using a PerkinElmer Spectrum Two
FT-IR or Bruker Alpha II Di-ATR.

4.10.2 Experimental Procedures for Selected Products

dimethyl 2-(but-3-en-1-yl)malonate (4-33)
4-bromobutene (25 g, 185 mmol, 1 equiv.) and dimethylmalonate (122 g,
926 mmol, 5 equiv.) were added to a 2L round bottom that had been flushed with argon.
356 mL of THF followed by 356 mL of DMF were added. Potassium carbonate (128 g,
926 mmol, 5 equiv.) was then added to the flask but with such a large amount the mixture
was tough to stir. The flask was then equipped with a reflux condenser and argon balloon
and heated at 90 °C for 20 hours. The flask was occasionally, carefully, swirled by hand
to help mix the contents of the reaction. When indicated complete by TLC the reaction
was diluted with hexanes and then vacuum filtered through a pad of Celite. The collected
volume was concentrated in vacuo and then re-dissolved in Et2O. The Et2O layer was
washed with bicarb and then the bicarb layer was extracted twice more with Et2O. The
combined organic fractions were washed 6 times with 1M NaOH or until all the malonate
was gone by TLC analysis (stains purple in acidic p-anisaldehyde). The organic layer was
then washed twice with water and once with brine. The organic layer was dried with
MgSO4, filtered and concentrated in vacuo yielding pure material (32 g, 93% yield, pale
yellow liquid). Rf = 0.36 (15% EtOAc: 85% Hexanes). 1H NMR (600 MHz, CDCl3)
∂ = 5.74 (ddt, J = 16.9, 10.2, 6.6 Hz, 1H), 5.05 – 4.95 (m, 2H), 3.72 (s, 6H), 3.38 (t, J =
7.4 Hz, 1H), 2.08 (q, J = 6.6 Hz, 2H), 1.99 (q, J = 7.4 Hz, 2H) data matches literature
report.148
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2-(but-3-en-1-yl)malonic acid (4-35)
(4-33) (25 g, 136 mmol, 1 equiv.) was added to a 5 L round bottom flask.
THF (680 mL) and MeOH (680 mL) were added and the mixture was
stirred open to air. While stirring 2M NaOH (544 mL, 1088 mmol, 8 equiv.) was added
slowly over approx. 10 mins to the stirring reaction. A small amount of heat was
generated. The reaction was stirred under an atmosphere of air for 20 hours. When TLC
confirmed complete consumption of starting materials the reaction was concentrated in
vacuo and extracted 1x with Et2O to remove any left-over starting material if there was
any (even if the TLC didn’t show any). The water layer was then acidified to pH =1 using
concentrated HCl and extracted three times with Et2O. The combined organic fractions
were washed with brine, dried with MgSO44, filtered and then concentrated in vacuo to
yield crude product (21 g, <94%, white, granular, “wet looking”, low melting solid). The
crude product was used without further purification in the next step. Rf = 0 (50%
EtOAc: 50% Hexanes). 1H NMR (400 MHz, CDCl3) ∂ = 11.42 (s, br, 1H), 5.76 (ddt, J =
16.9, 10.2, 6.6 Hz, 1H), 5.11 – 5.00 (m, 2H), 3.48 (t, J = 7.3 Hz, 1H), 2.22 – 2.12 (m,
2H), 2.09 – 2.00 (m, 2H) 13C NMR (101 MHz, CDCl3) ∂ = 175.6, 136.7, 117.0, 51.2,
31.5, 28.1.
2-methylenehex-5-enoic acid (4-28)
Diacid (4-35) (16.61 g, 105 mmol, 1 equiv.) was placed into a 500 mL roundbottom containing pyridine (35 mL) followed by paraformaldehyde (3.47 g,
115 mmol, 1.1 equiv.) and piperidine (1.04 mL, 10.5 mmol, 0.1 equiv.). The roundbottom flask was equipped with reflux condenser and placed into an oil bath at 130 ˚C. A
rubber septa containing an empty balloon was secured on top of the condenser only to
observe the evolution of gasses. Note that an excessively large flask was used as the
quick evolution of gasses create a foamy mixture that must be contained. The reaction
was left to reflux for 2 hours at which point TLC analysis confirmed completion of the
reaction. The mixture was cooled to rt, acidified with 5% HCl solution until pH 2-3 and
extracted with Et2O three times. The organic extracts were combined and washed with
5% HCl 5 times until the pyridine was gone as determined by TLC, followed by a brine
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wash. The organic extract was dried with MgSO4 and concentrated in vacuo to yield the
product as a yellow liquid (9.49 g, 72% yield) Rf = 0.75 (50% EtOAc:Hexanes)

1H

NMR (400 MHz, CDCl3) ∂ = 11.75 (s, br, 1H), 6.32 (s, 1H), 5.80 (ddt, J = 16.8, 10.2,
6.6 Hz, 1H), 5.66 (s, 1H), 5.09 – 4.92 (m, 2H), 2.40 (dt, J = 7.5, 1.2 Hz, 1H), 2.30 – 2.21
(m, 2H)

13C

NMR (101 MHz, CDCl3) ∂ = 173, 139.4, 137.6, 127.8, 115.4, 32.6, 31.0

IR (cm-1) 2922, 2603, 1693, 1627, 1422, 1295, 1221, 1161, 997, 948 HRMS m/z [M+]
125.06002 (calcd for C7H10O2, 125.06808).

tert-butyl (2-(1-(2-methylenehex-5-enoyl)-1H-indol-3yl)ethyl)carbamate (4-43)
Acrylic acid (4-28) (6.20 g, 49.1 mmol, 1 equiv) was added to a 25 mL
round-bottom and put under and inert atmosphere of argon. Oxalyl
chloride (4.45 mL, 51.0 mmol, 1.05 equiv.) was added slowly to the flask followed by a
single catalytic drop of DMF. This reaction mixture was stirred two hours. To a 500 mL
round-bottom was added boc-protected tryptamine 4-42 (6.39 g, 24.5 mmol, 1 equiv) in
250 mL of DCM. Bu4NHSO4 (0.83 g, 2.45 mmol, 0.1 equiv) was added to the
tryptamine followed by powdered NaOH (4.91 g, 122.7 mmol, 5 equiv.). The reaction
was put under and inert atmosphere of argon and allowed to stir for a minimum of 15
min. At this point the acid chloride generated in the 25 mL round bottom was cannula
transferred over in its entirety (~7.10 g, 49.1 mmol, 2 equiv). The mixture was stirred
under Ar at rt for 1 hr at which point TLC confirmed complete consumption of starting
material. The reaction was quenched with water and extracted with DCM 3 times. The
combined organic extracts were washed with water once, followed by brine and then
dried with MgSO4. The solvent was removed in vacuo to yield the crude material.
Purification of the crude compound by flash column chromatography was performed
using 30% EtOAc: 70% Hexanes to yield the product as a slightly yellow oil (8.81 g,
83%). Rf = 0.46 (30% EtOAc: 70% Hexanes)

1H

NMR (400 MHz, CDCl3) ∂ = 8.43

(d, J = 8.2 Hz, 1H), 7.54 (d, J = 7.8 Hz, 1H), 7.37 (t, J = 7.7 Hz, 1H), 7.33 – 7.27 (m,
2H), 5.81 (ddt, J = 16.9, 10.2, 6.6 Hz, 1H), 1H), 5.65 (s, 1H), 5.45 (s, 1H), 5.08 – 4.96
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(m, 2H), 4.63 (br, s, 1H), 3.44 (q, J = 6.6 Hz, 2H), 2H), 2.88 (t, J = 6.9 Hz, 2H), 2.62 (t, J
= 7.4 Hz, 2H), 2.34 – 2.26 (m, 2H), 1.43 (s, 9H)

13C

NMR (101 MHz, CDCl3) ∂ =

169.3, 156.0, 143.9, 137.2, 136.2, 131.1, 125.3, 123.9, 121.2, 119.0, 116.9, 116.0, 40.17,
32.0, 33.2, 28.5, 25.7 IR (cm-1) 3356, 2976, 2928, 1684, 1630, 1510, 1451, 1356, 1248,
1170 HRMS m/z [M+] 368.2094 (calcd for C22H28N2O3, 368.2099).
dimethyl 2-(2-(3-(2-((tert-butoxycarbonyl)amino)ethyl)-1H-indole1-carbonyl)hex-5-en-1-yl)malonate (4-44)

NaH (1.56 g, 39.0 mmol, 2 equiv.) was added to an argon flushed
round bottom followed by THF (98 mL, 0.2 M). The flask was placed under a balloon of
argon and then cooled to 0 °C. Dimethyl malonate (4.46 mL, 39 mmol, 2 equiv.) was
added dropwise at careful of violent bubbling. The mixture was stirred for 15 minutes.
Indole 4-43 (7.20 g ,19.5 mmol, 1 equiv.) was added via syringe and the reaction was
removed from the ice/water bath. Stirring at room temperature, when TLC indicated
complete consumption of starting material, the reaction was carefully quenched with
water. The mixture was transferred to a separatory funnel and extracted with EtOAc 3
times. The combined organic fractions were washed with brine and then dried with
MgSO4. The crude solution was filtered and concentrated in vacuo and the isolated
residue was subjected to column chromatography (25% EtOAc:75% Hexanes). The
purified material 4-44 was isolated as a pale-yellow oil (8.10 g, 83% yield). Rf = 0.23
(25% EtOAc: 75% Hexanes). 1H NMR (400 MHz, Chloroform-d) δ 8.50 (d, J = 8.2 Hz,
1H), 7.54 (d, J = 7.7 Hz, 1H), 7.40 – 7.27 (m, 3H), 5.83 – 5.66 (m, 1H), 5.01 (d, J = 1.3
Hz, 1H), 5.00 – 4.93 (m, 1H), 4.73 (s, br, 1H), 3.71 (s, 3H), 3.65 (s, 3H), 3.47 (m, 3H),
2.91 (t, J = 6.9 Hz, 2H), 2.48 (ddd, J = 14.5, 8.9, 6.2 Hz, 1H), 2.27 – 2.05 (m, 3H), 1.97
(dq, J = 14.6, 7.3 Hz, 1H), 1.77 – 1.63 (m, 1H), 1.43 (s, 9H). 13C NMR (101 MHz,
CDCl3) δ 173.2, 169.4, 169.4, 155.9, 137.2, 136.2, 130.6, 125.5, 123.8, 121.8, 120.1,
118.9, 117.2, 116.1, 60.4, 52.7, 49.2, 41.3, 31.9, 31.0, 28.4, 25.8, 21.1, 14.2. IR (cm-1)
3396, 2952, 1733, 1693, 1511, 1452, 1247, 1160 HRMS m/z [M+] 500.2529 (cald for
C27H36N2O7 500.2523)
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dimethyl 7-(but-3-en-1-yl)-10-(2-((tert-butoxycarbonyl)amino)ethyl)6-oxo-7,8-dihydropyrido[1,2-a]indole-9,9(6H)-dicarboxylate (4-45)
Indole (4-44) (5.75 g, 11.5 mmol, 1 equiv.) was dissolved in 164 mL of
MeOH. To the solution of indole was added Mn(OAc)3•2H20 (9.25 g, 34.5 mmol, 3
equiv.) and the mixture was fitted with a reflux condenser and purged with an atmosphere
of Argon. The reaction was left to reflux for 16 h before TLC indicated complete
consumption of starting materials. The crude mixture was concentrated to remove MeOH
and diluted with water. The water layer was extracted 3x with EtOAc and the combined
organic fractions were washed with brine 2x. The collected organic layer was dried with
MgSO4 and concentrated in vacuo. Pure material was isolated by flash column
chromatography using an eluent of 30% EtOAc: 70% Hexanes and collected as a white
solid (5.48 g, <94%). Rf = 0.41 (30% EtOAc: 70% Hexanes)

1H

NMR (400 MHz,

CDCl3) ∂ = 8.50 (d, J = 8.0 Hz, 1H), 7.66 (d, J = 7.6 Hz, 1H), 7.36 (t, J = 7.1 Hz, 1H),
7.30 (t, J = 7.5 Hz, 1H), 5.83 (ddt, J = 17.2, 10.2, 6.3 Hz, 1H), 5.13 – 5.00 (m, 2H), 4.81
(br, s, 1H), 3.85 (s, 3H), 3.80 (s, 3H), 3.42 (dt, J = 12.4, 6.0 Hz, 2H), 2.93 – 2.83 (m, 2H),
2.77 – 2.59 (m, 2H), 2.38 (t, J = 13.1 Hz, 1H), 2.33 – 2.17 (m, 3H), 1.67 (q, J = 8.3 Hz,
1H), 1.43 (s, 9H)

13C

NMR (101 MHz, CDCl3) ∂ = 170.5, 170.4, 168.9, 156.0, 137.5,

134.8, 128.7, 125.9, 124.3, 119.5, 119.0, 116.9, 115.9, 55.9, 53.9, 53.7, 39.3, 35.0, 30.8,
28.9, 28.6 IR (cm-1) 3272, 2956, 1736, 1697, 1456, 1377, 1242, 1167, 1075, 76 HRMS
m/z [M+] 498.2361 (calcd for C27H34N2O7, 498.2366).

methyl 6-(but-3-en-1-yl)-4,7-dioxo-1,2,3,4,4a,5,6,7octahydroazepino[3,4,5-hi]benzo[b]indolizine-4a-carboxylate (4-46)
Indole (4-45) (4.81 g, 9.65 mmol, 1 equiv.) was dissolved in benzene (96
mL) and p-toluenesulfonic acid (3.67 g, 19.3 mmol, 2 equiv) was added. The flask was
equipped with a Dean-Stark trap and reflux condenser and put on heat at 80 ˚C for 1.5 h.
At this point TLC indicated completion of the boc deprotection and the benzene was
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removed in vacuo. The crude mixture was dissolved in 193 mL of MeOH and Na2CO3
(9.21 g, 87.0 mmol, 9 equiv) was added and put under an atmosphere of argon. The
reaction was allowed to stir at rt for 3 h. MeOH was removed in vacuo and the crude
residue was dissolved in water. DCM was used to extract from the water layer 3x
followed by a brine wash of the collected organic fractions. The organic layer was
washed once more using brine and dried with MgSO4. The DCM was removed in vacuo
to reveal the pure product as a white solid (3.45 g, 98%). Rf = 0.13 (50%
EtOAc:Hexanes)

1H

NMR (400 MHz, CDCl3) ∂ = 8.51 (d, J = 8.2 Hz, 1H), 7.46 – 7.33

(m, 2H), 7.29 (t, J = 7.6 Hz, 1H), 6.57 (s, 1H), 5.80 (dddd, J = 17.6, 10.2, 7.7, 5.6 Hz,
1H), 5.10 – 4.98 (m, 2H), 3.79 (s, 3H), 3.58 (t, J = 8.8 Hz, 1H), 3.58 (t, J = 8.8 Hz, 1H),
3.50 – 3.41 (m, 1H), 2.94 (dd, J = 9.1, 3.6 Hz, 2H), 2.66 (dq, J = 12.1, 4.2 Hz, 2H), 2.48
(t, J = 14.7 Hz, 1H), 2.40 – 2.29 (m, 1H), 2.26 – 2.16 (m, 1H), 1.77 – 1.66 (m, 1H)

13C

NMR (101 MHz, CDCl3) ∂ = 171.3, 170.8, 169.9, 137.7, 134.8, 129.7, 126.6, 126.1,
124.1, 118.2, 118.2, 116.9, 115.8, 77.5, 77.4, 77.2, 76.8, 54.1, 53.8, 38.7, 37.9, 34.0, 30.8,
28.2, 26.1 IR (cm-1) 3213, 1732, 1695, 1672, 1614, 1457, 1366, 1291, 1228, 1193
HRMS m/z [M+] 366.1578 (calcd for C21H22N2O4, 366.1560).

4-59 precursor
DMAP (0.039 g, 0.32 mmol, 0.17 equiv.) and Boc2O (2.07 g, 9.5
mmol, 5 equiv.) were dissolved in 10 mL THF. The flask was
purged with argon and indole (4-45) (0.95 g, 1.90 mmol, 1 equiv.).
The reaction was stirred under argon for 24 hours and then concentrated in vacuo and
purified by column chromatography (20% EtOAc: 80% Hexanes Rf= 0.39). Product (#)
was isolated as a white solid (1.05 g, 92%). 1H NMR (400 MHz, CDCl3) ∂ = 8.49 (d, J
= 7.6 Hz, 1H), 7.89 (d, J = 7.3 Hz, 1H), 7.37 – 7.30 (m, 2H), 5.91 – 5.76 (m, 1H), 5.10
(d, J = 17.8 Hz, 1H), 5.02 (d, J = 10.8 Hz, 1H), 3.90 (s, 3H), 3.88 – 3.81 (m, 2H), 3.80 (s,
3H), 2.98 – 2.86 (m, 2H), 2.84 – 2.72 (m, 2H), 2.34 (t, J = 12.8 Hz, 1H), 2.31 – 2.17 (m,
3H), 1.73 – 1.64 (m, 1H), 1.51 (s, 18H) 13C NMR (101 MHz, CDCl3) δ = 170.6, 168.8,
153.1, 137.7, 134.8, 130.5, 128.8, 125.7, 124.3, 119.9, 119.0, 116.8, 115.8, 82.5, 55.6,
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54.0, 53.7, 44.6, 39.3, 35.3, 30.8, 29.0, 28.2, 24.7. IR (cm-1) 2983, 1733, 1694, 1456,
1367, 1347, 1275, 1134, 1119, 854, 761. HRMS m/z [M+] 598.2913 (calcd for
C32H42N2O9, 598.2890).
4-59
PdCl2 (0.082 g, 0.46 mmol, 0.3 equiv.) and CuCl2 (0.21 g, 1.55
mmol, 1 equiv.) were added to a round bottom flask and half the
volume (15 mL) of a 7:1 mixture of DMSO:water (29 mL total) was
added to the flask. The flask was evacuated and refilled with a balloon of oxygen 5 times.
Starting indole (4-59 precursor) (1.05 g, 1.75 mmol, 1.13 equiv.) was dissolved in the
other half of the DMSO:water solvent and then added dropwise to the palladium reaction.
The reaction was again evacuated and refilled with oxygen. The reaction was stirred at 40
°C under 1 atm of oxygen for 12 hours at which point TLC confirmed consumption of the
starting indole. The reaction was quenched with 5% HCl and extracted three times with
EtOAc. The organic fraction was washed with water 5 times, then brine, dried with
MgSO4 and filtered. The filtrate was concentrated in vacuo to yield the crude material
which was purified by column chromatography (40% EtOAc: 70% Hexanes Rf= 0.39) to
isolate pure the material (0.87 g, 81% yield, white solid).
1H

NMR (400 MHz, CDCl3) ∂ = 8.47 (dd, J = 6.2, 2.6 Hz, 1H), 7.93 – 7.84 (m, 1H),

7.38 – 7.28 (m, 2H), 3.89 (s, 3H), 3.87 – 3.82 (m, 2H), 3.80 (s, 3H), 2.93 (ddd, J = 13.6,
10.2, 6.0 Hz, 1H), 2.85 – 2.64 (m, 5H), 2.42 – 2.23 (m, 1H), 2.18 (s, 3H), 2.01 – 1.86 (m,
1H), 1.51 (s, 18H) 13C NMR (101 MHz, CDCl3) δ 207.9, 170.4, 170.2, 168.8, 153.1,
134.7, 130.5, 128.7, 125.8, 124.4, 119.9, 119.2, 116.8, 82.5, 77.5, 77.4, 77.2, 76.8, 60.5,
55.6, 54.1, 53.8, 53.7, 44.6, 42.3, 40.9, 39.4, 35.7, 30.1, 28.2, 24.7, 24.0, 21.2, 14.3. IR
(cm-1) 2980, 1747, 1732, 1693, 1457, 1367, 1350, 1164, 1134, 1119, 856. HRMS m/z
[M+] 614.2836 (calcd for C32H42N2O10, 614.2840).

3,3-diethoxypropanoic acid (4-69)
Synthesized following literature procedure.149
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N-(2-(1H-indol-3-yl)ethyl)-3,3-diethoxypropanamide (4-71)
Tryptamine (0.20 g, 1.25 mmol) and 3,3-diethoxypropanoic acid (4-69)
(0.20 g, 1.25 mmol) were added to a round bottom with 12.5 mL DCM
(0.1 M). EDC (0.19 g, 1.25 mmol) was added portion wise, and the flask
was placed under a balloon of argon. Upon TLC indication of
consumption of starting material, the reaction was quenched with water and extracted 3x
with DCM. The combined organic fractions were washed with brine, dried with MgSO4,
filtered and concentrated in vacuo. The crude oil was purified via column
chromatography (90% EtOAc:10% Hexanes Rf = 0.5) to yield 75% of product 4-71 as an
orange oil (0.28 g).

3,3-diethoxy-N-(2-(1-(2-methylenehex-5-enoyl)-1H-indol-3yl)ethyl)propenamide (4-73)
Acrylic acid (4-28) (0.0922 g, 0.66 mmol, 1 equiv.) was added to a round
bottom flask under argon and equipped with stir bar. Oxalyl chloride
(0.0937, 0.66 mmol, 1.01 equiv.) was added dropwise watching for the
violent formation of gas. One drop of DMF was added to the mixture using a
bleed needle for gaseous release. The mixture was stirred for 2 hours at room
temperature to form desired acid chloride.
In a separate round bottom indole (4-71) (0.10 g, 0.33 mmol, 1 equiv. (0.5 equiv. to acid
chloride)), tetrabutylammonium hydrogensulfate (0.01 g, 0.033 mmol, 0.1 equiv.) and
powdered NaOH (0.066 g, 1.65 mmol, 5 equiv.) were added to 3.3 mL of DCM. The
flask was purged with argon and stirred for 30 minutes before transferring (via cannula)
the contents of the acid chloride reaction. After 1.5 hours TLC determined consumption
of starting material and the reaction was quenched with water, extracted three times with
DCM, dried with MgSO4, filtered and concentrated in vacuo. The crude material was
purified by column chromatography (60% EtOAc: 40% Hexanes) to isolate 0.057 g of
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pure product (42%, yellow solid). Rf= 0.52 (60% EtOAc: 40% Hexanes). 1H NMR (600
MHz, CDCl3) ∂ = 8.42 (d, J = 8.2 Hz, 1H), 7.56 (d, J = 7.8 Hz, 1H), 7.37 (t, J = 8.2 Hz,
1H), 7.33 – 7.28 (m, 2H), 6.36 – 6.31 (m, br, 1H amide NH), 5.82 (ddt, J = 16.8, 10.1, 6.6
Hz, 1H), 5.65 (s, 1H), 5.45 (s, 1H), 5.07 – 4.97 (m, 2H), 4.71 (t, J = 5.3 Hz, 1H), 3.63 –
3.55 (m, 4H), 3.43 (dq, J = 9.4, 7.0 Hz, 2H), 2.90 (t, J = 7.1 Hz, 2H), 2.61 (t, J = 7.5 Hz,
2H), 2.51 (d, J = 5.3 Hz, 2H), 2.30 (q, J = 6.9 Hz, 2H), 1.11 (t, J = 7.0 Hz, 6H) IR (cm-1)
3295, 2974, 1677, 1634, 1553, 1454, 1371, 1211, 1062, 755. HRMS m/z [M+] 412.2353
(calcd for C24H32N2O4, 412.2362).

tert-butyl (3,3-diethoxypropanoyl)(2-(1-(2-methylenehex-5-enoyl)1H-indol-3-yl)ethyl)carbamate
DMAP (0.013 g, 0.10 mmol) and Boc2O (0.66 g, 3.05 mmol) were
added to THF (3 mL, 0.2 M) and the flask placed under an argon
atmosphere. 4-73 (0.25 g, 0.61 mmol) was added followed by NEt3
(0.08 mL, 0.61 mmol). The reaction was stirred at rt for 18 h at which
point TLC indicated consumption of starting materials. The reaction
was concentrated in vacuo and purified by column chromatography (10% EtOAc: 90%
Hexanes Rf= 0.21). Pure product was isolated as a clear pale-yellow oil (0.26 g, 85%
yield).
1H

NMR (599 MHz, Chloroform-d) δ 8.42 (dt, J = 8.1, 1.0 Hz, 1H), 7.64 (dt, J = 7.5,

1.1 Hz, 1H), 7.36 (ddd, J = 8.3, 7.1, 1.3 Hz, 1H), 7.31 (td, J = 7.5, 1.2 Hz, 1H), 7.27 (s,
1H), 5.82 (ddt, J = 16.8, 10.2, 6.5 Hz, 1H), 5.65 – 5.62 (m, 1H), 5.44 (s, 1H), 5.08 – 4.97
(m, 3H), 3.97 – 3.91 (m, 2H), 3.70 (dq, J = 9.3, 7.0 Hz, 2H), 3.58 (dq, J = 9.4, 7.0 Hz,
2H), 3.22 (d, J = 5.7 Hz, 2H), 2.92 – 2.87 (m, 2H), 2.62 – 2.58 (m, 2H), 2.30 (tdt, J = 7.9,
6.5, 1.4 Hz, 2H), 1.34 (s, 9H), 1.20 (t, J = 7.1 Hz, 6H). 13C NMR (101 MHz, CDCl3) δ
172.5, 169.4, 153.0, 143.9, 137.2, 136.1, 131.3, 125.3, 124.7, 124.0, 121.1, 119.1, 119.0,
116.9, 115.9, 100.3, 83.4, 62.3, 44.4, 43.7, 33.3, 32.0, 27.9, 24.3, 15.5. IR (cm-1) 2975,
1729, 1684, 1452, 1369, 1350, 1146, 1120, 749. HRMS m/z [M+] 512.2901 (calcd for
C29H40N2O6, 512.2886).
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1-(1H-indol-1-yl)-2-methylenehex-5-en-1-one (4-50)
Acrylic acid (4-28) (2.00 g, 15.8 mmol, 1 equiv.) is added to an
argon flushed round bottom. Oxalyl chloride (2.03 g, 16.0 mmol, 1.01 equiv.) was added
via syringe dropwise then one drop of DMF was added. The mixture was stirred for 2
hours before being added to the other reaction below.
In a separate round bottom flask was added indole (1-1) (0.93 g, 7.9 mmol, 1 equiv.),
tetrabutylammonium hydrogensulfate (0.27 g, 0.79 mmol, 0.1 equiv.), powdered NaOH
(1.58 g, 39.5 mmol, 5 equiv.) and DCM (79 mL). The mixture was stirred under argon for
30 minutes before adding the acid chloride reaction to the flask via cannula. Then the
reaction was monitored by TLC for consumption of the indole (1.5 hours). The reaction
was quenched with water and extracted with DCM three times, dried with MgSO4, and
filtered. The crude oil was purified by column chromatography (5% EtOAc: 95%
Hexanes) to isolate the pure product (1.65 g, 93%, pale yellow oil). Rf= 0.32 (5% EtOAc:
95% Hexanes). 1H NMR (400 MHz, CDCl3) ∂ = 8.44 (d, J = 8.3 Hz, 1H), 7.58 (d, J =
7.4 Hz, 1H), 7.47 (d, J = 3.8 Hz, 1H), 7.40 – 7.33 (m, 2H), 7.29 (td, J = 7.5, 1.1 Hz, 1H),
6.59 (d, J = 4.4 Hz, 1H), 5.90 – 5.76 (m, 1H), 5.67 (t, J = 1.2 Hz, 1H), 5.48 (s, 1H), 5.09
– 4.93 (m, 2H), 2.64 (t, J = 7.5 Hz, 2H), 2.37 – 2.26 (m, 2H)

13C

NMR (101 MHz,

CDCl3) δ = 169.5, 143.8, 137.1, 135.7, 131.0, 128.7, 127.2, 124.9, 123.9, 121.3, 120.8,
116.6, 115.9, 115.6, 108.4, 33.1, 31.9. IR(cm-1) 2979, 1686, 1535, 1449, 1343, 1204,
1017, 749. HRMS m/z [M+] 225.1155 (calcd for C15H15NO, 225.1154).

methyl 3-(ethylthio)-3-oxopropanoate (4-78)
Synthesized following literature procedure.150
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methyl 2-((ethylthio)carbonyl)-4-(1H-indole-1-carbonyl)oct-7-enoate
(4-86 precursor)
Indole (1-1) (0.79 g, 3.51 mmol), thioester 4-78 (1.19g, 7.37 mmol) and
K2CO3 were all added to a round bottom flask with 23 mL THF (0.15
M). One drop of water was added, and the flask equipped with reflux condenser under a
balloon of argon. The reaction was heated at reflux for 4 h when TLC indicated
consumption of starting material. The reaction was cooled to rt and diluted with EtOAc,
washed with water 3x followed by a brine was and then the organic fraction collected.
The organic fraction was dried with MgSO4, filtered and concentrated in vacuo. The
crude was purified by column chromatography (10% EtOAc: 90% Hexanes Rf= 0.3) but
was inseparable from the presence of ethylthiomethyl malonate. The product was a
mixture of diastereomers and used crude isolated as a colourless oil (1.45 g, >100% crude
(1.35 g theoretical)).

methyl 4-(3-(2-((tert-butoxycarbonyl)amino)ethyl)-1H-indole-1carbonyl)-2-((ethylthio)carbonyl)oct-7-enoate (4-79)
Indole 4-43 (1.00 g, 2.70 mmol, 1 equiv.), methyl 3-(ethylthio)-3oxopropanoate (1.10 g, 6.78 mmol, 2.5 equiv.), and K2CO3 (0.37 g,
2.70 mmol, 1 equiv.) were added to THF (18 mL) followed by one
drop of water. The reaction was refluxed under argon for 12 hours. The mixture was
diluted with EtOAc and washed with water three times and brine once. The collected
organic fraction was dried with MgSO4¸filtered and concentrated in vacuo to yield crude
product. Crude product was purified by column chromatography (25% EtOAc: 75%
Hexanes) and (4-79) was isolated (0.97 g, 67%, yellow oil). Rf= 0.33 (25% EtOAc: 75%
Hexanes).
1H

NMR (600 MHz, CDCl3) mixture of diastereomers ∂ = 8.51 (d, J = 6.5 Hz, 1H),

7.54 (d, J = 7.6 Hz, 1H), 7.36 (t, J = 7.7 Hz, 1H), 7.33 – 7.27 (m, 2H), 5.84 – 5.65 (m,
1H), 5.06 – 4.90 (m, 2H), 4.73 (s, 1H), 3.78 – 3.58 (m, 4H), 3.55 – 3.40 (m, 2H), 3.30 –
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3.12 (m, 1H), 2.89 (m, 4H), 2.55 – 2.38 (m, 1H), 2.32 – 2.20 (m, 1H), 2.12 (ddq, J =
21.6, 14.6, 7.7 Hz, 3H), 1.95 (dq, J = 15.0, 8.1, 7.3 Hz, 1H), 1.71 (dq, J = 13.9, 6.8 Hz,
2H), 1.43 (s, 9H), 1.30 – 1.10 (m, 3H) 13C NMR (101 MHz, CDCl3) mixture of
diastereomers δ 194.9, 194.7, 173.3, 173.3, 169.0, 156.0, 137.3, 136.3, 130.8, 125.7,
124.0, 122.0, 120.3, 119.0, 117.3, 116.2, 57.3, 53.0, 41.2, 40.2, 32.1, 31.5, 31.0, 28.5,
24.1, 14.5. IR(cm-1) 3356, 2936, 2830, 1743, 1686, 1452, 1164, 1025, 752. HRMS m/z
[M+] 530.2436 (calcd for C28H38N2O6S ,530.2451)
methyl 7-(but-3-en-1-yl)-10-(3-((tertbutoxycarbonyl)amino)propyl)-9-((ethylthio)carbonyl)-6-oxo6,7,8,9-tetrahydropyrido[1,2-a]indole-9-carboxylate (4-80)
Indole 4-79 (0.97 g, 1.82 mmol, 1 equiv.), Mn(OAc)3 (1.46 g, 5.47
mmol, 3 equiv.) and MeOH (26 mL) were added to a round bottom flask equipped with
stir bar and reflux condenser. The reaction was placed under a balloon atmosphere of
argon and lowered into a 65 °C oil bath. When TLC indicated the complete consumption
of starting material after 3 h, the reaction was cooled to room temperature and the MeOH
removed in vacuo. The crude residue was diluted with water and EtOAc and added to a
separatory funnel. The aqueous layer was extracted three time with EtOAc, and the
combined organic fractions were washed with brine and then dried with MgSO4. The
solid was filtered off and the solvent removed in vacuo to yield the crude residue of
product 4-80 as a white solid (0.89 g, 93 % yield). The product was used as isolated in
the next step without further purification. Rf = 0.61 (30% EtOAc: 70% Hexanes).
1H

NMR (599 MHz, Chloroform-d) mixture of diastereomers δ 8.53 (dd, J = 11.2, 8.1

Hz, 1H), 7.71 (d, J = 7.7 Hz, 1H), 7.38 (dt, J = 11.2, 7.8 Hz, 1H), 7.32 (dt, J = 10.7, 7.5
Hz, 1H), 5.82 (dddt, J = 23.7, 16.8, 9.9, 6.2 Hz, 1H), 5.14 – 5.05 (m, 1H), 5.01 (ddd, J =
12.3, 9.9, 1.8 Hz, 1H), 4.82 and 4.72 ( each a br, s, 1H total), 3.86 and 3.82 (each a s, 3H
total), 3.51 (m, 1H), 3.44 – 3.26 (m, 1H), 3.02 – 2.79 (m, 5H), 2.78 – 2.56 (m, 2H), 2.50
(t, J = 13.2 Hz, 0.5H) and 2.39 (t, J = 13.1 Hz, 0.5H) for 1H total, 2.35 – 2.12 (m, 3H),
1.67 (m, 1H), 1.45 and 1.43 (both s, 3H total), 1.32 – 1.16 (m, 3H). IR (cm-1) 3411, 2931,
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1741, 1705, 1511, 1455, 1365, 1240, 1167, 1072, 753. HRMS m/z [M+] 528.2291 (calcd
for C28H36N2O6S ,528.2294).

methyl 10-(2-((tert-butoxycarbonyl)amino)ethyl)-9((ethylthio)carbonyl)-6-oxo-7-(3-oxobutyl)-6,7,8,9tetrahydropyrido[1,2-a]indole-9-carboxylate (4-81)
PdCl2 (0.031 g, 0.18 mmol, 0.3 equiv.) and CuCl2 (0.079 g, 0.59
mmol, 1 equiv.) were added to a round bottom flask and half the
volume (5.5 mL) of a 7:1 mixture of DMSO:water (11mL total) was added to the flask.
The flask was evacuated and refilled with a balloon of oxygen 5 times. Starting indole (480) (0.35 g, 0.67 mmol, 1.13 equiv.) was dissolved in the other half of the DMSO:water
solvent and then added dropwise to the palladium reaction. The reaction was stirred at 40
°C for 12 hours at which point TLC confirmed consumption of the starting indole. The
reaction was quenched with 5% HCl and extracted three times with EtOAc. The organic
fraction was washed with water 5 times, then brine, dried with MgSO4 and filtered. The
filtrate was concentrated in vacuo to yield the crude material which was purified by
column chromatography (40% EtOAc: 60% Hexanes Rf = 0.21) to give pure product
(0.22 g, 60% yield, white foam solid). 1H NMR (600 MHz, CDCl3) mixture of
diastereomers ∂ = 8.51 (t, J = 8.0 Hz, 1H), 7.76 – 7.66 (m, 1H), 7.44 – 7.29 (m, 2H),
4.79 and 4.70 (br, s, 1H total), 3.85 and 3.84 (s, 3H total), 3.51 (dq, J = 13.6, 7.2 Hz, 1H),
3.44 – 3.25 (m, 1H), 3.01 – 2.58 (m, 8H), 2.57 – 2.36 (m, 1H), 2.34 – 2.21 (m, 1H), 2.19
and 2.17 (s, 3H total), 1.93 (dq, J = 13.5, 6.0 Hz, 1H), 1.45 and 1.44 (s, br, 9H total), 1.27
(t, J = 7.5 Hz) and 1.20 (t, J = 7.6 Hz) for 3H total. 13C NMR (101 MHz, CDCl3)
mixture of diastereomers δ 208.0, 198.5, 197.1, 170.5, 169.2, 156.3, 135.5, 126.8,
126.5, 124.8, 120.3, 117.2, 63.4, 61.5, 54.2, 41.3, 41.1, 39.2, 37.4, 36.7, 30.5, 28.9, 25.3,
24.9, 24.4, 24.3, 14.7, 14.4. IR (cm-1) 3386, 2973, 1740, 1704, 1513, 1455, 1365, 1240,
1165, 1136, 1136, 955, 754. HRMS m/z [M+] 544.2244 (calcd for C28H36N2O7S,
544.2243).
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(4-83)
PdCl2 (0.028 g, 0.16 mmol, 0.3 equiv.) and CuCl2 (0.070 g, 0.52
mmol, 1 equiv.) were added to a round bottom flask and half the
volume (5 mL) of a 7:1 mixture of DMSO:water (10 mL total) was
added to the flask. The flask was evacuated and refilled with a
balloon of oxygen 5 times. Starting indole (4-82) (0.37 g, 0.58 mmol, 1.13 equiv.) was
dissolved in the other half of the DMSO:water solvent and then added dropwise to the
palladium reaction. The reaction was again evacuated and refilled with oxygen. The
reaction was stirred at 40 °C under 1 atm of oxygen for 12 hours at which point TLC
confirmed consumption of the starting indole. The reaction was quenched with 5% HCl
and extracted three times with EtOAc. The organic fraction was washed with water 5
times, then brine, dried with MgSO4 and filtered. The filtrate was concentrated in vacuo
to yield the crude material which was purified by column chromatography (30% EtOAc:
70% Hexanes Rf= 0.31) to isolate pure the material (0.25 g, 67% yield, yellow solid). 1H
NMR (600 MHz, CDCl3) mixture of diastereomers ∂ = 8.50 (td, J = 7.2, 6.7, 2.0 Hz,
1H), 8.01 – 7.90 (m, 1H), 7.43 – 7.30 (m, 2H), 4.02 – 3.94 (m, 1H), 3.93 and 3.86 (each a
s, 3H total), 3.84 – 3.71 (m, 1H), 3.02 – 2.76 (m, 6H), 2.76 – 2.56 (m, 2H), 2.53 – 2.22
(m, 2H), 2.19 and 2.17 (each a s, 3H total), 1.92 (td, J = 16.2, 15.5, 6.7 Hz, 1H), 1.51 and
150 (each a s, 18H), 1.24 (t, J = 7.4 Hz) and 1.19 (t, J = 7.4 Hz) (for 3H total) 13C NMR
(101 MHz, CDCl3) δ 207.9, 197.9, 196.7, 170.3, 170.0, 168.8, 153.1, 135.1, 130.5,
130.3, 128.9, 128.2, 126.3, 126.0, 124.5, 124.4, 120.8, 120.6, 120.3, 120.3, 116.9, 116.8,
82.6, 82.5, 62.8, 61.2, 54.2, 53.9, 44.6, 41.0, 40.8, 39.7, 38.9, 37.2, 36.6, 30.2, 28.2, 26.0,
24.9, 24.9, 24.6, 24.1, 24.0, 14.2, 14.0. IR(cm-1) 2981, 1733, 1694, 1455, 1367, 1347,
1172, 1135, 1118, 855, 759 HRMS m/z [M+] 644.2765 (calcd for C33H44N2O9S,
644.2768).

3-tert-butyl 4a-methyl 6-(but-3-en-1-yl)-4,7-dioxo-1,2,4a,5,6,7hexahydroazepino[3,4,5-hi]benzo[b]indolizine-3,4a(4H)dicarboxylate (4-54)
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Indole 4-46 (0.17 g, 0.46 mmol, 1 equiv.) was dissolved in acetonitrile (2.3 mL). DMAP
(0.028 g, 0.23 mmol, 0.5 equiv.) and triethylamine (0.056 g, 0.55 mmol. 1.2 equiv.) were
added and the mixture was cooled to 0 °C. Boc2O (0.11 g, 0.51 mmol, 1.1 equiv.) was
added dropwise and the reaction was warmed to room temperature and stirred for 3
hours. The mixture was concentrated in vacuo and columned (30% EtOAc: 70% Hexanes
Rf = 0.45) to yield pure material (0.19 g, 87%, white solid). 1H NMR (600 MHz,
CDCl3) mixture of diastereomers ∂ = 8.55 (d, J = 8.2 Hz, 1H), 7.48 – 7.39 (m, 2H),
7.36 – 7.31 (m, 1H), 5.89 – 5.75 (m, 1H), 5.13 – 5.00 (m, 2H), 4.57 (dt, J = 15.7, 3.5 Hz,
1H), 3.84 (s, 3H), 3.57 (ddd, J = 15.4, 12.2, 2.7 Hz, 1H), 3.14 – 2.93 (m, 2H), 2.79 – 2.63
(m, 2H), 2.56 (t, J = 14.1 Hz, 1H), 2.45 – 2.18 (m, 3H), 1.81 – 1.66 (m, 1H), 1.58 (s, 8H)
13C

NMR (151 MHz, cdcl3) δ mixture of diastereomers 170.8, 170.4, 166.8, 152.5,

137.6, 137.4, 134.9, 129.2, 126.0, 124.0, 118.3, 118.2, 118.1, 116.8, 115.6, 115.4, 84.1,
56.5, 53.7, 52.6, 41.7, 37.6, 34.6, 30.6, 27.9, 24.6, 23.5. IR(cm-1) 2987, 1710, 1458,
1371, 1284, 1198, 1132, 753. HRMS m/z [M+] 466.2102 (calcd for C26H30N2O6,
466.2104).

methyl 7-(but-3-en-1-yl)-9-((ethylthio)carbonyl)-6-oxo-6,7,8,9tetrahydropyrido[1,2-a]indole-9-carboxylate (4-86 precursor)
Isolated with (4-78) (ethylthiomethyl malonate) impurity because
the molecules were the same rf under a variety of column eluents and could not be
separated. Attempts to distill off (4-78) led to complete decomposition of the desired
product as well. This data is crude with the malonate peaks indicated as not part of the
product.
4-86 precursor (1.36 g, 3.51 mmol) and Mn(OAc)3 (2.82 g, 10.5 mmol) were dissolved
in 50 mL of MeOH (0.07 M) and refluxed under an argon atmosphere at 65 °C. After 3 h
TLC indicated complete consumption of starting material and the reaction was cooled
and the MeOH was concentrated off in vacuo. The mixture was diluted with water and
EtOAc and transferred to a separatory funnel. The water layer was extracted 3x with
EtOAc, the combined organic fraction washed with brine and then dried with MgSO4,
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filtered and concentrated in vacuo. The crude mixture was attempted to be purified by
column chromatography (15% EtOAc: 85% Hexanes Rf= 0.40) but was unsuccessful in
removing ethylthiomethyl malonate impurity. Isolated as a pale-yellow oil (1.29g, 96%
crude)
1H

NMR (400 MHz, CDCl3) ∂ = 8.52-8.47 (m, 1H), 7.56 (t, J = 7.2 Hz, 1H), 7.42 – 7.26

(m, 2H), 6.83 and 6.77 (s, 1H total), 5.88-5.75 (m, 1H), 5.18 – 4.91 (m, 2H), 3.89 and
3.78 (s, 3H total), 3.74 and 3.57 MALONATE, 3.02 – 2.77 (m, 4H), 2.55 – 2.39 (m, 1H),
2.36 – 2.14 (m, 2H), 1.75-1.66 (m, 1H), 1.32 – 1.24 (m, 2H) (malonate overlapped) and
1.19 (t, J = 7.4 Hz, 1H) three total protons for the triplet SCH2CH3) 13C NMR (101
MHz, CDCl3) δ 198.2, 197.1, 170.6, 169.1, 168.6, 137.5, 137.4, 135.8, 135.5, 132.2,
129.2, 129.0, 126.0, 125.7, 124.5, 124.4, 121.0, 116.9, 116.8, 116.0, 115.9, 111.2, 111.2,
61.9, 61.3, 53.7, 52.8, 49.5, 39.7, 38.6, 34.1, 33.8, 30.9, 30.7, 29.1, 28.8, 24.9, 24.6, 24.1,
14.5, 14.2, 14.1. IR (cm-1) 2952, 2931, 1750, 1705, 1669, 1451, 1235, 1180, 914, 757.

methyl 9-((ethylthio)carbonyl)-6-oxo-7-(3-oxobutyl)-6,7,8,9tetrahydropyrido[1,2-a]indole-9-carboxylate (4-86)
PdCl2 (0.07 g, 0.39 mmol, 0.3 equiv.) and CuCl2 (0.17 g, 1.3 mmol,
1 equiv.) were added to a round bottom flask and half the volume
(12 mL) of a 7:1 mixture of DMSO:water (10 mL total) was added to the flask. The flask
was evacuated and refilled with a balloon of oxygen 5 times. Starting indole (4-86
precursor) (0.59 g, 1.50 mmol, 1.13 equiv.) was dissolved in the other half of the
DMSO:water solvent and then added dropwise to the palladium reaction. The reaction
was again evacuated and refilled with oxygen. The reaction was stirred at 40 °C under 1
atm of oxygen for 24 hours at which point TLC confirmed consumption of the starting
indole. The reaction was quenched with 5% HCl and extracted three times with EtOAc.
The organic fraction was washed with water 5 times, then brine, dried with MgSO4 and
filtered. The filtrate was concentrated in vacuo to yield the crude material which was
purified by column chromatography (30% EtOAc: 70% Hexanes) to isolate 4-86 as a
yellow oil (0.15 g, 25% yield). Rf = 0.29 (30% EtOAc: 70% Hexanes).
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1H

NMR (400 MHz, CDCl3) mixture of diastereomers ∂ = 8.48 (m, 1H), 7.56 (t, J =

7.0 Hz, 1H), 7.43 – 7.26 (m, 2H), 6.84 and 6.78 (s, 1H total), 3.89 and 3.80 (s, 3H total),
3.01 – 2.82 (m, 3H), 2.79 – 2.64 (m, 3H), 2.56 – 2.38 (m, 1H), 2.37 – 2.23 (m, 1H), 2.19
and 2.17 (s, 3H total), 2.01 – 1.88 (m, 1H), 1.27 (t, J = 7.4 Hz, 1.5H) and 1.20 (t, J = 7.4
Hz, 1.5H) for 3H total. 13C NMR (101 MHz, CDCl3) mixture of diastereomers δ 207.8,
198.1, 197.1, 170.2, 169.0, 168.5, 135.7, 135.5, 132.1, 129.3, 129.0, 126.1, 125.8, 124.6,
124.5, 121.1, 121.0, 116.9, 116.8, 111.5, 111.5, 61.9, 61.3, 53.8, 53.8, 41.0, 40.7, 39.8,
38.7, 34.5, 34.5, 30.2, 30.1, 25.0, 24.6, 24.3, 24.2, 14.2, 14.1. IR(cm-1) 2952, 1735, 1715,
1671, 1589, 1565, 1451, 1349, 1241, 942, 757. HRMS m/z [M+] 401.1303 (calcd for
C21H23N2O5S, 401.1297).

Dimethyl propargylmalonate (4-122)
This product was purchased from Aurum Pharmatech ($145.00/25 g) as
the cheapest option but is available from MilliporeSigma ($166.00/10g).

2-(prop-2-yn-1-yl)malonic acid (4-123)
Dimethyl propargylmalonate (4-122) (2.81 g, 16.5 mmol) was placed into
a round-bottom flask in 1:1 mixture of THF:MeOH (166 mL, 0.1 M), 2M NaOH (66 mL,
132 mmol) was added with rapid stirring and the mixture was left to stir O.N. at room
temperature. When complete the reaction was concentrated in vacuo to remove the THF
and MeOH and then was further diluted with water. The crude was extracted once with
Et2O to remove any remaining starting material and then the water later was acidified
carefully with concentrated HCl to pH=1. The acidic water layer was then extracted 3x
with Et2O and the combined organic fractions were washed with brine, dried with MgSO4
and concentrated in vacuo to yield pure product as a white solid (1.41 g, 66% yield).
1

H NMR data was in accordance with previously reported results.151
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2-methylenepent-4-ynoic acid (4-119)
To an argon flushed round bottom was added 4-123 (1.41 g, 9.9 mmol),
paraformaldehyde (0.36 g, 11.9 mmol), piperidine (0.1 mL, 0.99 mmol) and
5 mL of pyridine (2 M). The flask was equipped with reflux condenser and an empty
balloon with a 16 guage needle to monitor production of CO2 gas. The reaction was
placed in to a 130 °C oil bath and refluxed for 20-40 minutes depending on when gas
production ceases and TLC showed consumption of starting materials. The dark burnt
orange reaction was cooled to room temperature (no ice bath, just removed from the oil
bath) and then acidified with 5% HCl. The aqueous mixture was added to a separatory
funnel where the water layer was extracted 3x with Et2O. Using TLC to monitor for
pyridine the organic fraction was washed with 5% HCl until pyridine was no longer
detectable by TLC. Then the remaining organic fraction was washed with brine, dried
with MgSO4, filtered and concentrated in vacuo. This product (yellow-orange solid) was
pushed crude into the next step.
1H

NMR (400 MHz, Chloroform-d) δ 11.31 (br s, 1H), 6.50 (s, 1H), 6.19 (s, 1H), 3.25

(s, 2H), 2.23 (t, J = 2.6 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 171.87, 134.86, 129.42,
80.23, 72.67, 21.61. IR (cm-1) 3277, 2878, 2607, 1919, 1695, 1632, 1430, 1278, 1152,
932, 666. HRMS m/z [M+] 110.0365 (calcd for C6H6O2 110.0368)

tert-butyl (2-(1-(2-methylenepent-4-ynoyl)-1H-indol-3yl)ethyl)carbamate (4-124)
Acid 4-119 (0.77 g, 7.0 mmol) was added to an argon flushed round
bottom. The flask was placed under a balloon of argon and oxalyl chloride (COCl)2 (0.94
g, 7.4 mmol) was added dropwise carefully. One drop of DMF was added to catalyze the
reaction, and the mixture was stirred for 2 hours. 30 minutes prior to the 2-hour mark of
the acid chloride formation another round bottom was set up with the remaining required
reagents: Boc-protected tryptamine (4-42) (0.91 g, 3.5 mmol), tetrabutylammonium
hydrogensulfate (Bu4NHSO4) and powdered NaOH (0.70 g, 17.5 mmol) were all added
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to a round bottom containing 35 mL DCM (0.1 M). The mixture was stirred vigorously
for 30 minutes before transferring the contents of the acid chloride forming reaction to
the tryptamine containing reaction. The mixture was stirred for room temperature for 1 h
at which time TLC indicated complete consumption of starting materials. The reaction
was quenched with water and the extracted 3x with DCM. The organic fractions were
dried with MgSO4, filtered, concentrated and purified by column chromatography (20%
EtOAc: 80% Hexanes Rf= 0.4) to yield the product as a white solid (1.04 g, 84% yield).
1H

NMR (400 MHz, Chloroform-d) δ 8.41 (d, J = 8.2 Hz, 1H), 7.56 (dt, J = 7.5, 1.1 Hz,

1H), 7.38 (ddd, J = 8.3, 7.2, 1.4 Hz, 1H), 7.35 – 7.29 (m, 2H), 6.11 (t, J = 1.8 Hz, 1H),
5.67 (t, J = 1.5 Hz, 1H), 4.62 (br s, 1H), 3.51 – 3.40 (m, 4H), 2.90 (t, J = 7.0 Hz, 2H),
2.27 (t, J = 2.7 Hz, 1H), 1.44 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 168.19, 156.30,
138.93, 136.51, 131.51, 125.78, 124.70, 124.46, 123.18, 119.41, 117.18, 79.44, 73.32,
60.86, 40.50, 28.86, 26.09, 26.07, 23.63. IR (cm-1) 3312, 2973, 1740, 1703, 1513, 1455,
1365, 1240, 1165, 955, 754. HRMS m/z [M+] 352.1787 (calcd for C21H24N2O3,
352.1787).

methyl 4-(3-(2-((tert-butoxycarbonyl)amino)ethyl)-1H-indole-1carbonyl)-2-vinylhept-6-ynoate (4-118)
Indole 4-124 (0.16 g, 0.46 mmol) was dissolved in 1.6 mL THF
(0.28 M) and left to sit under a balloon of argon. A mixture of LDA was generated by
combining freshly distilled diisopropylamine in THF (1.5 mL, 0.3M) and cooling it to -78
°C. nBuLi (2.5 M in hexanes, 0.28 mL, 0.69 mmol) was added slowly dropwise and the
mixture stirred for 5 minutes. (E)-methyl but-2-enoate (0.73 g, 0.73 mmol) was added
slowly dropwise to the LDA solution at -78 °C and the reaction was stirred at this
temperature for 20 minutes. The indole solution was then added at -78 °C and the
reaction was closely monitored at this temperature every 20 minutes until the starting
material was mostly consumed but a third undesired spot began forming. The reaction
was quenched at -78 °C by adding wet THF followed by 5% HCl and then removed from
the dry-ice bath to warm to room temperature. The mixture was extracted 3x with EtOAc,
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the organic fractions washed with brine and dried with MgSO4. The crude material was
filtered, concentrated in vacuo and then purified by column chromatography (25%
EtOAc:75% Hexanes, Rf= 0.43) to isolate the desired product as a yellow oil and a
mixture of diastereomers. (0.072 g, 34%).
Mixture of Diastereomers:
1H

NMR (400 MHz, Chloroform-d) δ 8.52 (t, J = 7.7 Hz, 1H), 7.55 (d, J = 7.7 Hz, 1H),

7.45 – 7.28 (m, 3H), 5.90 – 5.69 (m, 1H), 5.24 – 4.94 (m, 2H), 4.70 (d, J = 13.7 Hz, 1H),
3.68 and 3.62 (s each, 3H total), 3.55 – 3.32 (m, 4H), 3.21 – 3.08 (m, 1H), 2.92 (t, J = 6.4
Hz, 2H), 2.75 – 2.65 (m, 1H), 2.59 – 2.40 (m, 2H), 1.43 (s, 9H). 13C NMR (101 MHz,
CDCl3) δ 173.6, 172.3, 172.2, 156.0, 136.4, 135.0, 125.7, 124.1, 119.0, 118.4, 117.4,
80.8, 71.4, 60.6, 52.3, 47.7, 41.7, 34.3, 33.9, 28.6, 25.8, 22.8, 22.5, 14.4. IR (cm-1) 2965,
1730, 1693, 1453, 1393, 1346, 1276, 1241, 1134, 750. HRMS m/z [M+] 452.2306 (calcd
for C26H32N2O5, 452.2311).

4-125
Indole 4-118 (0.92 g, 2.04 mmol) was dissolved in 7.3 mL THF
(0.28 M) and left to sit under a balloon of argon. A mixture of
LDA was generated by combining freshly distilled
diisopropylamine (0.31 g, 3.06 mmol) in THF (6.8 mL, 0.3M) and cooling it to -78 °C.
nBuLi (2.5 M in hexanes, 1.2 mL, 3.06 mmol) was added slowly dropwise and the
mixture stirred for 5 minutes. (E)-methyl but-2-enoate (0.33 g, 3.26 mmol) was added
slowly dropwise to the LDA solution at -78 °C and the reaction was stirred at this
temperature for 20 minutes. The indole solution was then added at -78 °C and the
reaction was closely monitored at this temperature every 20 minutes until the starting
material was mostly consumed but a third undesired spot began forming. The reaction
was quenched at -78 °C by adding wet THF followed by 5% HCl and then removed from
the dry-ice bath to warm to room temperature. The mixture was extracted 3x with EtOAc,
the organic fractions washed with brine and dried with MgSO4. The crude material was
filtered, concentrated in vacuo and then purified by column chromatography (15%
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EtOAc:85% Hexanes, Rf= 0.26) to isolate the desired product as a yellow oil and a
mixture of diastereomers. (0.28 g, 26%).
Mixture of diastereomers: 1H NMR (400 MHz, Chloroform-d) δ 8.51 (t, J = 7.5 Hz,
1H), 7.64 (d, J = 7.3 Hz, 1H), 7.42 – 7.27 (m, 3H), 5.90 – 5.69 (m, 1H), 5.22 – 4.97 (m,
2H), 3.93 – 3.86 (m, 2H), 3.68 and 3.63 (s each for 3H total), 3.38 (m, 1H), 3.20 – 3.10
(m, 1H), 3.05 – 2.93 (m, 2H), 2.74 – 2.62 (m, 1H), 2.58 – 2.40 (m, 2H), 2.21 (t, J = 7.2
Hz, 1H), 2.07 – 1.95 (m, 2H), 1.47 (s, 18H). 13C NMR (101 MHz, CDCl3) δ 173.6,
173.5, 172.3, 172.1, 152.7, 152.7, 136.3, 136.3, 135.1, 135.0, 131.0, 131.0, 125.6, 125.6,
124.1, 124.0, 122.3, 122.0, 120.2, 120.2, 119.2, 119.2, 119.1, 118.4, 117.3, 82.6, 82.6,
80.6, 80.5, 71.4, 71.4, 52.3, 52.2, 47.7, 47.6, 46.2, 46.2, 41.7, 41.6, 34.1, 33.8, 28.2, 24.9,
22.4, 22.3. IR (cm-1) 2965, 1730, 1693, 1453, 1393, 1346, 1276, 1240, 1134, 856, 750,
641. HRMS m/z [M+] 552.2836 (calcd for C31H40N2O7, 552.2836).

4-125b
DMAP (0.04 g, 0.34 mmol) and Boc2O in THF (10 mL, 0.2 M) were
placed under a balloon of argon with stirring. 4-124 (0.7 g, 1.99 mmol)
was added followed by NEt3 (0.3 mL, 2.18 mmol) and the reaction was left to stir at room
temperature overnight. When TLC indicated consumption of starting material the
reaction mixture was concentrated in vacuo and placed directly onto column (10%
EtOAc: 90 Hexanes, Rf = 0.3) to isolate the product as a white solid (0.85 g, 94%).
1H

NMR (400 MHz, Chloroform-d) δ 8.39 (d, J = 8.2 Hz, 1H), 7.67 – 7.60 (m, 1H),

7.41 – 7.31 (m, 2H), 7.30 (s, 1H), 6.11 (t, J = 1.8 Hz, 1H), 5.68 (t, J = 1.7 Hz, 2H), 3.92 –
3.81 (m, 2H), 3.47 – 3.40 (m, 2H), 3.01 – 2.93 (m, 2H), 2.27 (t, J = 2.6 Hz, 1H), 1.45 (s,
18H). 13C NMR (101 MHz, CDCl3) δ 167.9, 152.7, 138.5, 136.1, 131.4, 125.3, 124.5,
124.1, 123.0, 119.4, 119.2, 116.8, 82.5, 79.1, 73.00, 46.1, 28.2, 24.7, 23.3. IR(cm-1)
3270, 2979, 1741, 1724, 1704, 1682, 1449, 1365, 1135, 1120, 746. HRMS m/z [M+]
452.2315 (calcd for C26H32N2O5, 452.2311).
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4-117
To indole 4-125 (0.05g, 0.09mmol) in DCM (2 mL, 0.04 M) was
added Grubbs I catalyst (0.01 g, 0.009 mmol) and a balloon of
ethylene gas with long needle was placed into the solution followed
by a bleed needle to flush the gas through the reaction mixture for 5 minutes. The needle
was then lifted out of the reaction solution and the bleed needle removed to stir the
mixture under an atmosphere of ethylene equipped with reflux condenser. The mixture
was heated at 35 °C for four hours and aliquots monitored by 1H NMR was used to track
the reaction progress because no Rf change was detectable by TLC. When NMR had
indicated the starting material was consumed the reaction mixture was concentrated and
then directly purified by column chromatography. The two diastereomers were separated
to yield 2 clear oils (total mass 0.02g, 41% yield).
1H

NMR (400 MHz, Chloroform-d) δ 8.49 (d, J = 8.1 Hz, 1H), 7.64 (d, J = 7.8 Hz, 1H),

7.40 – 7.35 (m, 2H), 7.34 – 7.28 (m, 3H), 6.43 (dd, J = 17.5, 10.8 Hz, 1H), 5.92 (s, 1H),
5.19 (d, J = 17.4 Hz, 1H), 5.07 (d, J = 10.8 Hz, 1H), 3.92 – 3.85 (m, 2H), 3.73 (s, 3H),
3.52 – 3.41 (m, 1H), 3.37 – 3.26 (m, 1H), 3.04 – 2.96 (m, 2H), 2.57 (d, J = 8.2 Hz, 2H),
2.45 – 2.36 (m, 1H), 2.16 – 2.07 (m, 1H), 1.46 (s, 18H). 13C NMR (101 MHz, CDCl3) δ
173.5, 173.3, 152.8, 138.4, 136.3, 130.8, 125.7, 125.4, 124.0, 121.8, 120.4, 119.2, 117.2,
113.1, 82.6, 52.3, 46.3, 42.5, 39.4, 28.6, 28.2, 27.1, 24.8. IR(cm-1) 1694, 1453, 1349,
1135, 749. HRMS m/z [M+] 552.2830 (calcd for C31H40N2O7, 552.2836).

(4-108) and (4-105) synthesized following literature
procedure from previous Kerr group methodology.134

dimethyl 3-acetyl-5-methylenecyclohexane-1,1-dicarboxylate (4-109)
To half the desired volume of solvent DMF:H2O (7:1) (32 mL total) in a
round bottom was added PdCl2 (0.089 g, 0.5 mmol) and CuCl2 (0.22 g, 1.66
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mmol). The flask was evacuated and refilled with a balloon of O2 5 times and the
components left to stir for 10 minutes. Cyclohexane 4-105 (0.44 g, 1.88 mmol) was
dissolved in the other half-volume of solvent system remaining and then added to the
reaction flask via syringe. The mixture was then gently heated in a 40 °C oil bath with
rapid stirring for 24 h. Upon confirmation of consumption of cyclohexane by TLC the
reaction was quenched with 5% HCl and the reaction extracted 4x with EtOAc. The
combined organic fractions were washed with water 5x, brine 1 x and then dried with
MgSO4 , filtered and concentrated. The crude mixture was purified by column
chromatography (20% EtOAc:80% Hexanes Rf = 0.31) to isolate the desired material as a
clear, colourless oil (0.38 g, 81% yield).
1H

NMR (400 MHz, Chloroform-d) δ 4.82 (dt, J = 5.6, 1.6 Hz, 2H), 3.73 (s, 6H), 2.91

(dt, J = 13.6, 1.8 Hz, 1H), 2.80 (tt, J = 12.6, 3.8 Hz, 1H), 2.57 (ddt, J = 13.6, 3.7, 2.0 Hz,
1H), 2.50 – 2.41 (m, 2H), 2.19 (s, 3H), 2.07 – 1.96 (m, 1H), 1.72 (dd, J = 13.5, 12.5 Hz,
1H). IR (cm-1) 2954, 1731, 1709, 1433, 1256, 1236, 1206, 1094, 868. HRMS m/z [M+]
254.1149 (calcd for C13H18O5, 254.1154).

dimethyl 3-acetyl-5-(hydroxymethyl)cyclohexane-1,1-dicarboxylate
(4-110)
BH3•THF (1M in THF, 0.71 mL, 0.71 mmol) was added to a round
bottom flask under argon and equipped with stir bar. The flask was cooled to 0 °C and
cyclohexene (0.17 mL, 1.63 mmol) was added dropwise. This mixture was stirred at 0 °C
for 1 h to generate a white slurry at which point cyclohexane 4-109 (0.15 g, 0.59 mmol)
was added via syringe. The reaction was stirred again at 0 °C, monitoring by TLC after
1.5 h the starting material was gone and sodium perborate (0.32 g, 2.06 mmol) and water
(0.71 mL) was added to the mixture. The reaction was warmed to rt while stirring. After
2 h the reaction mixture was transferred to a separatory funnel and extracted with EtOAc
3x. The combined organic fractions were dried with MgSO4, filtered, concentrated and
purified by column chromatography (50% EtOAc: 50% Hexanes Rf= 0.18) to isolate the
product as a colourless oil (0.024 g, 15%).
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1H

NMR (400 MHz, Chloroform-d) δ 3.74 (s, 3H), 3.70 (s, 3H), 3.57 – 3.44 (m, 2H),

2.63 (tt, J = 12.6, 3.4 Hz, 1H), 2.51 (ddt, J = 13.5, 3.4, 2.0 Hz, 1H), 2.40 – 2.33 (m, 1H),
2.17 (s, 3H), 2.01 (ddt, J = 9.6, 3.3, 1.6 Hz, 1H), 1.87 (br s, 1H), 1.72 – 1.55 (m, 2H),
1.40 (t, J = 13.1 Hz, 1H), 0.97 (q, J = 12.6 Hz, 1H).

13C

NMR (101 MHz, CDCl3) δ

210.39, 172.17, 171.36, 67.49, 54.72, 53.02, 52.91, 46.94, 36.42, 33.50, 32.51, 30.43,
28.36. IR (cm-1) 3336, 2970, 2931, 1466, 1378, 1107, 1128, 950. HRMS m/z [M+]
272.1259 (calcd for C13H20O6, 272.1259).

dimethyl 3-(2-methyl-1,3-dioxolan-2-yl)-5-methylenecyclohexane-1,1dicarboxylate (4-112)
Cyclohexane 4-109 (0.075 g, 0.29 mmol), ethylene glycol (0.07 mL, 1.18
mmol), TsOH•H2O (0.006 g, 0.029 mmol) and trimethyl orthoformate (0.15 g, 1.45
mmol) were added to benzene (1 mL, 0.3 M). The flask was placed under argon and
stirred at room temperature for 48 h at which point 1H NMR indicated complete
consumption of starting material. The reaction mixture was quenched with bicarb,
extracted with EtOAc 3x and the organic fractions wash with brine 1x. The organic
fraction was collected was dried with MgSO4, filtered, concentrated and purified by
column chromatography (20% EtOAc:90% Hexanes Rf = 0.34) to collect the product as a
colourless oil (0.075 g, 86% yield).
1H

NMR (599 MHz, Chloroform-d) δ 4.77 (d, J = 9.5 Hz, 2H), 4.00 – 3.85 (m, 4H),

3.71 (s, 3H), 3.70 (s, 3H), 2.90 (d, J = 14.3 Hz, 1H), 2.53 (d, J = 12.9 Hz, 1H), 2.40 (t, J
= 11.8 Hz, 2H), 1.99 – 1.90 (m, 1H), 1.85 (t, J = 13.0 Hz, 1H), 1.57 (t, J = 12.8 Hz, 1H),
1.29 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 172.39, 170.93, 143.43, 111.60, 110.85,
64.98, 61.37, 56.51, 52.92, 52.55, 43.67, 39.56, 34.87, 32.05, 21.51. HRMS m/z [M+]
298.1419 (calcd for C15H22O6, 298.1416).
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dimethyl 3-acetyl-5-(((tertbutyldimethylsilyl)oxy)methyl)cyclohexane-1,1-dicarboxylate
(4-114)
To an argon flushed round bottom was added cyclohexane 4-110
(0.035 g, 0.13 mmol), TBS-Cl (0.023 g, 0.15 mmol), DCM (1.3 mL, 0.1 M), NEt3 (0.04
mL, 0.26 mmol) and DMAP (0.023 g, 0.19 mmol). The flask was placed under an
atmosphere of argon and stirred for 24 h at room temperature. The reaction was quenched
with H2O, extracted with DCM 3x and the combined organic fractions washed with brine,
dried with MgSO4, filtered and concentrated. The crude residue was purified by column
chromatography (20% EtOAc: 80% Hexanes Rf = 0.4) to isolate the desired product as a
colourless oil (0.036 g, 71 % yield).
1H

NMR (400 MHz, Chloroform-d) δ 3.74 (s, 3H), 3.71 (s, 3H), 3.49 (dd, J = 10.0, 5.6

Hz, 1H), 3.43 (dd, J = 10.0, 6.2 Hz, 1H), 2.65 (tt, J = 12.6, 3.4 Hz, 1H), 2.50 (ddt, J =
13.5, 3.4, 2.0 Hz, 2H), 2.39 – 2.31 (m, 2H), 2.17 (s, 3H), 2.02 – 1.93 (m, 1H), 1.64 – 1.54
(m, 2H), 1.39 (t, J = 13.0 Hz, 1H), 0.88 (s, 9H), 0.03 (s, 6H). 13C NMR (101 MHz,
CDCl3) δ 210.39, 172.31, 171.47, 67.72, 54.84, 52.95, 52.77, 47.08, 36.73, 33.66, 32.60,
30.71, 28.36, 26.03, 18.45, -5.24. HRMS m/z [M+H] 387.2203 (calcd for C19H35O6Si,
387.2208).
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Chapter 5 : Annulation of Oxime-Ether Tethered DonorAcceptor Cyclopropanes
5.0 Preface
This work is adapted from the following manuscript: Irwin, L. C.; Allen, M. A.; Vriesen,
M. R.; Kerr, M. A. Chem. Eur. J. 2019, Accepted and in early view.
10.1002/chem.201904521

5.1 Introduction
Donor-acceptor cyclopropanes (DA CPs) have been well-established as important
building blocks for the synthesis of heterocyclic compounds.152 Heterocycles, and
specifically those containing nitrogen, have widespread occurrence in highly sought
natural products and bio-active molecules.153 Our interest lies in the importance of
pyrrolidine-containing molecules and the precursors to access such scaffolding, like
hydropyrrolo-oxazines.154 Figure 20 showcases bio-active natural products alsaphorazine
A and B (5-1a, 5-1b)155, preussin C (5-4)156 and 5-methyl 2-(N-methyl-pyrrolidinane) (52)157 that have yet to see their total syntheses realized. Also exhibited is Abbott’s
influenza neuraminidase inhibitor; A-315675 (5-3), yet another important pyrrolidinecontaining molecule.158

Figure 20 – Pyrrolidine-containing compounds of interest.
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The task of synthesizing pyrrolidines in a diastereoselective manner is a central challenge
in the synthesis of target molecules of academic and industrial importance. In efforts to
address this challenge, we and others have shown that donor-acceptor cyclopropanes are
convenient starting materials for synthesizing the hexahydropyrrolo-oxazines (5-6) and
pyrrolidine molecules (5-7) in question.159 Donor-acceptor cyclopropanes with
appropriate intra- or intermolecular nucleophiles can synthesize these molecules with
ease, and previous work from our group showcases these claims nicely (Scheme 103).160
From O-hydroxylamine-tethered cyclopropanes (5-5), the addition of an aldehyde
followed by Yb(OTf)3 generates the hexahydropyrrolo-isoxazoles (5-6) but confined to the
5-membered bicyclic examples. The order of addition of the Lewis acid and aldehyde
defined the diastereomeric outcome of the annulation products (5-6cis/trans, Scheme 103).
However, these CPs (5-5) were not exceptionally stable and cyclize on themselves if left
to sit. Accessing the O-hydroxylamine cyclopropanes (5-5) took 9 steps and did not explore
any variation of the chain length off the donor acceptor cyclopropane.
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Scheme 103 - Current and related research from our group. [a] NaCN, DMSO, 140
°C [b] Pd/C (10 mol%), H2(g) (1 atm), AcCl, MeOH
The work herein aimed to address issues with the initial research and discover a method
by which more elaborate products could be synthesized. I describe a high yielding,
temperature controlled, diastereoselective route to hydropyrrolo-oxazines 5-11. The
hydropyrrolo-oxazines can be taken to their respective diastereospecific pyrrolidines in a
single step via hyrogenative N-O bond cleavage (Scheme 103). From a short and high
yielding 2-step synthesis of oxime-ether tethered cyclopropanes (5-10) the intramolecular
nucleophilic opening of the tethered cyclopropane proceeds with the aid of Lewis acid,
Yb(OTf)3. In one-pot, the bicyclic hydropyrrolo-oxazines (5-11cis/trans) are formed from
the annulation of the resulting intermediate in high yield and diastereoselectively controlled
by the temperature of the reaction.
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5.2 Optimization of the Synthesis of Oxime-Ether Tethered
DA Cyclopropanes
Requiring an accessible method for the synthesis of oxime-ether DA cyclopropanes (510), I envisioned that via a simple SN2 substitution with an oxime nucleophile (5-9) I
could access the desired material from bromocyclopropane 5-8. Attempts to construct a
reliable synthesis of 5-10a commenced using CP and phenyl oxime 5-9a. In the presence
of base and varying the reaction conditions I was able to optimize a route to desired
cyclopropanes 5-10 (Table 14).161 The synthesis of cyclopropane 5-12a, and the
synthesis of all oxime variants are outlined in the experimental details, Section 5.6 .
Table 14 - Optimization of oxime-ether tethered donor-acceptor cyclopropanes

Entry

Equiv. 5-9a

Base

Solvent/T (°C)

1

Equiv. 512a
1

1.2

DMF / 60 °C

2

1

1.2

3
4

1
1

1.5
1.5

5

1

1.5

6

1

1.5

7

1

1.0

K2CO3 (1.2
equiv.)
Na2CO3 (3.0
equiv.)
NaH (2.1 equiv.)
Ag2CO3 (3.0
equiv.)
Cs2CO3 (2.0
equiv.)
Cs2CO3 (3.0
equiv.)
Cs2CO3 (3.0
equiv.)

DMF/ 6080 °C
DMF/ 80 °C
Acetone/
55 °C
Acetone/
55 °C
Acetone/
55 °C
Acetone/
55 °C

Time
(h)
18
42
19
21
18
26
18

Result 5-10a
Incomplete
reaction
Incomplete
reaction
38%
Incomplete
reaction
Incomplete
reaction
Complete, not
isolated
76%

First attempts at generating product 5-10a from Table 14, entry 1, used K2CO3 as the
base in DMF heated to 60 °C. The reaction was incomplete but crude proton NMR
evidence suggested the desired product was being made. Changing the base to Na2CO3
resulted in an incomplete reaction after 42 h (Table 14, entry 2). Changing to a stronger
base NaH (Table 14, entry 3), resulted in the isolation of a low 38% yield of product 510a. I explored a few other base options because the DMF solvent became troublesome
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to remove to isolate pure product. Ultimately, switching the solvent to acetone and using
3 equivalents of Cs2CO3 and one equivalent of each of the oxime and the
bromocyclopropane afforded appreciable amounts of desired product 5-10a (76 %)
(Table 14, entry 7).
It is important to note that in accordance with literature reports, the E oximes were
synthesized selectively when making aromatic substituted oximes.162 Synthesizing
aliphatic oximes resulted in inseparable mixtures of E:Z oximes that could be separated
after synthesizing the oxime-ether CP.

5.3 Oxime-Ether Donor-Acceptor Cyclopropanes
Synthesized
Using the optimized conditions outlined in Table 14, a library of 15 oxime-ether products
(5-10a-o) were generated with ease (Table 15).
Aromatic phenyl containing E oxime-ethers (5-10a-g) were synthesized in good to
excellent yields (76%-90%). Synthesis of the thiophene-containing oxime ether 5-10h
worked, but in a lower 48% yield. When it came to synthesize the Z oxime-ether CPs, (510d and 5-10o) the yields were significantly lower, 32% and 18% respectively. It was
intriguing that the other isomer of the oxime would affect this displacement reaction so
heavily but working amounts of product were still easily generated. 1,2-benzo substituted
CP 5-10m and 5-10o were synthesized using an alternate bromo-cyclopropane, the
synthesis of which is outlined in Section 5.6.
This reaction proceeds with retained configuration of the oxime. 163 If the E oxime (5-9)
is the chosen nucleophile, then the resultant oxime-ether CP (5-10) will also be the E
oxime-ether product. To generate the few Z examples of oxime-ether CPs, the Z oximes
were synthesized by inverting the configuration of the E oximes using cold HCl (see
Section 5.6). To confirm this retained configuration, we opted to use X-ray
crystallography because 1H NMR provided inconclusive results and reports in the
literature were conflicting and lacked details on compounds of this type that have never
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been synthesized before. I could not be certain that trends in NMR data would be the
same. ORTEP drawings of E oxime 5-9c and E oxime-ether 5-10c are found in Figure
21.

Figure 21 - ORTEP drawings of structures 5-9c and 5-10c. Ellipsoids are at the 50%
probability level and hydrogen atoms were drawn with arbitrary radii for clarity.
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Table 15 - Library of generated oxime-ether tethered cyclopropanes 5-10a-o

[a] Yield of combined E and Z isomers. Isolated yield of E isomer 46% [b] Determined from crude 1H NMR

197

5.4 Annulation of Oxime-Ether Tethered Cyclopropanes
5.4.1 Initial Findings of the Annulation Reaction
With access to the desired oxime-ether starting materials cemented, experimentation with
the annulation reaction was initiated and a few interesting scenarios arose. Oxime-ether
5-10c reacted with 5 mol% of Yb(OTf)3 in refluxing toluene to access our desired
bicyclic hydropyrrolo-oxazine 5-11c in a quantitative yield (Scheme 104, 1). We were
thrilled to discover a single isomer of annulation product 5-11c had been synthesized.
Repeating this reaction with the Z-oxime (5-10d) (Scheme 104, 2) resulted in isolating the
exact same isomer observed in the previous reaction with the E oxime-ether 5-10c.
Isolating the same isomer was perturbing giving our understanding of the mechanism for
this annulation. The result implied that the geometry of the oxime does not control which
isomer of the annulation product is formed. I hypothesized that perhaps one of the isomers
could form both cis and trans annulation products.

Scheme 104 - Initial findings during the annulation reaction of oxime-ethers 5-10c
and 5-10d.
At this time, it could not be confirmed whether the cis or trans isomer of 5-11c had
formed using 1H or 13C NMR spectroscopy. NOESY experiments failed to provide any
correlation between the benzylic and the bridge head protons. We later confirmed by
single X-ray crystallography that we had isolated the cis isomer of annulation product 511c at 120 °C in both experiments shown in Scheme 104 (see Figure 23 for crystal
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structures). The details of this, and the determination of the isomers, will be outlined
further below.

5.4.2 Computational Insight on Isomer Formation
To provide some insight on which isomer we might be isolating, we turned to
computational calculations of the molecular energies comparing the cis and trans isomers
of 5-11a (Table 16). DFT calculations were performed on molecule 5-11a to keep the
calculation times reasonable. Using three popular computational theories at the highest
calculation level, results were similar, but conclusive to the same result; the cis isomer was
favoured by an average 21.42 kJ/mol. Dealing with two isomers that differ by the energy
of a hydrogen-bond, it definitely became apparent that both isomers were close in relative
stability, but that perhaps one isomer could be isolated over the other, starting with only
the E or Z oxime-ether.
Table 16 - DFT calculations of the molecular energies of cis and trans annulation
products 5-11a-cis and 5-11a-trans.

Intrigued by this interesting result, I employed a model kit to construct the annulation
reaction to help narrow our hypothesis further. The model kit informed us that likely the
E oxime-ether cyclopropane (5-10a) would more easily form the trans isomer of the
annulation product (5-11a-trans) and that the Z oxime-ether would access the cis product
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5-11a-cis (Figure 22). According to the computational results, the Z isomer 5-10d was
forming the most stable isomer and would never access the relatively less stable trans
isomer 5-11a-trans. This suggested that from the E oxime-ether 5-10c I should be able to
isolate both the trans and cis isomers. Although, I had isolated only the cis at this point I
hypothesized that part of the mechanism was either reversible or the oxime-ether (5-10c)
would isomerize to the Z oxime-ether (5-10d) before opening the cyclopropane.

Figure 22 - Model of E oxime-ether 5-10a forming the trans annulation product 511a-trans.

5.4.3 Experimental Probing of Isomer Generation
From the computational results and the model-kit insight, we hypothesized that this
reaction did not require such forcing conditions and that lowering the reaction
temperature would provide different results. This was to curb either the annulation
product reversibly opening and re-closing to a single isomer, or, to prevent the oximeether from isomerizing before opening the cyclopropane. Both scenarios would explain
the interesting findings. To our delight, as we altered the temperature of the annulation
reaction of oxime-ether 5-10c, evidence of the other isomer 5-11c-trans became apparent
(Scheme 105).
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Scheme 105 - [A] Effects of temperature on the annulation reaction of oxime-ether
tethered cyclopropanes. [B] Interconversion of the trans annulation product 5-11ctrans to cis annulation product 5-11c-cis.
From the results outlined in (Scheme 104, 1), at 120 °C only the cis annulation product
5-11c-cis was isolated. Lowering the reaction temperature from 120 °C to 90 °C (Scheme
105, Entry 2) resulted in a mixture of the cis:trans isomers (5-11c) in a 1:2 ratio by 1H
NMR. Lowering the temperature further to 60 °C resulted in isolating only the trans
isomer 5-11c-trans (Scheme 105, Entry 3). An exciting result, the lowering of the
temperature confirmed that, from the E-oxime-ether CPs, we gain access to both the cis
and trans isomer of the hydropyrrolo-oxazines (5-11c). To solidify our findings, taking
the trans isomer isolated at 60 °C and subjecting it to 5 mol% Yb(OTf)3 at 120 °C
(Scheme 105, B) resulted in quantitative conversion to the cis isomer, confirming that the
cis isomer is our thermodynamic product. This finding also proved that the annulation is
reversible, and access to the cis isomers is possible from the trans isomers, but that the cis
isomer cannot revert to the trans because it is the thermodynamic sink.164 Crystal
structures of E-oxime cyclopropane 5-10c and the cis isolated product (5-11c-cis) were
collected to confirm our identification of the isomers isolated (Figure 23).
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5-10c
5-11c-cis

Figure 23 - ORTEP drawings of E oxime-ether 5-10c and its cis annulation product
5-11c-cis. Ellipsoids are at the 50% probability level and hydrogen atoms were
drawn with arbitrary radii for clarity.
The proposed mechanism for the formation of both the cis/trans annulation isomers
is outlined in (Scheme 106).

Scheme 106 - Proposed mechanism for the cyclopropane ring-opening and
cyclization reaction of oxime-ether tethered cyclopropanes.
Coordination of ytterbium to the methyl ester carbonyls makes cyclopropane I
susceptible to attack via the oxime nitrogen. Opening the cyclopropane results in
zwitterionic species II, and from the oxime E isomer, the protons of interest (Scheme
106, red hydrogens) are trans to each other (II). Closure via attack of the anionic carbon
alpha to the esters results in desired product III as the trans isomer. Once closed, the
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lone-pair of the nitrogen atom can break the formed ring resulting in intermediate IV
again. At this point, closure from the opposite face occurs resulting in the thermodynamic
cis isomer V.
The crystal structures generated, and the experimental results allowed us to confirm that
we can control the diastereoselectivity of this annulation reaction by changing the
reaction temperature.

5.4.4 Substrate Scope for the Cis/Trans Isomers of the tandem
Cyclopropane Opening and Annulation
Having clarified the formation of each cis and trans isomer of 5-10c, we could expand the
annulation reaction to all the synthesized oxime-ether CPs (5-10a-o) elaborating a library
scope of the cis and trans hydropyrrolo-oxazines (5-11a-m-cis/trans) from reactions
performed at varied temperatures (Table 17).
Initial trends observed that electron withdrawing substituents on the oxime aromatic ring
resulted in high yields of the cis isomer at 120 °C (5-11b-cis, 5-11c-cis, 5-11d-cis).
Accessing the trans isomer at 60 °C also worked well in high yields for the electron
withdrawing examples (5-11b-trans, 5-11c-trans, 5-11d-trans).
However, when examining more electron-neutral examples, like phenyl 5-11a, a mixture
of the isomers was observed at 60 °C but were easily separated by column
chromatography. This trend continued with electron-donating examples 5-11f and 5-11g,
which saw the cis isomer isolated at both 120 °C and 60 °C. To combat the ease in which
these examples annulated to the thermodynamic cis isomer, we lowered the reaction
temperature further to 25 °C. The change resulted in electron-rich examples forming the
trans isomer but in lower yields than their withdrawing counterparts. In the case of 5-11ftrans, the reaction had unreacted starting material after 48 h. It can be rationalized by the
proposed mechanism in Scheme 106 that the electron-rich examples provide a more
favourable and stabilized intermediate of III (Scheme 106) and that closure to the cis
product could occur with greater ease.
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Table 17 - Substrate scope for the annulation reaction of oxime-ether cyclopropanes
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Thiophene oxime-ether annulation product 5-11h cyclized to the cis isomer at all
temperatures explored, in a maximum yield of 78%. The aliphatic isopropyl oxime-ether
product 5-10k failed to yield annulation product 5-11l. Dimethyl oxime annulation product
5-11j was acquired in a 78% yield and spirocycle 5-11k was acquired in a lower 52% yield.
The lower yield of product 5-11k is suspected to be the result of a side Beckmann
rearrangement.
Exploring the alternative chain-length examples, the 7-membered product 5-11i required
higher temperatures at 160 °C to successfully annulate in an 86% yield. Unfortunately, the
10-membered ring annulation product 5-11m was not successfully isolated.
The phenyl side chain oxime-ether CP 5-10m annulated smoothly at 120 °C to yield
product 5-11e-trans in a 99% yield. This product had an unexpected chemical shift of the
benzylic proton in the 1H NMR spectrum at 5.74 ppm. This seemed high because the trend
for all examples exhibited the cis isomer benzylic proton at a lower chemical shift than the
trans isomer benzylic proton. When the reaction was performed at the lower 60 °C and the
same isomer resulted, it became apparent that the phenyl side chain put alternative strain
on this reaction giving us a different isomer than expected, 5-11e-trans. To confirm these
suspicions, x-ray crystallography of the oxime-ether CP 5-10m confirmed we had made

5-10m

5-11e-trans

Figure 24 - ORTEP drawings of 5-10m and 5-11e-trans. Ellipsoids are at the 50%
probability level and hydrogen atoms were drawn with arbitrary radii for clarity.
the E-isomer as expected. And a crystal of 5-11e confirmed the trans isomer was being
isolated in this case, even at 120 °C (Figure 24).
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Synthesis of the cis isomer 5-11e-cis was possible using the Z-oxime-ether CP (5-10o)
which indeed had a benzylic proton chemical shift lower than that of the trans product 511e-trans at (5.04 ppm). The findings further solidify the observed chemical shift trend;
that the cis products have a benzylic proton shift at a lower ppm than the trans products.

5.4.5 Elaboration to Pyrrolidine
Following the procedure outline by Jackson et al. we were also able to isolate the
pyrrolidine (5-12) of hydropyrrolo-oxazine 5-11a-trans that retained its diastereomeric
relationship. The N-O bond was successfully cleaved under hydrogenative conditions to
give a quantitative yield of pyrrolidine HCL salt 5-12 (Scheme 107). We hope to use
chemistry like this in the future to access natural products.

Scheme 107 - Pyrrolidine synthesis from trans annulation product 5-11a-trans

5.5 Conclusions and Future Directions
In summary, we have developed a protocol for 2-step access to oxime-ether tethered
cyclopropanes 5-10a-o which support the synthesis of varied chain lengths. The
intramolecular cyclopropane opening, and annulation reaction of the E oxime-ether CPs
are diastereocontrolled by varying the temperature to provide access to both cis and trans
hydropyrrolo-oxazines (5-11a-m-cis/trans). We confirmed the isomeric configurations
via single crystal x-ray crystallography and the results were further supported by the
findings of DFT calculations. The hydropyrrolo-oxazines (5-11) can be taken to their
respective pyrrolidines by reductive N-O bond cleavage to access high-value heterocycles
with tune-able substitution and predictable stereochemistry.
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Exploring enantiopure examples of oxime-ether cyclopropanes may prove valuable to
access single enantiomers of products via the temperature-controlled procedure. This is
likely worth exploring in the future.

5.6 Experimental
5.6.1 General Experimental Details
All glassware was dried in a 120 °C oven for at least two hours before cooling in a
desiccator or under high vacuum (0.4 torr) before use. Toluene was passed over activated
alumina columns and was stored over 4Å molecular sieves and under argon for a
minimum of 24 h and a maximum of 2 weeks prior to use in the oxime ether annulation
reactions. Acetone was purchased as distilled in glass from Caledon and used as received.
All other commercial reagents and solvents were used as obtained without further
purification. Reactions were performed under a balloon of argon, but with minimal air
sensitive technique. Reagents and solvents were weighed and placed into reaction flasks
before the balloon of argon was added. The progress of reactions was followed by thin
layer chromatography (TLC) (silica gel 60 F254) and the developed plates were stained
using acidic p-anisaldehyde (oxime syntheses) or basic potassium permanganate (all
other reactions). Some reactions required the use of 1H NMR to monitor consumption of
starting material, these experiments are indicated below. Flash chromatography was
performed using silica gel (230- 400 mesh). All chromatography was performed using
Still’s procedure for flash chromatography.96 Attenuated Total Reflectance (ATR)
infrared spectra were obtained using Bruker Alpha II Di-ATR. NMR experiments were
performed on either a Bruker AvIII 400 or Inova 600 instrument and samples were
obtained in CDCl3 (referenced to 7.25 ppm for 1H and 77.0 ppm for 13C) or d6-DMSO
(referenced to 2.50 for 1H and 39.5 for 13C) as indicated. Coupling constants (J) are in Hz.
The multiplicities of the signals are described using the following abbreviations: s =
singlet, d = doublet, t = triplet, q = quartet, dd = doublet of doublets, dt = doublet of
triplets, dq = doublet of quartets, m = multiplet, br = broad. CDCl3 was kept over K2CO3.
High resolution mass spectra (HRMS) were obtained on a Thermo Scientific DFS mass
spectrometer using electron impact ionization or chemical ionization (isobutane) when
electron impact proved too harsh to acquire the exact mass of a sample.
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5.6.2 Cyclopropane Syntheses

5-8a
5-bromo-1-pentene (0.98 g, 6.6 mmol, 1.3 equiv.) was added to a dry
round bottom flask. CH2Cl2 (17 mL) was added and the flask was
purged with argon. Rh2(esp)2 (0.011 g, 0.015 mmol, 0.003 equiv.) was added.
Diazomalonate165 (0.8 g, 5.1 mmol, 1 equiv.) was dissolved in 2 mL CH2Cl2 and added
very slowly by syringe over 35 minutes. The reaction was stirred until TLC confirmed
consumption of starting material (1.5 hours). When complete, the reaction was
concentrated and purified by column chromatography (20 % EtOAc/Hexanes, Rf = 0.43)
to yield 1.22 g (87%) of a pale green oil (rhodium impurity).
1H

NMR (400 MHz, Chloroform-d) δ 3.74 (s, 3H), 3.69 (s, 3H), 3.38 (m, 2H), 1.96

(ddt, J = 14.1, 7.5, 6.8 Hz, 2H), 1.86 (p, J = 7.8 Hz, 1H), 1.55 (dq, J = 14.4, 7.2 Hz, 1H),
1.45 – 1.33 (m, 3H) 13C NMR (101 MHz, CDCl3) δ 170.7, 168.5, 52.7(4), 52.6(7), 33.9,
33.0, 31.9, 27.5, 27.2, 21.1. HRMS m/z 278.0149 (calc’d for C10H15BrO4, 278.0154) IR
2952, 2228, 1726, 1608, 1523, 1254, 1178, 1078, 1048, 732.
Precursor A
TBS-protected hexenol (1.71 g, 7.96 mmol) and Rh2(esp)2
(0.006 g, 0.008 mmol) were mixed in CH2Cl2 (50 mL, 0.15 M)
for 10 minutes at room temperature under an argon atmosphere. Diazomalonate165 (1.635
g, 10.3 mmol) in CH2Cl2 (3 mL) was subsequently added dropwise over ten minutes.
The solution was stirred at room temperature for 3 hours before the solvent was removed
in vacuo. The crude oil was purified by flash column chromatography (10%
EtOAc/hexanes) to yield 2.52 g (92%) of the desired cyclopropane as a pale-yellow oil.
Rf 0.37 (10% EtOAc/hexanes).
1H

NMR (600 MHz, CDCl3): δ = 3.75 (s, 3H), 3.72 (s, 3H), 3.59 (dd, J = 6.5 Hz, 6.5

Hz, 2H), 1.90 (dddd, J = 8.8 Hz, 8.2 Hz, 8.2 Hz, 5.9 Hz, 1H), 1.55- 1.43 (m, 5H), 1.41
(dd, J = 8.9 Hz, 4.6 Hz, 1H), 1.37 (dd, J = 7.8 Hz, 4.6 Hz, 1H), 1.21-1.13 (m, 1H), 0.89
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(s, 9H), 0.03 (s, 6H). ). 13C NMR (101 MHz, CDCl3) δ 171.1, 168.9, 63.1, 52.7, 52.6,
34.0, 32.6, 28.8, 28.7, 26.1, 25.3, 21.5, 18.5, -5.2. HRMS m/z [M+H] 345.2104 (calc’d
for C17H33O5Si+, 345.2097). IR (ATR) vmax = 2954, 2930, 2857, 1727, 1462, 1436, 1389,
1329, 1283, 1256, 1210, 1129, 1098, 1006, 939, 835, 776, 707, 662.
Precursor A-OH
To a solution of cyclopropane Precursor A (2.25 g, 6.54 mmol) in
MeOH (65 mL, 0.1 M) was added PPTS (0.24 g, 0.98 mmol). After 24 hours, the solvent
was removed in vacuo. 50 mL of a saturated solution of NaHCO3 and 50 mL of CH2Cl2
were added to the crude material and the layers were separated. The aqueous phase was
extracted twice with CH2Cl2, and the organic layers were combined and washed once
with brine. The solution was dried over MgSO4 and the solvent was removed in vacuo to
yield crude cyclopropyl alcohol (1.49 g, 99%). This material was used in the subsequent
transformation without purification. Rf =0.45 (60% EtOAc/hexanes)
1H

NMR (400 MHz, CDCl3): δ = 3.74 (s, 3H), 3.70 (s, 3H), 3.61 (ddd appearing as q, J

= 5.6 Hz, 2H), 1.95 – 1.83 (m, 1H), 1.63 – 1.33 (m, 8H), 1.27 – 1.15 (m, 1H). 13C NMR
(101 MHz, CDCl3): δ = 171.0, 168.9, 62.8, 52.7, 52.6, 34.0, 32.4, 28.7, 28.6, 25.1, 21.5
HRMS m/z 231.1235 (calc’d for C11H19O5+, 231.1227). IR (ATR) vmax = 3408, 3009,
2937, 2863, 1719, 1437, 1392, 1331, 1285, 1213, 1130, 1050, 990, 905, 753, 667.
5-8b-butyl chain
Cyclopropane Precursor A-OH (1.51 g, 6.55 mmol) and PPh3
(2.75 g, 10.5 mmol) were dissolved in CH2Cl2 (26 mL, 0.25 M) and
the flask was wrapped in aluminum foil to shield it from light. Imidazole (0.893 g, 13.11
mmol) and iodine (2.66 g, 10.5 mmol) were subsequently added. The reaction was
stirred at room temperature for 18 hours, after which it was quenched with NaSO3 (aq).
The layers were separated and the aqueous phase was extracted two additional times with
CH2Cl2. The organic layers were combined, washed once with brine, dried over MgSO4
and the solvent was removed in vacuo. The crude yellow solid was purified by flash
column chromatography (15% EtOAc/hexanes) to yield cyclopropane iodide 5-8bbutylchain (1.82 g, 82%). Rf = 0.39 (15% EtOAc/hexanes).
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1H

NMR (400 MHz, CDCl3): δ = 3.75 (s, 3H), 3.71 (s, 3H), 3.15 (dd appearing as t, J =

7.0 Hz, 2H), 1.94-1.75 (m, 3H), 1.55-1.45 (m, 3H), 1.43-1.32 (m, 2H), 1.27-1.16 (m, 1H).
13C

NMR (101 MHz, CDCl3): δ = 170.9, 168.8, 52.8, 52.7, 34.0, 33.2, 29.9, 28.4, 27.8,

21.4, 6.6; HRMS m/z 341.0250 (calc’d for C11H18O4I+, 341.0244). IR (ATR) vmax =
3004, 2950, 2859, 1723, 1435, 1392, 1328, 1279, 1253, 1212, 1131, 990, 905, 884, 756.
Precursor B
TBS-protected undecenol (2.52 g, 8.85 mmol) and
Rh2(esp)2 (0.007 g, 0.009 mmol) were mixed in
CH2Cl2 (43 mL, 0.15 M) for 10 minutes at room
temperature under an argon atmosphere. Diazomalonate165 (1.82 g, 11.5 mmol) in
CH2Cl2 (3 mL) was subsequently added dropwise over ten minutes. The solution was
stirred at room temperature for 15 minutes before the solvent was removed in vacuo. The
crude oil was purified by flash column chromatography (5% EtOAc/hexanes) to yield
2.72 g (74%) of the desired cyclopropane as a pale-yellow oil. Rf 0.38 (5%
EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3): δ = 3.75 (s, 3H), 3.71 (s, 3H), 3.59 (dd appearing as t, J =

6.7 Hz, 2H), 1.95 – 1.83 (m, 1H), 1.54 – 1.43 (m, 3H), 1.43 – 1.34 (m, 4H), 1.26 (m,
10H), 1.20 – 1.10 (m, 1H), 0.89 (s, 9H), 0.04 (s, 6H). 13C NMR (101 MHz, CDCl3) δ
171.1, 168.9, 63.5, 52.7, 52.6, 34.0, 33.0, 29.7, 29.6, 29.4, 29.0, 28.8, 26.1, 25.9, 21.6,
18.5, -5.1. HRMS m/z [M+H] 415.2890 (calc’d for C22H43O5Si+, 415.2874). IR (ATR)
vmax = 2927, 2855, 1727, 1462, 1436, 1389, 1330, 1283, 1254, 1211, 1130, 1098, 1006,
836, 775, 758, 665.
Precursor B-OH
To a solution of cyclopropane Precursor B (2.50 g, 6.03
mmol) in MeOH (60 mL, 0.1 M) was added PPTS (0.23
g, 0.90 mmol). After 22 hours of stirring at room temperature, the solvent was removed
in vacuo. 50 mL of a saturated solution of NaHCO3 and 50 mL of CH2Cl2 were added to
the crude material and the layers were separated. The aqueous phase was extracted twice
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with CH2Cl2, and the organic layers were combined and washed once with brine. The
solution was dried over MgSO4 and the solvent was removed in vacuo to yield crude
cyclopropyl alcohol (1.88 g, >100% crude). This material was used in the subsequent
transformation without purification. Rf 0.38 (40% EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3): δ = 3.74 (s, 3H), 3.71 (s, 3H), 3.63 (q, J = 6.5 Hz, 2H),

1.93 – 1.84 (m, 1H), 1.60-1.52 (m, 2H), 1.50-1.35 (m, 6 H), 1.35-1.23 (m, 10H), 1.191.10 (m, 1H).

13C

NMR (101 MHz, CDCl3) δ 171.1, 168.9, 63.2, 52.7, 52.6, 34.0, 32.9,

29.6, 29.5, 29.5, 29.3, 29.0, 28.9, 28.8, 25.8, 21.6. HRMS m/z [M+H] 301.2029 (calc’d
for C19H29O5+, 301.2010). IR (ATR) vmax = 3390, 3020, 2927, 2865, 1721, 1437, 1332,
1285, 1214, 1132, 1052, 906, 755, 667.
8b-nonyl chain
Crude cyclopropane Precursor B-OH (1.88 g, 6.26
mmol) and PPh3 (2.88 g, 11.0 mmol) were dissolved in
CH2Cl2 (27 mL, 0.25 M) and the flask was wrapped in aluminum foil to shield it from
light. Imidazole (0.935 g, 13.7 mmol) and iodine (2.78 g, 11.0 mmol) were subsequently
added. The reaction was stirred at room temperature for 21 hours, after which it was
quenched with saturated NaSO3. The layers were separated and the aqueous phase was
extracted two additional times with CH2Cl2. The organic layers were combined, washed
once with brine, dried over MgSO4 and the solvent was removed in vacuo. The crude
yellow solid was purified by flash column chromatography (15% EtOAc/hexanes) to
yield desired cyclopropane iodide (1.82 g, 71%, 2 steps). Rf 0.56 (20% EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3): δ = 3.74 (s, 3H), 3.71 (s, 3H), 3.17 (dd appearing as t, J =

7.0 Hz, 2H), 1.94 – 1.84 (m, 1H), 1.80 (p, J = 7.1 Hz, 2H), 1.50 – 1.32 (m, 6H), 1.32 –
1.21 (m, 9H), 1.20 – 1.07 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 171.1, 168.9, 52.7,
52.6, 34.0, 33.7, 30.6, 29.5, 29.4, 29.3, 28.9, 28.8, 28.6, 21.6, 7.5. HRMS m/z [M+H]
411.1040 (calc’d for C16H28O4I+, 411.1027). IR (ATR) vmax = 3024, 2925, 2864, 1725,
1436, 1330, 1283, 1211, 1131, 905, 756, 667.

211

5-8c
Synthesized following literature procedure.166

5.6.3

Oxime Syntheses
5-9a: Following a procedure by Yoon167, a mixture of benzaldehyde (5.00
g, 47.2 mmol), hydroxylamine hydrochloride (3.31 g, 47.6 mmol), K2CO3
(7.17 g, 51.9 mmol) and MeOH (235 mL, 0.2 M) were stirred at rt until the

reaction was complete by TLC. The solution was concentrated in vacuo, and then ether
was added. The resulting suspension was filtered and the filtrate was then concentration
in vacuo again and dried under vacuum. Yield: 48% as the E isomer (2.73 g) as a
colourless solid. The spectroscopic data is identical to that reported and was used crude
for the following alkylation.
5-9b: Following a procedure by Verkman168, hydroxylamine
hydrochloride (2.72 g, 39.13 mmol) was dissolved in 44 mL THF, 22 mL
H2O, and 111 mL EtOH. Sodium acetate (3.21 g, 39.13 mmol), and then
4-chlorobenzaldehyde (5.00 g, 35.57 mmol) were added to this solution. After the
reaction had not been completed at 40 h, another 0.5 equiv. of hydroxylamine
hydrochloride were added. Once the reaction was complete by TLC, the THF and EtOH
were concentrated in vacuo. The aqueous solution was then extracted with ether (3x), and
the combined organic fractions were washed with brine (1x). The solution was dried over
MgSO4 and concentrated in vacuo. The resulting white solid’s spectroscopic data is
identical to that reported and was used crude for the following alkylation. Yield: 20% as
the E oxime (1.10 g).
5-9c E-isomer
Following a procedure by Wang169, 4-nitrobenzaldehyde (3.02 g, 20.0
mmol) and hydroxylamine hydrochloride (1.67 g, 24.03 mmol) were
dissolved in 20 mL THF. Pyridine (1.90 g, 24.02 mL) in 2.5 mL THF was added
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dropwise and was stirred at rt until the reaction was complete by TLC. The solution was
concentrated in vacuo, and then water was added. It was extracted with EtOAc (2x) and
the combined organic layers were washed with brine, and then concentrated in vacuo
again. The resulting yellow solid’s spectroscopic data is identical to that reported and was
used crude for the following alkylation. Yield: 84% as the E isomer (2.77 g).
5-9d Z-isomer
3 mL of HCl was cooled in an ice/water bath for 5 minutes with stirring
before E-isomer 5-9c (0.55 g, 3.3 mmol) was added portion wise carefully. Once added,
the suspended mixture was left to stir rapidly for 25 minutes in the ice/water bath. The
mixture was then carefully vacuum filtered and washed dropwise with a minimum
amount of saturated aqueous NaHCO3. The collected solid was then added slowly,
portion wise, into ~10 mL of cooled saturated aqueous NaHCO3 solution to avoid over
bubbling. Once the bubbling had ceased, the solid was vacuum filtered and washed with
cold saturation bicarb solution and then dried under vacuum. Z-isomer 5-9d was isolated
as an off white solid (0.49 g, 89%). Spectral data matched that reported.170
5-9e: Following a procedure by Ismail171, hydroxylamine hydrochloride
(4.17 g, 60 mmol) was dissolved in 40 mL of H2O and was subsequently
neutralized with 2 M NaOH. A solution of 4-cyanobenzaldehyde (6.56 g,
50 mmol.) in 90 mL EtOH was added slowly to the mixture. The reaction was stirred at rt
for 100 minutes until completion as monitored by TLC. The solution was concentrated in
vacuo, and then water was added. The solution was extracted with DCM (3x), and the
combined organic fractions were washed with brine (1x). The solution was dried over
MgSO4 and concentrated in vacuo. The resulting white solid’s spectroscopic data is
identical to that reported and was used crude for the following alkylation. Yield: 44% as
the E isomer (3.23 g).
5-9f: Following a procedure by Yoon167, 4-methoxybenzaldehyde (5.0
mL, 41.5 mmol), hydroxylamine hydrochloride (2.92 g, 42 mmol), and
K2CO3 (6.29 g, 45.4 mmol) were added to 200 mL of MeOH. Once the
reaction was complete as monitored by TLC, the reaction mixture was concentrated in
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vacuo, cold ether was added, and the solution was filtered. The resulting white solid’s
spectroscopic data is identical to that reported and was used crude for the following
alkylation. Yield: 22% as the E isomer (1.38 g).

5-9g: Following a procedure by Zhang172, 4(dimethylamino)benzaldehyde (3.00 g, 20.1 mmol), hydroxylamine
hydrochloride (1.68 g, 24.1), and 2 M NaOH (20 mL, 40.2 mmol) were
added to EtOH (20 mL). After 4 h, the ethanol was removed in vacuo, and the resulting
reaction mixture was extracted with EtOAc (4x). The organic layers were combined and
washed with brine (1x), then dried over MgSO4, and concentrated in vacuo. The resulting
yellow solid’s spectroscopic data is identical to that reported and was used crude for the
following alkylation. Yield: 80% as the E isomer (2.65 g).

5-9h: Following a procedure by Aicher173, K2CO3 (3.11 g, 22.5 mmol) was
dissolved in 225 mL water, then hydroxylamine hydrochloride (3.13 g, 45
mmol) was added and stirred for 5 minutes. Isobutyraldehyde (3.24 g, 45
mmol) was added to the solution and the mixture was stirred at room temperature for 18
hours. The solution was extracted with ether (3x), and the organic layers were combined
and washed with brine (1x). The solution was dried over MgSO4 and concentrated in
vacuo. The resulting clear liquid’s spectroscopic data is identical to that reported and
was used crude for the following alkylation. Yield: 87% as an 8:1 mixture of E/Z isomers
(3.41 g).
5-9i: Following a procedure by Chan174, acetone (3.6 mL, 50 mmol),
hydroxylamine hydrochloride (5.2 g, 75 mmol), and Na2CO3 (8 g, 75 mmol) were
added to 10 mL of water. The reaction was stirred for 16 h, and then was
extracted with ether (5x). The combined aqueous fractions were dried over MgSO4, and
concentrated in vacuo. The resulting white solids spectroscopic data is identical to that
reported and was used crude for the following alkylation. Yield: 72% (2.63 g).
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5-9j: Following a procedure by Pierce175, thiophene-2-carbaldehyde (1.87 mL, 20 mmol)
was dissolved in 40 mL EtOH. Hydroxylamine hydrochloride (1.67 g, 24 mmol)
and subsequently pyridine (3.9 mL, 48 mmol) were added. The reaction mixture
was stirred for 24 h at room temperature until complete by TLC. The reaction
was quenched with 5% HCl. The solution was extracted with EtOAc (2x) and the
combined organic fracters were washed with 5% HCl (1x) and brine (1x). The solution
was then dried over MgSO4 and concentrated in vacuo. To the resulting oil was added
hexanes which lead to the crystallization of the oxime. The white solid was collected and
washed with hexanes, then dried in vacuo. The E isomer was isolated as white crystals,
which had identical spectroscopic data to that reported.176 Yield: 49% (1.26 g) E isomer.
5-9k: Following procedure as reported by Schneider177, sodium acetate (3.68 g,
44.9 mmol) was dissolved in 12 mL of methanol. Hydroxylamine hydrochloride
(3.12 g, 44.9 mmol) was added to the flask and the mixture stirred at room temperature
for 45 minutes. Cyclohexanone (4.00 g, 40.8 mmol) was added dropwise and the white
suspension was stirred for 23 h. 12 mL of water was added to the suspension and stirred
for 1 additional hour before being filtered. The collected material was washed with water
and then dried under vacuum. The pure oxime was acquired as a white solid (1.93 g, 42%
yield). Characterization data matched reported results.178

5.6.4

Synthesis of Oxime-Ether Donor-Acceptor Cyclopropanes

Scheme 108 - General procedure for the synthesis of oxime-ether tethered
cyclopropanes 5-10a-o
A mixture of oxime (1.0 equiv), cyclopropane alkyl halide (bromo or iodo as indicated)
(1.0 equiv), and cesium carbonate (3.0 equiv) in glass-distilled acetone (0.1 M) was
heated in a 55 °C oil bath for the indicated time. Formation of oxime ether was primarily
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monitored by thin layer chromatography but was supplemented with 1H NMR
spectroscopy when required. Once cyclopropane alkyl halide and oxime were consumed,
the solution was filtered over celite and rinsed with Et2O three times and then
concentrated in vacuo. The crude residues were purified via flash column
chromatography.
5-10a
The title compound was synthesized via General Procedure
A (18.5 h). The amounts of reagents employed were: oxime
5-9a (0.11 g, 0.87 mmol), cyclopropane 5-8a (0.28 g, 0.87
mmol), and cesium carbonate (0.85 g, 2.6 mmol) in 9.0 mL of acetone. The resulting oil
was purified via column chromatography (18% EtOAc/hexanes). Yield: 76% (0.213 g)
>19:1 mixture of E:Z isomers as a pale yellow oil. Rf 0.33 (18% EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3): δ = 8.05 (s, 1H), 7.59-7.55 (m, 2H), 7.38-7.34 (m, 3H),

4.16 (dd, J = 6.4 Hz, 6.4 Hz, 2H), 3.73 (s, 3H), 3.71 (s, 3H), 1.95 (ddt, J = 15.7 Hz, 7.9
Hz, 6.8 Hz, 1H), 1.91-1.78 (m, 2H), 1.63-1.53 (m 1H), 1.41 (m, 2H), 1.38-1.27 (m, 1H).
13C

NMR (101 MHz, cdcl3) δ 171.0, 168.8, 148.6, 132.5, 129.9, 128.8, 127.1, 77.5, 77.4,

77.2, 76.8, 73.6, 52.7, 52.7, 34.1, 28.5, 28.5, 25.4, 21.5. HRMS m/z 319.1430 (calc’d for
C17H21NO5+, 319.1420). IR (ATR) Vmax = 3033, 2954, 2870, 1723, 1436, 1329, 1211,
1129, 694.
5-10b
The title compound was synthesized via General
Procedure A (2 h). The amounts of reagents employed
were: oxime 5-9b (0.111 g, 0.71 mmol),
bromocyclopropane 5-8a (0.20 g, 0.71 mmol), and cesium carbonate (0.70 g, 2.15 mmol)
in 7.1 mL of acetone. The resulting oil was purified via column chromatography (20%
EtOAc/hexanes). Yield: 86% (0.22 g) >19:1 mixture of E:Z isomers as a clear oil. Rf =
0.36 (20% EtOAc/hexanes).
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1H

NMR (400 MHz, CDCl3): δ = 8.00 (s, 1H), 7.49 (d, J = 8.5 Hz, 2H), 7.33 (d, J = 8.5

Hz, 2H), 4.16 (dd as apparent t, J = 6.4 Hz, 2H), 3.73 (s, 3H), 3.71 (s, 3H), 1.99 – 1.88
(m, 1H), 1.87 – 1.76 (m, 2H), 1.62 – 1.51 (m, 1H), 1.45 – 1.37 (m, 2H), 1.37 – 1.26 (m,
1H)

13C

NMR (101 MHz, CDCl3) δ 170.9, 168.8, 147.4, 135.7, 131.0, 129.1, 128.3,

73.7, 52.7, 52.6 34.1, 28.5, 28.4, 25.4, 21.4. HRMS m/z 353.1043 (calc’d for C17H20
ClN2O5+, 353.1030). IR (ATR) vmax = 3016, 2954, 2875, 1723, 1436, 1331, 1211, 1129,
825, 754.

5-10c
E-isomer
The title compound was synthesized via General
Procedure A (1.5 h). The amounts of reagents employed
were: oxime 5-9c (0.15 g ,0.89 mmol), cyclopropane 5-8a (0.25 g, 0.89 mmol), and
cesium carbonate (0.87 g, 2.67 mmol) in 9.0 mL of acetone. The resulting oil was
purified via column chromatography (23% EtOAc/hexanes). Yield: 90% (0.29 g) >19:1
mixture of E:Z isomers as a white solid and as confirmed by x-ray crystallography. Mp =
60 – 62 °C. Rf = 0.31 (20% EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3) δ 8.22 (d, J = 8.9 Hz, 2H), 8.09 (s, 1H), 7.73 (d, J = 8.8

Hz, 2H), 4.22 (t, J = 6.4 Hz, 2H), 3.74 (s, 3H), 3.71 (s, 3H), 2.00 – 1.89 (m, 1H), 1.90 –
1.79 (m, 2H), 1.64 – 1.50 (m, 1H), 1.45-1.37 (m, 2H), 1.37 – 1.27 (m, 1H) 13C NMR
(151 MHz, CDCl3) δ 170.7, 168.5, 148.2, 146.1, 138.4, 127.4, 123.9, 74.1, 52.5, 52.4,
33.9, 28.2, 28.1, 25.1, 21.2. HRMS m/z [M+H] 365.1352 (calc’d for C17H21N2O7+,
365.1349). IR (ATR) vmax = 2963, 2892, 1723, 1518, 1335, 1296, 1209, 1132, 840, 831.
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5-10d Z-isomer
The title compound was synthesized via General Procedure A
(1.5 h). The amounts of reagents employed were: oxime 5-9d
(0.12 g ,0.72 mmol), cyclopropane 5-8a (0.20 g, 0.72 mmol), and cesium carbonate (0.70
g, 2.15 mmol) in 7.2 mL of acetone. The resulting oil was purified via column
chromatography (20% EtOAc/hexanes). Yield: 32% (0.07 g) >19:1 mixture of Z:E
isomers as a white solid. Rf = 0.19 (20% EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3) δ 8.26 (dt, J = 9.0, 2.1 Hz, 2H), 8.05 – 7.96 (m, 2H), 7.38

(s, 1H), 4.27 (t, J = 6.4 Hz, 2H), 3.72 (s, 3H), 3.71 (s, 3H), 1.99 – 1.81 (m, 3H), 1.64 –
1.52 (m, 1H), 1.46 – 1.29 (m, 3H). 13C NMR (101 MHz, CDCl3) δ 170.8, 168.7, 148.0,
143.5, 135.9, 131.5, 123.8, 75.1, 52.8, 34.1, 28.5, 28.2, 25.4, 21.4. HRMS m/z [M+H]
365.1360 (calc’d for C17H21N2O7, 365.1349) IR (ATR) vmax = 2957, 1723, 1518, 1334,
1297, 1207, 1131, 1064, 1038, 990.

5-10e
The title compound was synthesized via General
Procedure A (5 h). The amounts of reagents employed
were: oxime 5-9e (0.10 g, 0.72 mmol),
bromocyclopropane 5-8a (0.20 g, 0.72 mmol), and cesium
carbonate (0.70 g, 2.15 mmol) in 7.2 mL of acetone. Resulting crude was purified by
flash column chromatography Rf 0.40 (20% EtOAc/hexanes); Yield: 90% (0.22 g) >19:1
mixture of E:Z isomers as a white solid. Mp = 74 – 75 °C.
1H

NMR (400 MHz, CDCl3): δ 8.04 (s, 1H), 7.70 – 7.59 (AA’BB’ spin system m, 4H),

4.20 (t, J = 6.4 Hz, 2H), 3.73 (s, 3H), 3.71 (s, 3H), 1.99 – 1.89 (m, 1H), 1.84 (dddd, J =
9.8, 8.1, 6.5, 3.6 Hz, 2H), 1.62 – 1.51 (m, 1H), 1.41 (ddd, J = 12.4, 8.4, 4.6 Hz, 2H), 1.36
– 1.27 (m, 1H) 13C NMR (101 MHz, CDCl3) δ 170.9, 168.7, 146.7, 136.9, 132.6, 127.5,
118.7, 113.1, 74.2, 52.7, 34.1, 28.5, 28.3, 25.3, 21.4. HRMS m/z [M+H] 345.1453
(calc’d for C18H21N2O5+, 345.1445). IR (ATR) vmax = 2958, 2884, 2227, 1720, 1444,
1326, 1295, 1213, 1133, 833.
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5-10f
The title compound was synthesized via General
Procedure A (2.5 h). The amounts of reagents employed
were: oxime 5-9f (0.11 g, 0.72 mmol),
bromocyclopropane 5-8a (0.20 g, 0.72 mmol), and cesium carbonate (0.70 g, 2.15 mmol)
in 7.2 mL of acetone. The resulting oil was purified via column chromatography (20%
EtOAc/hexanes). Yield: 83% (0.21 mg) >19:1 mixture of E:Z isomers as a clear oil. Rf
0.26 (20% EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3): δ 8.00 (s, 1H), 7.50 (d, J = 8.8 Hz, 2H), 6.88 (d, J = 8.8

Hz, 2H), 4.13 (t, J = 6.4 Hz, 2H), 3.82 (s, 3H), 3.73 (s, 3H), 3.71 (s, 3H), 1.99-191 (m,
1H), 1.89 – 1.76 (m, 2H), 1.62 – 1.50 (m, 1H), 1.45 – 1.37 (m, 2H), 1.37 – 1.26 (m, 1H)
13C

NMR (101 MHz, CDCl3) δ 170.7, 168.5, 160.7, 147.9, 128.2, 124.8, 114.0, 73.0,

55.1, 52.4, 52.3, 33.8, 28.2, 28.2, 25.1, 21.1. HRMS m/z 349.1519 (calc’d for
C18H23NO6+, 349.1525). IR (ATR) vmax = 3024, 2954, 2839, 2875, 1723, 1606, 1513,
1437, 1332, 1300, 1250, 1212, 1171, 1158, 1130, 1031, 832.

5-10g
The title compound was synthesized via General
Procedure A (21 h). The amounts of reagents employed
were: oxime 5-9g (0.12 g, 0.72 mmol),
bromocyclopropane 5-8a (0.20 g, 0.72 mmol), and cesium carbonate (0.70 mg, 2.15
mmol) in 7.2 mL of acetone. The resulting oil was purified via column chromatography
(20% EtOAc/hexanes). Yield: 84% (0.22 g) >19:1 mixture of E:Z isomers as a yellow oil.
Rf 0.28 (20% EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3) δ 7.96 (s, 1H), 7.42 (d, J = 8.9 Hz, 2H), 6.65 (d, J = 8.9 Hz,

2H), 4.11 (t, J = 6.4 Hz, 2H), 3.73 (s, 3H), 3.70 (s, 3H), 2.98 (s, 6H), 1.99 – 1.90 (m, 1H),
1.82 (tdt, J = 12.5, 8.2, 3.9 Hz, 2H), 1.62 – 1.51 (m, 1H), 1.41 (dq, J = 8.7, 4.6 Hz, 2H),
1.37 – 1.28 (m, 1H) 13C NMR (101 MHz, CDCl3) δ 171.0, 168.8, 151.5, 149.1, 128.4,
120.2, 112.0, 73.1, 52.7, 40.4, 34.1, 28.5, 25.5, 21.5. HRMS m/z 362.1846 (calc’d for

219

C19H26N2O5+, 362.1842). IR (ATR) vmax = 2950, 2861, 2809, 1723, 1609, 1525, 1436,
1337, 1278, 1212, 1130, 818.

5-10k
The title compound was synthesized via General Procedure A
(22 h). The amounts of reagents employed were: oxime 5-9h
(0.062 g, 0.72 mmol), cyclopropane 5-8a (0.20 g, 0.72 mmol),
and cesium carbonate (0.70 g, 2.19 mmol) in 7.2 mL of acetone. The resulting oil was
purified via column chromatography (15% EtOAc/hexanes) to yield a fraction containing
pure E isomer and a mixed fraction containing a 1.4:1 mixture of E/Z isomers. Total
yield: 70% (0.14 g) as a clear oil. E fraction (46%, 0.094 g), mix fraction (24%, 0.049 g).
Rf = 0.32 (15% EtOAc/hexanes)
1H

NMR (400 MHz, CDCl3) δ E isomer = 7.24 (d, J = 6.4 Hz, 1H), 3.98 (dd, J = 6.5

Hz, 6.5 Hz, 2H), 3.74 (s, 3H), 3.70 (s, 3H), 2.46 (dq, J = 13.6, 6.8 Hz, 1H), 1.94 – 1.88
(m, 1H), 1.80-1.70 (m, 2H), 1.58-1.49 (m, 1H), 1.44-1.36 (m, 2H), 1.31-1.21 (m, 1H),
1.07 (d, J = 6.8 Hz, 6H). 13C NMR (101 MHz, CDCl3) δ 171.0, 168.8, 155.8, 72.7, 52.7,
52.6, 34.1, 29.5, 28.5, 25.5, 21.5, 20.3. HRMS m/z 285.1587 (calc’d for C14H23NO5+,
285.1576). IR (ATR) vmax = 2954, 2871, 1725, 1436, 1329, 1210, 1129.

5-10i
The title compound was synthesized via General Procedure A.
The amounts of reagents employed were: oxime 5-9i (0.065 g,
0.89 mmol), bromocyclopropane 5-8a (0.25 g, 0.89 mmol), and cesium carbonate (0.87 g,
2.69 mmol) in 8.9 mL of acetone. The resulting oil was purified via column
chromatography (20% EtOAc/hexanes) to yield a clear colourless oil. Yield: 0.15 g
(64%). Rf = 0.30 (20% EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3) δ 4.00 (t, J = 6.4 Hz, 2H), 3.74 (s, 3H), 3.70 (s, 3H), 1.98 –

1.88 (m, 1H), 1.84 (s, 3H), 1.82 (s, 3H), 1.79-1.66 (m, 2H), 1.53 (dq, J = 14.5, 6.5 Hz,
1H), 1.39 (ddd, J = 11.7, 8.4, 4.5 Hz, 2H), 1.25 (dq, J = 14.7, 8.2 Hz, 1H). 13C NMR
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(101 MHz, CDCl3) δ 171.0, 168.8, 154.7, 72.6, 52.7, 52.6, 34.1, 28.5, 25.5, 22.0, 21.5,
15.7. HRMS m/z 271.1421 (calc’d for C13H21NO5+, 271.1420). IR (ATR) vmax 3020,
2952, 2874, 1724, 1436, 1369, 1329, 1210, 1129.

5-10j
The title compound was synthesized via General Procedure A.
The amounts of reagents employed were: oxime 5-9k (0.081
g, 0.72 mmol), bromocyclopropane 5-8a (0.20 g, 0.72 mmol),
and cesium carbonate (0.70 g, 2.15 mmol) in 7.2 mL acetone. The resulting oil was
purified via column chromatography (20% EtOAc/hexanes) to yield a clear colourless oil.
Yield: 0.12 g (52%). Rf 0.31 (20% EtOAc/hexanes).
1H

NMR (599 MHz, CDCl3) δ 3.99 (t, J = 6.5 Hz, 2H), 3.74 (s, 3H), 3.70 (s, 3H), 2.42

(t, J = 5.2 Hz, 2H), 2.22 – 2.13 (m, 2H), 1.97 – 1.87 (m, 1H), 1.83 – 1.69 (m, 2H), 1.69 –
1.61 (m, 2H), 1.62 – 1.48 (m, 5H), 1.39 (dddd, J = 18.8, 7.0, 4.6, 2.2 Hz, 2H), 1.30 – 1.18
(m, 1H). 13C NMR (101 MHz, CDCl3) δ 171.0, 168.8, 160.3, 72.4, 52.7, 52.6, 34.1,
32.4, 28.6, 28.5, 27.2, 26.0, 25.9, 25.6, 21.5. HRMS m/z 311.1739 (calc’d for
C16H25NO5+, 311.1733) IR (ATR) vmax 2931, 2860, 1724, 1435, 1327, 1280, 1208, 1127,
1056, 991, 882.

5-10h

The title compound was synthesized via General Procedure
A (18 h). The amounts of reagents employed were: E-oxime
5-9j (0.11 g, 0.89 mmol), bromocyclopropane 5-8a (0.89 g, 0.89 mmol), and cesium
carbonate (0.87 g, 2.69 mmol) in 9.0 mL of acetone. The resulting oil was purified via
column chromatography (20% EtOAc/hexanes) to yield the desired product (0.14 g,
48%) as the single E-isomer as a clear oil. Rf 0.27 (20% EtOAc/Hexanes).
1H

NMR (400 MHz, CDCl3): δ = 7.62 (s, 1H), 7.51 (d, J = 5.1 Hz, 1H), 7.32 (dd, J =

3.7, 1.0 Hz, 1H), 7.06 (dd, J = 5.1, 3.8 Hz, 1H), 4.31 – 4.25 (m, 2H), 3.70 (s, 6H), 2.01 –

221

1.84 (m, 3H), 1.70 – 1.57 (m, 1H), 1.45-1.36 (m, 3H)

13C

NMR (101 MHz, CDCl3) δ

171.0, 168.7, 140.3, 131.6, 131.5 131.3, 126.3, 74.3, 52.7, 52.6, 34.1, 28.6, 28.4, 25.6,
21.4. 714 HRMS m/z 325.0994 (calc’d for C15H19NO5S+, 325.0984). IR (ATR) vmax
2951, 1721, 1604, 1435, 1329, 1208, 1127, 1047.
5-10m E-isomer
The title compound was synthesized via General Procedure A
with the exception of using 1.2 equiv. of cyclopropane 5-8c in
place of bromocyclopropane 5-8a (30 min). The amounts of
reagents employed were: oxime 5-9c (0.27 g, 1.66 mmol), cyclopropane 5-8c (0.60 g,
1.83 mmol), and cesium carbonate (1.79 g, 5.49 mmol) in 18 mL of acetone. A single E
isomer (as confirmed by x-ray crystallography) was observed by 1H NMR spectroscopy.
The resulting oil was purified via column chromatography (20% EtOAc/hexanes). Yield:
66% (0.49 g) as a white solid. Mp = 82 – 85 °C. Rf = 0.23 (20% EtOAc/hexanes).
1H

NMR (599 MHz, CDCl3) δ 8.21 (d, J = 8.7 Hz, 2H), 8.17 (s, 1H), 7.75-7.73 (m, 2H),

7.41 – 7.36 (m, 1H), 7.29 – 7.26 (m, 2H), 7.14 – 7.10 (m, 1H), AB system with large
vab/Jab=11 reported as two doublets 5.49 (d, J = 12.3 Hz, 1H) and 5.27 (d, J = 12.3 Hz,
1H), 3.77 (s, 3H), 3.43 (t, J = 8.7 Hz, 1H), 3.30 (s, 3H), 2.33 (dd, J = 8.2, 5.2 Hz, 1H),
1.77 (dd, J = 9.2, 5.1 Hz, 1H) 13C NMR (101 MHz, CDCl3) δ 170.2, 167.1, 148.5, 146.9,
138.6, 137.5, 133.4, 129.7, 128.3, 127.8, 124.1, 75.1, 53.0, 52.3, 36.8, 30.5, 18.8. HRMS
m/z 412.1274 (calc’d for C21H20N2O7+, 412.1271). IR (ATR) vmax = 2954, 1888, 1742,
1707, 1506, 1338, 1121, 1092, 839, 759, 693.

5-10o Z-isomer

The title compound was synthesized following General Procedure A with
the exception of using 1.2 equiv. of cyclopropane 5-8c in place of
bromocyclopropane 5-8a (30 min). The amounts of reagents employed
were: z-oxime 5-9d (0.10 g, 0.62 mmol), cyclopropane 5-8c (0.24 g, 0.74
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mmol), and cesium carbonate (0.60 g, 1.84 mmol) in 6.2 mL of acetone. A single Z
isomer was observed by 1H NMR spectroscopy. The resulting oil was pushed crude into
the next step. Yield (crude): 18% (0.045 g) as a white foam. Rf 0.24 (20%
EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3) δ 8.27 – 8.13 (m, 2H), 8.03 (dt, J = 9.1, 2.2 Hz, 2H), 7.40

(s, 1H), 7.37 – 7.30 (m, 1H), 7.27 – 7.19 (m, 2H), 7.12 – 7.04 (m, 1H), 5.51 (d, J = 12.7
Hz, 1H), 5.27 (d, J = 12.7 Hz, 1H), 3.75 (s, 3H), 3.36 (dd as apparent t, J = 8.7 Hz, 1H),
3.28 (s, 3H), 2.27 (dd, J = 8.2, 5.1 Hz, 1H), 1.70 (dd, J = 9.1, 5.2 Hz, 1H). 13C NMR
(101 MHz, CDCl3) δ 170.1, 167.1, 148.0, 144.1, 137.5, 135.8, 133.3, 131.7, 129.4,
128.3, 127.9, 123.8, 75.5, 53.0, 52.3, 36.7, 30.1, 18.8. HRMS m/z [M+H] 413.1352
(calc’d for C21H21N2O7+, 413.1352) IR (ATR) Vmax = 2948, 2888, 1741, 1707, 1507,
1338, 1121, 1046, 936, 793.

5-10i
The title compound was synthesized via General
Procedure A (40 h). The amounts of reagents employed were: oxime 5-9c (0.24 g, 1.47
mmol), cyclopropane 5-8b-butylchain (0.50 g, 1.47 mmol), and cesium carbonate (1.92
g, 5.88 mmol) in 15 mL of acetone. The resulting oil was purified via column
chromatography (25% EtOAc/hexanes). Yield: 76% (0.42 g) >19:1 mixture of E:Z
isomers as a pale yellow oil which slowly crystallizes in the freezer. Mp = 59 – 61 °C. Rf
0.50 (25% EtOAc/hexanes),
1H

NMR (400 MHz, CDCl3): δ = 8.21 (d, J = 8.7 Hz, 2H), 8.11 (s, 1H), 7.73 (d, J = 8.7

Hz, 2H), 4.20 (dd, J = 6.4 Hz, 6.4Hz, 2H), 3.75 (s, 3H), 3.72 (s, 3H), 1.92 (dddd, J = 8.9
Hz, 8.0 Hz, 8.0 Hz, 5.6 Hz, 1H), 1.80-1.70 (m, 2H), 1.58-1.48 (m, 3H), 1.45-1.37 (m,
2H), 1.29-1.17 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 171.0, 168.8, 148.4, 146.2,
138.7, 127.6, 124.1, 74.9, 52.8, 52.6, 34.0, 28.8, 28.6, 28.6, 25.3, 21.5. HRMS m/z
[M+H] 379.1503 (calc’d for C18H23N2O7+, 379.1500). IR (ATR) vmax = 3007, 2953,
2883, 1717, 1588, 1509, 1479, 1438, 1387, 1329, 1278, 1261, 1207, 1131, 1107, 1077,
977, 945, 835.
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5-10n
The title compound was synthesized via
General Procedure A (15 h). The amounts of
reagents employed were: oxime 5-9c (0.20 g,
1.22 mmol), cyclopropane 5-8b-nonylchain (0.50 g, 1.22 mmol), and cesium carbonate
(0.780 g, 2.39 mmol) in 12 mL of acetone. The resulting oil was purified via column
chromatography (20% EtOAc/hexanes). Yield: 77% (423 mg) >19:1 mixture of E:Z
isomers as a pale yellow oil which slowly crystallizes in the freezer. Mp = 50 – 52 °C.
Rf 0.33 (20% EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3): δ = 8.24-8.21 (m, 2H), 8.10 (s, 1H), 7.76-7.72 (m, 2H),

4.20 (dd, J = 6.7 Hz, 6.7 Hz, 2H), 3.74 (s, 3H), 3.71 (s, 3H), 1.89 (dddd, J = 8.8 Hz, 8.0
Hz, 8.0 Hz, 6.1 Hz, 1H), 1.75-1.69 (m, 2H), 1.50 – 1.32 (m, 8H), 1.33 – 1.22 (m, 8H),
1.19-1.12 (m, 1H). 13C NMR (101 MHz, cdcl3) δ 171.0, 168.7, 148.2, 145.9, 138.7,
127.4, 124.0, 75.2, 52.6, 52.4, 33.9, 29.4, 29.4, 29.3, 29.2, 29.1, 28.8, 28.7, 25.8, 21.4.
(One carbon likely overlapped near 29 ppm). HRMS m/z [M+H] 449.2291 (calc’d for
C23H33N2O7+, 449.2282). IR (ATR) vmax = 3020, 2952, 2930, 2857, 1727, 1436, 1369,
1330, 1279, 1251, 1210, 1129, 1101, 1006, 835, 776, 758, 665.

5.6.5

Annulation of Oxime-Ether Tethered Cyclopropanes

Scheme 109 - General reaction for the synthesis of hexahydropyrollo-oxazines 5-11
A mixture of oxime ether tethered cyclopropane (1.0 equiv) and Yb(OTf)3 (5 mol%) in
toluene (0.1M) were heated to the indicated temperature and for the indicated time.
Formation of pyrrolo-oxazine was primarily monitored by thin layer chromatography but
was supplemented with 1H NMR spectroscopy when required. When TLC or 1H NMR
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indicated complete consumption of the cyclopropane the solution was concentrated in
vacuo prior to purification via flash column chromatography.

5-11a 120 °C Cis Isomer: The title compound was synthesized via
General Procedure 5.2. (19 h). The amounts of reagents employed were:
oxime ether 5-10a (0.10 g, 0.32 mmol), Yb(OTf)3 (10 mg, 5 mol%) in
3.2 mL of acetone. The resulting oil was purified via column
chromatography (15% EtOAc/hexanes). A 19:1 mixture of cis to trans isomers or greater
was observed by 1H NMR spectroscopy. Yield: 89% (0.089 g) as a clear oil. Rf = 0.50
(20% EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3) δ 7.48-7.45 (m, 2H), 7.31-7.26 (m, 2H), 4.76 (s, 1H), 3.96-

3.92 (m, 2H), 3.78 (s, 3H), 3.00 (s, 3H), 2.75-2.66 (m, 1H), 2.56 (dd, J = 12.5 Hz, 12.5
Hz, 1H), 2.30 (dd, J = 13.0 Hz, 6.1 Hz, 1H), 2.01-1.95 (m, 1H), 1.75-1.61 (m, 3H). 13C
NMR (101 MHz, CDCl3): δ 171.9, 169.4, 137.7, 128.2, 128.0, 127.8, 72.3, 70.3, 62.3,
61.0, 53.1, 52.2, 35.7, 29.1, 24.9. HRMS m/z 319.1424 (calc’d for C17H21NO5+,
319.1420). IR (ATR) vmax 3033, 2951, 2857, 1731, 1435, 1263, 1207, 1126, 700.

5-11a 60 °C Trans Isomer: The title compound was synthesized via
General Procedure B (19 h). The amounts of reagents employed were:
oxime ether 5-10a (0.060 g, 0.32 mmol), Yb(OTf)3 (6.0 mg, 5 mol%) in
3.2 mL of toluene. A mixture of 1.7:1 trans to cis isomers were observed
in the crude reaction mixture by 1H NMR spectroscopy. The resulting oil was purified via
column chromatography (20% EtOAc/hexanes). Yield: 95% combined isomers (0.057 g)
trans yield 60% (0.036 g) as a clear oil. Rf (trans) 0.34 (20% EtOAc/hexanes).
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1H

NMR (599 MHz, CDCl3) δ 7.28 – 7.21 (m, 4H), 7.20 – 7.14 (m, 1H), 5.46 (s, 1H),

3.95-3.87 (m, 2H), 3.84 (dd, J = 10.9, 3.6 Hz, 1H), 3.80 (s, 3H), 3.02 (s, 3H), 2.65 (dd, J
= 12.8, 6.2 Hz, 1H), 2.54 (dd, J = 12.8, 10.3 Hz, 1H), 2.10-2.04 (m, 1H), 1.80-1.73 (m,
2H), 1.49-1.44 (m, 1H). 13C NMR (151 MHz, CDCl3) δ 172.3, 170.8, 138.0, 128.2,
128.0, 127.6, 75.2, 68.2, 66.7, 63.4, 53.4, 52.3, 36.2, 23.4, 20.7. HRMS m/z 319.1409
(calc’d for C17H21NO5+, 319.1420). IR (ATR) vmax 2950, 2854, 1728, 1496, 1251, 1204,
1135, 1115, 1082, 1028

5-11b 120 °C Cis Isomer: The title compound was synthesized via
General Procedure B (20 h). The amounts of reagents employed were:
oxime ether 5-10b (0.070 g, 0.20 mmol), Yb(OTf)3 (6.1 mg, 5 mol%) in
2 mL of toluene. A 19:1 mixture or greater of cis to trans isomers was
observed in the crude reaction mixture by 1H NMR spectroscopy. The resulting oil was
purified via column chromatography (20% EtOAc/hexanes). Yield: 90% (0.063 g) as a
clear oil. Rf 0.50 (20% EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3): δ 7.44 – 7.37 (AA’BB’, 2H), 7.28 – 7.22 (AA’BB’, 2H),

4.70 (s, 1H), 3.91 (t, J = 5.6 Hz, 1H), 3.77 (s, 3H), 3.07 (s, 3H), 2.67 (ddt, J = 11.9, 6.1,
2.7 Hz, 1H), 2.57 – 2.46 (m, 1H), 2.31 (dd, J = 13.1, 6.2 Hz, 1H), 2.01 – 1.93 (m, 1H),
1.72 – 1.60 (m, 3H) 13C NMR (101 MHz, cdcl3) δ 171.5, 169.0, 135.9, 133.3, 129.4,
127.8, 71.3, 70.1, 62.0, 60.5, 52.9, 52.1, 35.3, 28.7, 24.5. HRMS m/z 353.1037 (calc’d
for C17H20ClNO5+, 353.1030). IR (ATR) vmax 3011, 2853, 2951, 1732, 1435, 1263,
1207, 1172, 1126, 1046, 842.

5-11b 60 °C Trans Isomer: The title compound was synthesized via
General Procedure B (20 h). The amounts of reagents employed were:
oxime ether 5-10b (0.070 g, 0.20 mmol), Yb(OTf)3 (6.1 mg, 5 mol%) in
2 mL of toluene. A 19:1 mixture or greater of trans to cis isomers was
observed in the crude reaction mixture by 1H NMR spectroscopy. The resulting oil was
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purified via column chromatography (20% EtOAc/hexanes). Yield: 69% (0.048 g) as a
clear oil. Rf 0.56 (20% EtOAc/hexanes).
NMR (400 MHz, CDCl3): δ = 7.21 (apparent s, 4H), 5.42 (s, 1H), 3.96 – 3.88 (m,

1H

1H), 3.84 (dt, J = 11.9, 3.8 Hz, 1H), 3.80 (s, 3H), 3.79 – 3.74 (m, 1H), 3.09 (s, 3H), 2.64
(dd, J = 12.9, 6.1 Hz, 1H), 2.50 (dd, J = 12.9, 9.8 Hz, 1H), 2.07-1.99 (m, 1H), 1.75 (dtq, J
= 17.3, 9.0, 4.4 Hz, 2H), 1.53 – 1.44 (m, 1H) 13C NMR (101 MHz, CDCl3) δ 172.0,
170.3, 136.3, 133.2, 129.2, 128.1, 73.7, 67.5, 66.0, 62.7, 53.3, 52.2, 36.0, 23.1, 20.6.
HRMS m/z 353.1033 (calc’d for C17H20ClNO5+, 353.1030). IR (ATR) vmax 2952, 2852,
1730, 1519, 1346, 1261, 1205, 1045, 838.

5-11c 120 °C Cis Isomer: The title compound was synthesized via
General Procedure B (18 h at 120 °C). The amounts of reagents
employed were: oxime ether 5-10c (0.030 g, 0. 082 mmol), Yb(OTf)3
(2.5 mg, 5 mol%) in 1 mL of toluene. A 19:1 mixture or greater of cis to
trans isomers was observed in the crude reaction mixture by 1H NMR spectroscopy. The
resulting oil was purified via column chromatography (20% EtOAc/hexanes). Yield: 99%
(0.03 mg) as a white solid. Rf 0.34 (20% EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3): δ 8.15 (d, J = 8.8 Hz, 2H), 7.66 (d, J = 8.7 Hz, 2H), 4.80

(s, 1H), 3.96 – 3.90 (m, 2H), 3.80 (s, 3H), 3.05 (s, 3H), 2.78 – 2.67 (m, 1H), 2.54 (dd as
apparent t, J = 13.2 Hz, 1H), 2.37 (dd, J = 13.2, 6.3 Hz, 1H), 2.02-1.99 (m, 1H), 1.75 –
1.62 (m, 3H) 13C NMR (101 MHz, CDCl3) δ 171.5, 168.9, 147.6, 145.5, 129.3, 123.1,
71.6, 70.5, 62.4, 60.9, 53.4, 52.5, 35.7, 29.0, 24.7. HRMS m/z 364.1273 (calc’d for
C17H20N2O7+, 364.1271). IR (ATR) vmax = 3029, 2954, 2853, 1732, 1520, 1435, 1348,
1263, 1208, 1173, 1126, 1046, 697.

5-11c 60 °C Trans Isomer: The title compound was synthesized via General Procedure
B (18 h at 60 °C). The amounts of reagents employed were: oxime ether 5-10c (0.030 g,
0. 082 mmol), Yb(OTf)3 (2.5 mg, 5 mol%). A 19:1 mixture or greater of trans to cis
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isomers was observed in the crude reaction mixture by 1H NMR
spectroscopy. The resulting oil was purified via column chromatography
(20% EtOAc/hexanes). Yield: 93% (0.028 mg) as a white solid. Rf 0.22
(20% EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3): δ 8.09 (d, J = 8.7 Hz, 2H), 7.46 (d, J = 8.9

Hz, 2H), 5.50 (s, 1H), 3.93-3.84 (m, 2H), 3.81 (s, 3H), 3.76 (dt, J = 12.5, 3.0 Hz, 1H),
3.07 (s, 3H), 2.62 (dd, J = 12.9, 6.1 Hz, 1H), 2.52 (dd, J = 12.9, 9.7 Hz, 1H), 2.10 – 1.94
(m, 1H), 1.82 – 1.66 (m, 2H), 1.56 – 1.43 (m, 1H) 13C NMR (101 MHz, CDCl3) δ 171.8,
170.1, 147.2, 145.6, 128.6, 123.1, 73.4, 67.4, 66.1, 62.7, 53.5, 52.3, 36.4, 23.1, 20.6.
HRMS m/z 364.1263 (calc’d for C17H20N2O7+, 364.1271) IR (ATR) vmax = 2952, 2855,
1723, 1603, 1518, 1254, 1110, 1064, 1046, 983.

5-11d 120 °C Cis Isomer: The title compound was synthesized via
General Procedure B (26 h). The amounts of reagents employed were:
oxime ether 5-10e (0.060 g, 0.17 mmol), Yb(OTf)3 (0.005 g, 5 mol%) in
2 mL of toluene. A 1:1 mixture of cis to trans isomers was observed in
the crude reaction mixture by 1H NMR spectroscopy. The resulting oil
was purified via column chromatography (20% EtOAc/hexanes). Yield: 93% (0.056 g) of
combined isomers (cis isomer 0.027 g) (trans isomer 0.029 g) as pale-yellow oils. Rf (cis)
= 0.28 (20% EtOAc/hexanes); Rf (trans) = 0.17 (20% EtOAc/hexanes).
1H

NMR (599 MHz, CDCl3) δ 7.63 – 7.51 (AA’BB’, 4H), 4.75 (s, 1H), 3.94 – 3.88 (m,

2H), 3.78 (s, 3H), 3.04 (s, 3H), 2.74 – 2.65 (m, 1H), 2.52 (dd as apparent t, J= 12.3 Hz,
1H), 2.34 (dd, J = 13.2, 6.3 Hz, 1H), 2.01 – 1.95 (m, 1H), 1.71 – 1.61 (m, 3H) 13C NMR
(101 MHz, CDCl3) δ 171.5, 168.9, 143.5, 131.8, 129.2, 119.1, 111.5, 71.7, 70.4, 62.4,
60.9, 53.3, 52.4, 35.6, 29.0, 24.7. HRMS m/z 344.1375 (calc’d for C18H20N2O5+,
344.1372). IR (ATR) vmax 3060, 2958, 2923, 2861, 2227, 1745, 1723, 1611, 1442, 1319,
1256, 1220, 1135, 1054.
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5-11d 60 °C Trans Isomer: The title compound was synthesized via
General Procedure B (48 h). The amounts of reagents employed were:
oxime ether 5-10e (0.070 g, 0.2 mmol), Yb(OTf)3 (6.0 mg, 5 mol%) in 2
mL of toluene. The resulting oil was purified via column
chromatography (20% EtOAc/hexanes). Yield: 85% (0.060 g) as a white
foam of a single isomer. Rf (trans) = 0.17 (20% EtOAc/hexanes)
1H

NMR (599 MHz, CDCl3) δ 7.55 (d, J = 8.3 Hz, 2H), 7.42 (d, J = 8.2 Hz, 2H), 5.47

(s, 1H), 3.94 – 3.90 (m, 1H), 3.87 – 3.82 (m, 1H), 3.81 (s, 3H), 3.07 (s, 3H), 2.63 (dd, J =
12.9, 6.0 Hz, 1H), 2.52 (dd, J = 12.8, 9.7 Hz, 1H), 2.06-2.01 (m, 1H), 1.80-1.73, (m, 2H),
1.53-1.49 (m, 1H). 13C NMR (151 MHz, CDCl3) δ 171.8, 170.1, 143.5, 131.8, 128.5,
118.9, 111.2, 73.6, 67.4, 66.1, 62.8, 53.4, 52.3, 36.3, 23.1, 20.6. HRMS m/z 344.1369
(calc’d for C18H20N2O5+, 344.1372). IR (ATR) vmax 2952, 2228, 1728, 1609, 1505, 1434,
1255, 1175, 840, 729.

5-11f 120 °C Cis Isomer: The title compound was synthesized via
General Procedure B (27 h). The amounts of reagents employed were:
oxime ether 5-10f (0.070 g, 0.20 mmol), Yb(OTf)3 (6.0 mg, 5 mol%) in
2 mL of toluene. The resulting oil was purified via column
chromatography (20% EtOAc/hexanes). Yield: 95% (0.066 g) >19:1
cis:trans isomer as a clear oil. Rf 0.33 (20% EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3) δ 7.41 – 7.34 (m, 2H), 6.85 – 6.79 (m, 2H), 4.69 (s, 1H),

3.92 (t, J = 5.6 Hz, 2H), 3.77 (s, 3H), 3.76 (s, 3H), 3.06 (s, 3H), 2.70-2.63 (m, 1H), 2.53
(dd as apparent t, J =12.9 Hz, 1H), 2.28 (dd, J = 13.0, 6.1 Hz, 1H), 2.01 – 1.93 (m, 1H),
1.71 – 1.59 (m, 3H) 13C NMR (151 MHz, CDCl3) δ 172.2, 169.8, 159.5, 129.9, 129.6,
113.7, 72.1, 70.6, 62.5, 61.1, 55.6, 53.3, 52.6, 35.8, 29.3, 25.1. HRMS m/z 349.1538
(calc’d for C18H23NO6+, 349.1525). IR (ATR) vmax 2951, 2848, 2226, 1729, 1609, 1511,
1435, 1280, 1247,1171,1126, 1045.
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5-11f 25 °C Trans Isomer: The title compound was synthesized via
General Procedure B (40 h). The amounts of reagents employed were:
oxime ether 5-10f (0.045 g, 0.13 mmol), Yb(OTf)3 (4.0 mg, 5 mol%) in
1.3 mL of toluene. The resulting oil was purified via column
chromatography (20% EtOAc/hexanes). Yield: 95% (0.041 g)
combined trans isomer 5-11f-trans (0.025 g) and unreacted starting material (0.015 g).
Yield of trans isomer 85% (brsm) (0.025 g) >19:1 trans:cis isomer as a clear oil. Rf =
0.23 (20% EtOAc/hexanes).

NMR (599 MHz, CDCl3) δ 7.18 (d, J = 8.6 Hz, 2H), 6.78 (d, J = 8.8 Hz, 2H), 5.42 (s,

1H

1H), 3.92 (dt, J = 7.9, 4.3 Hz, 1H), 3.89 – 3.80 (m, 2H), 3.79 (s, 3H), 3.74 (s, 3H), 3.08
(s, 3H), 2.67 (dd, J = 12.9, 6.3 Hz, 1H), 2.49 (dd, J = 12.9, 10.0 Hz, 1H), 2.08 – 1.99 (m,
1H), 1.79 – 1.71 (m, 2H), 1.50 – 1.44 (m, 1H). 13C NMR (151 MHz, CDCl3) δ 172.2,
170.6, 158.9, 129.8, 129.0, 113.4, 74.2, 67.7, 66.1, 62.7, 55.3, 53.2, 52.2, 35.8, 23.3, 20.6.
HRMS m/z 349.1524 (calc’d for C18H23NO6+, 349.1525). IR (ATR) vmax 2951, 2852,
1728, 1613, 1512, 1434, 1246, 1174, 1029, 729.

5-11g 120 °C Cis Isomer: The title compound was synthesized via
General Procedure B (25 h). The amounts of reagents employed were:
oxime ether 5-10g (0.070 g, 0.19 mmol), Yb(OTf)3 (0.0060 g, 5 mol%)
in 2 mL of toluene. The resulting oil was purified via column
chromatography (20% EtOAc/hexanes). Yield: 95% (0.069 mg) >19:1
cis:trans isomer as a pale-yellow solid. Mp = 157 – 160 °C. Rf = 0.22 (20%
EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3): δ = 7.30 (AA’BB’, 2H), 6.67 (AA’BB’, 2H), 4.65 (s, 1H),

3.94 – 3.89 (m, 2H), 3.76 (s, 3H), 3.08 (s, 3H), 2.88 (s, 6H), 2.70 – 2.61 (m, 1H), 2.53 (dd
overlapped as an apparent t, J = 12.4 Hz, 1H), 2.27 (dd, J = 12.9, 6.1 Hz, 1H), 1.99 – 1.91
(m, 1H), 1.69-1.59 (m, 3H). 13C NMR (101 MHz, cdcl3) δ 172.1, 169.8, 150.5, 128.9,
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125.4, 112.5, 72.1, 70.3, 62.3, 60.9, 53.0, 52.4, 40.9, 35.5, 29.2, 24.9. HRMS m/z
362.1838 (calc’d for C19H26N2O5+, 362.1842). IR (ATR) vmax 3465, 2948, 1752, 1615,
1329, 1228, 1124, 1045, 834.

5-11g 25 °C Trans Isomer: The title compound was synthesized via
General Procedure B (49 h). The amounts of reagents employed were:
oxime ether 5-10g (0.026 g, 0.07 mmol), Yb(OTf)3 (0.0020 g, 5 mol%)
in 1 mL of toluene. A 2:1 mixture of trans to cis isomers was observed
by 1H NMR spectroscopy. The resulting oil was purified via column chromatography
(25% EtOAc/hexanes). Yield: 98% combined trans:cis isomers (0.025 mg), trans isomer
62% (0.016 g, white solid) Rf (trans) = 0.14 (20% EtOAc/hexanes). and cis isomer 35%
(0.009 g, white solid) Rf (cis) = 0.22 (20% EtOAc/hexanes).
1H

NMR (599 MHz, CDCl3) δ 7.10 (AA’BB’, 2H), 6.62 (AA’BB’, 2H), 5.38 (s, 1H),

3.92 (dt, J = 11.7, 4.1 Hz, 1H), 3.89 – 3.80 (m, 2H), 3.79 (s, 3H), 3.11 (s, 3H), 2.87 (s,
6H), 2.70 (dd, J = 12.9, 6.4 Hz, 1H), 2.48 (dd, J = 12.9, 10.0 Hz, 1H), 2.07 – 1.99 (m,
1H), 1.78 – 1.70 (m, 2H), 1.50 – 1.42 (m, 1H). 13C NMR (151 MHz, CDCl3) δ 172.3,
170.7, 150.1, 128.7, 125.4, 112.4, 74.5, 67.7, 66.1, 62.6, 53.1, 52.3, 40.8, 35.6, 23.5, 20.7.
HRMS m/z 362.1832 (calc’d for C19H26N2O5+, 362.1842). IR (ATR) vmax 2949, 1728,
1614, 1522, 1433, 1349, 1204, 1168, 864, 823.

5-11j The title compound was synthesized via General Procedure B (21
h). The amounts of reagents employed were: oxime ether 5-10i (0.070
g, 0.26 mmol), Yb(OTf)3 (0.008 g, 5 mol%) in 2.6 mL of toluene. The
resulting oil was purified via column chromatography (20% EtOAc/hexanes). Yield: 78%
(0.054 g) as a clear, colorless oil. Rf 0.47 (20% EtOAc/hexanes).
1H

NMR (599 MHz,CDCl3) δ 3.91 – 3.89 (m, 2H), 3.72 (s, 3H), 3.68 (s, 3H), 2.87 (tdd,

J = 9.3, 9.3, 2.6 Hz, 1H), 2.61 (dd, J = 13.8, 9.2 Hz, 1H), 1.96 (dd, J = 13.8, 8.4 Hz, 1H),
1.93 – 1.87 (m, 1H), 1.62 – 1.51 (m, 3H), 1.39 (s, 3H), 1.04 (s, 3H) 13C NMR (151 MHz,
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CDCl3) δ 171.0, 170.6, 70.2, 62.7, 57.8, 52.5, 33.7, 29.9, 25.3, 23.1, 16.6. HRMS m/z
271.1410 (calc’d for C13H21NO5+, 271.1420). IR (ATR) vmax 2949, 1737, 1434, 1380,
1260, 1194, 1137, 1038, 918, 887.

5-11k The title compound was synthesized via General Procedure B (18
h). The amounts of reagents employed were: oxime ether 5-10j (0.050 g,
0.16 mmol), Yb(OTf)3 (0.005 g, 5 mol%) in 2 mL of toluene. The
resulting oil was purified via column chromatography (20% EtOAc/hexanes). Yield: 47%
(0.025 g) as a clear, colorless oil. Rf 0.47 (20% EtOAc/hexanes).
1H

NMR (599 MHz, Chloroform-d) δ 3.89 – 3.82 (m, 1H), 3.69 (s, 3H), 3.65 (s, 3H),

3.51 (br s, 1H), 2.72 (br, 1H), 2.63 (dd, J = 13.7, 8.5 Hz, 2H), 1.97 (tdt, J = 11.3, 8.7, 4.1
Hz, 1H), 1.77 – 1.60 (m, 7H), 1.60 – 1.53 (m, 2H), 1.35 (m, 2H), 1.30 – 1.19 (m, 2H).
13C

NMR (151 MHz, CDCl3) δ 171.1, 170.5, 69.0, 58.2, 52.6, 52.3, 34.8, 30.2, 26.1,

23.4, 22.4. HRMS m/z 311.1723 (calc’d for C16H25NO5+, 311.1733). IR (ATR) vmax
2936, 2853, 1732, 1433, 1223, 1166, 1124, 1014, 965, 796.

5-11h 120 °C, 60 °C or 25 °C Cis Isomer: The title compound was
synthesized via General Procedure B (2 days). The amounts of reagents
employed were: oxime ether 5-10h (0.043 g, 0.13 mmol), Yb(OTf)3
(0.004 g, 5 mol%) in 1.5 mL of toluene. The resulting oil was purified via column
chromatography (25% EtOAc/hexanes) to yield a greater than 19:1 of cis to trans isomers
by 1H NMR. (0.031 mg, 78%, colourless oil) Rf = 0.43 (20% EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3): δ 7.19 (dd, J = 5.1, 1.2 Hz, 1H), 7.10 – 7.06 (m, 1H), 6.94

(dd, J = 5.1, 3.5 Hz, 1H), 4.99 (s, 1H), 3.98-3.95 (m, 2H), 3.79 (s, 3H), 3.22 (s, 3H), 2.712.63 (m, 1H), 2.55 (t, J = 12.3 Hz, 1H), 2.33 (dd, J = 13.0, 6.1 Hz, 1H), 1.97 – 1.94 (m,
1H), 1.72 – 1.59 (m, 3H). 13C NMR (101 MHz, CDCl3) δ 171.3, 169.0, 141.1, 126.3,
126.1, 124.8, 70.1, 68.4, 62.2, 60.8, 52.9, 52.4, 35.0, 28.7, 24.4. HRMS m/z 325.0977

232

(calc’d for C15H19NO5S+, 325.0984). IR (ATR) vmax 2948, 1726, 1507, 1431, 1283,
1264, 1207, 1004, 936, 695.

5-11e 120 °C Trans Isomer: The title compound was synthesized via
General Procedure B (28 h). The amounts of reagents employed were:
oxime ether 5-10m (0.17 g, 0.27 mmol), Yb(OTf)3 (0.013 g, 5 mol%)
in 2.7 mL of toluene. The resulting white solid was purified via column
chromatography (20% EtOAc/hexanes). Yield: 94% (0.16 g) of a white
solid as the trans isomer confirmed by x-ray crystallography. Mp = 159 – 160 °C. Rf =
0.25 (20% EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3): δ = 8.16-8.12 (AA’BB’, 2H), 7.55-7.51 (AA’BB’, 2H),

7.29-7.23 (m, 2H), 7.10-7.06 (m, 1H), 5.74 (s, 1H), 5.14 (d, J = 14.8 Hz, 1H), 4.87 (dd, J
= 11.7, 5.8 Hz, 1H), 4.75 (d, J = 14.8 Hz, 1H), 3.80 (s, 3H), 3.15 (s, 3H), 2.99 (dd, J =
12.8 Hz, 5.8 Hz, 1H), 2.68 (dd, J = 12.8 Hz, 11.7 Hz, 1H). 13C NMR (151 MHz, CDCl3)
δ 171.4, 170.4, 147.4, 145.9, 133.5, 133.1, 128.7, 127.5, 127.5, 127.2, 124.7, 123.4, 76.8,
70.2, 67.8, 66.9, 53.7, 52.6, 42.3. HRMS m/z 412.1271 (calc’d for C21H20N2O7+,
412.1271). IR (ATR) vmax = 2958, 2928, 1852, 1725, 1510, 1430, 1343, 1262, 1436,
1046, 698.

5-11e Cis Isomer made from Z-oxime: The title compound was
synthesized via General Procedure B (1.5 h). The amounts of reagents
employed were: oxime ether 5-10o (0.044 g, 0.11 mmol), Yb(OTf)3
(0.003 g, 5 mol%). The resulting white solid was purified via column
chromatography (20% EtOAc/hexanes). Yield: 87% (0.0.35 g) of a
white solid as the cis isomer. Rf = 0.25 (20% EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3) δ 8.18 (d, J = 8.6 Hz, 2H), 7.74 (d, J = 8.9 Hz, 2H), 7.31 –

7.19 (m, 2H), 7.16 – 7.10 (m, 1H), 7.10 – 7.03 (m, 1H), 5.25 (d, J = 14.2 Hz, 1H), 5.04
(s, 1H), 4.89 (d, J = 14.3 Hz, 1H), 4.09 (t, J = 9.3 Hz, 1H), 3.87 (s, 3H), 3.09 (s, 3H), 2.87
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(d, J = 8.5 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 171.4, 168.5, 147.7, 144.8, 135.4,
133.6, 129.4, 127.3, 126.8, 124.7, 124.1, 123.2, 71.9, 62.1, 53.6, 52.6. HRMS m/z
412.1270 (calc’d for C21H20N2O7+, 412.1271) IR (ATR) vmax = 2953, 1731, 1603, 1493,
1345, 1270, 1041, 1026, 747, 697.

5-11i 160 °C Isomer (unconfirmed designation): Yb(OTf)3
(0.016 mg, 0.026 mmol) was added to a solution of oxime ether
5-10l (0.050 g, 0.132 mmol) in toluene (1.3 mL, 0.1 M). The vial
was sealed with a crimped aluminum cap bearing a teflon seal and
heated to 160 °C for 8 hours. The toluene was removed in vacuo
and the crude oil was purified by flash column chromatography (20% EtOAc/hexanes) to
yield 5-11i as a single isomer (0.043 g, 86%) as a pale-yellow solid. Mp = 112 – 114 °C.
Rf = 0.40 (20% EtOAc/hexanes).
1H

NMR (400 MHz, CDCl3): δ 8.18-8.14 (AA’BB‘, 2H), 7.74-7.70 (AA’BB‘, 2H),

4.89 (s, 1H), 3.81 – 3.77 (m, 1H), 3.76 (s, 3H), 3.47 (td, J = 10.9, 6.4 Hz, 1H), 3.09 (s,
3H), 2.98 (tdd, J = 11.0, 7.6, 4.0 Hz, 1H), 2.56 (dd, J = 13.7, 11.3 Hz, 1H), 2.38 (dd, J =
13.7 Hz, 7.8 Hz, 1H), 2.07-1.96 (m, 2H), 1.87-1.81 (m, 2H), 1.71-1.60 (m, 1H), 1.54-1.44
(m, 1H). 13C NMR (101 MHz, CDCl3) δ 171.8, 169.5, 146.8, 129.7, 123.4, 73.9, 71.7,
66.6, 62.2, 53.6, 52.8, 36.9, 35.5, 30.0, 23.2. HRMS m/z 378.1434 (calcd for
C18H22N2O7+ 378.1427). IR (ATR) vmax 3112, 3081, 2947, 2869, 17.53, 1730, 1601,
1518, 1432, 1342, 1276, 1212, 1203, 1135, 1081, 1032, 1020, 973, 873, 839, 750, 698,
570;

5.6.6

Pyrrolidine Synthesis

5-12
Compound 5-11a-trans (0.030 g, 0.094 mmol) and Pd/C (10% on
carbon, 0.0035 g) were dissolved in MeOH (1.2 mL). AcCl (0.016
mL, 0.20 mmol) was added. The flask was equipped with a balloon
of H2(g) and evacuated and refilled in 5 cycles. The flask was left to remain under a balloon
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of hydrogen and was stirred at rt for 20 h. When TLC confirmed consumption of starting
material the mixture was filtered through Celite and concentrated to yield salt 5-12 (0.029
g, 87% yield) as a light green foam.
1H

NMR (599 MHz, DMSO-d6) δ 10.72 (s br 1H), 9.74 (s br, 1H), 7.42 (apparent s, 5H),

5.43 (s br, 1H), 4.59 (s, br, 1H), 4.16 (p br, J = 7.5 Hz, 1H), 3.72 (s, 3H), 3.44 (s br, 2H),
3.27 (s, 3H), 2.89 (dd, J = 13.5, 6.5 Hz, 1H), 2.24 (dd, J = 13.3, 10.0 Hz, 1H), 1.95-1.89
(m br, 1H), 1.80-1.74 (m br, 1H), 1.62 – 1.50 (m br, 2H). 13C NMR (101 MHz, DMSOd6) δ 168.6, 168.2, 132.1, 129.2, 128.3, 128.2, 64.3, 63.8, 60.0, 59.4, 53.3, 52.7, 38.1,
29.0, 28.4. HRMS m/z 321.1554 (calcd for C17H23NO5+ 321.1576). IR (ATR) vmax 3382,
2872, 1730, 1579, 1500, 1434, 1264, 1210, 1002, 699.

5.6.7

Computational Calculation Data

DFT Calculations were calculated at B3LYP, M062x179 and PBEh1PBE180 level of theory with 6-311G+(2d,p) basis
set on Guassian 09.181

Table 18- Computational calculation data

Computational Theory
M062X/6-311+G(2d,p)
B3LYP/6-311+G(2d,p)
PBEh1PBE/6-311+G(2d,p)

5.6.8

Cis Isomer E (kJ/mol)
-2864880.50868623
-2865998.64891367
-2863027.96102236

Trans Isomer E (kJ/mol)
2864859.05073564
-2865977.22496331
-2863006.58882062

Ecis-trans (kJ/mol)
-21.456
-21.424
-21.371

Single Crystal X-Ray Diffraction Data

All crystals were grown by Lauren Irwin and submitted to Dr. Paul Boyle for data
collection, processing and refinement.
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Experimental for C7H6N2O3 (b19170) E-oxime

X-ray quality crystals were prepared by vapour diffusion of pentane into a saturated
solution of oxime 5-9c dissolved in CDCl3.

Data Collection and Processing. The sample (b19170) was submitted by Lauren Irwin of
the Kerr research group at the University of Western Ontario. The sample was mounted
on a Mitegen polyimide micromount with a small amount of Paratone N oil. All X-ray
measurements were made on a Bruker Kappa Axis Apex2 diffractometer at a temperature
of 110 K. The unit cell dimensions were determined from a symmetry constrained fit of
8137 reflections with 6.72° < 2θ < 95.9°. The data collection strategy was a number of 
and  scans which collected data up to 98.26° (2 θ ). The frame integration was
performed using SAINT.182 The resulting raw data was scaled, and absorption corrected
using a multi-scan averaging of symmetry equivalent data using SADABS.183

Structure Solution and Refinement. The structure was solved by using a dual space
methodology using the SHELXT program.184 All non-hydrogen atoms were obtained
from the initial solution. All hydrogen atom positions were obtained from a difference
Fourier map and were allowed to refine isotropically. The structural model was fit to
the data using full matrix least-squares based on F2. The calculated structure factors
included corrections for anomalous dispersion from the usual tabulation. The structure
was refined using the SHELXL program from the SHELXTL suite of crystallographic
software.185 Graphic plots were produced using the XP program suite.186 Additional
information and other relevant literature references can be found in the reference section
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of this website (http://xray.chem.uwo.ca).

Figure 25 - ORTEP drawing of b19170 showing naming and numbering
scheme. Ellipsoids are at the 50% probability level and hydrogen atoms
were omitted for clarity.
Table 19 - Summary of Crystal Data for b19170
Formula

C7H6N2O3

Formula Weight (g/mol)

166.14

Crystal Dimensions (mm )

0.244 × 0.200 × 0.194

Crystal Color and Habit

yellow square

Crystal System

monoclinic

Space Group

P 21/c

Temperature, K

110

a, Å

6.244(3)

b, Å

4.822(2)

c, Å

24.355(13)
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,°

90

,°

94.782(17)

,°

90

V, Å3

730.7(6)

Number of reflections to determine final unit cell

8137

Min and Max 2 for cell determination, °

6.72, 95.9

Z

4

F(000)

344

 (g/cm)

1.510

, Å, (MoK)

0.71073

, (cm-1)

0.121

Diffractometer Type

Bruker Kappa Axis Apex2

Scan Type(s)

phi and omega scans

Max 2 for data collection, °

98.26

Measured fraction of data

0.973

Number of reflections measured

34297

Unique reflections measured

7219

Rmerge

0.0354

Number of reflections included in refinement

7219

Cut off Threshold Expression

I > 2sigma(I)

Structure refined using

full matrix least-squares using F2

Weighting Scheme

w=1/[sigma2(Fo2)+(0.0653P)2+0.05
86P] where P=(Fo2+2Fc2)/3

Number of parameters in least-squares

133

R1

0.0407

wR2

0.1139

R1 (all data)

0.0601

wR2 (all data)

0.1256

GOF

1.051

Maximum shift/error

0.001

Min & Max peak heights on final F Map (e-/Å)

-0.221, 0.768

Where:
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R1 = ( |Fo| - |Fc| ) /  Fo
wR2 = [ ( w( Fo2 - Fc2 )2 ) / (w Fo4 ) ]½
GOF = [ ( w( Fo2 - Fc2 )2 ) / (No. of reflns. - No. of params. ) ]½

Experimental for C7H6N2O3 (b19175)

X-ray quality crystals were prepared by vapour diffusion of pentane into a saturated
solution of oxime 5-9d dissolved in EtOAc.
Data Collection and Processing. The sample (b19175) was submitted by Lauren Irwin of
the Kerr research group at the University of Western Ontario. The sample was mounted
on a Mitegen polyimide micromount with a small amount of Paratone N oil. All X-ray
measurements were made on a Bruker Kappa Axis Apex2 diffractometer at a temperature
of 110 K. The unit cell dimensions were determined from a symmetry constrained fit of
5015 reflections with 7.2° < 2θ < 56.28°. The data collection strategy was a number of ω
and φ scans which collected data up to 61.106° (2θ). The frame integration was
performed using SAINT. The resulting raw data was scaled, and absorption corrected
using a multi-scan averaging of symmetry equivalent data using SADABS.

Structure Solution and Refinement. The structure was solved by using a dual space
methodology using the SHELXT program. All non-hydrogen atoms were obtained from
the initial solution. The hydrogen atom positions were obtained from a difference Fourier
map and were allowed to refine isotropically. The structural model was fit to the data
using full matrix least-squares based on F2. The calculated structure factors included
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corrections for anomalous dispersion from the usual tabulation. The structure was refined
using the SHELXL program from the SHELX suite of crystallographic software. Graphic
plots were produced using the NRCVAX program suite. Additional information and
other relevant literature references can be found in the reference section of this website
(http://xray.chem.uwo.ca).

Figure 26 - ORTEP drawing of b19175 showing naming and numbering scheme.
Ellipsoids are at the 50% probability level and hydrogen atoms were drawn with
arbitrary radii for clarity.

Table 20 - Summary of Crystal Data for b19175
Formula

C7H6N2O3
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Formula Weight (g/mol)

166.14

Crystal Dimensions (mm )

0.268 × 0.197 × 0.042

Crystal Color and Habit

colourless plate

Crystal System

orthorhombic

Space Group

P 21 21 21

Temperature, K

110

a, Å

4.8632(10)

b, Å

6.6115(17)

c, Å

21.884(6)

,°

90

,°

90

,°

90

V, Å3

703.6(3)

Number of reflections to determine final unit cell

5015

Min and Max 2 for cell determination, °

7.2, 56.28

Z

4

F(000)

344

 (g/cm)

1.568

, Å, (MoK)

0.71073

, (cm-1)

0.126

Diffractometer Type

Bruker Kappa Axis Apex2

Scan Type(s)

phi and omega scans

Max 2 for data collection, °

61.106

Measured fraction of data

0.999

Number of reflections measured

24066

Unique reflections measured

2150

Rmerge

0.0529

Number of reflections included in refinement

2150

Cut off Threshold Expression

I > 2sigma(I)

Structure refined using

full matrix least-squares using F2

Weighting Scheme

w=1/[sigma2(Fo2)+(0.0469P)2+0.03
27P] where P=(Fo2+2Fc2)/3
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Number of parameters in least-squares

133

R1

0.0348

wR2

0.0796

R1 (all data)

0.0472

wR2 (all data)

0.0839

GOF

1.048

Maximum shift/error

0.000

Min & Max peak heights on final F Map (e-/Å)

-0.254, 0.201

Where:
R1 = ( |Fo| - |Fc| ) /  Fo
wR2 = [ ( w( Fo2 - Fc2 )2 ) / (w Fo4 ) ]½
GOF = [ ( w( Fo2 - Fc2 )2 ) / (No. of reflns. - No. of params. ) ]½

Experimental for C17H20N2O7 (b19163)

X-ray quality crystal was grown by vapour diffusion of pentane into a saturated solution
of compound 5-10c in benzene.
Data Collection and Processing. The sample (b19163) was submitted by Lauren Irwin of
the Kerr research group at the University of Western Ontario. The sample was mounted
on a Mitegen polyimide micromount with a small amount of Paratone N oil. All X-ray
measurements were made on a Bruker Kappa Axis Apex2 diffractometer at a temperature
of 110 K. It was apparent from the initial indexing that the sample crystals were nonmerohedrally twinned (vide infra). The twin ratio was approximately 85:15 for the major
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and minor twin components respectively. The unit cell dimensions were determined from
a symmetry constrained fit of 8787 reflections with 4.76° < 2θ < 50.5°. The data
collection strategy was a number of ω and φ scans which collected data up to 50.744°
(2θ). The frame integration was performed using SAINT. The resulting raw data was
scaled and absorption corrected using a multi-scan averaging of symmetry equivalent
data using SADABS.
Structure Solution and Refinement. The structure was solved by using a dual space
methodology using the SHELXT program. All non-hydrogen atoms were obtained from
the initial solution. The hydrogen atoms were introduced at idealized positions and were
allowed to ride on the parent atom. The refinement converged with the R1 value
unsatisfactorily high. Incorporating the data from the twin domain did neither alleviated
the high R1 factor nor did it ameliorate the other symptoms of twinning (i.e. Fo2 >> Fc2
for the worst fitting reflections and a high K value for the weakest data). After
considerable investigation (see. Analysis of Twinning below), it was determined that the
best fitting model disregard the data from the twin altogether and refine the structure
against on the data from the predominant domain. The structural model was fit to the
data using full matrix least-squares based on F2. The calculated structure factors included
corrections for anomalous dispersion from the usual tabulation. The structure was refined
using the SHELXL program from the SHELX suite of crystallographic software. Graphic
plots were produced using the Mercury program. Additional information and other
relevant literature references can be found in the reference section of this website
(http://xray.chem.uwo.ca).

Analysis of Twinning. Two individual domains were successfully indexed. There were
other reflections which suggested additional domains but could not be sensibly indexed.
The twin law for the two-domain twinning model is given below:
Twin Law, Sample 1 of 1
Transforms h1.1(1)->h1.2(2)

243

0.62291 -1.61323 -0.00071
-0.37934 -0.62293 -0.00026
-0.05119

0.06100 -0.99998

As noted above, despite including the data from the second domain caused the R1 factor
to worsen rather than improve. In addition, there were still indications of twinning.
Therefore, a combination of two different types of twinning were considered, a so called
“twin of twins”. The “twin of twins” model entailed lowering the symmetry of the
structure from C 2/c to P 1 and assuming twinning by pseudo-merohedry in addition to
the non-merohedral twinning. The appropriate twin law for the pseudo-merohedral was
derived by the COSET program as a 180º rotation about the [210] which is expressed by
the following twin law:
1.00

0.00

0.00

-1.00 -1.00

0.00

0.00

0.00 -1.00

While the R1 factor improved and the symptoms of twinning were ameliorated, this
model lead to physically impossible anisotropic displacement parameters (ADPs). In
addition, running the triclinic structure through the PLATON missing symmetry routines
indicated that the structure was indeed C centred monoclinic. For these reasons, the
triclinic structural model was discounted.
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Figure 27 - ORTEP drawing of b19163 showing naming and numbering
scheme. Ellipsoids are at the 50% probability level and hydrogen atoms were
drawn with arbitrary radii for clarity.

Table 21 - Summary of Crystal Data for b19163
Formula

C17H20N2O7

Formula Weight (g/mol)

364.35

Crystal Dimensions (mm )

0.398 × 0.384 × 0.195

Crystal Color and Habit

colourless prism

Crystal System

monoclinic

Space Group

C 2/c

Temperature, K

110

a, Å

14.533(2)

b, Å

7.0474(11)

c, Å

34.203(7)

,°

90

,°

90.766(7)

,°

90
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V, Å3

3502.8(11)

Number of reflections to determine final unit cell

8787

Min and Max 2

4.76, 50.5

for cell determination, °

Z

8

F(000)

1536

(g/cm)

1.382

, Å, (MoK )

0.71073

, (cm-1)

0.108

Diffractometer Type

Bruker Kappa Axis Apex2

Scan Type(s)

phi and omega scans

Max 2

50.744

for data collection, °

Measured fraction of data

0.944

Number of reflections measured

3052

Unique reflections measured

3052

Rmerge

0.0800

Number of reflections included in refinement

3052

Cut off Threshold Expression

I > 2sigma(I)

Structure refined using

full matrix least-squares using F2

Weighting Scheme

w=1/[sigma2(Fo2)+(0.0430P)2+44.7
018P] where P=(Fo2+2Fc2)/3

Number of parameters in least-squares
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R1

0.1020

wR2

0.2263

R1 (all data)

0.1159

wR2 (all data)

0.2322

GOF

1.179

Maximum shift/error

0.000

Min & Max peak heights on final
Where:
R1 =  ( |Fo| - |Fc| ) / Fo
wR2 = [ ( w( Fo2 - Fc2 )2 ) /

F Map (e-/Å)

(w Fo4 ) ]½

-0.367, 0.896
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GOF = [ ( w( Fo2 - Fc2 )2 ) / (No. of reflns. - No. of params. ) ]½

Experimental for C17H20N2O7 (b19193)

X-ray quality crystal was grown by vapour diffusion of pentane into a
saturated solution of compound 5-11c-cis in benzene.
Data Collection and Processing. The sample (b19193) was submitted
by Lauren Irwin of the Kerr research group at the University of Western Ontario. The
sample was mounted on a Mitegen polyimide micromount with a small amount of
Paratone N oil. All X-ray measurements were made on a Bruker Kappa Axis Apex2
diffractometer at a temperature of 110 K. It was apparent from the initial indexing that
the crystal was non-merohedrally twinned. The diffraction pattern was indexed to two
different unit cells and the an approximate twin law was derived. The unit cell
dimensions were determined from a symmetry constrained fit of 9820 reflections with
4.66° < 2θ < 65.04°. The data collection strategy was a number of ω and φ scans which
collected data up to 65.248° (2θ). The frame integration was performed using SAINT.
The resulting raw data was scaled and absorption corrected using a multi-scan averaging
of symmetry equivalent data using TWINABS.

Structure Solution and Refinement. The structure was solved by using a dual space
methodology using the SHELXT program. All non-hydrogen atoms were obtained from
the initial solution. The asymmetric unit contains two symmetry independent molecules
which were designated by the suffixes A and B in naming and numbering scheme. The
hydrogen atoms were introduced at idealized positions and were allowed to refine
isotropically.
Analysis of Twinning. The data were integrated as two component twin where the two
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individuals were related by an approximate 180º rotation about the [100]. An analysis of
the twinning is given below:
===============================================================
===============
Solution number : 1
--------------------New Cell: a=10.6658 b=10.8239 c=17.2378 alpha=99.296 beta=92.069 gamma=115.950

Figure of Merit (0=ideal)

: 0.03

Rotation angle (degrees)

:-179.996

Rotation vector (laboratory)

: 0.9047 -0.3437 0.2518

Rotation vector (reciprocal cell) : -2.00
Rotation vector (direct cell)

Superposition matrix

: -1.00

1.00

0.00

0.06 -0.02

: H' = +0.939 * H -0.122 * K +0.030 * L
K' = -0.969 * H -0.939 * K -0.015 * L
L' = -0.002 * H

-1.000 * L

===============================================================
===============
During the structure refinement the twin fraction of the minor component refined to a
value of 0.2179(4).
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The structural model was fit to the data using full matrix least-squares based on F2. The
calculated structure factors included corrections for anomalous dispersion from the usual
tabulation. The structure was refined using the SHELXL program from the SHELX suite
of crystallographic software. Graphic plots were produced using the NRCVAX program
suite. Additional information and other relevant literature references can be found in the
reference section of this website (http://xray.chem.uwo.ca).

Figure 28 - ORTEP drawing of b19193 showing naming and numbering scheme.
Ellipsoids are at the 50% probability level and hydrogen atoms were drawn with
arbitrary radii for clarity.
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Table 22 - Summary of Crystal Data for b19193
Formula

C17H20N2O7

Formula Weight (g/mol)

364.35

Crystal Dimensions (mm )

0.468 × 0.251 × 0.134

Crystal Color and Habit

colourless prism

Crystal System

triclinic

Space Group

P -1

Temperature, K

110

a, Å

10.6658(14)

b, Å

10.8239(18)

c, Å

17.238(3)

,°

99.296(4)

,°

92.069(6)

,°

115.950(7)

V, Å3

1753.0(5)

Number of reflections to determine final unit cell

9820

Min and Max 2 for cell determination, °

4.66, 65.04

Z

4

F(000)

768

 (g/cm)

1.380

, Å, (MoK)

0.71073

, (cm-1)

0.108

Diffractometer Type

Bruker Kappa Axis Apex2

Scan Type(s)

phi and omega scans

Max 2 for data collection, °

65.248

Measured fraction of data

0.999

Number of reflections measured

41111

Unique reflections measured

41111

Rmerge

?

Number of reflections included in refinement

41111

Cut off Threshold Expression

I > 2sigma(I)

Structure refined using

full matrix least-squares using F2
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Weighting Scheme

w=1/[sigma2(Fo2)+(0.0615P)2+0.15
47P] where P=(Fo2+2Fc2)/3

Number of parameters in least-squares

630

R1

0.0439

wR2

0.1115

R1 (all data)

0.0620

wR2 (all data)

0.1223

GOF

1.037

Maximum shift/error

0.001

Min & Max peak heights on final F Map (e-/Å)

-0.286, 0.425

Where:
R1 = ( |Fo| - |Fc| ) /  Fo
wR2 = [ ( w( Fo2 - Fc2 )2 ) / (w Fo4 ) ]½
GOF = [ ( w( Fo2 - Fc2 )2 ) / (No. of reflns. - No. of params. ) ]½

Experimental for C21H20N2O7 (b19192)

X-ray quality crystal was grown by slow vapour diffusion of pentane into a saturated
solution of compound 5-10m in benzene.
Data Collection and Processing. The sample (b19192) was submitted by Lauren Irwin of
the Kerr research group at the University of Western Ontario. The sample was mounted
on a Mitegen polyimide micromount with a small amount of Paratone N oil. All X-ray
measurements were made on a Bruker Kappa Axis Apex2 diffractometer at a temperature
of 110 K. The unit cell dimensions were determined from a symmetry constrained fit of
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6805 reflections with 4.9° < 2θ < 50.28°. The data collection strategy was a number of ω
and φ scans which collected data up to 50.462° (2θ). The frame integration was
performed using SAINT. The resulting raw data was scaled, and absorption corrected
using a multi-scan averaging of symmetry equivalent data using SADABS.

Structure Solution and Refinement. The structure was solved by using a dual space
methodology using the SHELXT program. All non-hydrogen atoms were obtained from
the initial solution. The hydrogen atoms were introduced at idealized positions and were
allowed to refine isotropically. The structural model was fit to the data using full matrix
least-squares based on F2. The calculated structure factors included corrections for
anomalous dispersion from the usual tabulation. The structure was refined using the
SHELXL program from the SHELX suite of crystallographic software. Graphic plots
were produced using the NRCVAX program suite. Additional information and other
relevant literature references can be found in the reference section of this website
(http://xray.chem.uwo.ca).
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Figure 29 - ORTEP drawing of b19192 showing naming and numbering scheme.
Ellipsoids are at the 50% probability level and hydrogen atoms were drawn with
arbitrary radii for clarity.

Table 23 - Summary of Crystal Data for b19192
Formula

C21H20N2O7

Formula Weight (g/mol)

412.39

Crystal Dimensions (mm )

0.127 × 0.096 × 0.052

Crystal Color and Habit

colourless rectangular

Crystal System

monoclinic

Space Group

P 21/c

Temperature, K

110

a, Å

17.717(12)

b, Å

8.628(6)

c, Å

13.831(8)

,°

90
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,°

110.043(11)

,°

90

V, Å3

1986(2)

Number of reflections to determine final unit cell

6805

Min and Max 2 for cell determination, °

4.9, 50.28

Z

4

F(000)

864

 (g/cm)

1.379

, Å, (MoK)

0.71073

, (cm-1)

0.105

Diffractometer Type

Bruker Kappa Axis Apex2

Scan Type(s)

phi and omega scans

Max 2 for data collection, °

50.462

Measured fraction of data

0.999

Number of reflections measured

32877

Unique reflections measured

3596

Rmerge

0.0808

Number of reflections included in refinement

3596

Cut off Threshold Expression

I > 2sigma(I)

Structure refined using

full matrix least-squares using F2

Weighting Scheme

w=1/[sigma2(Fo2)+(0.0339P)2+0.77
22P] where P=(Fo2+2Fc2)/3

Number of parameters in least-squares
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R1

0.0392

wR2

0.0778

R1 (all data)

0.0752

wR2 (all data)

0.0919

GOF

1.011

Maximum shift/error

0.000

Min & Max peak heights on final F Map (e-/Å)

-0.220, 0.210

Where:
R1 = ( |Fo| - |Fc| ) /  Fo
wR2 = [ ( w( Fo2 - Fc2 )2 ) / (w Fo4 ) ]½
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GOF = [ ( w( Fo2 - Fc2 )2 ) / (No. of reflns. - No. of params. ) ]½

Experimental for C21H20N2O7 (b19156)
X-ray quality crystal grown by slow vapour diffusion of pentane
into a saturated solution of 5-11e-trans in benzene.
Data Collection and Processing. The sample (b19156) was
submitted by Lauren Irwin of the Kerr research group at the
University of Western Ontario. The sample was mounted on a Mitegen polyimide
micromount with a small amount of Paratone N oil. All X-ray measurements were made
on a Bruker Kappa Axis Apex2 diffractometer at a temperature of 110 K. The unit cell
dimensions were determined from a symmetry constrained fit of 9959 reflections with
4.48° < 2

< 59.98°. The data collection strategy was a number of

and

scans which

collected data up to 62.396° (2 ). The frame integration was performed using SAINT.
The resulting raw data was scaled and absorption corrected using a multi-scan averaging
of symmetry equivalent data using SADABS.

Structure Solution and Refinement. The structure was solved by using a dual space
methodology using the SHELXT program. All non-hydrogen atoms were obtained from
the initial solution. The hydrogen atoms were introduced at idealized positions and were
allowed to refine isotropically. The structural model was fit to the data using full matrix
least-squares based on F2. The calculated structure factors included corrections for
anomalous dispersion from the usual tabulation. The structure was refined using the
SHELXL program from the SHELX suite of crystallographic software. Graphic plots
were produced using the NRCVAX program suite. Additional information and other
relevant literature references can be found in the reference section of this website
(http://xray.chem.uwo.ca).
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Figure 30 - ORTEP drawing of b19156 showing naming and numbering scheme.
Ellipsoids are at the 50% probability level and hydrogen atoms were drawn with
arbitrary radii for clarity.

Table 24 - Summary of Crystal Data for b19156
Formula

C21H20N2O7

Formula Weight (g/mol)

412.39

Crystal Dimensions (mm )

0.289 × 0.271 × 0.079

Crystal Color and Habit

colourless prism

Crystal System

monoclinic

Space Group

P 21/c

Temperature, K

110

a, Å

11.544(4)

b, Å

18.172(7)

c, Å

9.560(3)

,°

90

256

,°

105.803(12)

,°

90

V, Å3

1929.6(11)

Number of reflections to determine final unit cell

9959

Min and Max 2 for cell determination, °

4.48, 59.98

Z

4

F(000)

864

 (g/cm)

1.420

, Å, (MoK)

0.71073

, (cm-1)

0.108

Diffractometer Type

Bruker Kappa Axis Apex2

Scan Type(s)

phi and omega scans

Max 2 for data collection, °

62.396

Measured fraction of data

0.999

Number of reflections measured

71853

Unique reflections measured

6182

Rmerge

0.0657

Number of reflections included in refinement

6182

Cut off Threshold Expression

I > 2sigma(I)

Structure refined using

full matrix least-squares using F2

Weighting Scheme

w=1/[sigma2(Fo2)+(0.0445P)2+0.55
72P] where P=(Fo2+2Fc2)/3

Number of parameters in least-squares
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R1

0.0422

wR2

0.0909

R1 (all data)

0.0774

wR2 (all data)

0.1056

GOF

1.014

Maximum shift/error

0.000

Min & Max peak heights on final F Map (e-/Å)

-0.280, 0.330

Where:
R1 = ( |Fo| - |Fc| ) /  Fo
wR2 = [ ( w( Fo2 - Fc2 )2 ) / (w Fo4 ) ]½
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GOF = [ ( w( Fo2 - Fc2 )2 ) / (No. of reflns. - No. of params. ) ]½
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Chapter 6
6.0 Summary,Conclusions and Future Directions of
Projects Discussed
6.1 Future Directions
Future directions for the projects in this dissertation are discussed in detail at the end of
their respective chapters. This was to ensure that the future directions followed the story
the reader had just completed, and because many of these projects, while they share a
common link of indoles and cyclopropanes, they could be taken to new projects on their
own. It seemed in the best interest of comprehension to put future experimental planning
before the experimental details of each chapter.

6.2 Chapter Summaries and Conclusions
The research disclosed in the antecedent sections aimed to expand chemical
transformations of indole heterocycles. The research generated novel reactivity and
further functionalized indoles to access value-added products while aiding the pursuit of
the first total syntheses of tronocarpine and dippinine B. While the complete total
syntheses were not realized, valuable chemistry was discovered, and road blocks were
identified that future chemists can hopefully overcome.
Chapter 2 disclosed the first use of hydrogen-bonding interactions as a metal-free
alternative for the opening of donor-acceptor cyclopropanes. Opened using indole
nucleophiles in a medium of HFIP, a variety of 3-position functionalized indole products
were generated both from diester and hemi-malonate cyclopropanes (Scheme 110).
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Scheme 110 - Graphical summary of the work in Chapter 2. Novel hydrogen-bond
interaction activating DA-CPs.
This work is the first to demonstrate how donor-acceptor cyclopropanes can be opened
with indole nucleophiles without the use of Lewis acids or under high-pressure reaction
conditions. It expands on how indoles can be functionalized to value-added products
because all substituent patterns tested worked, and both malonate and hemi-malonate
cyclopropanes access the products under these neutral conditions. This work will pioneer
access to other annulation and elaborated products without the need for dangerous highpressure equipment and expensive Lewis acid catalysts.
Chapter 3 reports a one-pot procedure for the generation of tricyclic indole containing
molecules. The 1,2-substituted indole product map well to the scaffold and functional
handles required to access natural products tronocarpine and dippinine B. Using a single
electron oxidant, Mn(OAc)3 generates radicals of malonyl tethers resultant of a Michael
addition with acryloyl indoles. 10 different products were generated in modest yields
including a product which has all required carbons for the natural products sought
(Scheme 111).

Scheme 111 - Graphical summary of the work in Chapter 3. One-pot Michael
addition and cyclization of indoles.
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This procedure outlined is exceptional for creating highly substituted indole scaffolds
which map onto many different natural products. These natural products are desirable for
future pharmaceuticals and drug discovery purposes, and this methodology will easily
generate unique products en route to developing syntheses to natural product targets. This
work also gave me the opportunity to perfect a method of reproducibly acquiring
Mn(OAc)3, a reagent that is known to have quality issues when purchased, even if from
the same source. My procedure developed should be helpful to future chemists wanting to
use Mn(OAc)3 as a SET agent in their own chemistry, and give them the highest yields
possible.
Chapter 4 is tough to summarize concisely. The work reported outlines a variety of
strategies towards the first syntheses of indole alkaloids tronocarpine and dippinine B.
Major intermediates containing all the necessary atoms for the natural products were
generated but were not successfully taken to the final products. The chemistry indicated
the difficulty of employing either, a Dieckmann cyclization, or aldol ring-closing reaction
to form ring E of both natural products (Scheme 112). Conclusions are drawn that a
substrate resembling 6-1, where the difficult ring E is synthesized as a separate
component, could later join the tryptamine portion of the natural products. The work
discovered many different road-blocks that provide valuable knowledge for how to
overcome these unforeseen obstacles. The routes developed provide insight for how to
change the chemistry in the future and avoid the ring-closing difficulties discovered. A
new a successful route to synthesize dippinine B and tronocarpine can be built in future
based on the difficulties discussed in Chapter 4.
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Scheme 112 - Graphical represention of the work outlined in Chapter 4. Progress
and major intermediates towards the synthesis of tronocarpine and dippinine B.
Chapter 5 summarizes the synthesis of novel oxime-ether containing DA CPs that
rearrange in the presence of Yb(OTf)3 to access selectively, the cis or trans bicyclic
hydropyrollooxazine products (6-2cis/trans). The diastereomer of the product obtained is
controlled by the reaction temperature, with higher temperatures yielding the cis
annulation product. The oxazines can be taken to their respective diastereo-retained
pyrrolidines.

Scheme 113 - Graphical representation of the work completed in Chapter 5.
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This work impressively accessed novel oxime-ether donor-acceptor cyclopropanes in
only two steps. They were determined to generate tetrahydropyrrolo-oxazines in high
yield and with diastereomeric control, making this an interesting and effective reaction.
The operating chemist can use simple temperature changes in the reaction to access the
correct diastereomers of the annulated products. These products can then be pushed
forward to synthesize desirable pyrrolidine natural products or drug candidates. This
work will be valuable in the future to try and synthesize natural products like preussin C.
The research conducted and reported in this thesis outlines successful improvements and
progress modifying indole heterocycles to access valuable products and doing so in novel
ways.
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Appendices – Spectral Data for Selected Compounds in
Chapters 2-5
Chapter 2 1H, 19F and 13C NMR Spectra
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Organic Chemistry, Progress Towards the Total Synthesis of Tronocarpine Awarded
third place. 2016.
2016 Halifax, Nova Scotia, Canada. 99th Canadian Society for Chemistry
Conference and Exhibition, Synthetic Strategies Towards the Total Synthesis of
Tronocarpine. 2016.
2015 University of Toronto Mississauga, Southern Ontario Undergraduate Student
Chemistry Conference, Tandem Michael-Addition, C-H Insertions of N-Acryloyl
Indoles. Second Place in Organic Chemistry. 2015.
2014 University of Western Ontario Internship Day. Work and Research Experiences
at Lanxess Inc. International Butyl Rubber Business Unit R&D. 2014.
2013 Irwin, L.C.; Vriesen, M. R. 2013 Analytical Poster Presentation Day,
University of Western Ontario. The potential of matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry for the identification of biogroups
of Cronobacter sakazaki. (Based on the following research paper: Karamanova et. al:
Rapid Commun. Mass Spectrom. 2013, 27 (3), 409-418). Awarded 1st place.

D. Awards/Scholarships
2019

Poster prize for organic chemistry at the 102nd CCCE; $100

2018-2020

NSERC Post Graduate Scholarship – Doctoral; $21,000

2018-2019

Ontario Graduate Scholarship; $15,000 (declined)

2017-2018

Nominated for a Graduate Student Teaching Award; $500

2017-2018
$15,000

Queen Elizabeth II Graduate Scholarship in Science and Technology;

2016-2017

Western Doctoral Scholarship; $8,000

2016

Second Place Oral Presentation at Quebec Ontario Mini-Symposium for

Bioorganic and Organic Chemistry, $50
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2015 - 2016
$15,000

Queen Elizabeth II Graduate Scholarship in Science and Technology;

2015

Second Place Oral Presentation at Southern Ontario Undergraduate

Student Chemistry Conference, $150
2011-2015

Deans Honour Roll, University of Western Ontario

E. Technical Reports
1. Gilles Arsenault, Lauren Irwin, Sharon Guo. (2013). Butyl Rubber Aging Processes. Title has been modified due to Non-Disclosure Agreement Conflict. Number of
Contributors: 3
F. Volunteer Work
2019

Pint of Science London: managed the coordination of speakers, advertisements

and event activities for the May 22nd evening of the event.
2017-2018

Science Rendezvous: Designed, prepared and executed the Chemistry

with a Bang show for the finale of Science Rendezvous events. Worked in the chemistry
booth showcases chemical reactions to budding young scientists.
2015-2018

Western Chemistry Outreach Activities: Chemical preparations and

equipment organization for the “Chemistry with a Bang” shows for incoming first year
students, and elementary school visitors

